LC4-1::Linsitinib
C32::I-BET-762
EW-18::Lapatinib
IGR-1::Linsitinib
SK-MEL-5::Palbociclib
P31-FUJ::Palbociclib
NCI-H1975::PFI-1
NB17::I-BET-762
CAL-12T::I-BET-762
SW756::PFI-1
SCC-25::I-BET-762
HCC1937::AZD6482
KYSE-520::RVX-208
U031::Osimertinib
OV-17R::Sorafenib
C-33-A::RVX-208
LU-139::PFI-1
RPMI-6666::PFI-1
REH::VE-822
SN12C::Palbociclib
SK-MEL-3::IOX2
NCI-H727::PRT062607
NB14::I-BET-762
OE19::PRT062607
JHU-022::Osimertinib
THP-1::Palbociclib
SK-MES-1::Lapatinib
NCI-H1944::Ibrutinib
HOS::Linsitinib
KINGS-1::Temozolomide
WSU-NHL::Linsitinib
NCI-H211::Sorafenib
KY821::RVX-208
BEN::VE-822
PANC-10-05::Doramapimod
NCI-H292::RVX-208
EMC-BAC-1::I-BET-762
COLO-679::PRT062607
NCI-H1155::Osimertinib
NCI-H2291::Sorafenib
HOP-62::RVX-208
UACC-257::RVX-208
ONS-76::Lapatinib
MKN7::PFI-1
NCI-H835::Avagacestat
TE-12::SL0101
SNU-449::I-BET-762
HSC-4::Osimertinib
SUP-T1::Linsitinib
OAW-28::Sorafenib
ECC12::VE-822
KARPAS-1106P::Ibrutinib
SCC-15::Lapatinib
L-428::RVX-208
PA-1::Ibrutinib
KNS-81-FD::Dactolisib
NCI-H716::Lapatinib
KU812::Temozolomide
HCC1395::Palbociclib
HuH-7::RVX-208
NCCIT::Doramapimod
A673::Palbociclib
NCI-H69::PFI-1
HCC-827::Dactolisib
HEL::Temozolomide
ECC12::Doramapimod
HCC1143::Temozolomide
OVMIU::Lapatinib
SW1710::VE-822
Daudi::Avagacestat
K2::RVX-208
CHP-212::Sorafenib
LB771-HNC::Avagacestat
JHH-2::PRT062607
CHSA8926::Avagacestat
TE-1::I-BET-762
BT-474::Avagacestat
CHSA0011::PRT062607
LB1047-RCC::PRT062607
K5::Temozolomide
PCI-15A::IOX2
EFM-192A::Avagacestat
NCI-H2110::Ibrutinib
SK-MEL-5::Avagacestat
MDA-MB-453::Dactolisib
RPMI-8402::Lapatinib
NCI-H441::VE-822
RCC-AB::PRT062607
PANC-03-27::Palbociclib
KYSE-410::PFI-1
HCC1806::Palbociclib
ESS-1::Ibrutinib
HuO-3N1::Sorafenib
MEG-01::VE-822
DB::Ibrutinib
HT-1080::Ibrutinib
HT-1197::I-BET-762
COR-L279::Avagacestat
KYSE-450::Linsitinib
DB::Sorafenib
COR-L95::PFI-1
LU-65::Dactolisib
EMC-BAC-2::Osimertinib
JHU-029::Linsitinib
HCC1428::VE-822
NCI-H3122::Doramapimod
KARPAS-620::Doramapimod
SAT::RVX-208
ABC-1::VE-822
HO-1-N-1::Palbociclib
SW620::AZD6482
RERF-GC-1B::Sorafenib
LB647-SCLC::Doramapimod
SK-MEL-3::Palbociclib
PWR-1E::Lapatinib
NCI-H835::Dactolisib
BPH-1::Palbociclib
MEL-HO::RVX-208
SCC-4::I-BET-762
U-118-MG::Linsitinib
NCC010::AZD6482
CAPAN-1::Ibrutinib
UMC-11::Lapatinib
NCI-H1563::Sorafenib
STS-0421::Osimertinib
KU812::PFI-1
NCI-H1666::Ibrutinib
EMC-BAC-2::Temozolomide
KU812::Lapatinib
D-336MG::Temozolomide
MHH-PREB-1::PRT062607
G-MEL::Avagacestat
KARPAS-45::Doramapimod
KY821::Dactolisib
SW780::Palbociclib
VMRC-LCD::Osimertinib
TK::Lapatinib
KARPAS-620::PRT062607
GI-1::Linsitinib
LU-135::Osimertinib
BB49-HNC::Ibrutinib
CGTH-W-1::Avagacestat
KP-1N::Doramapimod
A427::Dactolisib
Calu-6::PFI-1
SUP-B15::Ibrutinib
LAMA-84::Ibrutinib
DEL::Avagacestat
IM-9::Osimertinib
IGR-37::Osimertinib
MEL-JUSO::Sorafenib
HCC1569::Temozolomide
D-502MG::RVX-208
SW1783::Linsitinib
SNB75::AZD6482
SW626::Linsitinib
RCH-ACV::Dactolisib
IGR-1::VE-822
TT::Linsitinib
OC-314::Avagacestat
GCIY::RVX-208
JJN-3::Osimertinib
JM1::I-BET-762
EFO-27::AZD6482
KOPN-8::Doramapimod
LS-513::VE-822
KNS-62::Palbociclib
BALL-1::Dactolisib
SKG-IIIa::PRT062607
MOLP-8::Doramapimod
CaR-1::Temozolomide
SUIT-2::RVX-208
KARPAS-1106P::VE-822
SLVL::PRT062607
SK-OV-3::Osimertinib
CAL-12T::IOX2
PCI-6A::Ibrutinib
UACC-62::Lapatinib
CAKI-1::AZD6482
IST-MES1::I-BET-762
SIG-M5::Osimertinib
JHH-4::Lapatinib
LC-1-sq::I-BET-762
NCI-H1963::VE-822
KURAMOCHI::PFI-1
A388::I-BET-762
ES7::Osimertinib
LB2241-RCC::AZD6482
L-540::Palbociclib
COLO-792::I-BET-762
OCI-LY-19::VE-822
MS-1::Ibrutinib
EB2::PFI-1
OE21::PRT062607
DND-41::PRT062607
JHH-2::I-BET-762
EJM::PRT062607
KYSE-520::Linsitinib
NCI-H1944::Avagacestat
HT-1080::PRT062607
DOK::VE-822
SU-DHL-4::RVX-208
KY821::Temozolomide
MPP-89::Temozolomide
NB13::Palbociclib
JEKO-1::SL0101
OC-314::Osimertinib
GI-ME-N::Doramapimod
ES4::I-BET-762
KE-37::PFI-1
OCI-LY-19::Ibrutinib
KYSE-180::PFI-1
D-566MG::Doramapimod
COR-L88::Lapatinib
MDA-MB-468::RVX-208
JHH-4::VE-822
HCC70::I-BET-762
SK-MES-1::Temozolomide
C3A::Ibrutinib
451Lu::VE-822
PFSK-1::Temozolomide
CTB-1::Doramapimod
NCI-H847::Sorafenib
SW13::Lapatinib
KP-N-YN::Lapatinib
MIA-PaCa-2::I-BET-762
NCI-H2291::Palbociclib
G-MEL::Sorafenib
HCC-78::PFI-1
ECC10::Ibrutinib
SW872::I-BET-762
CAL-72::PFI-1
FTC-133::I-BET-762
NCI-H1568::Osimertinib
CW-2::Doramapimod
SLVL::Osimertinib
HCC1954::Doramapimod
TGBC11TKB::Dactolisib
FLO-1::Temozolomide
NCI-H1623::Lapatinib
LU-99A::Dactolisib
HCC1599::Dactolisib
NALM-6::Ibrutinib
LB996-RCC::Avagacestat
RT-112::Sorafenib
DMS-53::RVX-208
GI-1::PFI-1
SUP-T1::Palbociclib
SK-LMS-1::Linsitinib
SK-HEP-1::Ibrutinib
A101D::Avagacestat
NCI-H847::Osimertinib
HH::Dactolisib
A3-KAW::Palbociclib
NCI-H1355::Dactolisib
BICR31::Palbociclib
HCC1395::PFI-1
NCI-H1963::Avagacestat
SNG-M::Dactolisib
T84::PFI-1
LOXIMVI::Ibrutinib
NCI-H1155::Sorafenib
NCI-H2444::PFI-1
TOV-112D::Lapatinib
LC4-1::Avagacestat
NCI-H1623::I-BET-762
NCI-H727::Dactolisib
NB7::Dactolisib
SK-MEL-24::Lapatinib
CAL-85-1::Palbociclib
NCI-H1836::Avagacestat
CHL-1::RVX-208
SISO::PRT062607
JHH-2::VE-822
A204::Linsitinib
EC-GI-10::RVX-208
HT-115::RVX-208
BB30-HNC::Dactolisib
SW1573::VE-822
BV-173::Linsitinib
LCLC-97TM1::RVX-208
NCI-H1694::PFI-1
PANC-04-03::Osimertinib
NCI-H1648::Linsitinib
A375::PFI-1
BV-173::Sorafenib
SLVL::I-BET-762
T84::Temozolomide
NCI-H1793::Doramapimod
NCI-H520::Palbociclib
MOLP-8::Ibrutinib
A427::Temozolomide
CHSA0011::Doramapimod
CGTH-W-1::Palbociclib
8505C::Ibrutinib
NCI-H929::VE-822
ES5::Sorafenib
NB1::Linsitinib
OV-90::Osimertinib
SUP-HD1::PRT062607
WM1552C::Ibrutinib
D-542MG::Osimertinib
COR-L23::Doramapimod
CAL-148::Doramapimod
LS-1034::Dactolisib
Raji::Doramapimod
NCI-H1563::Osimertinib
RS4-11::Linsitinib
DMS-53::I-BET-762
SNU-423::Palbociclib
ECC12::SL0101
SU-DHL-6::PFI-1
SCC-25::SL0101
C-4-I::Ibrutinib
LNCaP-Clone-FGC::Osimertinib
RL95-2::PFI-1
ES8::PRT062607
COLO-800::VE-822
SF539::I-BET-762
MC116::Lapatinib
EW-18::I-BET-762
OVCAR-3::Linsitinib
IPC-298::Osimertinib
SW1710::Temozolomide
ALL-PO::Linsitinib
CPC-N::Ibrutinib
LU-165::Doramapimod
RPMI-6666::Osimertinib
KNS-62::Doramapimod
DND-41::RVX-208
ECC10::Doramapimod
KALS-1::VE-822
DEL::Osimertinib
EJM::PFI-1
CHSA0011::IOX2
A704::Temozolomide
NCI-H1963::PRT062607
DJM-1::Doramapimod
KY821::Sorafenib
HCC1428::AZD6482
EoL-1-cell::PRT062607
SK-MEL-5::Osimertinib
PANC-02-03::Sorafenib
LC-1-sq::Ibrutinib
KYSE-70::Avagacestat
L-363::Sorafenib
QIMR-WIL::PRT062607
TYK-nu::Osimertinib
Caov-4::Linsitinib
BV-173::Osimertinib
NB14::Avagacestat
ESO26::Temozolomide
UACC-257::PFI-1
SNU-398::VE-822
RPMI-7951::Osimertinib
Saos-2::PFI-1
D-566MG::Temozolomide
NCI-H2052::I-BET-762
COLO-829::I-BET-762
LU-134-A::AZD6482
NCI-H1563::Lapatinib
EVSA-T::PRT062607
huH-1::Linsitinib
HCT-116::Palbociclib
NCI-H1563::Avagacestat
KARPAS-422::Avagacestat
WSU-NHL::Palbociclib
COLO-800::IOX2
ChaGo-K-1::VE-822
NCI-H838::Doramapimod
L-540::RVX-208
NCI-H740::IOX2
EW-12::Sorafenib
EW-13::Dactolisib
IM-9::Sorafenib
NB17::AZD6482
NCI-H1436::SL0101
C-33-A::Avagacestat
SK-N-SH::Linsitinib
NCI-H748::Linsitinib
NCI-H2291::SL0101
HCC-78::Lapatinib
KYM-1::Sorafenib
Hs-445::Linsitinib
A2058::Dactolisib
ES1::Temozolomide
NCI-H250::Temozolomide
NCI-H28::Palbociclib
LB373-MEL-D::Osimertinib
KP-2::Lapatinib
Mo-T::RVX-208
JHH-1::Dactolisib
SK-GT-2::Sorafenib
NB5::I-BET-762
A704::VE-822
CA46::Palbociclib
MDA-MB-231::Palbociclib
KYM-1::Dactolisib
UWB1.289::Ibrutinib
NCI-H2141::Linsitinib
NCI-H661::Osimertinib
DU-4475::Linsitinib
DAN-G::Linsitinib
A673::Temozolomide
Calu-6::Sorafenib
NCI-H2228::Dactolisib
CAL-62::Sorafenib
KNS-42::PRT062607
NCI-H2110::Temozolomide
RPMI-8866::Ibrutinib
AM-38::Avagacestat
U-2-OS::Sorafenib
LoVo::Lapatinib
KURAMOCHI::PRT062607
SW1088::PFI-1
RPMI-7951::VE-822
PA-1::Palbociclib
VAL::RVX-208
HCC1419::PFI-1
DK-MG::Lapatinib
NCI-H2135::RVX-208
HSC-2::PRT062607
EW-24::Osimertinib
A427::Sorafenib
HCC2157::PRT062607
KMS-11::Sorafenib
NCI-H1651::PRT062607
NCI-H1755::Palbociclib
PC-14::PFI-1
KYSE-180::Lapatinib
COR-L321::I-BET-762
KALS-1::Osimertinib
NCI-H1993::RVX-208
ES4::Doramapimod
L-540::Lapatinib
JURL-MK1::Doramapimod
DMS-114::Doramapimod
NCI-H526::VE-822
KCL-22::Temozolomide
CP50-MEL-B::Dactolisib
BL-41::Sorafenib
Ramos-2G6-4C10::VE-822
C-33-A::Lapatinib
HCC2157::Lapatinib
EW-13::Sorafenib
EMC-BAC-1::PRT062607
HMV-II::Linsitinib
SBC-1::AZD6482
SH-4::Sorafenib
SNU-61::Ibrutinib
MV-4-11::Linsitinib
TC-71::I-BET-762
MPP-89::I-BET-762
CAL-62::Lapatinib
ABC-1::Ibrutinib
NMC-G1::Sorafenib
SW156::Osimertinib
NCI-H2087::I-BET-762
VMRC-LCD::VE-822
NCI-H2030::Linsitinib
NCI-H660::Temozolomide
RCC-ER::PFI-1
CAS-1::Osimertinib
SUP-T1::Temozolomide
NCI-H1436::I-BET-762
KMOE-2::RVX-208
NCCIT::Lapatinib
KELLY::Linsitinib
D-263MG::Lapatinib
HLE::VE-822
NCI-H929::Avagacestat
SNU-387::Dactolisib
Farage::SL0101
CAL-54::Temozolomide
JJN-3::I-BET-762
BICR31::Doramapimod
SK-MM-2::Palbociclib
NCC021::Lapatinib
T47D::Dactolisib
HCC1500::Linsitinib
CL-11::Avagacestat
DOHH-2::Avagacestat
NCI-H1876::Osimertinib
SK-MES-1::Sorafenib
IM-95::Temozolomide
T47D::VE-822
ME-180::I-BET-762
MN-60::Lapatinib
LS-180::VE-822
NCC010::Linsitinib
ASH-3::Ibrutinib
VCaP::Sorafenib
MHH-PREB-1::Sorafenib
JiyoyeP-2003::PFI-1
JHH-7::Temozolomide
NCI-H226::Doramapimod
KNS-42::SL0101
SF126::I-BET-762
P12-ICHIKAWA::Osimertinib
JEKO-1::Lapatinib
WSU-NHL::Ibrutinib
SK-MEL-31::PRT062607
ZR-75-30::Palbociclib
SK-MG-1::Temozolomide
SK-MES-1::Palbociclib
SHP-77::Palbociclib
RKN::VE-822
COLO-679::Osimertinib
SW626::RVX-208
NCC010::Dactolisib
MFH-ino::Avagacestat
RERF-LC-MS::VE-822
P32-ISH::Lapatinib
ML-1::VE-822
RPMI-8226::RVX-208
NCI-H292::PRT062607
AGS::VE-822
LN-405::Lapatinib
LU-65::Sorafenib
MFE-280::Palbociclib
Saos-2::PRT062607
NU-DUL-1::Linsitinib
KELLY::Doramapimod
CAL-12T::Lapatinib
SNG-M::VE-822
MZ1-PC::Lapatinib
NCI-H660::Sorafenib
DB::Osimertinib
NCI-H2172::RVX-208
EW-12::SL0101
LB647-SCLC::AZD6482
TE-441-T::Doramapimod
CHP-212::Lapatinib
BT-549::Doramapimod
ALL-SIL::Avagacestat
Jurkat::PRT062607
SK-MEL-2::RVX-208
LU-65::Ibrutinib
NCI-H1993::Doramapimod
RVH-421::Linsitinib
TUR::Ibrutinib
RERF-GC-1B::Temozolomide
A704::PFI-1
ECC10::Palbociclib
THP-1::Lapatinib
HuP-T4::Palbociclib
NCI-H1703::Sorafenib
HOP-92::Dactolisib
EC-GI-10::Temozolomide
HOP-92::Avagacestat
SNU-449::Dactolisib
DOV13::Temozolomide
HDLM-2::Sorafenib
YKG-1::VE-822
SNU-C2B::RVX-208
697::Palbociclib
NCI-H1299::RVX-208
DOK::PFI-1
COLO-320-HSR::Linsitinib
COLO-783::I-BET-762
MDA-MB-157::Sorafenib
RMG-I::Sorafenib
SK-N-SH::Palbociclib
SF268::Osimertinib
D-283MED::Ibrutinib
SAS::Avagacestat
MFE-319::Palbociclib
SU-DHL-16::Doramapimod
SU-DHL-16::Palbociclib
CAL-54::Linsitinib
BT-483::Dactolisib
RCM-1::Osimertinib
OV-56::Temozolomide
KGN::PFI-1
GP5d::PRT062607
NCI-H1568::Lapatinib
VA-ES-BJ::Palbociclib
COLO-680N::I-BET-762
NB69::PRT062607
FTC-133::Doramapimod
BICR31::Lapatinib
CHP-212::Palbociclib
WM1552C::Dactolisib
COLO-829::PRT062607
NCI-H1563::I-BET-762
NCI-H847::Linsitinib
SUIT-2::VE-822
T84::Sorafenib
LS-180::Dactolisib
JAR::SL0101
CAL-85-1::Doramapimod
HL-60::Doramapimod
SR::Temozolomide
LOU-NH91::Linsitinib
SK-MEL-28::RVX-208
SNU-C1::RVX-208
ESO51::Osimertinib
HAL-01::Palbociclib
PFSK-1::Sorafenib
NCI-H1436::AZD6482
BEN::Linsitinib
HCC-827::PRT062607
Calu-6::Dactolisib
JEG-3::Temozolomide
EW-13::Avagacestat
SNU-387::I-BET-762
IST-SL2::VE-822
MKN28::Avagacestat
JSC-1::PFI-1
RPMI-6666::Palbociclib
SK-MES-1::PRT062607
LAN-6::Linsitinib
PL4::PFI-1
A4-Fuk::Ibrutinib
NCI-H1355::PRT062607
U031::PFI-1
MOLM-16::Temozolomide
NEC8::Dactolisib
697::Sorafenib
RCC-FG2::Avagacestat
LXF-289::Palbociclib
NCI-H1563::Temozolomide
HOS::VE-822
NCI-N87::VE-822
RERF-LC-MS::Ibrutinib
Hs-578-T::Palbociclib
RT-112::Lapatinib
DB::PRT062607
JHOS-3::PRT062607
MFE-296::Avagacestat
SCH::SL0101
NCI-H1623::Osimertinib
KE-37::Avagacestat
KYSE-510::Linsitinib
SK-LU-1::PRT062607
HuO9::Avagacestat
SW1710::Doramapimod
no-11::PRT062607
HTC-C3::Lapatinib
HOP-92::I-BET-762
CHP-134::Temozolomide
RPMI-8866::Avagacestat
AsPC-1::VE-822
MOG-G-CCM::PFI-1
ES5::SL0101
23132-87::Ibrutinib
YAPC::Lapatinib
BFTC-905::Doramapimod
MDA-MB-453::RVX-208
U-698-M::Doramapimod
MS-1::Osimertinib
ABC-1::Linsitinib
MG-63::PFI-1
MDA-MB-415::PFI-1
RERF-LC-Sq1::Ibrutinib
A4-Fuk::I-BET-762
ROS-50::Sorafenib
EMC-BAC-2::I-BET-762
NCI-H647::Sorafenib
EW-13::Lapatinib
ES7::Temozolomide
COLO-680N::Linsitinib
TE-5::I-BET-762
SU8686::Lapatinib
SK-LMS-1::PRT062607
OVCAR-4::RVX-208
JHU-011::AZD6482
SW13::Palbociclib
HuP-T3::Doramapimod
JHOS-4::PRT062607
MC116::PFI-1
SNU-81::Avagacestat
KP-2::PRT062607
ES5::Ibrutinib
DMS-273::Sorafenib
D-336MG::Avagacestat
ONS-76::PFI-1
LAMA-84::Avagacestat
LB373-MEL-D::RVX-208
H-EMC-SS::Osimertinib
RH-1::Palbociclib
MZ7-mel::SL0101
CPC-N::RVX-208
SUIT-2::Temozolomide
DU-145::Doramapimod
LB831-BLC::PRT062607
K-562::Temozolomide
PCI-15A::RVX-208
LC-2-ad::Osimertinib
TCCSUP::Lapatinib
REH::Linsitinib
COLO-792::PRT062607
LS-1034::Linsitinib
NCI-H510A::Linsitinib
SW1417::Lapatinib
SAS::Linsitinib
ARH-77::Linsitinib
SNU-61::PFI-1
SW620::VE-822
SW156::Lapatinib
COR-L279::Linsitinib
RKO::Doramapimod
SK-MM-2::PRT062607
HCT-116::I-BET-762
EVSA-T::Sorafenib
TE-1::Palbociclib
MDA-MB-453::Avagacestat
KINGS-1::PFI-1
HC-1::Doramapimod
A253::PFI-1
HCE-4::Lapatinib
NCI-H23::PFI-1
NCI-H2023::Palbociclib
L-428::PFI-1
NCI-H1092::Osimertinib
GAMG::I-BET-762
NCI-H196::Osimertinib
SK-MEL-3::AZD6482
EB-3::VE-822
OV-17R::PRT062607
SW948::I-BET-762
NCI-H2110::Lapatinib
DU-145::Sorafenib
BFTC-905::Palbociclib
SAT::Palbociclib
SW837::Avagacestat
NCI-H2110::Osimertinib
D-392MG::Doramapimod
ECC10::PFI-1
SJSA-1::Lapatinib
CPC-N::Doramapimod
KMRC-20::Temozolomide
LU-134-A::PFI-1
OSC-19::PFI-1
MC116::Linsitinib
COR-L321::RVX-208
GP5d::Lapatinib
SUP-M2::Linsitinib
HCE-4::PRT062607
SUP-B8::Linsitinib
ChaGo-K-1::Dactolisib
LS-411N::Avagacestat
NCI-H250::Linsitinib
SW1116::Ibrutinib
SK-N-FI::Dactolisib
WSU-NHL::PRT062607
BICR78::PRT062607
769-P::VE-822
MDA-MB-436::VE-822
SK-N-AS::Lapatinib
MPP-89::PFI-1
ONS-76::Avagacestat
OS-RC-2::Ibrutinib
NCI-H1694::Avagacestat
ACHN::Sorafenib
L-540::Linsitinib
CHSA0108::Doramapimod
SF539::Palbociclib
CAKI-1::PFI-1
A101D::Ibrutinib
KELLY::PRT062607
NCI-H520::Temozolomide
639-V::Sorafenib
SK-GT-4::Osimertinib
CAL-62::Ibrutinib
SW48::VE-822
BC-1::PRT062607
MHH-NB-11::Lapatinib
CHSA0108::Avagacestat
CAL-12T::RVX-208
SK-GT-4::Temozolomide
RCC-ER::VE-822
U-118-MG::Temozolomide
SNU-423::Avagacestat
RERF-LC-MS::Avagacestat
G-401::PFI-1
COLO-783::Temozolomide
CHSA0011::AZD6482
OVISE::Sorafenib
MG-63::Temozolomide
SAS::Ibrutinib
TE-15::Palbociclib
EoL-1-cell::Sorafenib
Mewo::Palbociclib
KCL-22::Avagacestat
OVTOKO::Osimertinib
23132-87::VE-822
PL-21::SL0101
SW780::VE-822
HCE-4::Palbociclib
BB65-RCC::Lapatinib
CAL-39::Palbociclib
ABC-1::I-BET-762
SK-LMS-1::RVX-208
RC-K8::PRT062607
SW1990::Dactolisib
NCI-H2110::Avagacestat
STS-0421::Temozolomide
Raji::Palbociclib
DU-145::Osimertinib
NCI-H2196::SL0101
NCI-H250::VE-822
C-4-I::Linsitinib
Farage::PRT062607
NCI-H1648::Avagacestat
SNG-M::I-BET-762
HCC1937::RVX-208
GP5d::Avagacestat
UWB1.289::PFI-1
SNB75::Avagacestat
IHH-4::Palbociclib
786-0::RVX-208
MN-60::Avagacestat
MS-1::Linsitinib
HGC-27::Lapatinib
KP-1N::Palbociclib
NCI-H747::Osimertinib
MOLM-13::I-BET-762
SIMA::Ibrutinib
AM-38::Dactolisib
COLO-320-HSR::Sorafenib
RT4::Lapatinib
NB7::Osimertinib
IPC-298::Linsitinib
NCI-H1666::Doramapimod
WM35::RVX-208
SK-CO-1::Temozolomide
MDA-MB-361::Linsitinib
WSU-NHL::Temozolomide
LS-1034::Temozolomide
Jurkat::PFI-1
AM-38::PFI-1
NCI-H748::Sorafenib
D-247MG::I-BET-762
SK-MEL-28::I-BET-762
HCC2218::Palbociclib
DJM-1::PFI-1
NCI-H226::Linsitinib
786-0::Linsitinib
NOS-1::PFI-1
ES7::Lapatinib
RCC10RGB::Osimertinib
KU-19-19::Palbociclib
SUP-HD1::Ibrutinib
A673::PRT062607
COR-L303::RVX-208
HCC-44::RVX-208
LK-2::RVX-208
RCC-FG2::Sorafenib
TUR::Osimertinib
HCC-44::Dactolisib
LS-411N::RVX-208
OACM5-1::Doramapimod
HCC1500::VE-822
KASUMI-1::Linsitinib
SiHa::Doramapimod
DK-MG::Osimertinib
EJM::Linsitinib
AU565::Palbociclib
RT-112::VE-822
CP66-MEL::IOX2
OE21::I-BET-762
RERF-LC-MS::RVX-208
NUGC-3::RVX-208
RC-K8::Temozolomide
NCI-H1781::RVX-208
OCI-AML2::Sorafenib
MDA-MB-415::Osimertinib
LXF-289::Linsitinib
BxPC-3::Osimertinib
NCI-H1299::Sorafenib
Mewo::Osimertinib
NCI-H1092::Avagacestat
JHU-029::VE-822
MZ2-MEL::I-BET-762
SK-MM-2::Linsitinib
RO82-W-1::Temozolomide
SK-N-DZ::Osimertinib
JAR::AZD6482
NCI-H2087::PFI-1
NCI-H2342::Temozolomide
COR-L88::Sorafenib
ESO51::Dactolisib
SK-MEL-31::VE-822
NCI-H2066::Linsitinib
NCI-H647::Temozolomide
COR-L303::SL0101
SW1573::I-BET-762
EW-12::Temozolomide
SW1116::Doramapimod
EW-1::RVX-208
JEKO-1::Osimertinib
KM-H2::Linsitinib
EW-7::Osimertinib
MOG-G-CCM::Avagacestat
RCC-MF::Ibrutinib
OVCAR-3::Temozolomide
NCI-H2052::Linsitinib
HCC1954::Ibrutinib
SK-MEL-31::SL0101
JJN-3::VE-822
THP-1::IOX2
WM793B::Doramapimod
SNU-C5::Palbociclib
NCI-H660::Palbociclib
CAL-33::Ibrutinib
KYSE-50::Linsitinib
SK-N-AS::VE-822
RCC-ER::Temozolomide
HSC-3::Avagacestat
VA-ES-BJ::Dactolisib
GAMG::Palbociclib
JSC-1::Avagacestat
NCI-H2347::Osimertinib
SK-GT-2::Lapatinib
OCI-AML2::PFI-1
LOU-NH91::Avagacestat
OAW-28::I-BET-762
BV-173::Temozolomide
CS1::PFI-1
IM-95::Linsitinib
TE-11::I-BET-762
KYSE-180::Temozolomide
EFO-21::Linsitinib
MES-SA::Ibrutinib
NCI-H1993::Linsitinib
K2::Linsitinib
SNG-M::RVX-208
HCC1806::PRT062607
SW962::AZD6482
KYSE-70::PRT062607
SF295::Ibrutinib
JIMT-1::Avagacestat
YT::Osimertinib
NCI-H2342::Osimertinib
MFM-223::Osimertinib
K2::Ibrutinib
RT4::Ibrutinib
NY::Avagacestat
SU8686::Dactolisib
H-EMC-SS::Doramapimod
SK-MEL-1::Avagacestat
NCI-H211::Temozolomide
STS-0421::IOX2
OACM5-1::Ibrutinib
A101D::RVX-208
KMRC-20::PFI-1
DB::PFI-1
NCI-H2052::Lapatinib
EMC-BAC-2::PFI-1
EC-GI-10::PFI-1
CHP-212::Avagacestat
KP-3::Palbociclib
CAL-72::Dactolisib
KLE::Linsitinib
NCI-H1770::Lapatinib
STS-0421::VE-822
EW-3::Palbociclib
NCI-H1436::Palbociclib
NCI-H292::AZD6482
NCI-H2405::Palbociclib
KP-3::PFI-1
BONNA-12::Osimertinib
KARPAS-422::PFI-1
HCC38::I-BET-762
VMRC-RCZ::Palbociclib
OVK-18::PFI-1
CAL-54::Sorafenib
JHOS-4::SL0101
MDA-MB-468::Temozolomide
RCH-ACV::AZD6482
GCIY::I-BET-762
NCI-N87::I-BET-762
RCC-FG2::Osimertinib
NKM-1::Palbociclib
JHH-7::RVX-208
HOS::Avagacestat
769-P::Dactolisib
SK-MM-2::PFI-1
5637::VE-822
OVK-18::PRT062607
AU565::Ibrutinib
EW-12::Doramapimod
HuO-3N1::Avagacestat
VCaP::I-BET-762
KLE::Dactolisib
IMR-5::RVX-208
CHSA8926::Ibrutinib
KNS-42::Ibrutinib
Calu-6::Lapatinib
KP-N-YN::Sorafenib
NCI-H1563::Doramapimod
Jurkat::Lapatinib
NCI-H69::Doramapimod
SF126::Dactolisib
KURAMOCHI::Linsitinib
CHP-134::RVX-208
TE-4::Sorafenib
huH-1::Lapatinib
NCI-H1876::Lapatinib
SNU-81::RVX-208
MFE-319::Ibrutinib
TGBC24TKB::I-BET-762
MFH-ino::PFI-1
HCC1569::RVX-208
SK-PN-DW::I-BET-762
BEN::Osimertinib
A204::Lapatinib
SNU-387::VE-822
MDA-MB-157::Dactolisib
HCC-366::SL0101
HDQ-P1::Ibrutinib
JHOS-4::Doramapimod
PL4::VE-822
IST-MEL1::Dactolisib
COR-L23::Sorafenib
NCI-H1755::Dactolisib
KMS-12-BM::Dactolisib
CAL-78::Dactolisib
HSC-3::PRT062607
WM35::Palbociclib
HDQ-P1::Lapatinib
EVSA-T::Doramapimod
LS-513::Ibrutinib
ES8::Linsitinib
SCC90::RVX-208
NAMALWA::Temozolomide
SW1417::I-BET-762
EFO-27::PRT062607
NCI-H1734::RVX-208
JHH-2::Temozolomide
HCC1500::I-BET-762
NCI-H2052::Avagacestat
CP50-MEL-B::I-BET-762
HT-29::Ibrutinib
P12-ICHIKAWA::VE-822
SNB75::Dactolisib
KNS-62::Avagacestat
RCC-JF::Osimertinib
NB1::Lapatinib
FTC-133::Dactolisib
EN::I-BET-762
SW1573::Avagacestat
SNU-C2B::Palbociclib
ME-1::Lapatinib
LP-1::Linsitinib
SIG-M5::Palbociclib
GI-1::Lapatinib
U031::SL0101
NCI-H2228::PRT062607
OVCAR-3::Palbociclib
JURL-MK1::PRT062607
SNU-387::Ibrutinib
JVM-2::Doramapimod
OCI-AML3::RVX-208
NCI-H835::Lapatinib
Hey::VE-822
FTC-133::Temozolomide
TE-8::Doramapimod
NCI-H2227::Avagacestat
DOK::Sorafenib
Daoy::Osimertinib
UACC-257::Avagacestat
SK-MG-1::Doramapimod
DMS-53::Palbociclib
NCI-H1341::Lapatinib
COLO-668::PFI-1
CAL-12T::Linsitinib
SUP-M2::Sorafenib
NCI-H358::PRT062607
HCC70::Osimertinib
HCC2998::VE-822
CAL-33::Linsitinib
NCI-H1963::Lapatinib
U-266::Temozolomide
NMC-G1::Palbociclib
BICR31::AZD6482
OVISE::Temozolomide
CAS-1::Temozolomide
LOUCY::Dactolisib
J82::Doramapimod
LB771-HNC::Linsitinib
MC116::Temozolomide
SNU-81::Temozolomide
KP-3::Avagacestat
CL-11::Palbociclib
HCC1187::PRT062607
ES7::Ibrutinib
SK-ES-1::Lapatinib
SK-MEL-30::RVX-208
MHH-CALL-4::Lapatinib
no-11::Avagacestat
GR-ST::Palbociclib
EJM::RVX-208
huH-1::VE-822
BE-13::VE-822
PCI-30::Osimertinib
P12-ICHIKAWA::Lapatinib
ARH-77::PFI-1
BC-1::Doramapimod
L-363::Linsitinib
KYSE-180::RVX-208
HuO-3N1::Ibrutinib
EB-3::Doramapimod
KARPAS-1106P::Sorafenib
LoVo::PRT062607
CAL-72::Temozolomide
Hs-578-T::Osimertinib
LB1047-RCC::Ibrutinib
IPC-298::PFI-1
Ca-Ski::I-BET-762
HT55::VE-822
HCC1187::RVX-208
COR-L279::Sorafenib
NALM-6::Palbociclib
SIG-M5::PFI-1
NCI-H2029::PRT062607
EW-16::Temozolomide
42-MG-BA::Sorafenib
BT-549::Palbociclib
MM1S::PFI-1
COLO-684::VE-822
D-392MG::VE-822
HPAF-II::Linsitinib
ES8::Doramapimod
OACp4C::PFI-1
TK10::Lapatinib
UMC-11::Temozolomide
EW-24::PRT062607
SNU-407::Linsitinib
P30-OHK::Linsitinib
NCI-H1623::Temozolomide
NCI-H2196::Linsitinib
CW-2::Linsitinib
RPMI-6666::Dactolisib
SK-MEL-30::Dactolisib
VMRC-RCZ::RVX-208
IM-9::Lapatinib
CP66-MEL::AZD6482
OCI-LY7::Osimertinib
CAL-120::Ibrutinib
NCI-H23::Osimertinib
HDLM-2::PFI-1
EW-3::Ibrutinib
TC-71::Linsitinib
MRK-nu-1::AZD6482
NCI-H810::Palbociclib
BHY::I-BET-762
HSC-3::Sorafenib
D-336MG::Linsitinib
HMV-II::Palbociclib
LU-135::Sorafenib
KMS-12-BM::Lapatinib
KE-37::Ibrutinib
CAL-120::RVX-208
CAL-120::Avagacestat
KURAMOCHI::Avagacestat
OVISE::Osimertinib
Farage::IOX2
RC-K8::Osimertinib
MEL-HO::PRT062607
NCI-H716::Avagacestat
NCI-H1666::Sorafenib
UACC-893::Doramapimod
CAKI-1::Dactolisib
NUGC-4::Ibrutinib
NB5::Doramapimod
SW1271::PRT062607
NCI-H1993::PFI-1
HT55::Avagacestat
EW-7::Lapatinib
COLO-320-HSR::PRT062607
KARPAS-620::Linsitinib
A549::Ibrutinib
KMOE-2::Linsitinib
D-542MG::Doramapimod
TT2609-C02::Temozolomide
NCI-H2029::SL0101
L-540::I-BET-762
SW1417::Palbociclib
SK-N-AS::Avagacestat
CS1::Doramapimod
LXF-289::Temozolomide
HCE-4::AZD6482
SKN-3::Linsitinib
NCI-H1105::Palbociclib
HCC-366::RVX-208
GI-ME-N::PRT062607
RPMI-8402::Avagacestat
KM-H2::Dactolisib
PL-21::Lapatinib
MS-1::VE-822
AGS::Sorafenib
ECC12::Lapatinib
SF295::IOX2
KP-4::I-BET-762
NCI-H2023::Sorafenib
D-542MG::SL0101
CA46::Ibrutinib
ONS-76::Palbociclib
NCI-H82::Dactolisib
SIG-M5::Linsitinib
SW756::Lapatinib
RERF-LC-KJ::Osimertinib
NCI-H1341::Avagacestat
42-MG-BA::PRT062607
MHH-CALL-4::Linsitinib
NCI-H835::Osimertinib
PA-TU-8988T::Dactolisib
EW-22::Dactolisib
NOS-1::I-BET-762
NCI-H747::Avagacestat
DAN-G::Avagacestat
HPAC::PRT062607
D-263MG::Ibrutinib
ABC-1::IOX2
NCI-H524::Temozolomide
A3-KAW::RVX-208
D-542MG::IOX2
TK10::VE-822
EW-3::PRT062607
COLO-783::Osimertinib
OSC-19::Avagacestat
TE-8::VE-822
LOXIMVI::Osimertinib
CAL-33::Doramapimod
CAL-54::I-BET-762
RH-41::Sorafenib
NCI-H740::Osimertinib
HuP-T4::VE-822
JEKO-1::Palbociclib
SW954::PFI-1
JVM-2::VE-822
GAMG::Linsitinib
NCI-H747::PFI-1
PSN1::Palbociclib
ALL-PO::VE-822
OCUB-M::Sorafenib
NCI-H1155::RVX-208
NCI-H660::AZD6482
HSC-2::Lapatinib
QIMR-WIL::Ibrutinib
NCI-H2110::Dactolisib
BT-20::Osimertinib
MHH-CALL-4::Ibrutinib
Mo-T::Sorafenib
CHL-1::PFI-1
NB14::Dactolisib
MOLT-16::Palbociclib
BONNA-12::Avagacestat
SNU-449::Linsitinib
WSU-NHL::I-BET-762
IST-SL2::Sorafenib
SW620::Dactolisib
YKG-1::Temozolomide
COLO-829::PFI-1
OC-314::PFI-1
CAL-51::Linsitinib
MRK-nu-1::Doramapimod
RD::Dactolisib
SW962::RVX-208
DBTRG-05MG::PRT062607
U251::Temozolomide
SNU-387::RVX-208
WM793B::Temozolomide
ECC10::Dactolisib
NCI-H510A::PFI-1
SF295::Linsitinib
KINGS-1::Linsitinib
KATOIII::Osimertinib
TE-9::Ibrutinib
NCI-H1688::Lapatinib
NCI-H2291::PFI-1
SF268::Ibrutinib
EB2::I-BET-762
ECC12::PRT062607
SW872::PFI-1
PL4::Palbociclib
JEG-3::Lapatinib
CESS::Lapatinib
JAR::PRT062607
NCI-H1623::Ibrutinib
EKVX::Ibrutinib
EC-GI-10::VE-822
MZ2-MEL::Temozolomide
HCC1187::Dactolisib
NCI-H1651::Ibrutinib
ATN-1::Doramapimod
TOV-112D::Linsitinib
BFTC-909::Lapatinib
EKVX::AZD6482
D-542MG::VE-822
RPMI-6666::Temozolomide
CHP-134::Palbociclib
SKM-1::Ibrutinib
SKM-1::Palbociclib
KE-37::Sorafenib
OPM-2::VE-822
D-502MG::IOX2
NCI-H28::Dactolisib
MEL-HO::Sorafenib
KP-N-YN::RVX-208
NCI-H1734::Doramapimod
PCI-15A::AZD6482
P32-ISH::Ibrutinib
U-698-M::PFI-1
SK-MEL-24::Palbociclib
JAR::Sorafenib
CW-2::Sorafenib
SNU-81::Osimertinib
SW1710::Dactolisib
SUP-T1::PFI-1
IPC-298::Temozolomide
QGP-1::I-BET-762
SUP-B8::Ibrutinib
NCI-H1781::Palbociclib
H4::PFI-1
A431::Palbociclib
HCC-15::PFI-1
NCI-H2172::Lapatinib
A172::PRT062607
NCC021::SL0101
SK-MEL-28::Osimertinib
CCRF-CEM::I-BET-762
COR-L303::Dactolisib
MOLP-8::PRT062607
LU-134-A::Dactolisib
CS1::VE-822
SF268::Avagacestat
NCI-H510A::I-BET-762
8-MG-BA::I-BET-762
EW-1::I-BET-762
DAN-G::VE-822
CL-11::Doramapimod
BONNA-12::SL0101
OCI-LY7::AZD6482
MFE-280::Avagacestat
NCI-H23::Lapatinib
JM1::Doramapimod
OV-7::Osimertinib
NCI-H748::Lapatinib
OVISE::Avagacestat
RPMI-8866::Doramapimod
COLO-684::I-BET-762
CCK-81::Palbociclib
SU8686::Linsitinib
Becker::RVX-208
FTC-133::Palbociclib
42-MG-BA::I-BET-762
HT-3::Temozolomide
8-MG-BA::PRT062607
CCRF-CEM::Palbociclib
PA-TU-8988T::Palbociclib
BB49-HNC::RVX-208
NB14::Palbociclib
MRK-nu-1::PRT062607
COR-L303::Temozolomide
IGR-1::Osimertinib
NCI-H292::SL0101
NALM-6::VE-822
COR-L23::PFI-1
MFM-223::VE-822
NCI-H2052::PFI-1
LS-411N::Lapatinib
TE-11::SL0101
YAPC::Doramapimod
NCI-H2452::Linsitinib
OE19::Linsitinib
NCI-H1436::Doramapimod
H9::Temozolomide
TC-71::PFI-1
CAL-27::PRT062607
D-283MED::Osimertinib
NCI-H1155::Temozolomide
SCC-3::Dactolisib
CAL-39::RVX-208
UWB1.289::VE-822
WSU-DLCL2::Palbociclib
UACC-812::Lapatinib
BB65-RCC::Dactolisib
BT-20::Palbociclib
L-363::Dactolisib
OV-56::Ibrutinib
RXF393::Palbociclib
HCC1187::AZD6482
NUGC-3::Sorafenib
DAN-G::Temozolomide
MC116::PRT062607
EPLC-272H::Linsitinib
HH::Sorafenib
NB14::Ibrutinib
HT-115::Doramapimod
JHH-1::Osimertinib
OAW-42::Linsitinib
ME-1::I-BET-762
OE33::Lapatinib
OVCAR-8::Palbociclib
QGP-1::PFI-1
MOLT-16::Lapatinib
LS-180::Ibrutinib
NCI-H250::IOX2
SK-MEL-24::Ibrutinib
COLO-800::PRT062607
BB30-HNC::VE-822
Hey::Temozolomide
TK10::Palbociclib
RL::Dactolisib
IGROV-1::Avagacestat
SW684::Doramapimod
SK-PN-DW::Linsitinib
SNU-387::Lapatinib
SNU-398::PRT062607
COLO-678::Lapatinib
SNU-407::Ibrutinib
VAL::Osimertinib
KP-N-YN::Avagacestat
LS-123::Sorafenib
JHH-7::Sorafenib
NCC010::Osimertinib
MOLT-16::Ibrutinib
SW1710::Lapatinib
Hs-578-T::I-BET-762
DoTc2-4510::Palbociclib
FADU::Temozolomide
KASUMI-1::Doramapimod
Caov-4::Palbociclib
EB-3::Dactolisib
SBC-5::Ibrutinib
A388::Linsitinib
SH-4::Dactolisib
CAL-54::Dactolisib
KOSC-2::Avagacestat
TE-5::Doramapimod
MZ2-MEL::PFI-1
GR-ST::VE-822
HAL-01::Avagacestat
HEC-1::Lapatinib
OV-90::PRT062607
NCI-H810::PFI-1
647-V::Sorafenib
HuO-3N1::PFI-1
NCI-H2227::PFI-1
A388::Osimertinib
CTV-1::VE-822
NCI-H660::Avagacestat
LC4-1::VE-822
COR-L303::Palbociclib
CL-11::Sorafenib
YT::Temozolomide
JM1::RVX-208
LB771-HNC::VE-822
UM-UC-3::PFI-1
A388::Avagacestat
LU-134-A::Linsitinib
Hs-578-T::Dactolisib
RCC-ER::Sorafenib
RCC-JW::I-BET-762
PC-3::Avagacestat
MOLT-16::Osimertinib
SNU-283::AZD6482
JEG-3::Doramapimod
786-0::I-BET-762
G-MEL::AZD6482
SCH::AZD6482
BFTC-905::I-BET-762
SUP-B15::I-BET-762
FLO-1::Ibrutinib
SF295::SL0101
DND-41::VE-822
DJM-1::PRT062607
UWB1.289::IOX2
AM-38::Lapatinib
JHH-6::PRT062607
YKG-1::IOX2
OVCAR-3::Dactolisib
LB373-MEL-D::Linsitinib
Hs-578-T::Doramapimod
JAR::Palbociclib
JHH-6::Temozolomide
SUP-T1::Ibrutinib
CRO-AP2::Dactolisib
SNB75::SL0101
KALS-1::PRT062607
SK-ES-1::RVX-208
D-502MG::PRT062607
CAL-12T::Osimertinib
OSC-20::Dactolisib
HCC2218::Dactolisib
H4::Sorafenib
A204::Palbociclib
HCC-366::Doramapimod
SU-DHL-4::VE-822
SLVL::VE-822
SNU-398::Sorafenib
SU-DHL-1::Sorafenib
MDA-MB-330::Linsitinib
KYM-1::I-BET-762
ME-180::VE-822
CAL-120::Dactolisib
KALS-1::Lapatinib
KM12::I-BET-762
KP-3::Ibrutinib
NCI-H1993::I-BET-762
DJM-1::VE-822
FU-OV-1::Doramapimod
SK-MG-1::Ibrutinib
COLO-800::SL0101
NCI-H510A::Temozolomide
SBC-5::PRT062607
NCI-H2029::Linsitinib
SK-LU-1::VE-822
LB2241-RCC::SL0101
LCLC-97TM1::I-BET-762
SW1990::Lapatinib
IGR-37::VE-822
NCI-H211::Lapatinib
MIA-PaCa-2::RVX-208
MIA-PaCa-2::Sorafenib
EW-12::Linsitinib
RCC-JF::Dactolisib
NCI-H727::Doramapimod
HCC-78::RVX-208
MES-SA::RVX-208
OCI-M1::Doramapimod
OCI-LY-19::IOX2
MS751::Temozolomide
OAW-28::Temozolomide
JHOS-3::Ibrutinib
SW1271::VE-822
OAW-42::Ibrutinib
HCT-116::Lapatinib
A101D::Doramapimod
D-423MG::Dactolisib
MFE-296::PFI-1
L-428::Dactolisib
RKO::Temozolomide
HT-144::Temozolomide
Calu-3::Ibrutinib
PSN1::Sorafenib
COLO-205::Ibrutinib
NCI-H345::VE-822
KYSE-180::Palbociclib
KNS-42::Temozolomide
TT2609-C02::Linsitinib
NCI-H1092::Sorafenib
KMRC-1::Dactolisib
Mo-T::Avagacestat
CAL-51::Doramapimod
KMS-11::Avagacestat
KYSE-140::Temozolomide
JHU-022::Linsitinib
NCI-H524::Avagacestat
DND-41::Doramapimod
M059J::RVX-208
OACM5-1::PFI-1
SW837::Temozolomide
JJN-3::Temozolomide
QIMR-WIL::Lapatinib
MRK-nu-1::Sorafenib
CAMA-1::Dactolisib
ECC12::Palbociclib
Hs-445::Avagacestat
OAW-42::RVX-208
D-566MG::PFI-1
NOS-1::Palbociclib
JHU-022::RVX-208
MRK-nu-1::Dactolisib
EJM::VE-822
NCI-H1693::Ibrutinib
HCC1500::Palbociclib
SKG-IIIa::Avagacestat
UM-UC-3::Temozolomide
LNCaP-Clone-FGC::Doramapimod
SW48::Osimertinib
SF539::Doramapimod
ES-2::PRT062607
TYK-nu::PFI-1
NCI-H1792::Sorafenib
MOLT-16::Doramapimod
KE-37::Linsitinib
JVM-2::Dactolisib
NCI-H2052::Temozolomide
NUGC-4::PFI-1
COLO-783::Dactolisib
SW1463::Dactolisib
JiyoyeP-2003::VE-822
OVCAR-4::Palbociclib
CTB-1::I-BET-762
SU8686::Osimertinib
RPMI-8866::I-BET-762
HL-60::Temozolomide
AMO-1::Osimertinib
RCM-1::PRT062607
SW156::IOX2
LN-229::Doramapimod
SBC-1::PRT062607
HCC1599::RVX-208
BALL-1::RVX-208
NCI-H647::AZD6482
IST-SL2::PRT062607
OSC-20::Avagacestat
KARPAS-620::RVX-208
K5::Linsitinib
BE2-M17::RVX-208
IST-MES1::Doramapimod
NCI-H292::Ibrutinib
MG-63::Dactolisib
T98G::Temozolomide
KYSE-220::Sorafenib
NCI-H226::RVX-208
KON::SL0101
DU-4475::AZD6482
FADU::Ibrutinib
JHOS-2::Ibrutinib
PWR-1E::PFI-1
COLO-783::Ibrutinib
NB10::I-BET-762
NALM-6::Dactolisib
SK-MEL-30::PFI-1
PSN1::PFI-1
KINGS-1::Palbociclib
CP66-MEL::Palbociclib
DMS-79::Lapatinib
SJRH30::Temozolomide
PF-382::PFI-1
NCI-H1355::VE-822
MKN7::Linsitinib
TYK-nu::Dactolisib
MOLM-16::VE-822
CRO-AP2::I-BET-762
EW-3::I-BET-762
UWB1.289::Sorafenib
SW48::Temozolomide
SW620::Doramapimod
PA-TU-8902::I-BET-762
LOXIMVI::I-BET-762
DEL::Palbociclib
NCI-H441::PRT062607
U-266::Palbociclib
NCI-H1781::Ibrutinib
HCC1599::Lapatinib
GI-1::Temozolomide
ZR-75-30::Doramapimod
U-118-MG::Dactolisib
NCI-H1836::AZD6482
MDA-MB-231::Temozolomide
A388::Ibrutinib
SNU-C5::I-BET-762
LS-180::PRT062607
ESO51::Lapatinib
LOUCY::Temozolomide
HCC1806::Sorafenib
LU-135::Dactolisib
NB6::VE-822
BE-13::Temozolomide
PEO1::Temozolomide
CA46::Dactolisib
NCI-H2228::VE-822
HCC1500::Ibrutinib
NOMO-1::PRT062607
NCI-H810::Sorafenib
NUGC-4::Lapatinib
NCI-H1915::I-BET-762
BICR22::RVX-208
DG-75::Ibrutinib
MZ1-PC::VE-822
SNU-283::Doramapimod
CA46::Osimertinib
TGBC24TKB::VE-822
RT4::VE-822
NCI-H838::Linsitinib
LC-1-sq::PFI-1
MDA-MB-231::AZD6482
KARPAS-299::PFI-1
NCI-H64::Doramapimod
TE-5::VE-822
NCI-H522::Sorafenib
QGP-1::Avagacestat
HT-3::Sorafenib
HCC-366::Sorafenib
BFTC-909::Avagacestat
SNU-C2B::I-BET-762
HT-1197::Linsitinib
NCI-H1650::Sorafenib
OCI-M1::VE-822
P32-ISH::Doramapimod
MHH-CALL-4::IOX2
KASUMI-1::Ibrutinib
A4-Fuk::Temozolomide
A101D::Temozolomide
TOV-112D::PFI-1
NAMALWA::Palbociclib
DK-MG::Dactolisib
MDA-MB-436::Temozolomide
BT-549::PRT062607
NCI-H720::Ibrutinib
UMC-11::PRT062607
TC-71::PRT062607
PC-14::IOX2
WM1552C::Temozolomide
SNU-423::Sorafenib
Daoy::Doramapimod
HSC-4::Ibrutinib
HCC2157::PFI-1
MOLT-4::Doramapimod
NCI-H1770::SL0101
H9::Palbociclib
U-698-M::RVX-208
HuP-T4::Sorafenib
ARH-77::Osimertinib
A549::Linsitinib
KYSE-140::Dactolisib
RCC-ER::AZD6482
LB1047-RCC::I-BET-762
PANC-02-03::PFI-1
SK-MEL-28::Ibrutinib
JHU-022::VE-822
NCI-H1734::Osimertinib
RMG-I::Doramapimod
MKN28::Lapatinib
U-87-MG::Dactolisib
LCLC-97TM1::Doramapimod
SK-N-AS::Doramapimod
NCI-H2023::Osimertinib
FU97::Linsitinib
CP66-MEL::VE-822
OPM-2::Avagacestat
GRANTA-519::Dactolisib
HCE-4::Doramapimod
SW620::PRT062607
MOLT-13::PFI-1
SNU-175::Doramapimod
D-263MG::Sorafenib
HCC1569::VE-822
G-401::VE-822
SW156::PRT062607
LAN-6::Palbociclib
PCI-6A::I-BET-762
HPAF-II::I-BET-762
CAL-29::Avagacestat
COLO-824::Palbociclib
KE-37::RVX-208
BT-483::Avagacestat
MES-SA::PRT062607
DJM-1::Dactolisib
EFO-21::Ibrutinib
RS4-11::Dactolisib
C-33-A::Sorafenib
697::I-BET-762
HuO-3N1::RVX-208
PWR-1E::Osimertinib
HCT-116::PFI-1
RCC-JW::Avagacestat
SW620::PFI-1
JHH-4::Linsitinib
NCI-H1568::RVX-208
JHOS-4::IOX2
COLO-205::VE-822
OSC-19::PRT062607
SJRH30::RVX-208
NCI-H446::VE-822
Hey::PFI-1
NCI-H2196::Sorafenib
EW-11::Sorafenib
NCI-H1048::Linsitinib
HH::VE-822
COLO-320-HSR::Osimertinib
MRK-nu-1::Osimertinib
MKN45::VE-822
LB373-MEL-D::PFI-1
EW-11::Dactolisib
JAR::Temozolomide
A427::VE-822
TOV-112D::VE-822
GI-1::Doramapimod
SK-MM-2::Lapatinib
42-MG-BA::Palbociclib
KYSE-150::Linsitinib
SF126::Avagacestat
NCI-H650::I-BET-762
MOLT-16::I-BET-762
HuH-7::PFI-1
8305C::Dactolisib
HSC-4::Doramapimod
NB5::IOX2
GCT::PRT062607
JHH-6::RVX-208
NMC-G1::PFI-1
SW954::Ibrutinib
HCE-4::Temozolomide
VMRC-RCZ::I-BET-762
NCI-H1793::Linsitinib
EFM-192A::Doramapimod
BFTC-905::Sorafenib
PANC-10-05::Avagacestat
LP-1::VE-822
LS-180::Lapatinib
JEKO-1::AZD6482
PFSK-1::PRT062607
NUGC-4::Palbociclib
EW-22::VE-822
SF539::Sorafenib
SU-DHL-6::Lapatinib
SU-DHL-8::VE-822
BE2-M17::Osimertinib
SUP-B8::PRT062607
KYAE-1::Osimertinib
KNS-81-FD::Ibrutinib
Becker::PRT062607
C32::AZD6482
NCI-H146::Sorafenib
OSC-20::Doramapimod
BEN::PRT062607
KYSE-410::VE-822
LOXIMVI::Palbociclib
AGS::Avagacestat
SK-MEL-3::Lapatinib
D-336MG::Doramapimod
NCI-H358::Osimertinib
HuP-T3::Avagacestat
TGBC11TKB::Linsitinib
ASH-3::PRT062607
KM12::PFI-1
LS-123::Dactolisib
NCI-H716::Sorafenib
BFTC-905::Lapatinib
A4-Fuk::Lapatinib
NCI-H524::PRT062607
NCCIT::Palbociclib
FLO-1::Dactolisib
ST486::PFI-1
SW1710::Osimertinib
PL4::Dactolisib
KYSE-50::Avagacestat
NCI-H345::Osimertinib
NCI-H524::PFI-1
AN3-CA::Palbociclib
TE-15::Ibrutinib
SU8686::Ibrutinib
SW620::I-BET-762
huH-1::Temozolomide
MDA-MB-361::PRT062607
CAL-120::Linsitinib
LN-18::PFI-1
MOLT-16::Dactolisib
U-87-MG::Palbociclib
NCI-H596::RVX-208
NCI-H1975::Sorafenib
EFO-21::Avagacestat
HCC70::VE-822
NCI-H211::Avagacestat
MFM-223::RVX-208
SCC-3::Linsitinib
ESO26::Sorafenib
COR-L321::Palbociclib
DMS-53::Lapatinib
C2BBe1::Lapatinib
RKN::Linsitinib
NCI-H1993::Sorafenib
EW-22::Doramapimod
SU-DHL-16::Dactolisib
ML-2::Linsitinib
LU-134-A::Palbociclib
SIG-M5::SL0101
KARPAS-45::PFI-1
JIMT-1::PRT062607
L-363::Doramapimod
OE21::VE-822
MDA-MB-415::Palbociclib
NALM-6::PFI-1
COR-L88::Temozolomide
COR-L321::VE-822
CCRF-CEM::Lapatinib
SW1116::PRT062607
LB771-HNC::Dactolisib
639-V::VE-822
HSC-2::Palbociclib
LB647-SCLC::PFI-1
HARA::Doramapimod
TGBC11TKB::PFI-1
KCL-22::Ibrutinib
HCC-827::Osimertinib
HL-60::Sorafenib
DG-75::Doramapimod
COR-L32::Palbociclib
JHOS-4::I-BET-762
OCI-LY7::Linsitinib
8305C::Lapatinib
PCI-4B::PFI-1
CAL-78::Sorafenib
HT-29::I-BET-762
MDA-MB-453::Sorafenib
C-33-A::Ibrutinib
LU-134-A::I-BET-762
MLMA::Doramapimod
JHU-029::Palbociclib
CFPAC-1::Avagacestat
HO-1-N-1::I-BET-762
HCC1569::Osimertinib
IPC-298::Sorafenib
NCI-H1435::VE-822
CAL-39::Doramapimod
LNZTA3WT4::PFI-1
ZR-75-30::Osimertinib
JHOS-2::AZD6482
MZ2-MEL::Palbociclib
IM-9::Linsitinib
OVCAR-3::Lapatinib
KS-1::PRT062607
MPP-89::Ibrutinib
MOLP-8::Avagacestat
MOLT-13::Dactolisib
SW13::Temozolomide
H4::RVX-208
D-542MG::Lapatinib
BICR10::Ibrutinib
EW-1::Lapatinib
ETK-1::I-BET-762
SK-CO-1::Palbociclib
KOSC-2::Lapatinib
no-10::Palbociclib
LAN-6::RVX-208
BB30-HNC::SL0101
HCC1395::Sorafenib
SK-MES-1::Avagacestat
SR::Linsitinib
MZ1-PC::Osimertinib
COR-L303::AZD6482
NCI-H747::Sorafenib
MHH-CALL-2::Dactolisib
KARPAS-422::Ibrutinib
NCI-H2085::Lapatinib
TOV-21G::Sorafenib
HT-115::I-BET-762
BT-20::AZD6482
BL-41::Avagacestat
LB831-BLC::Sorafenib
MKN45::Lapatinib
SNU-C2B::Ibrutinib
NH-12::Ibrutinib
RCC-FG2::SL0101
UACC-893::PFI-1
MDA-MB-436::Dactolisib
CAMA-1::Ibrutinib
EW-12::PFI-1
SCC-9::Doramapimod
IST-SL1::VE-822
HCC1599::Linsitinib
KMS-12-BM::Osimertinib
PWR-1E::Ibrutinib
KNS-42::Palbociclib
RERF-LC-MS::Osimertinib
OCI-M1::Dactolisib
SW982::Osimertinib
MSTO-211H::VE-822
NCI-H1836::Osimertinib
PSN1::I-BET-762
ES-2::Avagacestat
SU-DHL-1::SL0101
LS-180::Sorafenib
OVKATE::Temozolomide
KATOIII::VE-822
Daudi::Doramapimod
H9::I-BET-762
JM1::Palbociclib
NEC8::PRT062607
KU812::PRT062607
SW954::Palbociclib
NCI-H2085::PFI-1
SU-DHL-10::Ibrutinib
ME-1::Ibrutinib
A3-KAW::Ibrutinib
CHSA8926::PFI-1
NB13::Dactolisib
CHSA0011::Ibrutinib
D-336MG::VE-822
HT-144::Avagacestat
SK-PN-DW::PRT062607
NCI-H1869::Ibrutinib
A498::Temozolomide
SNB75::Sorafenib
KGN::Linsitinib
EW-1::Temozolomide
STS-0421::I-BET-762
SCC-9::Ibrutinib
SK-MEL-30::Ibrutinib
NB17::Ibrutinib
ASH-3::PFI-1
OS-RC-2::I-BET-762
786-0::PRT062607
NALM-6::Doramapimod
OVCAR-4::Lapatinib
CAL-29::Sorafenib
OVKATE::Avagacestat
NCI-H1869::Dactolisib
SJSA-1::Avagacestat
SF268::Lapatinib
HT-1080::Doramapimod
U031::RVX-208
KMS-11::SL0101
OCUM-1::Palbociclib
LS-411N::VE-822
RXF393::PRT062607
HCC-366::PFI-1
NCI-H1666::I-BET-762
SW948::Avagacestat
MKN7::VE-822
MDA-MB-436::PRT062607
CGTH-W-1::Temozolomide
HDLM-2::PRT062607
HCC1937::Lapatinib
LOU-NH91::Dactolisib
BICR31::PRT062607
NCI-H226::PFI-1
ESO26::PFI-1
BT-20::Doramapimod
JHH-1::PRT062607
SKG-IIIa::Palbociclib
KU-19-19::RVX-208
SNG-M::Sorafenib
NCI-H748::IOX2
BV-173::PFI-1
NCI-H1963::Osimertinib
YT::Doramapimod
SW1573::Osimertinib
CAL-33::Osimertinib
NCI-H1092::Ibrutinib
SK-MEL-5::PRT062607
DU-145::Ibrutinib
SCC-4::PFI-1
NCI-H441::Ibrutinib
HO-1-N-1::Sorafenib
G-361::Dactolisib
CTB-1::Dactolisib
CML-T1::Temozolomide
SISO::I-BET-762
SKG-IIIa::Temozolomide
SNU-387::PFI-1
ME-180::Linsitinib
OVMIU::VE-822
HCC1419::Temozolomide
TGBC24TKB::Linsitinib
T-T::PFI-1
MHH-CALL-2::Doramapimod
OCI-LY-19::PFI-1
BHT-101::Sorafenib
NUGC-3::Dactolisib
L-363::Osimertinib
COR-L88::Doramapimod
SU-DHL-16::Sorafenib
A549::RVX-208
NCI-H2141::Dactolisib
ES5::Lapatinib
HuH-7::Linsitinib
D-423MG::SL0101
JM1::AZD6482
LC-2-ad::VE-822
RO82-W-1::Ibrutinib
NCI-H2141::Osimertinib
KALS-1::Dactolisib
ACHN::Dactolisib
A498::Linsitinib
GCIY::Palbociclib
ATN-1::Osimertinib
CW-2::PRT062607
FLO-1::RVX-208
NEC8::Linsitinib
CAL-148::Dactolisib
HLE::Linsitinib
PA-TU-8902::Temozolomide
GAK::PRT062607
NCI-H64::Lapatinib
NCI-H2228::PFI-1
SUP-B15::Osimertinib
CW-2::Avagacestat
SN12C::RVX-208
C-33-A::Palbociclib
SBC-1::Sorafenib
OV-17R::Ibrutinib
PL-21::Linsitinib
RERF-GC-1B::Avagacestat
EBC-1::I-BET-762
BONNA-12::Lapatinib
HCC-827::PFI-1
PANC-02-03::Temozolomide
KYSE-270::Osimertinib
OV-7::Lapatinib
MS751::Doramapimod
CML-T1::VE-822
HT55::Temozolomide
NCI-H2444::Palbociclib
TE-4::PRT062607
SK-MEL-28::SL0101
MZ7-mel::Osimertinib
ML-2::Doramapimod
HCC2157::Temozolomide
VMRC-RCZ::Linsitinib
SJSA-1::Palbociclib
MHH-CALL-2::Ibrutinib
A498::I-BET-762
NCI-H1915::PRT062607
PFSK-1::PFI-1
JHH-1::Temozolomide
SK-MEL-5::Linsitinib
LC4-1::Ibrutinib
SK-N-SH::Avagacestat
A4-Fuk::Avagacestat
KON::Dactolisib
OACp4C::VE-822
KP-N-YN::PFI-1
CHP-126::Doramapimod
RCH-ACV::IOX2
SCH::PRT062607
FU97::Avagacestat
SU-DHL-10::RVX-208
DOV13::Ibrutinib
NCI-H358::VE-822
Hey::Sorafenib
OVISE::I-BET-762
WM-115::Sorafenib
DK-MG::Avagacestat
ALL-PO::I-BET-762
SW1990::Temozolomide
BICR22::Linsitinib
MZ7-mel::Ibrutinib
P30-OHK::Doramapimod
SK-MEL-28::Temozolomide
HCC70::Dactolisib
EN::Dactolisib
NCI-H748::Ibrutinib
TE-10::Temozolomide
EFM-19::Ibrutinib
5637::I-BET-762
SBC-1::SL0101
GAMG::Dactolisib
EW-18::Ibrutinib
OAW-42::Dactolisib
no-11::Linsitinib
GOTO::VE-822
MHH-CALL-2::Linsitinib
HuH-7::Dactolisib
OVCAR-4::Ibrutinib
COLO-668::Ibrutinib
H-EMC-SS::PFI-1
LU-65::PRT062607
SNU-398::Avagacestat
HA7-RCC::Palbociclib
ES6::Temozolomide
BT-549::Dactolisib
NCI-H23::Doramapimod
SW1573::Palbociclib
TGBC24TKB::Dactolisib
GOTO::Osimertinib
PANC-02-03::PRT062607
SNU-407::Osimertinib
BT-20::Temozolomide
SK-MEL-1::Dactolisib
JiyoyeP-2003::Palbociclib
OCI-M1::RVX-208
ALL-SIL::VE-822
CCK-81::PFI-1
NCI-H1666::Linsitinib
647-V::PRT062607
SH-4::Avagacestat
SJSA-1::Sorafenib
RPMI-8226::Palbociclib
EW-24::RVX-208
COLO-678::PRT062607
JHOS-4::Sorafenib
DJM-1::Lapatinib
PANC-03-27::Dactolisib
MOLP-8::VE-822
DBTRG-05MG::Temozolomide
EW-13::VE-822
NCI-H2122::Doramapimod
SU-DHL-4::Osimertinib
NB(TU)1-10::RVX-208
AU565::Osimertinib
EW-22::Osimertinib
HCC-366::Palbociclib
NCI-H322M::Lapatinib
KM12::Ibrutinib
CHP-126::Sorafenib
8505C::Dactolisib
KYSE-50::Dactolisib
ARH-77::Temozolomide
MES-SA::Palbociclib
SK-MEL-31::Sorafenib
ROS-50::RVX-208
NCI-H1770::Sorafenib
TE-12::Linsitinib
BE2-M17::Avagacestat
HOP-92::RVX-208
EJM::Temozolomide
WM35::I-BET-762
HSC-2::RVX-208
NCI-H1435::Doramapimod
NCI-H358::Doramapimod
A2780::Dactolisib
RXF393::Dactolisib
D-247MG::Osimertinib
ALL-SIL::Doramapimod
NCI-H2172::VE-822
MFM-223::Palbociclib
SK-UT-1::PFI-1
NCI-H2085::Linsitinib
COLO-684::Ibrutinib
NCI-H740::Linsitinib
MZ7-mel::Temozolomide
KMRC-20::Avagacestat
NCI-H82::Avagacestat
RL95-2::RVX-208
SR::RVX-208
NKM-1::Lapatinib
TUR::Lapatinib
JHOS-3::IOX2
UACC-257::Temozolomide
BB30-HNC::Temozolomide
SW1417::Linsitinib
HCC2218::SL0101
AMO-1::PRT062607
OCI-LY-19::Dactolisib
NCI-H1734::Sorafenib
SNU-398::Temozolomide
PCI-6A::Temozolomide
RD::Osimertinib
HOP-92::PFI-1
G-402::PRT062607
EBC-1::Dactolisib
PC-3::Linsitinib
RVH-421::Palbociclib
DK-MG::Ibrutinib
CADO-ES1::VE-822
CAL-51::I-BET-762
SK-MM-2::Temozolomide
A375::I-BET-762
QIMR-WIL::Sorafenib
SAT::Osimertinib
SK-UT-1::I-BET-762
NCI-H1876::PFI-1
KYSE-140::Linsitinib
PANC-10-05::Lapatinib
EW-7::PRT062607
AMO-1::Avagacestat
LS-123::PFI-1
ChaGo-K-1::SL0101
K5::VE-822
NB10::Palbociclib
SU-DHL-1::Ibrutinib
OE21::Palbociclib
SF539::Osimertinib
LN-229::PFI-1
CaR-1::Ibrutinib
KNS-62::PFI-1
KYSE-70::Palbociclib
MFE-280::I-BET-762
CAL-33::Sorafenib
HCC-366::Avagacestat
GRANTA-519::RVX-208
MKN28::Dactolisib
HA7-RCC::Lapatinib
VMRC-RCZ::Temozolomide
RERF-LC-Sq1::Linsitinib
RS4-11::Temozolomide
A388::AZD6482
8505C::Doramapimod
U251::Linsitinib
IM-95::Ibrutinib
ME-180::Avagacestat
OVISE::PFI-1
COR-L105::Osimertinib
CHP-126::Avagacestat
P12-ICHIKAWA::PRT062607
RERF-LC-MS::SL0101
PL-21::Temozolomide
TGBC24TKB::Sorafenib
NCC010::SL0101
NB69::RVX-208
NEC8::I-BET-762
TE-15::Temozolomide
NCI-H1573::Palbociclib
NCI-H2405::Dactolisib
KS-1::Dactolisib
KMRC-1::Lapatinib
Saos-2::Temozolomide
DOHH-2::PFI-1
LB647-SCLC::Linsitinib
TE-8::RVX-208
ROS-50::Dactolisib
EMC-BAC-1::Sorafenib
NCI-H2228::Lapatinib
NCI-H720::Dactolisib
MDA-MB-415::VE-822
L-428::VE-822
NCI-H322M::PFI-1
ATN-1::I-BET-762
JHU-011::Ibrutinib
HT-1197::Doramapimod
RD::RVX-208
SU8686::VE-822
PCI-4B::Sorafenib
EoL-1-cell::RVX-208
COLO-783::Avagacestat
DU-4475::Lapatinib
BICR78::Lapatinib
NCI-H647::VE-822
GB-1::I-BET-762
JVM-3::Dactolisib
ABC-1::PRT062607
BC-1::Lapatinib
SK-MEL-28::Dactolisib
PF-382::Doramapimod
CAL-78::Osimertinib
SAS::Palbociclib
OE19::Osimertinib
Ramos-2G6-4C10::Lapatinib
OCI-AML2::Linsitinib
5637::Osimertinib
CAL-54::Ibrutinib
KYSE-140::Ibrutinib
RH-41::Osimertinib
KOPN-8::Ibrutinib
MDA-MB-330::Temozolomide
JHH-7::Ibrutinib
RL::Avagacestat
EBC-1::Lapatinib
SNU-423::I-BET-762
EJM::Palbociclib
K-562::VE-822
ES8::Dactolisib
KGN::Palbociclib
SK-MEL-2::I-BET-762
SW626::Temozolomide
NCI-H1092::Temozolomide
SU-DHL-10::Temozolomide
JHOS-2::Lapatinib
BB30-HNC::PRT062607
NCI-H2141::PRT062607
NCI-H1755::PFI-1
RH-1::Linsitinib
JHOS-2::Osimertinib
RXF393::Doramapimod
JIMT-1::Doramapimod
NCI-H2405::Doramapimod
DU-4475::Osimertinib
NCI-H1651::Dactolisib
NCI-H1876::Temozolomide
RVH-421::VE-822
OV-56::Osimertinib
IST-SL1::I-BET-762
U-698-M::Lapatinib
NEC8::Osimertinib
SNU-175::RVX-208
NB5::Osimertinib
RVH-421::RVX-208
OCI-AML2::Temozolomide
GAMG::Lapatinib
NCI-H660::I-BET-762
MKN7::Dactolisib
D-502MG::Sorafenib
MHH-NB-11::SL0101
KINGS-1::Lapatinib
COR-L88::Palbociclib
Calu-3::PFI-1
SNU-449::PFI-1
SKG-IIIa::RVX-208
MOLT-4::I-BET-762
COLO-320-HSR::RVX-208
SNU-398::I-BET-762
KASUMI-1::PFI-1
NCI-H740::Temozolomide
D-247MG::Dactolisib
SK-GT-2::Osimertinib
LOUCY::PRT062607
NB6::Avagacestat
SUP-T1::Avagacestat
NCI-H1792::PFI-1
C-33-A::Osimertinib
MONO-MAC-6::Osimertinib
SUP-HD1::Sorafenib
KMOE-2::Doramapimod
CESS::PFI-1
EFM-19::Avagacestat
GOTO::PFI-1
HCC1569::Linsitinib
EPLC-272H::PRT062607
GRANTA-519::Temozolomide
FTC-133::Osimertinib
HCC1599::Avagacestat
BC-1::Ibrutinib
KINGS-1::PRT062607
LB647-SCLC::VE-822
NCI-N87::PFI-1
LS-123::Ibrutinib
U-266::Lapatinib
PANC-08-13::I-BET-762
NCI-H1755::Osimertinib
LB1047-RCC::Doramapimod
IST-MEL1::Linsitinib
HEL::Palbociclib
KYSE-220::Dactolisib
YKG-1::I-BET-762
MS751::PRT062607
SK-MEL-2::Avagacestat
NCI-H1688::Avagacestat
HT-29::RVX-208
NCI-H1838::Doramapimod
SU-DHL-4::Linsitinib
LCLC-103H::PFI-1
RERF-LC-Sq1::Lapatinib
SK-MEL-3::Osimertinib
TC-YIK::Ibrutinib
EJM::Lapatinib
LU-135::Ibrutinib
OSC-19::IOX2
HCC2998::RVX-208
SU-DHL-4::AZD6482
CTB-1::SL0101
KS-1::Osimertinib
MG-63::Avagacestat
NH-12::Sorafenib
TE-15::PRT062607
SNU-283::Lapatinib
BT-483::Osimertinib
MSTO-211H::Temozolomide
L-428::Linsitinib
HCC-15::Linsitinib
A673::RVX-208
G-361::Lapatinib
HCC1806::Temozolomide
NCI-H740::Doramapimod
HCC2998::Osimertinib
KP-3::Sorafenib
EW-22::Ibrutinib
SF126::Osimertinib
Ca9-22::VE-822
SK-MEL-31::Dactolisib
HuH-7::Doramapimod
SJRH30::Sorafenib
MKN45::Doramapimod
YH-13::I-BET-762
A2058::Ibrutinib
HOP-92::Osimertinib
YH-13::Osimertinib
HuCCT1::Ibrutinib
A375::Doramapimod
ME-180::Osimertinib
8505C::I-BET-762
SW1573::Ibrutinib
EB-3::PRT062607
BHT-101::PRT062607
OV-90::Linsitinib
8305C::I-BET-762
LS-180::Palbociclib
BONNA-12::IOX2
CHSA0011::Osimertinib
CPC-N::PRT062607
ESS-1::Lapatinib
TE-4::Palbociclib
SW1116::Sorafenib
NCI-H358::Linsitinib
D-283MED::VE-822
VA-ES-BJ::RVX-208
KS-1::PFI-1
OVCA420::RVX-208
CCK-81::Doramapimod
Jurkat::Temozolomide
TE-15::VE-822
HT-1197::Dactolisib
KARPAS-299::Temozolomide
BFTC-905::VE-822
SNU-1040::PRT062607
MDA-MB-330::Doramapimod
EW-16::Lapatinib
NB12::Doramapimod
OVCAR-8::PFI-1
FTC-133::Ibrutinib
ESO26::PRT062607
RKN::Doramapimod
MZ2-MEL::Lapatinib
NCI-H1355::Ibrutinib
LC-1-sq::PRT062607
D-283MED::Temozolomide
GP5d::PFI-1
COLO-792::Avagacestat
NOS-1::PRT062607
NCI-H2227::AZD6482
CTV-1::Lapatinib
A427::SL0101
MEG-01::Osimertinib
42-MG-BA::Ibrutinib
WIL2-NS::VE-822
SK-OV-3::Doramapimod
ChaGo-K-1::I-BET-762
SKM-1::Avagacestat
CAL-78::Palbociclib
KP-4::Doramapimod
CCRF-CEM::Sorafenib
BFTC-905::PFI-1
COR-L311::Linsitinib
LB373-MEL-D::AZD6482
P30-OHK::PFI-1
RCC-AB::Dactolisib
SUP-HD1::Lapatinib
IM-9::VE-822
NCI-H1869::PRT062607
DND-41::Avagacestat
NU-DUL-1::Avagacestat
P31-FUJ::Linsitinib
EVSA-T::Linsitinib
UACC-257::Sorafenib
RT4::PFI-1
GAK::Linsitinib
SW837::Dactolisib
CAS-1::Avagacestat
COLO-792::Ibrutinib
MZ1-PC::AZD6482
SNU-61::Avagacestat
EW-7::Linsitinib
CML-T1::I-BET-762
CAMA-1::PFI-1
TE-441-T::Linsitinib
OCUM-1::RVX-208
SKN-3::Lapatinib
BB30-HNC::IOX2
LAN-6::IOX2
MOLT-4::Lapatinib
MOLM-16::PFI-1
NU-DUL-1::Osimertinib
KARPAS-231::Linsitinib
HCC1569::IOX2
KARPAS-620::I-BET-762
SJSA-1::PFI-1
JHOS-2::Doramapimod
no-11::Osimertinib
BFTC-905::Ibrutinib
RCC-ER::RVX-208
A2058::Linsitinib
CAL-148::Temozolomide
CML-T1::Sorafenib
DSH1::Ibrutinib
A4-Fuk::Sorafenib
8505C::PRT062607
YKG-1::RVX-208
BT-549::Sorafenib
5637::Lapatinib
BPH-1::Avagacestat
SK-UT-1::Lapatinib
NCI-H1355::I-BET-762
SK-N-FI::Lapatinib
SK-GT-2::Avagacestat
BE-13::Ibrutinib
Hs-445::VE-822
769-P::Ibrutinib
PCI-6A::Sorafenib
FU97::Osimertinib
HT-144::Lapatinib
NCI-H2122::Avagacestat
HuH-7::Ibrutinib
RL95-2::Sorafenib
D-423MG::I-BET-762
LU-165::Palbociclib
SU-DHL-1::Doramapimod
SK-MEL-3::SL0101
JHOS-3::PFI-1
IA-LM::Avagacestat
M14::Temozolomide
DOK::Doramapimod
SW837::Sorafenib
DU-4475::Doramapimod
LS-513::PRT062607
LS-180::RVX-208
SW756::Palbociclib
EB2::Osimertinib
NCI-H647::Lapatinib
GA-10::Linsitinib
SK-MM-2::Avagacestat
NCI-H526::Linsitinib
OV-7::PRT062607
NCCIT::Linsitinib
AM-38::Ibrutinib
TK::PRT062607
DMS-273::PFI-1
Detroit562::Palbociclib
SK-MEL-24::PRT062607
SNU-1040::Palbociclib
OVISE::Linsitinib
CAL-120::Palbociclib
NCC021::Dactolisib
EW-1::Palbociclib
SU-DHL-6::RVX-208
RF-48::Linsitinib
CW-2::Ibrutinib
G-401::Ibrutinib
NEC8::RVX-208
AsPC-1::Ibrutinib
CHSA0108::I-BET-762
NKM-1::PFI-1
KYSE-520::VE-822
BT-549::Lapatinib
HDQ-P1::Palbociclib
BICR78::Dactolisib
EW-3::Doramapimod
K-562::Linsitinib
REH::Ibrutinib
PEO1::Sorafenib
MZ1-PC::Sorafenib
KARPAS-422::VE-822
Hs-578-T::VE-822
MCF7::PFI-1
SW954::PRT062607
KYSE-510::RVX-208
RKN::Osimertinib
SUP-T1::VE-822
FLO-1::Sorafenib
NCI-H2172::Linsitinib
BB30-HNC::Osimertinib
HSC-4::VE-822
RL::Osimertinib
HCC2157::Ibrutinib
CAL-29::RVX-208
HCC-827::Lapatinib
HCC-78::VE-822
Hey::Lapatinib
NCI-H2122::VE-822
MEL-HO::AZD6482
MFE-319::Sorafenib
OVISE::VE-822
HO-1-u-1::Temozolomide
IGR-37::Ibrutinib
BB65-RCC::Doramapimod
SW948::PFI-1
NCI-H2087::Osimertinib
REH::Doramapimod
Daoy::PFI-1
NCI-H292::Temozolomide
JEG-3::PRT062607
CESS::Ibrutinib
DG-75::Osimertinib
NY::PRT062607
MS751::VE-822
MOG-G-UVW::Dactolisib
GRANTA-519::Ibrutinib
NCI-H2227::RVX-208
VMRC-RCZ::Sorafenib
JEKO-1::I-BET-762
MOG-G-UVW::Temozolomide
LU-165::Osimertinib
BB65-RCC::PRT062607
SK-ES-1::Temozolomide
SW982::Linsitinib
JSC-1::RVX-208
CTB-1::Sorafenib
MIA-PaCa-2::Ibrutinib
HT-1080::I-BET-762
OAW-42::Palbociclib
CHP-212::RVX-208
LU-65::Doramapimod
NCI-H1781::Lapatinib
NCI-H2452::Doramapimod
TE-15::RVX-208
SW1783::Dactolisib
ONS-76::Doramapimod
NCI-H2444::Lapatinib
BEN::IOX2
MZ1-PC::Palbociclib
CP50-MEL-B::Doramapimod
RMG-I::Osimertinib
VMRC-RCZ::Ibrutinib
C-4-I::Temozolomide
NCI-H661::Avagacestat
PL4::Avagacestat
BT-483::Linsitinib
KOSC-2::SL0101
SK-MES-1::VE-822
T47D::PRT062607
SW756::Linsitinib
JVM-2::Avagacestat
HCC-78::I-BET-762
CAS-1::PRT062607
KY821::Lapatinib
RS4-11::Ibrutinib
EN::Temozolomide
TE-10::RVX-208
NCI-H1915::RVX-208
NCI-H810::Ibrutinib
SW1417::RVX-208
IM-9::Ibrutinib
PL4::Temozolomide
A427::Lapatinib
DBTRG-05MG::PFI-1
Farage::Palbociclib
HT-29::PFI-1
EMC-BAC-2::Palbociclib
SNU-81::IOX2
DMS-53::Linsitinib
EFM-19::AZD6482
NCI-H322M::Palbociclib
NCI-H1781::PRT062607
DMS-79::I-BET-762
LN-229::VE-822
NCI-H2023::PFI-1
RPMI-8866::Linsitinib
BE-13::Dactolisib
SLVL::Doramapimod
EW-1::Avagacestat
A498::Sorafenib
KELLY::Ibrutinib
SNU-C5::RVX-208
SCH::RVX-208
LB996-RCC::Sorafenib
EFM-19::Linsitinib
HPAF-II::RVX-208
NCI-H1105::PRT062607
TE-5::PRT062607
KYSE-220::PRT062607
HCC2157::RVX-208
ChaGo-K-1::Temozolomide
QIMR-WIL::Temozolomide
SKN::Doramapimod
HeLa::Lapatinib
SJRH30::Linsitinib
LB373-MEL-D::I-BET-762
JVM-2::Palbociclib
FLO-1::VE-822
NY::Dactolisib
Farage::RVX-208
WM35::Avagacestat
NCI-H345::Ibrutinib
NCI-H146::Linsitinib
MRK-nu-1::Avagacestat
NCI-H1341::Linsitinib
KYSE-270::Sorafenib
LXF-289::Ibrutinib
MRK-nu-1::PFI-1
CAS-1::Linsitinib
CAL-27::Ibrutinib
PCI-15A::PRT062607
BxPC-3::Sorafenib
NCI-H1876::Dactolisib
OCUB-M::I-BET-762
PA-TU-8902::Ibrutinib
PCI-4B::Linsitinib
NCI-H720::Avagacestat
MC116::Dactolisib
NCI-H1573::Osimertinib
22RV1::RVX-208
JURL-MK1::RVX-208
HDQ-P1::RVX-208
KASUMI-1::Palbociclib
MSTO-211H::Dactolisib
NCI-H1650::Dactolisib
NCI-H716::Doramapimod
VAL::Sorafenib
RCC-JW::Linsitinib
OVMIU::RVX-208
A549::Lapatinib
SW962::Palbociclib
ESS-1::RVX-208
NAMALWA::VE-822
CAL-39::Avagacestat
LS-180::Doramapimod
LB831-BLC::Ibrutinib
NCI-H1836::PRT062607
MFM-223::Doramapimod
TYK-nu::Lapatinib
OACM5-1::Avagacestat
KNS-62::Dactolisib
OV-17R::Avagacestat
EW-1::Linsitinib
NCI-H1876::Ibrutinib
KINGS-1::Doramapimod
RXF393::VE-822
UMC-11::Linsitinib
PC-3::I-BET-762
KMS-11::IOX2
ES8::PFI-1
TGBC24TKB::Osimertinib
Jurkat::Linsitinib
TUR::PFI-1
8-MG-BA::Palbociclib
RPMI-6666::PRT062607
FADU::Lapatinib
HCC2157::Avagacestat
JHH-4::Avagacestat
MIA-PaCa-2::Osimertinib
COR-L105::Doramapimod
NCI-H2110::SL0101
JHU-011::I-BET-762
GA-10::Sorafenib
YKG-1::Sorafenib
SKN::Dactolisib
NCI-H1693::Osimertinib
JAR::Dactolisib
MFH-ino::Lapatinib
A388::IOX2
T98G::Avagacestat
NB(TU)1-10::VE-822
SK-MEL-30::Linsitinib
J82::Palbociclib
451Lu::Temozolomide
ChaGo-K-1::Osimertinib
A673::Avagacestat
PSN1::Dactolisib
SW684::Palbociclib
H-EMC-SS::I-BET-762
MM1S::Sorafenib
BEN::Palbociclib
COR-L32::IOX2
ARH-77::Ibrutinib
D-566MG::Sorafenib
OSC-19::Sorafenib
ML-2::PFI-1
KMOE-2::Sorafenib
TE-4::I-BET-762
PEO1::PFI-1
COLO-679::RVX-208
H-EMC-SS::Ibrutinib
KARPAS-299::Osimertinib
RPMI-8402::PFI-1
TC-YIK::Doramapimod
NCC021::Doramapimod
WSU-NHL::Dactolisib
NCI-H1355::Sorafenib
SW156::Dactolisib
HT-115::SL0101
PF-382::Temozolomide
COLO-668::I-BET-762
SR::VE-822
KON::VE-822
NCI-H2110::AZD6482
D-247MG::Linsitinib
EFM-192A::PRT062607
KARPAS-231::PRT062607
UACC-812::Dactolisib
A2780::RVX-208
EW-12::AZD6482
TE-15::PFI-1
OVK-18::Lapatinib
CPC-N::Linsitinib
MHH-PREB-1::I-BET-762
LU-99A::PRT062607
SHP-77::Sorafenib
ACHN::Temozolomide
MKN28::Ibrutinib
MFE-280::Dactolisib
NCI-H226::PRT062607
KYSE-520::Temozolomide
KASUMI-1::PRT062607
KARPAS-1106P::I-BET-762
NCI-H1650::Temozolomide
SNU-61::I-BET-762
SBC-3::Osimertinib
KYSE-510::Doramapimod
NCI-H847::Dactolisib
KMS-12-BM::PFI-1
K-562::Dactolisib
KYSE-150::Sorafenib
SK-MES-1::Doramapimod
T-T::Sorafenib
SNU-398::Lapatinib
OVTOKO::Sorafenib
MKN28::Sorafenib
SNB75::Temozolomide
SK-MEL-24::PFI-1
MKN45::Dactolisib
MDA-MB-157::I-BET-762
WM793B::Avagacestat
NCI-H82::RVX-208
HeLa::PRT062607
JHOS-2::Dactolisib
U-87-MG::Temozolomide
HCT-116::Osimertinib
AU565::RVX-208
Farage::Ibrutinib
LOU-NH91::Sorafenib
RPMI-7951::Sorafenib
A253::Doramapimod
SW48::RVX-208
IGR-37::PFI-1
HEC-1::RVX-208
NCI-H146::Dactolisib
647-V::VE-822
NCI-H2023::PRT062607
GA-10::PRT062607
MFE-280::Ibrutinib
Daudi::Linsitinib
NOS-1::VE-822
LK-2::Palbociclib
SW948::Lapatinib
IGR-1::Temozolomide
LB2241-RCC::RVX-208
RPMI-6666::RVX-208
LC-2-ad::I-BET-762
NCI-H1048::Dactolisib
P31-FUJ::Osimertinib
ABC-1::AZD6482
KOPN-8::I-BET-762
PANC-03-27::Lapatinib
HCC38::Doramapimod
SW13::RVX-208
JVM-3::PFI-1
RMG-I::Avagacestat
SNU-398::Doramapimod
SUP-HD1::Doramapimod
BICR31::SL0101
SK-UT-1::Linsitinib
PL-21::VE-822
CHSA8926::PRT062607
WM278::VE-822
OCI-LY-19::SL0101
NCI-H2029::Palbociclib
BT-549::Osimertinib
NCI-H1436::PFI-1
PCI-15A::Avagacestat
UACC-62::Osimertinib
JM1::IOX2
LB373-MEL-D::SL0101
KMS-12-BM::Ibrutinib
EW-16::Dactolisib
NCI-H1792::I-BET-762
SU8686::Palbociclib
HOP-62::I-BET-762
HT-3::I-BET-762
NCI-H1781::Linsitinib
DBTRG-05MG::Sorafenib
NCI-H3122::Linsitinib
VMRC-RCZ::Dactolisib
SW954::IOX2
BFTC-909::PRT062607
RVH-421::I-BET-762
P12-ICHIKAWA::PFI-1
SK-MES-1::Ibrutinib
DB::Avagacestat
MOLM-16::Doramapimod
ASH-3::Palbociclib
NB17::PFI-1
MZ7-mel::PFI-1
KYSE-150::Dactolisib
EW-18::Dactolisib
Calu-6::RVX-208
BB65-RCC::AZD6482
SCC-15::Temozolomide
HCC2218::IOX2
HuCCT1::Osimertinib
AMO-1::Palbociclib
TE-11::Lapatinib
KYSE-410::Dactolisib
ALL-SIL::Lapatinib
KYSE-150::Temozolomide
NCI-H1623::PRT062607
CAL-78::RVX-208
SW684::I-BET-762
NCI-H1734::VE-822
C3A::Doramapimod
TE-8::I-BET-762
EW-16::VE-822
NCI-H841::Avagacestat
K2::VE-822
BHY::SL0101
CAS-1::I-BET-762
TK::Ibrutinib
AN3-CA::Lapatinib
NB1::Osimertinib
EW-13::I-BET-762
EVSA-T::Avagacestat
MV-4-11::Dactolisib
KS-1::RVX-208
KALS-1::Temozolomide
DG-75::Lapatinib
OVCAR-8::I-BET-762
TGBC1TKB::Dactolisib
JHH-1::Lapatinib
MHH-CALL-2::I-BET-762
NCI-H2170::PRT062607
NCI-H1975::Temozolomide
HuO-3N1::Temozolomide
MHH-CALL-4::PRT062607
Ramos-2G6-4C10::Doramapimod
SK-MEL-30::Sorafenib
KYSE-50::Doramapimod
IGR-37::I-BET-762
SCH::Dactolisib
NCI-H720::Osimertinib
HCC1954::Linsitinib
HEL::PFI-1
MZ1-PC::Dactolisib
JHH-7::Linsitinib
SNU-283::Dactolisib
HEL::IOX2
DK-MG::Palbociclib
TGBC24TKB::PFI-1
OVTOKO::RVX-208
D-502MG::I-BET-762
STS-0421::Linsitinib
SF539::VE-822
K5::Palbociclib
TC-71::VE-822
5637::Doramapimod
SU-DHL-8::Doramapimod
LS-411N::Sorafenib
ME-180::Lapatinib
A431::AZD6482
RCC-ER::I-BET-762
HT-29::Lapatinib
KG-1::Dactolisib
NCI-H441::Dactolisib
RCC-JF::AZD6482
SUP-M2::PRT062607
NCI-H2029::Avagacestat
SNU-C5::PFI-1
U-2-OS::Osimertinib
HC-1::Temozolomide
DG-75::Sorafenib
KP-3::I-BET-762
SU-DHL-4::Lapatinib
L-363::Ibrutinib
PWR-1E::RVX-208
CAL-33::Temozolomide
SW13::PRT062607
RF-48::VE-822
IST-SL1::Avagacestat
SU-DHL-4::Sorafenib
MZ2-MEL::Dactolisib
D-283MED::I-BET-762
NCI-H1703::Lapatinib
SJRH30::PRT062607
IGR-1::PRT062607
OVKATE::PFI-1
HSC-39::Temozolomide
MHH-PREB-1::Osimertinib
P12-ICHIKAWA::Sorafenib
NCI-H838::Lapatinib
LB1047-RCC::Temozolomide
CaR-1::PFI-1
FADU::Osimertinib
HeLa::Doramapimod
TE-10::Ibrutinib
OVMIU::Avagacestat
MDA-MB-157::Ibrutinib
IMR-5::Palbociclib
OVMIU::PRT062607
A172::PFI-1
C3A::RVX-208
SBC-1::Dactolisib
DoTc2-4510::Avagacestat
CGTH-W-1::Dactolisib
ML-1::SL0101
MOLT-4::Osimertinib
ML-2::Sorafenib
OVCA420::Doramapimod
SNU-449::PRT062607
DB::Lapatinib
PCI-30::Sorafenib
NCI-H209::Dactolisib
KMS-12-BM::RVX-208
OVISE::PRT062607
NB12::Osimertinib
PA-1::VE-822
NCI-H1648::Dactolisib
T84::I-BET-762
GDM-1::Osimertinib
NCI-H1435::Lapatinib
ONS-76::Sorafenib
SNU-387::Palbociclib
DMS-79::RVX-208
WM793B::I-BET-762
OAW-42::I-BET-762
ARH-77::Dactolisib
A204::Temozolomide
ROS-50::IOX2
NB14::Osimertinib
MG-63::Lapatinib
SW962::Ibrutinib
HT55::Linsitinib
HuP-T3::PFI-1
23132-87::Lapatinib
NB(TU)1-10::Dactolisib
NCI-H1869::Osimertinib
CHP-134::Osimertinib
NCI-H650::Doramapimod
BPH-1::PFI-1
COLO-680N::Temozolomide
SW48::Sorafenib
P32-ISH::Sorafenib
JEKO-1::Dactolisib
TE-11::Avagacestat
RC-K8::I-BET-762
SW1783::Lapatinib
UWB1.289::RVX-208
NB12::Palbociclib
OCI-AML2::VE-822
HAL-01::Osimertinib
SK-PN-DW::Doramapimod
NCI-H211::RVX-208
ECC12::Linsitinib
SK-MEL-2::VE-822
PA-TU-8988T::Temozolomide
LCLC-97TM1::PRT062607
LS-411N::PFI-1
NCI-H660::Dactolisib
SNG-M::PRT062607
COR-L32::Sorafenib
KM-H2::Palbociclib
RF-48::PFI-1
CHSA0011::Sorafenib
SCH::Lapatinib
RMG-I::Lapatinib
D-566MG::VE-822
no-10::I-BET-762
MG-63::Sorafenib
OVCAR-8::Lapatinib
RVH-421::Lapatinib
SW837::Palbociclib
MOLM-13::Osimertinib
SUIT-2::Palbociclib
CA46::VE-822
CP66-MEL::Sorafenib
DJM-1::Ibrutinib
EPLC-272H::VE-822
CAL-72::I-BET-762
NU-DUL-1::RVX-208
PWR-1E::Avagacestat
IHH-4::VE-822
MDA-MB-330::Osimertinib
D-263MG::Doramapimod
YH-13::Temozolomide
NCI-H2196::RVX-208
HuP-T4::Temozolomide
LOUCY::Avagacestat
EPLC-272H::Osimertinib
22RV1::Palbociclib
KP-3::Linsitinib
RPMI-6666::Avagacestat
RH-1::PFI-1
JHU-029::Sorafenib
IHH-4::Dactolisib
NCI-H2172::AZD6482
OAW-42::Temozolomide
SNU-61::Linsitinib
RD::PFI-1
huH-1::Avagacestat
CRO-AP2::Linsitinib
A704::Dactolisib
SiHa::Sorafenib
LOU-NH91::PRT062607
COR-L32::Temozolomide
TGW::I-BET-762
RKO::PFI-1
A253::I-BET-762
KYSE-140::Palbociclib
SU-DHL-6::Palbociclib
G-MEL::Ibrutinib
KYSE-510::IOX2
SCC-25::Linsitinib
BALL-1::Palbociclib
SH-4::VE-822
LU-135::RVX-208
MIA-PaCa-2::Avagacestat
RCC-JW::PRT062607
A549::Temozolomide
VMRC-RCZ::PRT062607
HCC-78::Linsitinib
CESS::Linsitinib
CHSA8926::VE-822
HTC-C3::Osimertinib
NB(TU)1-10::I-BET-762
MV-4-11::Avagacestat
TT2609-C02::PRT062607
SNU-407::PFI-1
K-562::Avagacestat
KYSE-510::Osimertinib
CHSA0011::Linsitinib
MOLT-16::PFI-1
MFE-280::Lapatinib
L-1236::Ibrutinib
COLO-205::Palbociclib
SH-4::Lapatinib
LC-1-sq::Osimertinib
OPM-2::Lapatinib
IST-SL2::RVX-208
IST-SL1::Lapatinib
U251::PRT062607
SK-N-DZ::PFI-1
ES-2::Ibrutinib
RCC-FG2::Linsitinib
NCI-H522::Avagacestat
RH-1::Doramapimod
ONS-76::Linsitinib
RVH-421::PFI-1
U-118-MG::Doramapimod
AU565::Doramapimod
SNU-398::Palbociclib
NCI-H1755::Temozolomide
NCI-H2009::Osimertinib
PCI-30::Avagacestat
BE-13::Sorafenib
MOLT-13::Linsitinib
no-11::VE-822
LN-18::Lapatinib
M059J::Lapatinib
COR-L32::Linsitinib
KE-37::Palbociclib
MKN7::AZD6482
NCI-H1436::Temozolomide
BONNA-12::Palbociclib
SW1271::Avagacestat
CAKI-1::PRT062607
P12-ICHIKAWA::Palbociclib
BL-41::I-BET-762
SK-CO-1::Doramapimod
COLO-800::Osimertinib
IGROV-1::Osimertinib
GI-ME-N::RVX-208
ESS-1::I-BET-762
LS-1034::Lapatinib
SNU-C5::Temozolomide
COLO-824::Lapatinib
NCI-H1299::Doramapimod
huH-1::Osimertinib
ALL-SIL::PRT062607
SW1417::Sorafenib
DMS-114::RVX-208
Ca-Ski::Lapatinib
MDA-MB-157::Lapatinib
RERF-LC-MS::PFI-1
CFPAC-1::Palbociclib
Jurkat::RVX-208
KYSE-70::Ibrutinib
DMS-79::SL0101
OVCAR-4::VE-822
TC-YIK::Temozolomide
OCUB-M::Osimertinib
THP-1::Sorafenib
KASUMI-1::RVX-208
NCI-H345::Linsitinib
LAMA-84::Linsitinib
IST-SL1::RVX-208
AsPC-1::Temozolomide
KU-19-19::Lapatinib
COLO-792::RVX-208
SW1088::RVX-208
LC4-1::I-BET-762
SUIT-2::Dactolisib
SK-N-AS::Dactolisib
NCI-H660::RVX-208
PC-3::Temozolomide
NCI-H82::I-BET-762
IPC-298::Avagacestat
LAN-6::Lapatinib
HO-1-N-1::Osimertinib
OCI-LY7::Avagacestat
RXF393::Sorafenib
ES8::Temozolomide
SISO::Avagacestat
AM-38::Palbociclib
HuP-T4::I-BET-762
BE-13::I-BET-762
NCI-H2087::RVX-208
CPC-N::Dactolisib
SW982::PFI-1
OCUM-1::Lapatinib
OACM5-1::Palbociclib
Hs-578-T::Temozolomide
GRANTA-519::Doramapimod
HuH-7::Osimertinib
LK-2::Temozolomide
OVMIU::I-BET-762
GCT::Dactolisib
MOLT-16::Linsitinib
TE-8::Palbociclib
EoL-1-cell::Linsitinib
HSC-3::Linsitinib
HH::I-BET-762
TUR::PRT062607
G-401::Temozolomide
MONO-MAC-6::Doramapimod
CS1::Linsitinib
H-EMC-SS::Linsitinib
T-T::Doramapimod
NEC8::Palbociclib
D-566MG::IOX2
ST486::Ibrutinib
RPMI-6666::I-BET-762
RPMI-8866::Lapatinib
AM-38::I-BET-762
H4::Osimertinib
EFM-192A::Palbociclib
ES4::Avagacestat
MFE-319::RVX-208
KELLY::Lapatinib
SKN-3::Palbociclib
NCI-H2085::Dactolisib
SNU-398::Ibrutinib
IST-SL2::Linsitinib
KS-1::Doramapimod
KYSE-220::PFI-1
NCI-H1975::Osimertinib
PA-TU-8988T::Ibrutinib
SK-PN-DW::RVX-208
CAL-62::PRT062607
HuCCT1::Lapatinib
8-MG-BA::Doramapimod
SU-DHL-4::PFI-1
Ca-Ski::Palbociclib
EM-2::VE-822
KYSE-410::Avagacestat
U-118-MG::PFI-1
NCI-H748::VE-822
NCI-H146::Doramapimod
KON::Ibrutinib
WM35::Linsitinib
NCI-H2122::I-BET-762
CAKI-1::Avagacestat
HLE::I-BET-762
DOHH-2::Doramapimod
HCC-78::Sorafenib
TGBC1TKB::Doramapimod
KMS-11::VE-822
HCC1500::Lapatinib
NCI-H1568::PFI-1
OE21::Temozolomide
HMV-II::Doramapimod
YAPC::Palbociclib
MSTO-211H::Ibrutinib
KU812::VE-822
UWB1.289::Avagacestat
CTB-1::Osimertinib
JHU-011::Avagacestat
COR-L321::Doramapimod
JiyoyeP-2003::Avagacestat
MOLT-4::RVX-208
FU-OV-1::Osimertinib
MOG-G-CCM::Lapatinib
MZ7-mel::PRT062607
PC-14::Linsitinib
MHH-PREB-1::Doramapimod
KU-19-19::VE-822
GDM-1::Sorafenib
CAL-62::Palbociclib
NH-12::Osimertinib
DJM-1::Sorafenib
HCE-4::PFI-1
PCI-15A::Temozolomide
MHH-PREB-1::Temozolomide
SKN-3::I-BET-762
HCC1143::Ibrutinib
A375::Osimertinib
HSC-3::PFI-1
SUP-B8::Lapatinib
NCI-H727::VE-822
KU-19-19::PFI-1
FTC-133::RVX-208
ALL-PO::Osimertinib
SNU-398::PFI-1
HCT-116::Dactolisib
HuCCT1::PRT062607
LOUCY::Ibrutinib
BICR78::Osimertinib
TE-10::Doramapimod
SK-N-SH::Osimertinib
NCI-H510A::RVX-208
HT-115::Lapatinib
CaR-1::VE-822
TE-10::Sorafenib
NCI-H1944::PRT062607
CAL-78::Avagacestat
BALL-1::Linsitinib
U-266::Dactolisib
T98G::VE-822
KP-1N::PFI-1
ES6::Dactolisib
ME-180::RVX-208
HCC1143::PFI-1
RT4::Palbociclib
MS751::Linsitinib
NCI-H1993::VE-822
DMS-53::Avagacestat
WM793B::Sorafenib
NCI-H1693::PFI-1
LK-2::Avagacestat
HCC-827::Temozolomide
A704::RVX-208
BT-474::PRT062607
NCI-H1651::Palbociclib
HCC1569::Dactolisib
MCF7::Dactolisib
CCK-81::Avagacestat
U-118-MG::RVX-208
OCI-AML5::Avagacestat
NCI-H1876::Linsitinib
KYM-1::Lapatinib
KP-2::PFI-1
Raji::Ibrutinib
IGROV-1::Temozolomide
MFM-223::Sorafenib
NCI-H2228::Linsitinib
BB49-HNC::Dactolisib
VCaP::Dactolisib
KYSE-410::Temozolomide
SW872::Temozolomide
HCC1806::Doramapimod
PF-382::Linsitinib
DoTc2-4510::PFI-1
DMS-114::Linsitinib
HCC1395::Linsitinib
OACp4C::Palbociclib
TT::Osimertinib
RERF-LC-KJ::Dactolisib
PCI-4B::Osimertinib
HOP-62::Lapatinib
NOMO-1::Linsitinib
PCI-6A::RVX-208
NCI-H69::Avagacestat
EBC-1::Ibrutinib
JJN-3::PFI-1
BALL-1::Ibrutinib
MC116::VE-822
SU-DHL-5::I-BET-762
GAMG::Doramapimod
LS-411N::Ibrutinib
HLE::Avagacestat
MC116::SL0101
KCL-22::I-BET-762
PA-TU-8902::PRT062607
UACC-893::SL0101
CAL-62::Linsitinib
QGP-1::VE-822
WM35::Doramapimod
NCI-H82::Linsitinib
MM1S::Linsitinib
PWR-1E::Temozolomide
NCI-H2087::Linsitinib
8-MG-BA::Lapatinib
KYSE-520::Sorafenib
HuO-3N1::Osimertinib
NCI-H748::Palbociclib
KYSE-450::PRT062607
K-562::Osimertinib
RXF393::I-BET-762
KYSE-180::Sorafenib
SNU-175::PFI-1
KY821::PFI-1
OCUB-M::PFI-1
RERF-GC-1B::Linsitinib
AGS::RVX-208
SW1710::Linsitinib
NCI-H446::Ibrutinib
NCI-H2135::Temozolomide
RCC-FG2::AZD6482
SK-N-AS::PFI-1
ABC-1::Doramapimod
HCC1187::Osimertinib
ALL-PO::PFI-1
A673::I-BET-762
HuP-T3::Temozolomide
MEL-HO::Avagacestat
COR-L311::RVX-208
HCC1395::Dactolisib
U031::AZD6482
SUP-B15::Dactolisib
COLO-680N::Sorafenib
IHH-4::Osimertinib
JURL-MK1::VE-822
OSC-20::Ibrutinib
NCI-H1993::Dactolisib
MDA-MB-157::RVX-208
LS-1034::Sorafenib
SK-LMS-1::Avagacestat
CHP-126::Lapatinib
SU-DHL-16::IOX2
Mewo::Dactolisib
A375::Palbociclib
SK-N-FI::Temozolomide
NCI-H1436::IOX2
KM-H2::Lapatinib
CAL-33::PRT062607
KMOE-2::VE-822
RH-41::Ibrutinib
COR-L105::Palbociclib
MKN45::Avagacestat
HCC2157::Palbociclib
SW982::RVX-208
NCI-H838::IOX2
NCI-H2452::Temozolomide
OVCA420::Sorafenib
NKM-1::Doramapimod
EW-3::Lapatinib
HCC1599::PRT062607
COLO-205::Lapatinib
EW-24::Lapatinib
HCC38::Linsitinib
PC-14::Osimertinib
CaR-1::Palbociclib
KNS-42::Dactolisib
AGS::Doramapimod
STS-0421::PRT062607
KYSE-520::Palbociclib
ONS-76::RVX-208
COR-L105::Ibrutinib
KYSE-50::Sorafenib
NY::Osimertinib
COR-L105::Dactolisib
HCC1500::Temozolomide
LB2518-MEL::IOX2
LB1047-RCC::Palbociclib
CAL-78::PRT062607
SCH::Ibrutinib
TUR::I-BET-762
NCI-H748::Doramapimod
TK::VE-822
NCI-H1568::Dactolisib
P32-ISH::VE-822
G-401::I-BET-762
HO-1-u-1::Sorafenib
HA7-RCC::I-BET-762
A101D::Palbociclib
HCC38::PFI-1
C3A::PRT062607
RS4-11::Avagacestat
CRO-AP2::Temozolomide
D-392MG::Dactolisib
SK-HEP-1::Avagacestat
COLO-678::VE-822
COR-L321::SL0101
NCI-H1666::Palbociclib
L-428::I-BET-762
HCC1599::PFI-1
NB10::Lapatinib
EW-18::PRT062607
DMS-273::I-BET-762
NCI-H2085::Palbociclib
CAL-148::Palbociclib
HCC2998::Ibrutinib
CS1::Dactolisib
HSC-3::Dactolisib
RCC-AB::Temozolomide
NCI-H1105::PFI-1
NCI-H1792::Dactolisib
OAW-28::Ibrutinib
SK-HEP-1::PRT062607
RH-41::VE-822
SU-DHL-1::Linsitinib
NH-12::Lapatinib
ES5::Doramapimod
WM793B::Ibrutinib
NAMALWA::Doramapimod
SU-DHL-1::Temozolomide
TGBC1TKB::Lapatinib
SU-DHL-5::Lapatinib
TGBC24TKB::Doramapimod
OCI-LY-19::RVX-208
SW1573::Dactolisib
OCI-AML2::RVX-208
NH-12::PFI-1
FU-OV-1::Temozolomide
ST486::Sorafenib
SW948::RVX-208
D-392MG::Sorafenib
ATN-1::Linsitinib
MN-60::Osimertinib
KP-3::RVX-208
CaR-1::Doramapimod
SF126::SL0101
RCM-1::Ibrutinib
HPAC::Avagacestat
Becker::Dactolisib
LS-411N::Doramapimod
DMS-114::PFI-1
OVTOKO::PFI-1
TE-12::Osimertinib
KYSE-450::Ibrutinib
MSTO-211H::I-BET-762
DoTc2-4510::Osimertinib
IHH-4::Ibrutinib
NCI-H1876::PRT062607
ME-1::Palbociclib
TT::Temozolomide
OCI-AML5::Palbociclib
NCI-H1770::Temozolomide
NCI-H358::I-BET-762
CAL-85-1::AZD6482
NCC010::VE-822
J82::PRT062607
HDLM-2::Linsitinib
EKVX::Lapatinib
SF126::Temozolomide
K2::Palbociclib
PA-TU-8988T::Osimertinib
CAL-51::PRT062607
SNU-283::Temozolomide
D-423MG::Avagacestat
NCI-H1688::Doramapimod
NCI-H660::PFI-1
UMC-11::PFI-1
23132-87::I-BET-762
KNS-42::PFI-1
NCI-H23::Dactolisib
JHH-2::Osimertinib
NCI-H358::Sorafenib
NCI-H2196::AZD6482
IST-MES1::VE-822
BEN::Ibrutinib
NCI-H1869::I-BET-762
NCI-H1693::Palbociclib
UACC-893::RVX-208
SNU-C2B::Sorafenib
QIMR-WIL::Doramapimod
Mo-T::PRT062607
MEG-01::Linsitinib
HARA::Lapatinib
MOLP-8::Osimertinib
LC-2-ad::Sorafenib
NCI-H2052::Dactolisib
SK-MM-2::Dactolisib
SISO::Ibrutinib
NCI-H1581::PFI-1
COLO-829::Lapatinib
DBTRG-05MG::Doramapimod
RPMI-8226::Sorafenib
TGBC24TKB::PRT062607
KGN::Dactolisib
CTV-1::Palbociclib
NCI-H2030::Avagacestat
NCI-H1092::Palbociclib
OCUB-M::VE-822
NB69::Sorafenib
MOLT-16::RVX-208
ACHN::RVX-208
HDQ-P1::AZD6482
OCI-AML3::Doramapimod
NAMALWA::Avagacestat
RKO::Lapatinib
YH-13::PFI-1
SUP-M2::Temozolomide
GI-1::Dactolisib
SBC-5::I-BET-762
SN12C::Ibrutinib
NCI-H716::I-BET-762
HCT-15::Osimertinib
SK-N-FI::Doramapimod
CAL-12T::Palbociclib
D-542MG::Sorafenib
SNU-449::RVX-208
H3255::SL0101
DMS-79::Avagacestat
ESO51::PFI-1
BB30-HNC::Ibrutinib
NCI-H1581::Lapatinib
SNU-407::Temozolomide
NCI-H1355::Osimertinib
HEC-1::I-BET-762
NCI-H2066::Doramapimod
HCC1428::Temozolomide
BC-1::Avagacestat
NCI-H1650::Palbociclib
IGR-1::PFI-1
NCI-H716::Ibrutinib
SNU-81::AZD6482
NCI-H1299::Osimertinib
KELLY::PFI-1
REH::Temozolomide
MEL-JUSO::Linsitinib
A375::VE-822
P30-OHK::Palbociclib
DAN-G::RVX-208
ES1::Lapatinib
TCCSUP::Sorafenib
SW1417::Temozolomide
SW872::RVX-208
Ca9-22::Sorafenib
NCI-H1436::Lapatinib
COLO-320-HSR::VE-822
ATN-1::Ibrutinib
KP-2::Palbociclib
COLO-205::RVX-208
SCH::Linsitinib
RVH-421::IOX2
LOUCY::Sorafenib
COLO-668::Palbociclib
K5::Lapatinib
BB49-HNC::VE-822
SW48::Dactolisib
GRANTA-519::Avagacestat
HPAC::Ibrutinib
RD::PRT062607
COLO-829::RVX-208
NCI-H1793::Palbociclib
GCT::PFI-1
COLO-684::Osimertinib
MCF7::Osimertinib
TE-6::Sorafenib
SU-DHL-16::SL0101
HL-60::RVX-208
IGROV-1::Lapatinib
EM-2::Lapatinib
NOMO-1::Palbociclib
SK-LU-1::Doramapimod
NCI-H1836::Palbociclib
PANC-10-05::PRT062607
ML-2::Osimertinib
HT-144::Osimertinib
SK-MG-1::Palbociclib
L-428::Osimertinib
SW1710::Ibrutinib
JIMT-1::Osimertinib
TYK-nu::Doramapimod
HCC1428::PFI-1
AU565::Sorafenib
ES4::Palbociclib
MDA-MB-361::Palbociclib
SW948::Ibrutinib
LK-2::PFI-1
SBC-5::VE-822
A204::Doramapimod
TT::Lapatinib
COLO-829::Osimertinib
SBC-3::Palbociclib
TK::RVX-208
MEL-HO::Dactolisib
T47D::Temozolomide
EM-2::Doramapimod
KARPAS-1106P::Lapatinib
Hey::I-BET-762
SKG-IIIa::Sorafenib
KM-H2::I-BET-762
SW684::VE-822
TC-71::Ibrutinib
KP-1N::Sorafenib
SF295::PFI-1
DOK::Palbociclib
NCI-H2170::I-BET-762
BT-474::Lapatinib
SBC-1::Lapatinib
SKM-1::Doramapimod
COLO-800::AZD6482
KON::I-BET-762
NCI-H2052::Osimertinib
NCI-H2110::Doramapimod
MKN7::Doramapimod
huH-1::Ibrutinib
SLVL::Temozolomide
NCI-H1650::RVX-208
RF-48::Lapatinib
NCI-H810::Dactolisib
TE-8::Temozolomide
EMC-BAC-2::VE-822
NCI-H810::Linsitinib
HuO9::PFI-1
OPM-2::RVX-208
ES8::Avagacestat
SK-LMS-1::Temozolomide
RC-K8::Sorafenib
TOV-21G::PFI-1
RT-112::Osimertinib
D-423MG::Temozolomide
C2BBe1::Linsitinib
NCI-H2172::Temozolomide
NCI-H650::Ibrutinib
SIG-M5::RVX-208
SCC-3::Doramapimod
MOLM-16::Linsitinib
SK-N-DZ::VE-822
SBC-3::I-BET-762
NY::Palbociclib
HCE-4::Ibrutinib
CTV-1::Linsitinib
SKN-3::Ibrutinib
HT-144::Ibrutinib
HSC-39::Sorafenib
HO-1-u-1::Linsitinib
OVTOKO::PRT062607
HOS::Dactolisib
HTC-C3::PFI-1
COR-L32::Lapatinib
NB69::PFI-1
MDA-MB-436::Avagacestat
NCI-H2196::Lapatinib
UM-UC-3::Palbociclib
CP50-MEL-B::VE-822
SK-N-AS::Sorafenib
D-336MG::Dactolisib
KYSE-410::Palbociclib
HARA::PRT062607
RKN::Avagacestat
BB49-HNC::Temozolomide
EW-12::Ibrutinib
KARPAS-422::Palbociclib
EW-3::Avagacestat
RL95-2::Doramapimod
OVCA420::PFI-1
K2::AZD6482
NCI-H2291::Linsitinib
RCC10RGB::Doramapimod
ESO51::Linsitinib
PCI-30::Linsitinib
KARPAS-1106P::Osimertinib
CML-T1::PFI-1
RERF-LC-MS::Palbociclib
KYSE-510::PRT062607
BT-549::Temozolomide
NCI-H2087::VE-822
OVCAR-3::I-BET-762
A204::PRT062607
KNS-81-FD::Sorafenib
ML-1::Sorafenib
NCI-H596::Ibrutinib
MKN7::Temozolomide
HT-29::SL0101
COLO-792::Temozolomide
COLO-824::Dactolisib
NCI-H1993::Temozolomide
CS1::Lapatinib
SU-DHL-5::RVX-208
JVM-2::I-BET-762
KARPAS-620::Avagacestat
KYSE-220::Ibrutinib
A3-KAW::Linsitinib
HEC-1::Linsitinib
MDA-MB-231::Osimertinib
SUP-B8::AZD6482
WM-115::VE-822
IGROV-1::Dactolisib
NCI-H196::I-BET-762
NCI-H1092::VE-822
NCI-H661::Dactolisib
HARA::Sorafenib
LAN-6::Temozolomide
SU-DHL-5::Temozolomide
AMO-1::RVX-208
NCI-H1694::I-BET-762
OCUM-1::Sorafenib
HCC1419::VE-822
COLO-800::RVX-208
NB6::Lapatinib
GRANTA-519::Palbociclib
HA7-RCC::PFI-1
NCI-H650::Temozolomide
ZR-75-30::Linsitinib
JAR::PFI-1
C32::Doramapimod
RCC-AB::Doramapimod
KELLY::Avagacestat
Raji::Osimertinib
NCI-H510A::IOX2
BICR10::Temozolomide
SK-MEL-28::Lapatinib
RXF393::Avagacestat
KARPAS-299::Linsitinib
786-0::Doramapimod
NCI-H1944::RVX-208
CHSA0108::Lapatinib
CAPAN-1::Dactolisib
EB-3::PFI-1
NCC021::IOX2
BHT-101::Linsitinib
D-423MG::RVX-208
NCI-H1048::Sorafenib
ML-2::Palbociclib
ESS-1::Dactolisib
CAS-1::Sorafenib
SUP-B8::PFI-1
KP-1N::PRT062607
NCI-H2172::Palbociclib
JAR::Linsitinib
NCI-H1693::Temozolomide
ME-180::Dactolisib
OCI-LY-19::Doramapimod
HCC1569::SL0101
D-566MG::AZD6482
EVSA-T::Dactolisib
EVSA-T::Palbociclib
HEC-1::PRT062607
HCC1428::Osimertinib
Hey::Ibrutinib
IGR-37::RVX-208
OE33::Avagacestat
NCI-H2170::Osimertinib
COLO-679::Doramapimod
SiHa::PFI-1
KON::Palbociclib
KARPAS-231::Palbociclib
IGR-37::Linsitinib
SK-LMS-1::Doramapimod
NCI-H1869::Temozolomide
EW-1::Ibrutinib
SU-DHL-6::VE-822
HCC1143::VE-822
NB10::Dactolisib
A427::I-BET-762
RT-112::Ibrutinib
ALL-PO::Ibrutinib
L-363::RVX-208
WSU-DLCL2::Lapatinib
RL95-2::Ibrutinib
HCT-116::PRT062607
RERF-GC-1B::Palbociclib
MDA-MB-361::AZD6482
GB-1::RVX-208
KYAE-1::Doramapimod
CAKI-1::IOX2
YH-13::Linsitinib
SK-PN-DW::Temozolomide
MES-SA::Linsitinib
KMRC-20::Sorafenib
MDA-MB-361::I-BET-762
LU-65::Linsitinib
KS-1::Linsitinib
LU-134-A::Osimertinib
OCI-AML3::I-BET-762
RERF-LC-KJ::Avagacestat
SW13::Dactolisib
JHU-022::Avagacestat
HuCCT1::Sorafenib
DBTRG-05MG::Linsitinib
NCI-H2228::Sorafenib
H9::Osimertinib
NCI-H2405::Linsitinib
A431::IOX2
HCE-4::Osimertinib
RL::AZD6482
RC-K8::Lapatinib
KOPN-8::Palbociclib
DMS-273::Avagacestat
EW-24::Sorafenib
SKN::Avagacestat
SK-GT-2::Doramapimod
769-P::Palbociclib
BICR31::Linsitinib
OVKATE::Lapatinib
PF-382::Lapatinib
PANC-04-03::Avagacestat
NCI-H322M::Avagacestat
KINGS-1::I-BET-762
NCI-H660::Osimertinib
OVCAR-4::I-BET-762
COLO-684::Temozolomide
NCI-H28::PFI-1
NB13::Sorafenib
KYSE-410::Osimertinib
AN3-CA::Osimertinib
YAPC::Ibrutinib
HuH-7::Palbociclib
SU-DHL-10::VE-822
CAL-72::Sorafenib
NCI-H720::Sorafenib
ES8::Ibrutinib
SU-DHL-16::RVX-208
SISO::Temozolomide
NCI-H1993::Ibrutinib
KP-3::Doramapimod
LU-99A::RVX-208
PCI-6A::VE-822
REH::Avagacestat
639-V::Lapatinib
U031::I-BET-762
Calu-3::Palbociclib
LAN-6::SL0101
VAL::PFI-1
LN-405::PRT062607
CPC-N::Osimertinib
VCaP::Osimertinib
COLO-320-HSR::Doramapimod
OVMIU::Palbociclib
UACC-257::Dactolisib
SKN::PFI-1
NCI-H23::Ibrutinib
ALL-PO::RVX-208
PF-382::PRT062607
CAL-120::VE-822
EW-7::RVX-208
HuCCT1::Temozolomide
NCI-H211::VE-822
EoL-1-cell::Lapatinib
Calu-3::RVX-208
CAL-29::PFI-1
SNU-175::Avagacestat
NCI-H838::Ibrutinib
ES7::Avagacestat
NCI-H1651::PFI-1
KYSE-410::PRT062607
KYSE-140::PFI-1
HCC1937::Osimertinib
NCI-H1694::Doramapimod
HCC1500::Osimertinib
HEL::Avagacestat
NUGC-4::I-BET-762
A4-Fuk::VE-822
Ramos-2G6-4C10::PFI-1
KYSE-70::PFI-1
COLO-792::Palbociclib
LS-411N::Osimertinib
HT-144::PRT062607
KM12::RVX-208
SAS::PFI-1
OV-7::RVX-208
AGS::Ibrutinib
CHP-134::Ibrutinib
KALS-1::PFI-1
HMV-II::Avagacestat
HH::Osimertinib
BT-474::VE-822
HSC-2::Osimertinib
MKN28::I-BET-762
NCI-H1836::PFI-1
KLE::PFI-1
SHP-77::PRT062607
NCI-H1836::Dactolisib
ST486::Palbociclib
TE-15::Lapatinib
RPMI-8402::Dactolisib
MDA-MB-468::Lapatinib
JHOS-2::IOX2
SU-DHL-5::VE-822
CAL-29::Temozolomide
Daudi::PRT062607
HOP-62::Osimertinib
ALL-SIL::Ibrutinib
OCI-LY7::Palbociclib
D-247MG::IOX2
SK-N-DZ::RVX-208
LB771-HNC::Temozolomide
SUP-HD1::Avagacestat
NCI-H1793::Sorafenib
COLO-680N::Doramapimod
NU-DUL-1::IOX2
CAL-148::Linsitinib
EW-18::Osimertinib
451Lu::AZD6482
22RV1::Ibrutinib
SF295::PRT062607
MFH-ino::Linsitinib
no-10::PFI-1
HPAC::Osimertinib
EoL-1-cell::Doramapimod
SW13::I-BET-762
NCI-H1105::I-BET-762
MG-63::Ibrutinib
KE-37::Osimertinib
STS-0421::Avagacestat
HeLa::RVX-208
EC-GI-10::Linsitinib
NCI-H2141::Palbociclib
COR-L311::PRT062607
KNS-62::Lapatinib
MDA-MB-468::Sorafenib
NUGC-4::Avagacestat
HT-3::Linsitinib
G-361::Doramapimod
OPM-2::PFI-1
HT-115::PFI-1
NCI-H2066::PFI-1
OCI-M1::I-BET-762
OCUM-1::PRT062607
KNS-62::Linsitinib
NH-12::I-BET-762
HGC-27::Doramapimod
OS-RC-2::Lapatinib
EMC-BAC-2::Avagacestat
OV-7::I-BET-762
CHP-212::I-BET-762
MEG-01::Palbociclib
MOLM-13::VE-822
T84::Dactolisib
JHU-011::RVX-208
SF295::Temozolomide
NCI-H2228::I-BET-762
KU-19-19::Avagacestat
TK::Doramapimod
RCC-ER::Doramapimod
NCI-H2444::Ibrutinib
OV-90::I-BET-762
NCI-H211::Dactolisib
JEG-3::Linsitinib
MCF7::VE-822
T-T::Lapatinib
IHH-4::I-BET-762
HuO9::I-BET-762
MKN28::Palbociclib
MEL-JUSO::PFI-1
NCI-H1944::Sorafenib
D-247MG::VE-822
SUP-HD1::VE-822
PCI-15A::Osimertinib
HCC1419::Lapatinib
NCI-H211::Doramapimod
SK-MEL-31::Linsitinib
U251::Sorafenib
ECC12::AZD6482
COLO-678::RVX-208
MZ1-PC::PFI-1
Calu-3::Sorafenib
OCUM-1::Doramapimod
L-428::Ibrutinib
SK-MEL-30::SL0101
NCI-H2347::Linsitinib
A388::Temozolomide
JVM-3::Palbociclib
SUP-B15::VE-822
SCC-4::Doramapimod
SW982::Lapatinib
BEN::RVX-208
LP-1::Lapatinib
HSC-3::Palbociclib
LU-99A::Doramapimod
ES1::Dactolisib
JHH-1::Avagacestat
NB69::Osimertinib
DAN-G::PRT062607
NCI-H2342::Avagacestat
CESS::Sorafenib
KYSE-180::PRT062607
TE-441-T::PFI-1
LN-405::Sorafenib
LK-2::Dactolisib
KARPAS-620::VE-822
OE21::RVX-208
MDST8::Sorafenib
HeLa::PFI-1
BICR22::VE-822
KARPAS-45::RVX-208
Ca9-22::I-BET-762
MKN1::Temozolomide
HSC-2::Sorafenib
U031::Palbociclib
NCI-H1876::Sorafenib
JEG-3::Dactolisib
SW156::VE-822
SW626::PFI-1
IST-SL1::Dactolisib
NUGC-3::I-BET-762
SNU-81::I-BET-762
LB831-BLC::Doramapimod
NCI-H1944::VE-822
K5::PFI-1
KYSE-270::Avagacestat
OVK-18::VE-822
MDA-MB-468::Ibrutinib
RPMI-7951::Doramapimod
COR-L105::Avagacestat
HCC1428::Dactolisib
ESO26::Ibrutinib
BC-1::Sorafenib
HuO9::Dactolisib
NCI-H720::Linsitinib
LAMA-84::PFI-1
NCI-H1568::PRT062607
CRO-AP2::Doramapimod
Calu-3::Temozolomide
PANC-02-03::Dactolisib
JHU-011::Dactolisib
PCI-4B::SL0101
KNS-81-FD::VE-822
NCI-H146::PRT062607
HCC2998::Linsitinib
NCI-H2122::PFI-1
CAMA-1::Lapatinib
BB65-RCC::VE-822
MHH-CALL-2::Palbociclib
8-MG-BA::RVX-208
DoTc2-4510::Linsitinib
SAS::Dactolisib
HA7-RCC::PRT062607
NCI-H810::RVX-208
GAK::Palbociclib
CHP-126::Ibrutinib
NCI-H1299::Ibrutinib
NCI-H2405::I-BET-762
H3255::I-BET-762
MM1S::Palbociclib
LS-513::Doramapimod
KNS-81-FD::RVX-208
LB771-HNC::Lapatinib
EBC-1::Palbociclib
BHY::VE-822
HCC1569::Avagacestat
UACC-62::Palbociclib
NCI-H2172::Dactolisib
HEL::Sorafenib
H3255::AZD6482
MLMA::Palbociclib
CAMA-1::Linsitinib
DG-75::Palbociclib
MDA-MB-415::AZD6482
NCI-H1436::Osimertinib
DB::I-BET-762
PANC-03-27::Avagacestat
NCI-H446::Doramapimod
KS-1::Avagacestat
CML-T1::Linsitinib
RL95-2::VE-822
NCI-H3122::PFI-1
HPAC::VE-822
IM-9::Dactolisib
P31-FUJ::Temozolomide
BHT-101::VE-822
MHH-NB-11::Avagacestat
OVISE::Dactolisib
SU-DHL-6::I-BET-762
KP-N-YN::PRT062607
LC-1-sq::Lapatinib
RS4-11::I-BET-762
MFE-319::Doramapimod
SU-DHL-1::AZD6482
SW1417::Doramapimod
NCI-H526::PFI-1
JVM-3::I-BET-762
MEL-HO::Ibrutinib
HT-1197::Temozolomide
EKVX::Osimertinib
SK-MG-1::Avagacestat
D-336MG::Osimertinib
TGW::VE-822
RT4::Dactolisib
OVCAR-3::Sorafenib
EW-11::Palbociclib
EFO-21::I-BET-762
MN-60::Sorafenib
NCI-H146::SL0101
Calu-3::Avagacestat
COLO-205::PRT062607
SW948::Osimertinib
MKN1::VE-822
EKVX::PRT062607
JM1::Ibrutinib
HCC38::Lapatinib
MG-63::PRT062607
HEC-1::Doramapimod
GI-1::Palbociclib
WIL2-NS::Linsitinib
P30-OHK::Avagacestat
BICR31::PFI-1
SK-GT-2::Ibrutinib
SCC-25::Ibrutinib
RKN::Ibrutinib
LB1047-RCC::Lapatinib
K5::Avagacestat
SNU-61::PRT062607
HeLa::Avagacestat
HCT-116::Doramapimod
KATOIII::I-BET-762
HCC2157::VE-822
OV-7::VE-822
SNU-81::Dactolisib
NCI-H1915::Doramapimod
U-698-M::Avagacestat
OVCAR-8::RVX-208
COLO-678::I-BET-762
TOV-112D::PRT062607
NCI-H2291::I-BET-762
RCC-ER::Lapatinib
YT::PFI-1
COLO-800::Doramapimod
SK-LU-1::Ibrutinib
NB17::RVX-208
SNU-61::Osimertinib
DEL::PFI-1
TE-11::AZD6482
KP-3::Lapatinib
OSC-20::I-BET-762
TE-5::Sorafenib
SCC90::Osimertinib
NCI-H1693::Sorafenib
EB-3::Lapatinib
JHU-022::Sorafenib
GB-1::Avagacestat
KMS-11::Temozolomide
LAN-6::Osimertinib
HO-1-u-1::Doramapimod
huH-1::RVX-208
NOMO-1::Temozolomide
HSC-4::Sorafenib
PANC-10-05::Temozolomide
MDA-MB-157::VE-822
MOLM-16::Sorafenib
NCI-H1876::Doramapimod
LS-1034::I-BET-762
EW-18::PFI-1
HT-1197::Sorafenib
NMC-G1::Lapatinib
PANC-04-03::Linsitinib
A3-KAW::Temozolomide
WM35::Lapatinib
SW1116::Dactolisib
NCI-H28::RVX-208
TC-YIK::Palbociclib
LNCaP-Clone-FGC::Dactolisib
HCC-827::Ibrutinib
LU-139::Linsitinib
RH-41::PRT062607
D-502MG::Avagacestat
MHH-PREB-1::Lapatinib
HCC-15::VE-822
769-P::Avagacestat
OVTOKO::Temozolomide
NCI-H1869::Linsitinib
DOK::Temozolomide
NCI-H2066::Osimertinib
OCI-LY-19::AZD6482
RH-41::Lapatinib
ES4::VE-822
Mewo::Doramapimod
CAL-51::RVX-208
A388::Dactolisib
A253::RVX-208
NCI-H1105::Dactolisib
OVCAR-3::RVX-208
SUP-B15::PRT062607
LC-2-ad::Ibrutinib
SCC-15::I-BET-762
PL-21::I-BET-762
697::VE-822
SNU-C1::Dactolisib
OS-RC-2::Dactolisib
SK-LMS-1::Lapatinib
huH-1::Sorafenib
A3-KAW::Doramapimod
IST-MEL1::Osimertinib
NCI-H345::Doramapimod
T47D::Avagacestat
HCC38::Sorafenib
RCC-AB::I-BET-762
RT4::RVX-208
ROS-50::Doramapimod
HSC-39::PFI-1
NCI-H1092::PRT062607
BONNA-12::AZD6482
OACp4C::Temozolomide
BPH-1::I-BET-762
DMS-114::I-BET-762
SK-PN-DW::Ibrutinib
42-MG-BA::Osimertinib
OCI-LY7::Doramapimod
SNB75::Palbociclib
NCI-H358::Lapatinib
NCI-H810::Temozolomide
no-10::RVX-208
ChaGo-K-1::AZD6482
NCI-H661::I-BET-762
KELLY::Palbociclib
CESS::Doramapimod
HCE-4::RVX-208
SKN-3::Avagacestat
DAN-G::Osimertinib
PANC-04-03::Dactolisib
JHU-011::Osimertinib
REH::RVX-208
P30-OHK::Osimertinib
SK-MG-1::Linsitinib
DEL::Lapatinib
MEL-HO::IOX2
LP-1::Avagacestat
NCCIT::Osimertinib
HSC-2::I-BET-762
KGN::Osimertinib
SAS::VE-822
MG-63::I-BET-762
SBC-3::Lapatinib
LN-405::Ibrutinib
HA7-RCC::RVX-208
SCC-9::Temozolomide
NCI-H1993::Palbociclib
KYSE-410::Lapatinib
SH-4::Doramapimod
MOG-G-UVW::Doramapimod
RERF-LC-MS::Temozolomide
MKN1::PRT062607
ME-180::Sorafenib
SW872::Lapatinib
MEG-01::Ibrutinib
MDST8::Temozolomide
Hs-578-T::PRT062607
OV-90::PFI-1
CADO-ES1::I-BET-762
KON::Lapatinib
HC-1::I-BET-762
DSH1::Linsitinib
A388::VE-822
DOV13::RVX-208
EW-13::RVX-208
OV-7::PFI-1
TE-11::Osimertinib
ACHN::Lapatinib
AsPC-1::Lapatinib
COLO-679::Sorafenib
JSC-1::Lapatinib
MM1S::I-BET-762
KYSE-150::Lapatinib
LOU-NH91::I-BET-762
RMG-I::Linsitinib
ES-2::Lapatinib
TE-441-T::IOX2
LP-1::IOX2
AGS::Temozolomide
G-MEL::SL0101
MM1S::PRT062607
MHH-PREB-1::Ibrutinib
NCI-H510A::Sorafenib
MEL-JUSO::Lapatinib
NCI-H358::PFI-1
JHU-011::Temozolomide
IHH-4::RVX-208
NCI-H1651::Sorafenib
BC-1::Osimertinib
SW780::Linsitinib
NCI-H838::Palbociclib
CAL-39::Dactolisib
NCI-H2135::Lapatinib
LB831-BLC::Palbociclib
SK-CO-1::Ibrutinib
SW620::SL0101
OCI-AML3::Linsitinib
FADU::Avagacestat
ABC-1::Temozolomide
NCI-H2342::Dactolisib
U-2-OS::Palbociclib
EW-7::I-BET-762
NCI-H810::Doramapimod
CAL-72::Doramapimod
UWB1.289::Linsitinib
no-10::Sorafenib
SW13::Linsitinib
LB647-SCLC::Lapatinib
NB14::Temozolomide
OV-90::Doramapimod
LC-1-sq::Temozolomide
HCT-15::Doramapimod
GDM-1::Ibrutinib
NB10::RVX-208
J82::Sorafenib
BxPC-3::RVX-208
LB2518-MEL::Doramapimod
SK-MEL-24::I-BET-762
PANC-04-03::Lapatinib
NCI-H2291::Lapatinib
NCI-H64::Avagacestat
KARPAS-45::Avagacestat
TE-441-T::Palbociclib
DAN-G::Doramapimod
JVM-2::Temozolomide
LoVo::Dactolisib
RPMI-8402::Doramapimod
HPAC::I-BET-762
HT-1080::RVX-208
MDA-MB-157::Doramapimod
OV-90::Sorafenib
RCC-MF::Linsitinib
COR-L321::Osimertinib
U-698-M::PRT062607
WSU-DLCL2::Sorafenib
SW872::PRT062607
SW954::Doramapimod
8-MG-BA::Linsitinib
SHP-77::I-BET-762
NCI-H1963::I-BET-762
NCI-H1694::Dactolisib
HPAC::Sorafenib
KARPAS-45::Ibrutinib
NCI-H1836::Ibrutinib
8305C::PFI-1
D-247MG::Sorafenib
AM-38::Doramapimod
OS-RC-2::RVX-208
BPH-1::Lapatinib
NCI-H740::VE-822
SAS::RVX-208
Detroit562::Temozolomide
SF539::PFI-1
OCUB-M::AZD6482
RF-48::Temozolomide
RCC-JF::Palbociclib
C2BBe1::I-BET-762
DG-75::Avagacestat
CHL-1::PRT062607
MES-SA::Avagacestat
CP66-MEL::Doramapimod
DU-145::PRT062607
PANC-02-03::Ibrutinib
OV-7::Ibrutinib
YKG-1::Dactolisib
NCI-H2227::Sorafenib
BB30-HNC::Lapatinib
BICR78::PFI-1
SCC-3::Ibrutinib
NCI-H1792::VE-822
NCI-H1915::Avagacestat
SUIT-2::Doramapimod
C32::Dactolisib
KY821::Linsitinib
MOLM-13::RVX-208
NCI-H838::Osimertinib
HH::PRT062607
SK-GT-2::Dactolisib
C2BBe1::Palbociclib
TOV-21G::Osimertinib
LAMA-84::Temozolomide
UMC-11::Avagacestat
KCL-22::Linsitinib
HEL::PRT062607
ALL-PO::Palbociclib
no-11::Ibrutinib
M059J::PFI-1
MDA-MB-361::Lapatinib
SAS::Sorafenib
CP66-MEL::Avagacestat
SK-OV-3::Palbociclib
JEKO-1::VE-822
HSC-39::Doramapimod
A204::Dactolisib
SW962::Temozolomide
U-2-OS::Ibrutinib
PEO1::RVX-208
OE33::Doramapimod
CAPAN-1::VE-822
SNU-387::Sorafenib
LOXIMVI::Dactolisib
LOU-NH91::Osimertinib
OSC-20::Temozolomide
MDST8::RVX-208
MC116::Sorafenib
RCC-FG2::Dactolisib
MHH-NB-11::Linsitinib
YKG-1::Lapatinib
HPAF-II::VE-822
JJN-3::Sorafenib
HDQ-P1::Avagacestat
EFO-27::Lapatinib
JHH-6::Osimertinib
MFE-280::Osimertinib
OACM5-1::Sorafenib
CHP-126::Linsitinib
LCLC-97TM1::Osimertinib
H9::Sorafenib
D-542MG::AZD6482
SUIT-2::I-BET-762
NCI-H2452::PFI-1
DU-4475::Palbociclib
A204::Ibrutinib
SNU-175::Temozolomide
MS751::Avagacestat
U-266::Doramapimod
PANC-02-03::Avagacestat
KNS-42::AZD6482
NCI-H526::Avagacestat
BC-1::PFI-1
OV-7::Temozolomide
SW626::VE-822
SNG-M::Temozolomide
C-4-I::VE-822
SNU-C1::Sorafenib
JHOS-2::PFI-1
JHOS-3::Palbociclib
NCI-H520::PRT062607
JHOS-3::Dactolisib
DBTRG-05MG::Ibrutinib
CFPAC-1::Sorafenib
TE-12::VE-822
Becker::VE-822
WSU-NHL::VE-822
NCI-H1755::PRT062607
MOG-G-CCM::Sorafenib
EMC-BAC-1::Temozolomide
IM-9::Palbociclib
NCI-H2444::I-BET-762
CAKI-1::Sorafenib
CAL-54::PFI-1
MFE-296::Sorafenib
SK-GT-2::PRT062607
GRANTA-519::Sorafenib
LK-2::Linsitinib
JHU-011::VE-822
L-428::Palbociclib
NCI-H1838::Osimertinib
MONO-MAC-6::Linsitinib
TT2609-C02::Ibrutinib
JEG-3::AZD6482
NCI-H2170::Linsitinib
KU-19-19::Ibrutinib
J82::I-BET-762
NMC-G1::Avagacestat
ALL-PO::Sorafenib
ARH-77::PRT062607
YH-13::Dactolisib
SK-ES-1::VE-822
PC-3::Doramapimod
MDA-MB-468::PFI-1
HCT-15::Palbociclib
NCI-H2452::Lapatinib
CAL-78::Temozolomide
OCI-AML5::PRT062607
NCI-H510A::VE-822
PANC-10-05::I-BET-762
HC-1::RVX-208
SW620::Temozolomide
ALL-PO::Temozolomide
NCI-H1563::Linsitinib
EFO-27::I-BET-762
DOV13::I-BET-762
GRANTA-519::Lapatinib
PA-TU-8902::Osimertinib
Ca9-22::Doramapimod
LB996-RCC::Temozolomide
NCI-H1299::Dactolisib
LN-18::Osimertinib
GAMG::Avagacestat
NCI-N87::Avagacestat
MDA-MB-468::PRT062607
LS-411N::Dactolisib
HAL-01::Temozolomide
KP-4::Linsitinib
LU-65::PFI-1
KURAMOCHI::Lapatinib
NCI-H196::Linsitinib
BHT-101::Ibrutinib
HOP-62::Linsitinib
NCI-H2227::Lapatinib
JAR::RVX-208
MS-1::Doramapimod
BE2-M17::Doramapimod
MDA-MB-330::SL0101
KARPAS-1106P::Linsitinib
SUP-B8::Sorafenib
HCT-116::Linsitinib
HCC-366::VE-822
NCI-H64::PFI-1
EBC-1::Doramapimod
SK-MEL-30::Lapatinib
EW-11::PFI-1
Hs-578-T::Linsitinib
A101D::Dactolisib
HCC1395::Osimertinib
SW1417::PFI-1
NCI-H1563::Ibrutinib
P30-OHK::I-BET-762
MDA-MB-453::Temozolomide
SW48::Avagacestat
CFPAC-1::Doramapimod
JM1::Linsitinib
CCRF-CEM::Dactolisib
NCI-H1781::VE-822
HT-3::Lapatinib
EW-1::VE-822
L-1236::Doramapimod
HuP-T3::Osimertinib
RXF393::RVX-208
A427::Doramapimod
SCC-15::Palbociclib
MDST8::PFI-1
HCC1937::Dactolisib
TE-6::Lapatinib
DMS-273::Palbociclib
NCI-H1869::RVX-208
CAL-33::Lapatinib
SR::I-BET-762
RERF-LC-Sq1::VE-822
U-118-MG::Lapatinib
COLO-668::VE-822
Saos-2::Linsitinib
COR-L95::Linsitinib
NB5::PFI-1
NCI-H209::Linsitinib
HCC-15::Palbociclib
Daudi::Lapatinib
SW962::Dactolisib
NCI-H358::Palbociclib
SK-MG-1::Osimertinib
Raji::Avagacestat
EB2::Avagacestat
NCI-H1838::Dactolisib
SU-DHL-4::Dactolisib
ROS-50::Temozolomide
NOS-1::Sorafenib
CHP-212::Ibrutinib
CAL-27::Sorafenib
HCC-44::Temozolomide
CAL-39::PRT062607
5637::Palbociclib
BB49-HNC::Sorafenib
NCI-H720::Lapatinib
BEN::AZD6482
SLVL::RVX-208
KP-1N::Osimertinib
QGP-1::Linsitinib
GAK::Temozolomide
VCaP::Ibrutinib
SK-MEL-5::RVX-208
CHP-126::Osimertinib
L-1236::Dactolisib
HT-1376::Lapatinib
WM-115::Osimertinib
U-118-MG::Ibrutinib
DBTRG-05MG::Lapatinib
NCI-H3122::RVX-208
SCC90::PRT062607
CAL-78::Linsitinib
ES7::Sorafenib
NCI-H69::Palbociclib
SK-N-AS::Temozolomide
MHH-NB-11::Ibrutinib
G-402::PFI-1
HCC1569::I-BET-762
LU-65::Temozolomide
SW962::VE-822
COLO-668::Sorafenib
TGBC11TKB::Palbociclib
IM-9::RVX-208
SCC90::Temozolomide
C3A::PFI-1
CTB-1::Linsitinib
SCC-15::Linsitinib
IST-SL2::Temozolomide
NCI-H838::VE-822
SNB75::IOX2
PF-382::VE-822
PANC-02-03::Lapatinib
NCI-H1876::I-BET-762
DG-75::VE-822
NUGC-4::Doramapimod
EW-7::PFI-1
NCI-H2141::Avagacestat
JHH-1::PFI-1
SCC-25::Sorafenib
RXF393::Ibrutinib
SW626::Dactolisib
COLO-205::Sorafenib
ASH-3::Sorafenib
GI-1::Avagacestat
MKN45::Ibrutinib
NCI-H647::Avagacestat
P32-ISH::Osimertinib
OCI-LY7::Ibrutinib
IA-LM::Temozolomide
BICR22::PFI-1
LU-165::VE-822
LU-165::Temozolomide
HeLa::Temozolomide
A549::I-BET-762
HuP-T3::VE-822
YAPC::Sorafenib
HOP-92::Lapatinib
LU-65::Osimertinib
NOMO-1::VE-822
769-P::PRT062607
KOPN-8::RVX-208
BONNA-12::Sorafenib
HCC2218::Osimertinib
U-2-OS::Linsitinib
A2780::Lapatinib
EW-16::Ibrutinib
IST-MES1::Ibrutinib
LCLC-103H::Osimertinib
A388::RVX-208
MHH-CALL-2::PFI-1
SK-N-AS::PRT062607
MHH-CALL-2::PRT062607
NCI-H841::Dactolisib
Caov-4::Osimertinib
HCC1599::Doramapimod
LOU-NH91::Lapatinib
BICR10::VE-822
COR-L303::I-BET-762
RKO::PRT062607
SKM-1::IOX2
NCI-H847::Palbociclib
TOV-21G::Doramapimod
SJRH30::Doramapimod
COLO-783::RVX-208
DND-41::Osimertinib
JHU-011::Sorafenib
Calu-6::Osimertinib
SIG-M5::Avagacestat
BT-549::Ibrutinib
TGBC24TKB::Avagacestat
Farage::Sorafenib
HuCCT1::Linsitinib
RT4::I-BET-762
KYSE-410::RVX-208
NCI-H1299::PRT062607
HCC1500::RVX-208
SU-DHL-6::Temozolomide
ES4::Dactolisib
MCF7::PRT062607
NCI-H596::PRT062607
OCUM-1::PFI-1
NCI-H209::Avagacestat
PA-TU-8988T::Doramapimod
CAL-27::VE-822
PFSK-1::Ibrutinib
COLO-824::Avagacestat
ES7::PFI-1
NCI-H345::Lapatinib
LB2518-MEL::RVX-208
Daudi::PFI-1
MM1S::Dactolisib
LOUCY::RVX-208
HCC1500::Sorafenib
IST-SL1::AZD6482
KYAE-1::RVX-208
MPP-89::Sorafenib
G-MEL::VE-822
NCI-H747::PRT062607
KM-H2::PFI-1
SKM-1::Osimertinib
SF295::Lapatinib
RCH-ACV::Sorafenib
BB65-RCC::Sorafenib
SW982::Ibrutinib
no-10::Doramapimod
SK-LU-1::Temozolomide
OAW-28::Osimertinib
VAL::Temozolomide
MM1S::Osimertinib
KOSC-2::RVX-208
D-566MG::Lapatinib
NCI-H1581::Dactolisib
8505C::RVX-208
COLO-829::VE-822
SF539::Temozolomide
KG-1::Sorafenib
IST-MES1::Linsitinib
BFTC-909::Ibrutinib
BICR10::Lapatinib
IA-LM::I-BET-762
J82::Dactolisib
DB::Dactolisib
IM-95::RVX-208
ACHN::Doramapimod
NB69::Doramapimod
VMRC-LCD::Ibrutinib
Becker::Osimertinib
Mewo::Temozolomide
HOS::I-BET-762
SU-DHL-5::Avagacestat
UACC-257::Ibrutinib
NCI-H1648::Doramapimod
ML-1::AZD6482
MOLT-4::Avagacestat
SK-LU-1::Osimertinib
SK-N-FI::Sorafenib
NCI-H2085::Ibrutinib
JJN-3::Dactolisib
NCI-H661::RVX-208
TT2609-C02::RVX-208
SCC-25::Temozolomide
JHH-1::Palbociclib
CAL-78::I-BET-762
FLO-1::Doramapimod
A3-KAW::PRT062607
LP-1::AZD6482
EW-18::RVX-208
HCC1937::Avagacestat
NCI-H740::Dactolisib
786-0::Osimertinib
BALL-1::Lapatinib
IM-95::Osimertinib
GI-ME-N::I-BET-762
ROS-50::Lapatinib
MDA-MB-468::Dactolisib
CP50-MEL-B::Temozolomide
KARPAS-1106P::Dactolisib
RCC10RGB::Avagacestat
MOLM-16::RVX-208
HA7-RCC::Ibrutinib
MDA-MB-361::VE-822
HT-144::Doramapimod
BE2-M17::Temozolomide
BONNA-12::RVX-208
ME-1::RVX-208
MV-4-11::Palbociclib
LS-513::RVX-208
NCI-H1792::Linsitinib
NCI-H1781::Dactolisib
COLO-320-HSR::Ibrutinib
IHH-4::Sorafenib
WM1552C::PFI-1
Calu-3::I-BET-762
RF-48::Sorafenib
A375::Sorafenib
SU-DHL-16::PFI-1
MES-SA::Osimertinib
SiHa::I-BET-762
NB69::Temozolomide
TE-1::Dactolisib
LC-2-ad::Doramapimod
Calu-3::Doramapimod
SNU-C1::Linsitinib
NCI-H1836::SL0101
NCI-H209::Lapatinib
WIL2-NS::Avagacestat
CAL-27::I-BET-762
L-540::PFI-1
SK-GT-2::PFI-1
G-401::Sorafenib
K-562::Lapatinib
LB373-MEL-D::IOX2
NCI-H3122::Dactolisib
HCC1143::Osimertinib
RL::RVX-208
NCC021::Osimertinib
RT-112::Doramapimod
OCI-LY7::VE-822
NCI-H2227::Palbociclib
M059J::Dactolisib
NCI-H2227::VE-822
JAR::Osimertinib
RCC-FG2::Doramapimod
LN-18::RVX-208
SCC-3::Osimertinib
WM278::PRT062607
ALL-PO::Lapatinib
NCI-H1734::Lapatinib
MOLT-16::VE-822
JJN-3::RVX-208
EW-12::RVX-208
NCI-H747::Linsitinib
CHSA8926::Doramapimod
CP66-MEL::Osimertinib
RCC-JF::RVX-208
FADU::Doramapimod
LU-134-A::Sorafenib
KARPAS-231::Temozolomide
ML-1::IOX2
TYK-nu::Temozolomide
SW1463::Avagacestat
SW1783::Doramapimod
JHH-7::Osimertinib
HCC1937::VE-822
CAL-29::Doramapimod
RCM-1::Lapatinib
SW780::Lapatinib
NB69::Dactolisib
JHH-4::I-BET-762
KS-1::VE-822
KP-2::I-BET-762
IM-95::Doramapimod
KMRC-20::Linsitinib
U031::VE-822
PCI-15A::Doramapimod
PA-TU-8902::RVX-208
LS-123::VE-822
NCI-H1781::Temozolomide
HuP-T3::Palbociclib
IPC-298::Ibrutinib
PL4::Doramapimod
J82::RVX-208
MM1S::RVX-208
KARPAS-620::Palbociclib
NY::VE-822
SJSA-1::Linsitinib
NCI-H2087::Ibrutinib
SU-DHL-6::Dactolisib
KMRC-20::Ibrutinib
HuP-T3::Linsitinib
SUP-T1::Osimertinib
SF126::IOX2
ES6::Doramapimod
IGROV-1::Ibrutinib
MES-SA::Lapatinib
SUP-B8::SL0101
G-361::Palbociclib
LC-2-ad::PRT062607
SK-N-DZ::Avagacestat
JiyoyeP-2003::Lapatinib
EPLC-272H::Dactolisib
HT-1197::PFI-1
EJM::Avagacestat
LB2518-MEL::Avagacestat
DOHH-2::Temozolomide
MONO-MAC-6::Temozolomide
RCC-JF::SL0101
Hs-445::RVX-208
HO-1-N-1::RVX-208
JHU-022::Ibrutinib
Daudi::Ibrutinib
OVCA420::Palbociclib
KMOE-2::Palbociclib
EB-3::I-BET-762
OAW-28::Dactolisib
IA-LM::PFI-1
OV-56::Doramapimod
LU-99A::Linsitinib
VMRC-RCZ::PFI-1
ES6::VE-822
42-MG-BA::Doramapimod
A704::Avagacestat
SF126::PFI-1
CFPAC-1::Linsitinib
SW684::Lapatinib
ECC10::Temozolomide
NU-DUL-1::VE-822
MFE-319::VE-822
NCI-H596::Avagacestat
SW872::Linsitinib
SU-DHL-10::I-BET-762
COLO-792::PFI-1
IST-SL1::Osimertinib
ECC12::I-BET-762
SNB75::PRT062607
KALS-1::Palbociclib
ES8::I-BET-762
DOK::Avagacestat
MZ2-MEL::Linsitinib
WM-115::PFI-1
RCC10RGB::Ibrutinib
A2058::Sorafenib
639-V::Osimertinib
SUP-B15::Lapatinib
EFM-19::Lapatinib
HARA::Linsitinib
LS-513::Palbociclib
EW-13::Temozolomide
HDQ-P1::Osimertinib
MIA-PaCa-2::PFI-1
COR-L32::Avagacestat
NB7::Linsitinib
SNB75::PFI-1
LU-134-A::Lapatinib
GP5d::Linsitinib
HCT-15::I-BET-762
GOTO::Doramapimod
COR-L23::Ibrutinib
22RV1::PFI-1
KYM-1::RVX-208
ARH-77::RVX-208
ZR-75-30::Temozolomide
SK-OV-3::PRT062607
DoTc2-4510::RVX-208
D-283MED::Doramapimod
SW756::Temozolomide
UWB1.289::Lapatinib
MZ7-mel::Linsitinib
Ca-Ski::PRT062607
WIL2-NS::Osimertinib
RL::I-BET-762
NCI-H82::Lapatinib
769-P::Linsitinib
NB1::Sorafenib
U031::Doramapimod
EW-3::Sorafenib
CP50-MEL-B::Linsitinib
HDQ-P1::Linsitinib
MS-1::Palbociclib
NCI-H1693::Doramapimod
MFE-319::Temozolomide
SCC-9::Palbociclib
A427::PFI-1
CW-2::Temozolomide
ES-2::Linsitinib
HAL-01::Sorafenib
TE-9::I-BET-762
SW948::Linsitinib
SK-MEL-3::PFI-1
YAPC::Dactolisib
ChaGo-K-1::Ibrutinib
NCI-H747::Palbociclib
BB49-HNC::Lapatinib
KYSE-220::Palbociclib
RXF393::Lapatinib
RCC-ER::Dactolisib
ALL-PO::Avagacestat
RCC-FG2::RVX-208
DSH1::PRT062607
IST-MEL1::Lapatinib
BxPC-3::I-BET-762
TE-9::Avagacestat
GCT::Palbociclib
PC-3::VE-822
KURAMOCHI::RVX-208
LB831-BLC::Osimertinib
LCLC-103H::Ibrutinib
DU-4475::Ibrutinib
SIMA::Palbociclib
NCI-H2227::SL0101
NCI-H146::RVX-208
GB-1::Dactolisib
NCI-H1651::Linsitinib
KP-4::Sorafenib
451Lu::RVX-208
RCC-FG2::Ibrutinib
OC-314::Doramapimod
RVH-421::AZD6482
G-MEL::Temozolomide
SN12C::Sorafenib
TYK-nu::PRT062607
VMRC-LCD::Lapatinib
NCI-H520::Doramapimod
MDA-MB-453::AZD6482
COLO-829::Linsitinib
AM-38::VE-822
KCL-22::VE-822
BC-1::Dactolisib
BFTC-909::I-BET-762
LK-2::Lapatinib
SNU-423::PFI-1
D-423MG::Ibrutinib
NCI-H1755::Doramapimod
SIG-M5::I-BET-762
RPMI-7951::RVX-208
MOG-G-UVW::Lapatinib
HPAC::Lapatinib
NCI-H1651::Avagacestat
NCI-H522::Lapatinib
RL::SL0101
JHU-011::PRT062607
PL4::PRT062607
SUIT-2::PRT062607
EW-11::Avagacestat
OVK-18::I-BET-762
NCI-H740::Ibrutinib
SNU-423::Osimertinib
SW1417::Avagacestat
U-266::Avagacestat
NCI-H23::RVX-208
U-87-MG::Osimertinib
RT-112::RVX-208
BB65-RCC::RVX-208
KMRC-20::VE-822
JAR::I-BET-762
NCI-H345::RVX-208
HPAC::Temozolomide
MOLT-16::PRT062607
A4-Fuk::Doramapimod
SNG-M::Linsitinib
ATN-1::Sorafenib
23132-87::Doramapimod
Ramos-2G6-4C10::Osimertinib
HCC1143::Palbociclib
GP5d::RVX-208
KP-4::Lapatinib
LAN-6::PRT062607
RF-48::PRT062607
KMRC-20::I-BET-762
SK-MEL-1::Doramapimod
HCC70::PFI-1
EMC-BAC-1::Lapatinib
COR-L311::Sorafenib
NCI-H1623::RVX-208
KYAE-1::Avagacestat
TOV-112D::RVX-208
RERF-GC-1B::Doramapimod
TOV-21G::Dactolisib
MDA-MB-330::PFI-1
CAL-85-1::Sorafenib
HT-29::Dactolisib
HCC2218::Sorafenib
MFM-223::Lapatinib
ALL-SIL::Osimertinib
NCI-H596::I-BET-762
23132-87::Palbociclib
ABC-1::PFI-1
LK-2::VE-822
NCI-H69::Dactolisib
MPP-89::RVX-208
M14::Sorafenib
NCI-H524::VE-822
SUP-B8::Palbociclib
EM-2::Ibrutinib
Hey::Doramapimod
HCC1599::Temozolomide
CAL-33::Avagacestat
TE-441-T::VE-822
BICR78::Avagacestat
KMRC-1::Avagacestat
CAL-120::I-BET-762
SU-DHL-1::RVX-208
VCaP::Temozolomide
RCC-JW::RVX-208
SCH::Doramapimod
MFE-296::Palbociclib
FADU::PFI-1
NCI-H2444::Linsitinib
Ca9-22::Lapatinib
KURAMOCHI::Temozolomide
RO82-W-1::Dactolisib
DK-MG::Sorafenib
SBC-3::Dactolisib
SW756::I-BET-762
CA46::Temozolomide
NCI-H226::Sorafenib
HCC-366::Temozolomide
SW48::PRT062607
NCI-H82::VE-822
NCI-H146::Ibrutinib
PEO1::Linsitinib
SKG-IIIa::Osimertinib
TGBC24TKB::Palbociclib
CTV-1::PRT062607
EW-13::PFI-1
SU8686::Avagacestat
ESO26::Dactolisib
MEL-HO::Temozolomide
LAMA-84::Sorafenib
NCI-H1770::Avagacestat
COR-L279::Lapatinib
EFM-192A::RVX-208
COLO-824::Linsitinib
A704::Osimertinib
SCC-25::PRT062607
DND-41::Lapatinib
TE-5::Lapatinib
DG-75::Temozolomide
GAMG::Sorafenib
NCI-H522::Palbociclib
HDLM-2::Osimertinib
MDA-MB-157::Temozolomide
AsPC-1::I-BET-762
UACC-62::PFI-1
SU-DHL-6::Linsitinib
OVK-18::RVX-208
TT2609-C02::Sorafenib
OVK-18::Sorafenib
KARPAS-299::PRT062607
MOLT-13::Avagacestat
PCI-4B::VE-822
JHH-4::Palbociclib
HCC-366::Osimertinib
KALS-1::Ibrutinib
786-0::Avagacestat
LCLC-103H::RVX-208
HCC1419::Doramapimod
OVK-18::Dactolisib
TT2609-C02::VE-822
SK-MEL-3::RVX-208
GI-ME-N::Palbociclib
IPC-298::I-BET-762
NCI-H1694::VE-822
A2780::Avagacestat
COLO-679::Lapatinib
G-402::Dactolisib
LB831-BLC::Linsitinib
HOS::PFI-1
CAL-39::Osimertinib
OVCAR-4::Linsitinib
BT-549::RVX-208
KARPAS-231::Avagacestat
MKN28::Linsitinib
MOG-G-UVW::Linsitinib
TE-441-T::Temozolomide
no-10::SL0101
HCC70::Palbociclib
COR-L88::Dactolisib
OCI-AML3::Palbociclib
SW48::Doramapimod
RT-112::Linsitinib
KARPAS-231::Doramapimod
RCC-ER::Ibrutinib
JHH-2::Palbociclib
GOTO::Sorafenib
BFTC-905::Avagacestat
ES1::Palbociclib
LU-139::I-BET-762
HDLM-2::Temozolomide
MKN7::Lapatinib
NCI-H740::Palbociclib
TE-12::RVX-208
ES6::Avagacestat
TK10::PRT062607
SK-N-FI::Linsitinib
CL-11::Linsitinib
NCI-H1975::Linsitinib
OSC-20::Lapatinib
SK-MEL-5::Sorafenib
LAMA-84::VE-822
SCC-9::I-BET-762
MOLP-8::Dactolisib
HSC-2::Temozolomide
LU-165::RVX-208
NCI-H1435::Avagacestat
MHH-NB-11::Sorafenib
NCI-H1105::Linsitinib
CAL-29::PRT062607
OVTOKO::Ibrutinib
NCI-H526::Lapatinib
MKN28::PFI-1
UWB1.289::AZD6482
KYAE-1::Temozolomide
HCC38::Temozolomide
SW156::Temozolomide
COLO-824::Ibrutinib
SAT::Doramapimod
HCC38::Avagacestat
HCC-44::Doramapimod
MOLP-8::Temozolomide
COLO-320-HSR::Temozolomide
EJM::Doramapimod
AM-38::Osimertinib
8505C::VE-822
BICR78::RVX-208
SW1710::RVX-208
WSU-DLCL2::Avagacestat
BE-13::Lapatinib
NB17::VE-822
IST-SL1::Sorafenib
DK-MG::PFI-1
IST-MEL1::Sorafenib
NB5::RVX-208
SK-MM-2::VE-822
LS-180::PFI-1
THP-1::Osimertinib
RPMI-6666::Ibrutinib
OE33::VE-822
HCC1569::AZD6482
CAL-29::I-BET-762
HCC1806::RVX-208
K5::Doramapimod
NCI-H1869::VE-822
MZ7-mel::Sorafenib
BICR78::Doramapimod
NCC010::PRT062607
HSC-2::Doramapimod
MEL-HO::I-BET-762
K5::Dactolisib
ALL-SIL::Linsitinib
HCC1954::PRT062607
OCUB-M::Lapatinib
CTB-1::VE-822
NCI-H446::Avagacestat
VMRC-LCD::PFI-1
CP66-MEL::Linsitinib
CML-T1::Dactolisib
OCI-LY7::PFI-1
697::Dactolisib
COLO-829::Sorafenib
DG-75::RVX-208
JIMT-1::Linsitinib
8-MG-BA::Osimertinib
NCI-H23::PRT062607
H9::Lapatinib
NCI-H1341::Doramapimod
JHH-4::PRT062607
NU-DUL-1::Palbociclib
NCI-H441::Linsitinib
MHH-NB-11::PFI-1
LU-134-A::IOX2
NCI-H2085::PRT062607
NCI-H209::Ibrutinib
JEG-3::RVX-208
CP66-MEL::Ibrutinib
GI-1::VE-822
MS-1::Sorafenib
SCC-15::Osimertinib
MKN28::PRT062607
OCI-LY-19::PRT062607
HuCCT1::I-BET-762
Ca-Ski::Sorafenib
HuP-T3::RVX-208
ES6::Sorafenib
COR-L311::PFI-1
NCI-H28::VE-822
SK-MEL-28::AZD6482
NCI-H1770::Linsitinib
KMS-11::RVX-208
CL-11::Ibrutinib
D-502MG::Ibrutinib
SU-DHL-4::Doramapimod
OV-56::Linsitinib
OVCAR-5::Linsitinib
EFO-27::Linsitinib
COLO-668::Lapatinib
MOLT-4::Linsitinib
BC-1::I-BET-762
SF295::VE-822
RCC-JW::Osimertinib
ME-1::Sorafenib
NCI-H209::PFI-1
HT-1197::Palbociclib
SK-MEL-5::I-BET-762
CRO-AP2::IOX2
NCI-H1648::PFI-1
OVCAR-4::Avagacestat
GAK::Lapatinib
KARPAS-620::Ibrutinib
ESS-1::Palbociclib
NCI-H1770::PFI-1
MDA-MB-157::PRT062607
NCI-H3122::PRT062607
NB6::Dactolisib
DOV13::Osimertinib
DG-75::Dactolisib
NCI-H82::PRT062607
RPMI-8226::Linsitinib
VCaP::Linsitinib
NCI-H69::Lapatinib
AGS::PRT062607
PA-1::Sorafenib
A2058::I-BET-762
KGN::Temozolomide
HuH-7::Avagacestat
JIMT-1::Palbociclib
SF295::Doramapimod
CCRF-CEM::VE-822
H-EMC-SS::Lapatinib
HCC1806::PFI-1
GAK::Avagacestat
NCI-H1581::Sorafenib
MFE-280::PFI-1
ASH-3::Linsitinib
NCI-H510A::SL0101
RF-48::Doramapimod
SW1271::Sorafenib
YT::Palbociclib
KG-1::I-BET-762
T98G::Lapatinib
CP66-MEL::Dactolisib
NCI-H2135::VE-822
MFE-319::PFI-1
KNS-62::Temozolomide
EMC-BAC-1::IOX2
SKM-1::Linsitinib
OV-7::Dactolisib
Mo-T::Palbociclib
KYSE-510::I-BET-762
L-363::Lapatinib
D-247MG::Ibrutinib
RCC10RGB::Sorafenib
RCC-AB::Linsitinib
RD::I-BET-762
SCC90::Ibrutinib
U031::Temozolomide
OVCAR-8::Linsitinib
GRANTA-519::Linsitinib
MEL-HO::Osimertinib
RKO::Osimertinib
SK-OV-3::Ibrutinib
786-0::PFI-1
EW-16::RVX-208
NCI-H2196::Dactolisib
CCRF-CEM::Doramapimod
TC-71::Dactolisib
LB2518-MEL::Linsitinib
GCT::Avagacestat
COR-L279::PFI-1
NCI-H1836::Doramapimod
KOPN-8::Sorafenib
SCC-25::Osimertinib
GB-1::Lapatinib
RT-112::Dactolisib
TGBC11TKB::Avagacestat
TOV-21G::Lapatinib
HPAC::RVX-208
MHH-CALL-4::I-BET-762
BV-173::Dactolisib
NCI-H2444::Temozolomide
KP-2::Linsitinib
EW-24::Dactolisib
GOTO::Dactolisib
CCRF-CEM::Osimertinib
EW-16::I-BET-762
IST-MEL1::Temozolomide
JHU-029::AZD6482
D-247MG::Palbociclib
RPMI-7951::PFI-1
COLO-679::Palbociclib
SW780::PFI-1
BHY::Dactolisib
CHSA0108::Sorafenib
IM-9::Temozolomide
SW684::Sorafenib
A549::Sorafenib
DOV13::Linsitinib
PANC-04-03::Palbociclib
L-363::PFI-1
SCC-4::Palbociclib
PF-382::Dactolisib
RPMI-8226::PRT062607
NCI-H2405::Osimertinib
CAS-1::Lapatinib
HEC-1::Temozolomide
VCaP::Doramapimod
YKG-1::PFI-1
YAPC::Temozolomide
NCI-H2052::RVX-208
SW1990::Osimertinib
CaR-1::I-BET-762
OCI-AML3::Ibrutinib
COLO-824::Doramapimod
NB14::PRT062607
NCCIT::Sorafenib
P32-ISH::Dactolisib
ACHN::Palbociclib
NCI-H716::Dactolisib
ECC10::Linsitinib
CAL-27::PFI-1
MOLP-8::I-BET-762
A431::Lapatinib
TT2609-C02::Dactolisib
COR-L23::VE-822
KNS-42::VE-822
TK::PFI-1
C-33-A::Linsitinib
RCC-MF::Avagacestat
TT2609-C02::Lapatinib
HPAC::Palbociclib
ES8::Lapatinib
SW756::Doramapimod
SW1710::PFI-1
COR-L279::Doramapimod
ETK-1::RVX-208
JURL-MK1::Palbociclib
HA7-RCC::Dactolisib
BEN::Dactolisib
LS-513::Lapatinib
BE-13::RVX-208
COR-L303::Ibrutinib
COLO-792::Lapatinib
NCI-H522::PFI-1
KP-1N::Temozolomide
KYSE-270::PFI-1
SUP-B8::IOX2
ONS-76::Osimertinib
NCI-H2029::Ibrutinib
C2BBe1::Doramapimod
SF295::Sorafenib
KGN::Doramapimod
VA-ES-BJ::Sorafenib
NCI-H322M::Sorafenib
NCI-H1355::Doramapimod
8-MG-BA::VE-822
K5::RVX-208
GI-ME-N::Avagacestat
EFM-19::PRT062607
LoVo::Temozolomide
Becker::Linsitinib
Hs-445::Ibrutinib
NCI-H1155::Palbociclib
NCI-H650::Dactolisib
A204::VE-822
BT-20::Ibrutinib
CTV-1::PFI-1
HeLa::Linsitinib
KY821::Palbociclib
NCI-H1869::Sorafenib
RH-1::Sorafenib
SW1271::Palbociclib
MC116::Ibrutinib
CAL-39::PFI-1
MHH-NB-11::VE-822
NCI-H1105::Lapatinib
U031::IOX2
RO82-W-1::PRT062607
COR-L279::Osimertinib
DMS-53::Temozolomide
Caov-4::Doramapimod
RCC-MF::RVX-208
NMC-G1::Osimertinib
MC116::Osimertinib
BICR78::Ibrutinib
COLO-668::PRT062607
HLE::PRT062607
NCI-H2196::PRT062607
SBC-5::Linsitinib
NCI-H23::Temozolomide
WM-115::Dactolisib
SK-GT-4::Ibrutinib
NCI-H660::SL0101
A3-KAW::VE-822
CP50-MEL-B::RVX-208
NCI-H146::Avagacestat
LOUCY::Palbociclib
NCI-H1573::Linsitinib
WM793B::PRT062607
SNU-449::Lapatinib
RKO::RVX-208
SCC-4::Ibrutinib
SF126::Palbociclib
RCC-FG2::PRT062607
TE-9::VE-822
GDM-1::Palbociclib
SBC-3::Ibrutinib
SCC-4::PRT062607
HT-29::Palbociclib
ESO51::Sorafenib
ASH-3::Lapatinib
NCI-H727::Avagacestat
NEC8::Doramapimod
LB996-RCC::VE-822
WIL2-NS::PRT062607
FADU::I-BET-762
GCT::Linsitinib
NCI-H69::Temozolomide
SJRH30::Osimertinib
CHSA8926::Palbociclib
SNG-M::PFI-1
NCI-H1915::Ibrutinib
HuP-T3::Ibrutinib
G-402::Ibrutinib
HuO9::Lapatinib
ES1::Osimertinib
CCK-81::Osimertinib
NB6::PFI-1
NCI-H1703::PFI-1
BHY::Doramapimod
NCI-H748::PRT062607
COLO-668::Avagacestat
TUR::Linsitinib
COLO-320-HSR::Avagacestat
OVTOKO::I-BET-762
SW1573::Linsitinib
NB7::Lapatinib
NCI-H838::PRT062607
HuP-T4::Osimertinib
DJM-1::AZD6482
LS-180::Temozolomide
COR-L23::PRT062607
EMC-BAC-2::PRT062607
RCC-JW::Sorafenib
DOV13::Lapatinib
RXF393::Temozolomide
SW962::Lapatinib
WM35::Dactolisib
EW-11::VE-822
COLO-679::Dactolisib
NCI-H1105::AZD6482
DMS-79::Sorafenib
SBC-5::Lapatinib
BL-41::PFI-1
HSC-3::RVX-208
LS-123::Doramapimod
LP-1::Ibrutinib
CHL-1::Osimertinib
LU-139::Avagacestat
PC-14::Sorafenib
UACC-62::Temozolomide
GR-ST::PFI-1
NCI-H446::Lapatinib
NALM-6::Linsitinib
RS4-11::Osimertinib
CTB-1::Ibrutinib
PA-TU-8988T::Avagacestat
U031::Linsitinib
SNU-423::Linsitinib
TC-71::Avagacestat
NCI-H838::I-BET-762
KON::RVX-208
NH-12::Linsitinib
NCI-H1048::PFI-1
ES4::Linsitinib
CL-11::VE-822
RPMI-6666::Doramapimod
KATOIII::Ibrutinib
D-502MG::Doramapimod
DMS-114::Osimertinib
NAMALWA::Linsitinib
HLE::Sorafenib
SU-DHL-4::Palbociclib
RKO::Dactolisib
SK-MEL-3::Sorafenib
SN12C::Dactolisib
SCC-15::Doramapimod
LU-135::PFI-1
HuH-7::I-BET-762
U-2-OS::Dactolisib
EB-3::Sorafenib
HCC2998::Dactolisib
SKG-IIIa::Ibrutinib
NB10::Linsitinib
COR-L321::Dactolisib
BE-13::Linsitinib
SKG-IIIa::PFI-1
A498::Dactolisib
MKN7::Palbociclib
NCI-H1734::Linsitinib
DK-MG::Doramapimod
KARPAS-422::RVX-208
SK-N-SH::PFI-1
GA-10::Temozolomide
HEC-1::VE-822
NCI-H2030::Dactolisib
SW1088::Temozolomide
IM-95::Avagacestat
A253::VE-822
JIMT-1::AZD6482
ABC-1::Avagacestat
C-4-I::Sorafenib
NCI-H2227::Ibrutinib
SW837::Doramapimod
G-402::RVX-208
NCI-H2135::Doramapimod
CCK-81::Temozolomide
CHL-1::Linsitinib
A2780::I-BET-762
HGC-27::Avagacestat
HuO9::Palbociclib
CAL-54::RVX-208
KYSE-150::Palbociclib
8-MG-BA::Sorafenib
YAPC::PFI-1
KMRC-1::PFI-1
ES7::Palbociclib
NCI-H1755::VE-822
RCC-JF::Doramapimod
CAL-54::Osimertinib
NCI-H2087::PRT062607
OE19::Doramapimod
LNCaP-Clone-FGC::PFI-1
C32::PFI-1
LU-135::VE-822
H-EMC-SS::Avagacestat
NCI-H1436::VE-822
MLMA::VE-822
C-4-I::I-BET-762
LC-1-sq::Palbociclib
LS-411N::Palbociclib
OVCAR-5::Sorafenib
WM-115::Temozolomide
U251::Ibrutinib
MZ7-mel::Avagacestat
NCI-H441::PFI-1
LB2241-RCC::PFI-1
LOU-NH91::RVX-208
TE-11::Temozolomide
CTV-1::Ibrutinib
NCI-H1048::Temozolomide
COR-L311::Temozolomide
COLO-824::RVX-208
PL4::Ibrutinib
K-562::Ibrutinib
TE-441-T::Ibrutinib
NB5::PRT062607
LU-135::PRT062607
NCI-H2172::IOX2
OE19::Temozolomide
AN3-CA::PRT062607
TE-10::Linsitinib
Caov-4::Temozolomide
HT-1376::Osimertinib
PSN1::RVX-208
RKN::Dactolisib
YKG-1::Linsitinib
SW626::Osimertinib
EoL-1-cell::Avagacestat
COLO-680N::Dactolisib
UMC-11::Dactolisib
JHH-7::VE-822
BT-549::Linsitinib
KYAE-1::I-BET-762
NCI-H1435::Linsitinib
JEG-3::VE-822
PWR-1E::VE-822
OCUM-1::Avagacestat
A673::Ibrutinib
NCI-H1975::PRT062607
C2BBe1::Dactolisib
JEKO-1::Sorafenib
NCI-H1651::Lapatinib
KINGS-1::Ibrutinib
HCC-827::VE-822
RCH-ACV::VE-822
UM-UC-3::Lapatinib
SF539::RVX-208
RVH-421::SL0101
NCI-H1693::Lapatinib
HT-1080::VE-822
Detroit562::Doramapimod
LB373-MEL-D::Lapatinib
TE-1::Avagacestat
DND-41::Dactolisib
JHH-6::Lapatinib
YAPC::Avagacestat
AMO-1::Linsitinib
ChaGo-K-1::RVX-208
NMC-G1::VE-822
SUP-HD1::I-BET-762
D-542MG::Dactolisib
JM1::PRT062607
AU565::Linsitinib
DND-41::Ibrutinib
KNS-62::Ibrutinib
MDA-MB-157::AZD6482
SK-CO-1::RVX-208
NCI-H1963::Sorafenib
OSC-19::Lapatinib
KYSE-50::Palbociclib
NCI-H209::RVX-208
COR-L23::Avagacestat
CADO-ES1::Lapatinib
BE2-M17::PRT062607
LOU-NH91::Palbociclib
LXF-289::Lapatinib
PANC-10-05::Palbociclib
C2BBe1::VE-822
T98G::Dactolisib
SK-N-AS::Osimertinib
AMO-1::Ibrutinib
EPLC-272H::I-BET-762
KASUMI-1::I-BET-762
HuO-3N1::VE-822
LU-134-A::Avagacestat
HGC-27::VE-822
LN-18::VE-822
KOSC-2::PFI-1
DU-4475::PRT062607
A704::Ibrutinib
NCI-H2141::RVX-208
CAPAN-1::PRT062607
JIMT-1::RVX-208
TE-6::Avagacestat
MFE-296::PRT062607
NCI-H1105::Temozolomide
P30-OHK::PRT062607
HCC1569::PRT062607
ML-1::Linsitinib
ME-1::Dactolisib
IST-MES1::Lapatinib
NCI-H1963::Palbociclib
OV-17R::Osimertinib
HPAF-II::Osimertinib
NCI-H524::Dactolisib
ME-1::PFI-1
KE-37::I-BET-762
TE-6::Dactolisib
SF126::RVX-208
C32::PRT062607
A549::Avagacestat
HARA::PFI-1
697::Linsitinib
ALL-SIL::RVX-208
MC116::RVX-208
NCI-H226::Avagacestat
NCI-H810::VE-822
TE-15::Linsitinib
JHOS-2::Linsitinib
SU-DHL-4::SL0101
DND-41::PFI-1
HCC1806::VE-822
ML-1::Avagacestat
ECC10::I-BET-762
MLMA::Sorafenib
D-542MG::Temozolomide
SF295::RVX-208
NCI-H2227::Dactolisib
WM35::Temozolomide
SK-OV-3::Lapatinib
OVISE::Ibrutinib
ST486::Dactolisib
COR-L105::Sorafenib
PA-TU-8988T::Linsitinib
SK-MEL-28::PFI-1
NCI-H2110::I-BET-762
G-402::Temozolomide
DoTc2-4510::Temozolomide
GI-1::Sorafenib
A673::VE-822
CAPAN-1::Sorafenib
BHT-101::Avagacestat
LB1047-RCC::VE-822
KLE::Osimertinib
OCI-AML5::I-BET-762
SF126::Doramapimod
BEN::Avagacestat
CML-T1::Ibrutinib
SU-DHL-16::PRT062607
HCC1569::Ibrutinib
SW780::PRT062607
NCI-H660::Lapatinib
L-540::Osimertinib
NCC010::IOX2
SUP-B15::PFI-1
SU-DHL-16::Osimertinib
647-V::Palbociclib
KYSE-150::PFI-1
MOLT-13::PRT062607
NCI-H2170::Sorafenib
NOS-1::Avagacestat
SH-4::RVX-208
8505C::Palbociclib
D-336MG::PFI-1
SCC-25::Avagacestat
IPC-298::SL0101
SHP-77::Ibrutinib
EC-GI-10::PRT062607
KLE::RVX-208
EKVX::Palbociclib
GA-10::VE-822
EW-24::Ibrutinib
WIL2-NS::Doramapimod
PCI-4B::AZD6482
LAMA-84::RVX-208
KYSE-140::I-BET-762
UACC-812::Linsitinib
RCC-JF::Avagacestat
DMS-53::PFI-1
JVM-3::Temozolomide
NCI-H1770::Dactolisib
HCC2157::Sorafenib
COLO-205::Avagacestat
NCI-H1299::Lapatinib
DoTc2-4510::Doramapimod
SK-GT-2::VE-822
C3A::Linsitinib
NCI-H1436::Ibrutinib
G-401::Avagacestat
SUP-HD1::PFI-1
SNU-C5::Linsitinib
NCI-H1436::Avagacestat
NB(TU)1-10::Avagacestat
KMS-11::AZD6482
C32::VE-822
CHP-126::Dactolisib
LoVo::VE-822
OACM5-1::RVX-208
MZ2-MEL::PRT062607
NCI-H1573::Doramapimod
THP-1::Ibrutinib
8505C::PFI-1
HT-29::Temozolomide
Daoy::Lapatinib
QIMR-WIL::IOX2
RT-112::Palbociclib
A2780::Temozolomide
SK-MEL-5::Dactolisib
LB996-RCC::I-BET-762
NCI-H1573::Sorafenib
LCLC-97TM1::Avagacestat
BFTC-909::Temozolomide
NCI-H1355::Palbociclib
DMS-273::RVX-208
HuP-T4::Doramapimod
KNS-42::I-BET-762
CAL-29::Dactolisib
NAMALWA::PFI-1
HCC1143::Avagacestat
OVCAR-3::PFI-1
KYSE-70::I-BET-762
SUP-M2::Osimertinib
PC-3::Osimertinib
MIA-PaCa-2::Doramapimod
G-401::RVX-208
RCH-ACV::Palbociclib
SU-DHL-5::Ibrutinib
SU-DHL-10::Osimertinib
HCC1937::Linsitinib
GOTO::Linsitinib
NB17::Palbociclib
NCI-H250::RVX-208
RT4::Sorafenib
HAL-01::Doramapimod
C-4-I::Palbociclib
CRO-AP2::PRT062607
MZ2-MEL::Doramapimod
CTV-1::Dactolisib
EoL-1-cell::Osimertinib
UWB1.289::Dactolisib
OE21::Linsitinib
OCI-AML5::Linsitinib
BxPC-3::Linsitinib
KP-1N::I-BET-762
Farage::PFI-1
SF268::Sorafenib
HOS::Doramapimod
LU-65::Avagacestat
NCI-H748::Temozolomide
HCC1143::Lapatinib
LB996-RCC::Lapatinib
A2058::PFI-1
U-2-OS::IOX2
23132-87::Dactolisib
JHOS-2::RVX-208
KNS-81-FD::Lapatinib
YH-13::Doramapimod
SKM-1::Sorafenib
MFE-296::Temozolomide
LB2241-RCC::I-BET-762
SUP-T1::PRT062607
NB7::PFI-1
DMS-114::VE-822
NB10::Osimertinib
JSC-1::Osimertinib
MDA-MB-330::Dactolisib
SF268::PRT062607
KYSE-450::Avagacestat
OC-314::Linsitinib
CHSA0108::Osimertinib
TT::Palbociclib
HSC-39::Lapatinib
RCH-ACV::PRT062607
VAL::Dactolisib
T47D::PFI-1
EW-12::VE-822
JiyoyeP-2003::PRT062607
SW156::AZD6482
NUGC-3::PFI-1
NCI-H720::Temozolomide
LC-1-sq::Doramapimod
WM-115::RVX-208
EKVX::Avagacestat
MKN7::Osimertinib
OS-RC-2::Sorafenib
NCI-H838::RVX-208
HCC-78::Temozolomide
WM1552C::Sorafenib
KP-N-YN::Ibrutinib
NCI-H526::Doramapimod
BEN::I-BET-762
SiHa::Dactolisib
GCIY::Sorafenib
Becker::Doramapimod
MOLM-16::Ibrutinib
EKVX::Temozolomide
CAL-12T::Sorafenib
RS4-11::PRT062607
OSC-19::SL0101
SNU-175::VE-822
KYSE-180::Avagacestat
JHOS-4::PFI-1
HDLM-2::I-BET-762
SHP-77::Lapatinib
NCI-H2110::RVX-208
M14::Dactolisib
HuH-7::VE-822
KP-2::RVX-208
SK-MEL-30::Temozolomide
DND-41::Linsitinib
NCI-H2085::Osimertinib
SU-DHL-6::Avagacestat
SKN::Temozolomide
PEO1::I-BET-762
M059J::I-BET-762
NCI-H2009::Palbociclib
LNCaP-Clone-FGC::Temozolomide
NCI-H146::VE-822
SNU-81::VE-822
EFM-19::VE-822
JHOS-4::VE-822
KYSE-410::Doramapimod
SIMA::Dactolisib
SK-UT-1::Temozolomide
HGC-27::Ibrutinib
OE33::Dactolisib
KMS-11::PRT062607
SK-N-AS::Palbociclib
SBC-1::RVX-208
NCI-H596::Linsitinib
ML-1::I-BET-762
DOV13::PFI-1
MOLT-13::Ibrutinib
RKO::Avagacestat
CS1::Sorafenib
NKM-1::Temozolomide
SU8686::Doramapimod
RCC-MF::Doramapimod
Detroit562::VE-822
KCL-22::Lapatinib
H9::Linsitinib
Becker::Lapatinib
SNU-C5::Osimertinib
KYM-1::PFI-1
TE-4::RVX-208
Ramos-2G6-4C10::Linsitinib
KYSE-510::Lapatinib
EJM::Ibrutinib
CHSA0108::Temozolomide
Saos-2::VE-822
no-11::Lapatinib
639-V::Temozolomide
IPC-298::Lapatinib
KU812::Avagacestat
EFM-19::I-BET-762
U-87-MG::Doramapimod
HT-115::Temozolomide
Jurkat::Avagacestat
HCC-78::Osimertinib
DoTc2-4510::Sorafenib
RPMI-8402::Osimertinib
COLO-678::Palbociclib
RT4::Avagacestat
MDA-MB-453::Osimertinib
RMG-I::Temozolomide
NCI-H1651::Osimertinib
HCC1187::Ibrutinib
C2BBe1::Temozolomide
PCI-4B::I-BET-762
NB5::Linsitinib
NCI-H322M::I-BET-762
COLO-792::Linsitinib
KON::Sorafenib
SW756::Dactolisib
OCUM-1::Ibrutinib
ES5::PRT062607
COR-L311::VE-822
CAL-29::Palbociclib
NCI-H524::Sorafenib
IST-SL2::I-BET-762
HCC1599::SL0101
PFSK-1::Lapatinib
A427::Palbociclib
LB771-HNC::PRT062607
BHY::PRT062607
RPMI-8226::PFI-1
HOS::RVX-208
COLO-205::Osimertinib
KMOE-2::Dactolisib
D-336MG::I-BET-762
WM-115::Avagacestat
IA-LM::Ibrutinib
COR-L303::VE-822
KATOIII::PRT062607
BE-13::PFI-1
MEL-JUSO::Palbociclib
HSC-39::Palbociclib
RL95-2::Palbociclib
GDM-1::Temozolomide
PF-382::Ibrutinib
CaR-1::Osimertinib
NCI-H1944::Temozolomide
JVM-2::Lapatinib
SCC90::VE-822
D-423MG::Linsitinib
Mewo::Linsitinib
WIL2-NS::PFI-1
SK-MEL-3::Ibrutinib
HARA::Temozolomide
HT55::Lapatinib
MES-SA::PFI-1
KYSE-150::Osimertinib
P32-ISH::Temozolomide
NCI-H1793::I-BET-762
MSTO-211H::Linsitinib
Ca9-22::Ibrutinib
JHU-029::Avagacestat
SW1271::Ibrutinib
HL-60::VE-822
KYSE-520::Lapatinib
KLE::Sorafenib
MOLT-4::Temozolomide
OV-17R::I-BET-762
HCT-15::Temozolomide
KP-4::Temozolomide
TT::Dactolisib
OVCAR-5::RVX-208
A673::Osimertinib
HT-1376::Dactolisib
HPAF-II::Doramapimod
MDA-MB-361::Sorafenib
OE33::Sorafenib
LK-2::Doramapimod
BFTC-909::Doramapimod
IMR-5::PFI-1
NCI-H2009::Lapatinib
KOSC-2::Ibrutinib
COR-L88::Osimertinib
RO82-W-1::Osimertinib
MZ7-mel::Doramapimod
CAL-39::I-BET-762
HARA::RVX-208
NCI-H2291::IOX2
KARPAS-231::Lapatinib
KM-H2::Ibrutinib
A2058::Lapatinib
OVKATE::Sorafenib
NB10::Temozolomide
NCI-H2052::VE-822
SK-MEL-31::Avagacestat
KARPAS-299::I-BET-762
DK-MG::VE-822
BFTC-905::PRT062607
CHP-126::PFI-1
LNCaP-Clone-FGC::PRT062607
OVCAR-3::Doramapimod
Ca9-22::PRT062607
CS1::Avagacestat
EW-13::Osimertinib
OVTOKO::Palbociclib
NCI-H1623::Linsitinib
EFM-192A::Temozolomide
JM1::Temozolomide
COR-L303::Linsitinib
ES7::Linsitinib
NCI-H322M::Dactolisib
U-87-MG::Lapatinib
CAPAN-1::Doramapimod
A172::Doramapimod
KMS-11::Doramapimod
NCI-H1963::PFI-1
NCI-H345::I-BET-762
EC-GI-10::Osimertinib
OVCA420::Linsitinib
SW1783::Palbociclib
SR::Osimertinib
HuO-3N1::Linsitinib
NCI-H2342::Sorafenib
KG-1::RVX-208
NCI-H1623::PFI-1
D-392MG::Palbociclib
WIL2-NS::Ibrutinib
697::PRT062607
HC-1::VE-822
OC-314::Lapatinib
HH::Doramapimod
Ramos-2G6-4C10::Palbociclib
HT55::I-BET-762
451Lu::Sorafenib
OVMIU::Osimertinib
KYSE-50::Ibrutinib
MFE-280::VE-822
HCC1569::Doramapimod
SNU-C1::Doramapimod
KYSE-140::RVX-208
HCC2218::Temozolomide
KASUMI-1::Temozolomide
SCC-9::Osimertinib
SK-LU-1::Palbociclib
NCI-H1299::VE-822
KM12::Doramapimod
OACM5-1::Temozolomide
OAW-42::PRT062607
HSC-39::Dactolisib
HCC1599::VE-822
ECC12::RVX-208
EW-22::Linsitinib
MKN28::Temozolomide
HARA::VE-822
KLE::I-BET-762
WM1552C::Doramapimod
RCM-1::Linsitinib
TE-12::Ibrutinib
JSC-1::Linsitinib
MKN45::Palbociclib
SCC-4::Linsitinib
SU-DHL-16::Temozolomide
SW982::I-BET-762
OCUB-M::Linsitinib
NCC021::AZD6482
EMC-BAC-2::Linsitinib
ES7::I-BET-762
SNU-1040::I-BET-762
MONO-MAC-6::Lapatinib
HCC2218::I-BET-762
NCI-H1666::Lapatinib
JHH-2::Doramapimod
ST486::Temozolomide
NCI-H1581::RVX-208
U-2-OS::AZD6482
TT2609-C02::PFI-1
A172::VE-822
COR-L303::Sorafenib
KARPAS-231::Dactolisib
LU-65::RVX-208
HCC2998::Sorafenib
SK-ES-1::Palbociclib
DU-145::Avagacestat
TK::Sorafenib
IST-SL2::Lapatinib
WIL2-NS::I-BET-762
OVCAR-3::VE-822
SW48::Ibrutinib
TGW::Palbociclib
VMRC-RCZ::VE-822
MN-60::Ibrutinib
CAL-120::Lapatinib
THP-1::Avagacestat
IST-SL2::Ibrutinib
NB17::Doramapimod
FADU::PRT062607
KY821::I-BET-762
CAPAN-1::RVX-208
LP-1::SL0101
HGC-27::Dactolisib
LU-135::Avagacestat
HT-1376::Sorafenib
NCI-H2452::Palbociclib
JEKO-1::PFI-1
LOXIMVI::PRT062607
SW954::Linsitinib
BALL-1::PFI-1
SK-N-FI::Palbociclib
NB10::Ibrutinib
RPMI-7951::I-BET-762
REH::Sorafenib
CAPAN-1::PFI-1
NCI-H1975::RVX-208
SK-MEL-1::Linsitinib
BB30-HNC::Palbociclib
RXF393::AZD6482
VCaP::VE-822
D-283MED::PFI-1
NCI-H250::I-BET-762
STS-0421::Ibrutinib
DK-MG::RVX-208
SAT::Lapatinib
NCI-H1770::Palbociclib
SW1990::Sorafenib
A4-Fuk::Dactolisib
MSTO-211H::PFI-1
Hs-445::Palbociclib
NUGC-3::Palbociclib
TT::Sorafenib
MDA-MB-436::Doramapimod
NCI-H524::Ibrutinib
NCCIT::Avagacestat
NCI-H1944::Palbociclib
EMC-BAC-1::AZD6482
COR-L303::Avagacestat
NCI-H838::Sorafenib
NUGC-3::Avagacestat
COLO-205::Dactolisib
ARH-77::I-BET-762
IGR-1::I-BET-762
SK-MEL-28::IOX2
IMR-5::VE-822
EW-22::Lapatinib
NCI-H211::PRT062607
KATOIII::Lapatinib
GR-ST::Sorafenib
OCI-AML2::Ibrutinib
U-118-MG::VE-822
ESS-1::Linsitinib
COR-L311::I-BET-762
NCI-H322M::Linsitinib
RL::Lapatinib
NCI-H1975::I-BET-762
COLO-678::Dactolisib
HDLM-2::Palbociclib
CFPAC-1::VE-822
RCC-FG2::IOX2
RCC-AB::Lapatinib
FLO-1::Linsitinib
LB2518-MEL::Lapatinib
5637::RVX-208
SF295::Avagacestat
LB771-HNC::I-BET-762
CFPAC-1::PRT062607
A704::Doramapimod
BT-20::Avagacestat
NEC8::Lapatinib
HCC1143::AZD6482
EFO-21::Doramapimod
U031::PRT062607
COLO-679::VE-822
KURAMOCHI::Sorafenib
DMS-273::Dactolisib
U-266::PFI-1
HCT-15::Avagacestat
LCLC-97TM1::PFI-1
CHP-126::Palbociclib
FU97::Dactolisib
A673::Linsitinib
GA-10::PFI-1
MOLM-13::Ibrutinib
SU8686::PRT062607
VA-ES-BJ::PRT062607
RCC-MF::VE-822
HT-115::IOX2
RERF-GC-1B::Osimertinib
OCI-AML2::Palbociclib
LCLC-97TM1::Palbociclib
Caov-4::PFI-1
SW1271::Lapatinib
L-540::Ibrutinib
LB831-BLC::RVX-208
QIMR-WIL::AZD6482
RCH-ACV::Ibrutinib
D-423MG::IOX2
HMV-II::RVX-208
SK-MEL-1::PFI-1
NCI-H747::Dactolisib
SUP-T1::Sorafenib
NCI-H1436::PRT062607
LC-2-ad::Dactolisib
KP-4::Dactolisib
HO-1-N-1::Lapatinib
AU565::Dactolisib
ES8::RVX-208
HCC1806::Avagacestat
MOLM-16::Dactolisib
SF539::Avagacestat
CFPAC-1::PFI-1
OSC-20::Linsitinib
EW-7::Ibrutinib
SAT::I-BET-762
KYSE-520::Osimertinib
SLVL::Linsitinib
HCC-78::PRT062607
T84::VE-822
HCC2218::Lapatinib
IST-SL2::Avagacestat
D-392MG::I-BET-762
ME-180::Palbociclib
HEC-1::PFI-1
PC-3::PRT062607
NB7::Ibrutinib
HT-29::AZD6482
SU-DHL-8::Linsitinib
NCI-H647::Linsitinib
SW948::Dactolisib
RO82-W-1::Linsitinib
DB::Doramapimod
EMC-BAC-1::PFI-1
SK-UT-1::Ibrutinib
HSC-4::Palbociclib
RCC-JF::IOX2
MKN1::I-BET-762
CAL-12T::PRT062607
SNU-398::Linsitinib
T84::Doramapimod
G-401::Dactolisib
CHP-212::Doramapimod
CAL-27::Doramapimod
RERF-LC-KJ::Lapatinib
NCI-H2009::PFI-1
TK::Temozolomide
NCI-H2196::Avagacestat
EB-3::RVX-208
ACHN::Osimertinib
NMC-G1::I-BET-762
LOUCY::PFI-1
SIMA::VE-822
TE-11::Palbociclib
NB17::Osimertinib
LU-165::PRT062607
SW48::Linsitinib
NCI-H522::RVX-208
EFO-21::VE-822
FADU::Linsitinib
KYSE-410::I-BET-762
L-363::I-BET-762
MOLT-4::Dactolisib
HCE-4::Linsitinib
KM12::Avagacestat
LS-513::I-BET-762
KURAMOCHI::Dactolisib
Daudi::VE-822
Ca9-22::Osimertinib
MS-1::I-BET-762
OVCAR-8::Avagacestat
YKG-1::PRT062607
MONO-MAC-6::PFI-1
NCI-H727::Osimertinib
J82::Temozolomide
HTC-C3::Doramapimod
PC-14::AZD6482
MFE-296::Ibrutinib
KYSE-180::Osimertinib
JAR::Ibrutinib
PC-14::Avagacestat
JHU-011::Linsitinib
KYM-1::Linsitinib
SNU-81::Doramapimod
22RV1::Lapatinib
WM-115::PRT062607
LB1047-RCC::IOX2
ACHN::Linsitinib
DBTRG-05MG::Avagacestat
HL-60::Ibrutinib
CRO-AP2::Palbociclib
PANC-04-03::PFI-1
COLO-800::PFI-1
CAL-51::Ibrutinib
SJSA-1::Dactolisib
NCI-H2023::Doramapimod
EC-GI-10::Avagacestat
ST486::RVX-208
EW-1::Osimertinib
JJN-3::Palbociclib
CAS-1::PFI-1
LC4-1::Palbociclib
SK-PN-DW::VE-822
P12-ICHIKAWA::Ibrutinib
NCI-H2135::Dactolisib
RH-41::RVX-208
RD::VE-822
no-11::I-BET-762
SW780::Ibrutinib
SW982::Doramapimod
TE-9::RVX-208
COR-L303::PFI-1
OV-90::Lapatinib
COLO-783::Linsitinib
NH-12::VE-822
M14::RVX-208
P12-ICHIKAWA::Linsitinib
SK-LMS-1::VE-822
NCI-H1734::PFI-1
GA-10::Dactolisib
H-EMC-SS::Palbociclib
NCI-H2009::Temozolomide
HGC-27::PFI-1
LU-99A::Sorafenib
LS-123::I-BET-762
KYSE-50::Osimertinib
SNU-C5::Doramapimod
MCF7::RVX-208
BHY::Lapatinib
A375::Temozolomide
MOLM-13::Doramapimod
ATN-1::Dactolisib
IHH-4::PFI-1
CTB-1::Palbociclib
DMS-273::Lapatinib
RVH-421::Doramapimod
WSU-DLCL2::PFI-1
VA-ES-BJ::Lapatinib
ME-1::Osimertinib
BALL-1::Temozolomide
NCI-H747::I-BET-762
JiyoyeP-2003::Linsitinib
H3255::Sorafenib
DMS-114::Ibrutinib
SK-MEL-28::PRT062607
NCI-H2452::Dactolisib
SCC-3::RVX-208
IGROV-1::Linsitinib
HLE::PFI-1
NCI-H740::I-BET-762
SN12C::Linsitinib
NCI-H1666::Avagacestat
LU-65::I-BET-762
MFE-280::Linsitinib
GI-ME-N::Sorafenib
647-V::Osimertinib
PEO1::Dactolisib
OSC-20::Sorafenib
HCC1143::RVX-208
MHH-PREB-1::Linsitinib
COLO-668::Dactolisib
OCI-AML3::Osimertinib
HOS::Lapatinib
P31-FUJ::Doramapimod
COR-L303::IOX2
GAMG::VE-822
WM793B::VE-822
DJM-1::Linsitinib
BPH-1::Doramapimod
NCI-H23::Avagacestat
SK-ES-1::Osimertinib
Farage::Temozolomide
SW48::I-BET-762
LS-123::PRT062607
JHH-6::Avagacestat
Calu-6::Ibrutinib
MZ7-mel::VE-822
BONNA-12::Doramapimod
A388::PRT062607
LB2241-RCC::Linsitinib
LC4-1::Doramapimod
MLMA::PRT062607
SUIT-2::Osimertinib
D-566MG::I-BET-762
HDLM-2::RVX-208
LN-18::Ibrutinib
KY821::VE-822
KMS-11::Osimertinib
BT-483::Temozolomide
K2::I-BET-762
PL4::Sorafenib
CADO-ES1::Ibrutinib
A549::PFI-1
NCI-H1581::Doramapimod
Hs-445::I-BET-762
A172::Avagacestat
CHSA0011::I-BET-762
NH-12::Avagacestat
CAL-62::Osimertinib
PCI-4B::Avagacestat
BxPC-3::VE-822
COLO-684::Doramapimod
A3-KAW::PFI-1
MOLM-13::Lapatinib
Calu-6::I-BET-762
KELLY::Dactolisib
RPMI-8226::Temozolomide
CGTH-W-1::Linsitinib
BONNA-12::I-BET-762
42-MG-BA::Temozolomide
DOK::PRT062607
IMR-5::Avagacestat
UACC-257::Linsitinib
UWB1.289::PRT062607
NCI-H2405::PFI-1
GP5d::Palbociclib
HAL-01::PFI-1
no-10::Ibrutinib
DK-MG::Linsitinib
SW1463::RVX-208
GA-10::Ibrutinib
A2780::PFI-1
A549::Dactolisib
KP-4::PFI-1
AMO-1::Sorafenib
IST-MES1::Palbociclib
NCI-H1651::Temozolomide
COLO-783::AZD6482
EN::Osimertinib
OACp4C::RVX-208
NCI-H1563::Dactolisib
IST-MEL1::PFI-1
U-118-MG::PRT062607
GI-1::Ibrutinib
L-363::Avagacestat
LB647-SCLC::SL0101
MDA-MB-468::Doramapimod
SU-DHL-10::Dactolisib
JHOS-3::Lapatinib
NCI-H209::Sorafenib
CAL-39::Ibrutinib
PANC-02-03::Doramapimod
BICR31::VE-822
TE-8::PRT062607
NCI-H740::Lapatinib
SK-CO-1::VE-822
PA-1::RVX-208
HEL::RVX-208
YAPC::Linsitinib
GP5d::Dactolisib
JHH-1::I-BET-762
KCL-22::Osimertinib
NCI-H2170::RVX-208
JEKO-1::IOX2
JHU-022::Doramapimod
LB373-MEL-D::Ibrutinib
SCH::VE-822
SiHa::Palbociclib
DAN-G::Ibrutinib
CAMA-1::Avagacestat
MDA-MB-231::I-BET-762
IMR-5::Doramapimod
NCI-H250::PFI-1
PL-21::Sorafenib
DB::Palbociclib
BONNA-12::Linsitinib
LB2241-RCC::Osimertinib
NMC-G1::AZD6482
TE-11::PFI-1
SCH::I-BET-762
NCI-H2087::Sorafenib
HLE::Lapatinib
NB69::Lapatinib
LCLC-103H::Sorafenib
SU-DHL-1::VE-822
OACp4C::Osimertinib
769-P::Doramapimod
SK-MEL-28::VE-822
JEKO-1::PRT062607
KMRC-20::Doramapimod
NCI-H146::Temozolomide
KP-2::Ibrutinib
HEC-1::Palbociclib
BONNA-12::PFI-1
KARPAS-45::VE-822
A172::Lapatinib
HSC-2::Avagacestat
JJN-3::Lapatinib
T84::Linsitinib
TE-9::Osimertinib
COLO-800::Ibrutinib
IGR-37::Doramapimod
MOLP-8::Linsitinib
A388::Sorafenib
DOHH-2::Lapatinib
RCC-AB::VE-822
BT-474::Doramapimod
TK10::Linsitinib
MS751::Ibrutinib
HCC-78::Avagacestat
NCI-H650::Sorafenib
SW1271::Osimertinib
NCI-H2122::PRT062607
no-11::Dactolisib
COLO-679::Temozolomide
ES-2::VE-822
BFTC-905::Linsitinib
SUP-HD1::Temozolomide
RERF-LC-Sq1::RVX-208
MLMA::Lapatinib
OVCAR-8::VE-822
HCC-15::Lapatinib
RC-K8::Doramapimod
SCH::Osimertinib
DB::VE-822
NCI-H650::Lapatinib
PCI-4B::PRT062607
IHH-4::Lapatinib
SNU-61::Doramapimod
BHT-101::Lapatinib
JSC-1::VE-822
KARPAS-45::PRT062607
NCI-H196::Palbociclib
LOUCY::Lapatinib
LP-1::Doramapimod
MOG-G-UVW::Osimertinib
NB5::SL0101
769-P::Lapatinib
OCUM-1::I-BET-762
IMR-5::I-BET-762
OVCAR-3::PRT062607
EFO-21::Sorafenib
NCI-N87::Lapatinib
GI-1::RVX-208
PC-14::RVX-208
OV-56::Lapatinib
D-283MED::Dactolisib
ChaGo-K-1::IOX2
GCIY::Ibrutinib
MDA-MB-361::Avagacestat
KON::PFI-1
MKN1::RVX-208
EFM-19::Palbociclib
NCI-H2444::SL0101
SW1463::Doramapimod
HuO-3N1::PRT062607
SW1710::Avagacestat
KMRC-20::RVX-208
HCC1937::Ibrutinib
PCI-30::Dactolisib
CCRF-CEM::RVX-208
WSU-NHL::Avagacestat
C32::Linsitinib
OCI-LY-19::Temozolomide
NCI-H1092::Dactolisib
OE21::Doramapimod
TE-4::VE-822
NCI-H2122::Sorafenib
OCUB-M::RVX-208
SKM-1::I-BET-762
IST-SL1::Ibrutinib
A549::VE-822
CAL-54::Lapatinib
PCI-15A::I-BET-762
KYSE-410::Sorafenib
HuO9::VE-822
NCI-H727::Palbociclib
K5::Sorafenib
8305C::Palbociclib
PSN1::Avagacestat
HuP-T3::I-BET-762
D-336MG::Sorafenib
ONS-76::Dactolisib
HCC-827::RVX-208
NCI-H28::Avagacestat
OV-7::Linsitinib
SK-ES-1::Sorafenib
SNU-398::Osimertinib
MDA-MB-231::Ibrutinib
HH::Temozolomide
HPAC::PFI-1
GR-ST::Ibrutinib
D-263MG::VE-822
SW1116::PFI-1
KELLY::VE-822
SIMA::Avagacestat
NCI-H510A::Lapatinib
SW872::Palbociclib
JEG-3::Sorafenib
SUP-HD1::Osimertinib
NCI-H345::SL0101
HT-144::RVX-208
MZ2-MEL::Osimertinib
D-423MG::AZD6482
NCI-H1105::Sorafenib
NB6::Sorafenib
GCIY::Temozolomide
EM-2::Osimertinib
RPMI-6666::Sorafenib
LU-165::Lapatinib
DMS-53::Ibrutinib
CAL-33::Dactolisib
MS751::Palbociclib
RPMI-8866::Temozolomide
COLO-320-HSR::Dactolisib
DMS-273::Linsitinib
RL::Doramapimod
SLVL::Palbociclib
ATN-1::PFI-1
NOS-1::Doramapimod
OVCAR-5::PRT062607
HT-144::PFI-1
DoTc2-4510::Dactolisib
COLO-680N::Ibrutinib
OCI-AML5::Lapatinib
Mo-T::I-BET-762
EFO-21::Palbociclib
SW982::Palbociclib
BT-474::Osimertinib
LS-180::Osimertinib
NCI-H1436::RVX-208
P12-ICHIKAWA::Dactolisib
HMV-II::I-BET-762
VMRC-LCD::Dactolisib
OE19::Dactolisib
SW962::IOX2
OVCA420::PRT062607
K-562::PFI-1
MKN45::Temozolomide
NCI-H1563::Palbociclib
MDA-MB-157::Osimertinib
SW837::Osimertinib
CAL-72::Avagacestat
HT-1080::Palbociclib
NU-DUL-1::Doramapimod
ASH-3::I-BET-762
HT-1080::PFI-1
MDA-MB-231::Sorafenib
SW1463::Palbociclib
SK-CO-1::PFI-1
KARPAS-422::Lapatinib
RERF-LC-MS::PRT062607
KCL-22::Dactolisib
JHH-2::Lapatinib
NY::Ibrutinib
COLO-800::Palbociclib
NH-12::Temozolomide
NCI-H2052::Doramapimod
Hey::Osimertinib
JVM-2::Ibrutinib
MFM-223::PFI-1
MEL-JUSO::RVX-208
COR-L88::PFI-1
D-336MG::Ibrutinib
COLO-783::Doramapimod
OCI-LY7::I-BET-762
JHH-6::VE-822
Detroit562::Sorafenib
TE-12::AZD6482
SF295::I-BET-762
DSH1::Dactolisib
CML-T1::PRT062607
SNU-61::Palbociclib
TE-5::Linsitinib
NCI-H322M::PRT062607
AU565::VE-822
UACC-893::Temozolomide
NCI-H929::Palbociclib
HuP-T4::RVX-208
BHT-101::PFI-1
HGC-27::Palbociclib
NCI-H1770::I-BET-762
HC-1::Osimertinib
HSC-4::Lapatinib
NCI-H1048::Osimertinib
WM-115::Lapatinib
EMC-BAC-1::Linsitinib
CHL-1::I-BET-762
SW1417::VE-822
Mo-T::Temozolomide
SU-DHL-16::VE-822
MKN1::Palbociclib
ME-180::PRT062607
KMOE-2::Ibrutinib
OV-56::Palbociclib
HCC1569::PFI-1
COR-L279::Dactolisib
HDQ-P1::Sorafenib
JHH-6::Dactolisib
NCI-H1963::Ibrutinib
KP-3::Temozolomide
HT55::PRT062607
WM1552C::PRT062607
LB647-SCLC::Avagacestat
ES7::VE-822
Daoy::Ibrutinib
PFSK-1::Dactolisib
KMS-12-BM::Linsitinib
SW962::I-BET-762
SK-MEL-24::RVX-208
LB647-SCLC::RVX-208
CAL-85-1::PRT062607
NCI-H2087::Avagacestat
AGS::Linsitinib
YT::Sorafenib
TE-8::Avagacestat
Farage::Dactolisib
NCI-H1299::Palbociclib
MZ1-PC::PRT062607
HC-1::PRT062607
BT-20::Dactolisib
FLO-1::I-BET-762
L-540::Doramapimod
LB2518-MEL::Dactolisib
HCC-78::Palbociclib
NCI-H2030::IOX2
SW13::Doramapimod
NCI-H596::VE-822
NCI-H196::Temozolomide
NCI-H2196::Ibrutinib
KE-37::Dactolisib
AsPC-1::Sorafenib
ACHN::I-BET-762
SK-MEL-2::Doramapimod
P31-FUJ::Sorafenib
HEL::AZD6482
D-566MG::Osimertinib
IGROV-1::PFI-1
TE-5::Avagacestat
NCI-H740::AZD6482
RERF-GC-1B::Lapatinib
SW626::Ibrutinib
SUP-T1::Dactolisib
TUR::Dactolisib
HCT-15::PRT062607
ETK-1::Osimertinib
KALS-1::RVX-208
KP-1N::VE-822
MZ2-MEL::Avagacestat
SW1463::VE-822
A431::RVX-208
A673::PFI-1
TE-12::PFI-1
WSU-NHL::RVX-208
LS-1034::Avagacestat
HT-1376::Avagacestat
U-2-OS::I-BET-762
JHOS-3::Avagacestat
TGW::RVX-208
CL-11::Lapatinib
SCC-9::PRT062607
SNU-407::RVX-208
NCI-H345::PRT062607
DMS-273::Ibrutinib
SBC-5::Doramapimod
NCI-H1105::SL0101
SNU-407::PRT062607
GA-10::RVX-208
MKN7::Avagacestat
SF268::Doramapimod
KARPAS-1106P::Avagacestat
GI-ME-N::Lapatinib
HAL-01::I-BET-762
MS751::Sorafenib
JHH-1::Linsitinib
VAL::VE-822
NCI-H1299::PFI-1
EFM-19::RVX-208
ESS-1::Temozolomide
EW-24::Avagacestat
TE-10::PFI-1
KYM-1::Ibrutinib
TE-15::I-BET-762
MHH-CALL-4::PFI-1
COR-L311::Doramapimod
RT-112::PRT062607
CPC-N::PFI-1
NCI-H650::RVX-208
OV-7::AZD6482
NB69::Avagacestat
COLO-800::I-BET-762
HT-115::Palbociclib
RL::VE-822
TE-6::I-BET-762
OS-RC-2::Doramapimod
EW-22::Avagacestat
HC-1::Sorafenib
WM793B::RVX-208
SK-GT-4::Lapatinib
L-540::VE-822
FTC-133::PFI-1
Detroit562::PRT062607
A431::Doramapimod
HL-60::Linsitinib
KP-3::Dactolisib
SK-MEL-5::Ibrutinib
SAT::Linsitinib
NU-DUL-1::AZD6482
MONO-MAC-6::Dactolisib
RKO::Linsitinib
SNU-407::VE-822
SK-HEP-1::Lapatinib
SKM-1::PRT062607
HCC-15::Avagacestat
UACC-893::Palbociclib
NCI-H1341::Sorafenib
M059J::VE-822
COLO-783::Sorafenib
ST486::Avagacestat
MFH-ino::Doramapimod
OCI-LY-19::I-BET-762
SU-DHL-8::Sorafenib
CCRF-CEM::Ibrutinib
SW684::Ibrutinib
NCI-H196::RVX-208
OSC-19::Doramapimod
ES7::Dactolisib
D-423MG::Osimertinib
PFSK-1::VE-822
ESO51::Ibrutinib
BICR22::Palbociclib
NCI-H250::Dactolisib
SU-DHL-8::Dactolisib
KARPAS-299::Dactolisib
NCI-H2172::SL0101
OVCA420::Ibrutinib
8505C::Linsitinib
COLO-205::I-BET-762
786-0::Palbociclib
G-401::PRT062607
VMRC-LCD::I-BET-762
NB17::Linsitinib
D-502MG::AZD6482
JHU-029::Doramapimod
MN-60::PRT062607
SK-MEL-31::RVX-208
A431::Ibrutinib
A3-KAW::Osimertinib
SNU-175::Dactolisib
HCC1428::PRT062607
SK-MEL-1::Palbociclib
NCI-H3122::Lapatinib
SKN::Linsitinib
MKN28::VE-822
EFO-21::RVX-208
NCI-H1650::Osimertinib
HCC-366::I-BET-762
KYSE-50::RVX-208
EW-1::Doramapimod
NCI-H2066::Temozolomide
SK-N-AS::Linsitinib
D-336MG::AZD6482
C-4-I::RVX-208
SW1088::Sorafenib
SK-GT-4::Avagacestat
LB1047-RCC::Linsitinib
D-247MG::PRT062607
D-423MG::Palbociclib
MDA-MB-361::PFI-1
NCI-H1944::Doramapimod
HeLa::Sorafenib
TT2609-C02::Osimertinib
OSC-20::RVX-208
COLO-205::PFI-1
RCC-MF::AZD6482
HEL::VE-822
UM-UC-3::Dactolisib
MDA-MB-231::Lapatinib
OV-56::PRT062607
SCC90::Dactolisib
MFE-296::I-BET-762
GAMG::PFI-1
CML-T1::Palbociclib
NCI-H23::VE-822
C-4-I::PRT062607
HT-1376::Temozolomide
DMS-114::Lapatinib
NCI-H1650::I-BET-762
NCI-H747::Doramapimod
MRK-nu-1::VE-822
TT::Avagacestat
M059J::Osimertinib
DU-145::VE-822
RPMI-8226::Doramapimod
NCI-H660::PRT062607
LNCaP-Clone-FGC::VE-822
NCI-H720::I-BET-762
LNZTA3WT4::Linsitinib
OE19::PFI-1
YH-13::RVX-208
ECC12::Temozolomide
GOTO::Avagacestat
MHH-PREB-1::Palbociclib
CCRF-CEM::PFI-1
T84::Lapatinib
KARPAS-1106P::Palbociclib
SK-MEL-3::Temozolomide
KU812::Osimertinib
FLO-1::Avagacestat
TGW::Lapatinib
MKN45::PFI-1
CHP-126::VE-822
HuP-T3::PRT062607
HCC70::Linsitinib
Saos-2::I-BET-762
IST-MES1::Avagacestat
QGP-1::Temozolomide
SU-DHL-10::Doramapimod
HOS::PRT062607
COLO-824::VE-822
ES6::PRT062607
NCI-H1770::AZD6482
NCI-H740::PRT062607
EBC-1::PFI-1
KARPAS-45::Sorafenib
NCI-H596::Lapatinib
TUR::Temozolomide
SN12C::Avagacestat
RCC10RGB::Lapatinib
IMR-5::PRT062607
23132-87::Temozolomide
HEL::Doramapimod
LB2241-RCC::PRT062607
PANC-08-13::RVX-208
SiHa::VE-822
LB373-MEL-D::VE-822
Ramos-2G6-4C10::Sorafenib
HCC1428::Lapatinib
DEL::RVX-208
PA-TU-8902::Palbociclib
BE2-M17::Palbociclib
KYSE-70::VE-822
MZ1-PC::RVX-208
MOG-G-UVW::Sorafenib
NCI-H2228::Osimertinib
RPMI-7951::Avagacestat
SW756::PRT062607
CHL-1::Lapatinib
D-392MG::Ibrutinib
MDA-MB-330::IOX2
HuH-7::PRT062607
CHSA0108::Linsitinib
RCH-ACV::Temozolomide
NCI-H650::Osimertinib
CA46::Sorafenib
L-363::PRT062607
KOSC-2::IOX2
WM278::Doramapimod
BHT-101::Dactolisib
SK-GT-4::PRT062607
ES5::PFI-1
NCI-N87::Palbociclib
MFM-223::PRT062607
MDA-MB-453::VE-822
DBTRG-05MG::Dactolisib
Hs-578-T::Avagacestat
IGROV-1::Doramapimod
HuH-7::Temozolomide
MHH-CALL-2::Temozolomide
TE-11::Dactolisib
RKN::Temozolomide
HA7-RCC::Linsitinib
KYSE-180::I-BET-762
NCI-H345::Dactolisib
NCI-H2444::Osimertinib
DMS-79::VE-822
IGR-37::Dactolisib
KG-1::Doramapimod
NCI-H1963::RVX-208
NCI-H1993::Lapatinib
IGR-1::Sorafenib
KP-1N::Avagacestat
SKN-3::Temozolomide
EM-2::PRT062607
FU97::Temozolomide
CRO-AP2::Lapatinib
HT-1197::PRT062607
Mo-T::PFI-1
SNU-81::SL0101
TYK-nu::I-BET-762
SLVL::Dactolisib
LN-405::Osimertinib
NCI-H1299::Temozolomide
CP50-MEL-B::PFI-1
HSC-3::Doramapimod
NB(TU)1-10::Temozolomide
WIL2-NS::Dactolisib
SF539::PRT062607
Calu-3::Linsitinib
NCI-H510A::Doramapimod
SK-PN-DW::Lapatinib
CRO-AP2::Sorafenib
Hs-578-T::Sorafenib
TOV-112D::Palbociclib
QIMR-WIL::SL0101
KARPAS-1106P::RVX-208
JHOS-4::Dactolisib
NCI-H1573::Lapatinib
HSC-2::Linsitinib
HLE::Dactolisib
HMV-II::PRT062607
SIG-M5::Doramapimod
RPMI-7951::Linsitinib
KMS-12-BM::Temozolomide
EFO-21::Dactolisib
G-361::I-BET-762
EBC-1::Sorafenib
BICR10::Sorafenib
NCI-H2196::Temozolomide
SNU-283::RVX-208
MKN1::Doramapimod
K2::PFI-1
TE-12::Sorafenib
PCI-30::Lapatinib
Becker::Temozolomide
EW-12::IOX2
LC-1-sq::Sorafenib
SW1783::Osimertinib
NCI-H1581::Palbociclib
HCE-4::I-BET-762
SNU-61::Temozolomide
RERF-LC-MS::Lapatinib
NCI-H1993::Avagacestat
OV-56::VE-822
Farage::Lapatinib
MDA-MB-436::Sorafenib
IMR-5::Linsitinib
NCI-H1436::Sorafenib
HSC-4::Temozolomide
A204::Osimertinib
LC-1-sq::Dactolisib
NCI-H1836::IOX2
MES-SA::Dactolisib
G-401::Osimertinib
YKG-1::AZD6482
BC-1::RVX-208
VCaP::PRT062607
CAL-29::Osimertinib
HCC1428::Doramapimod
EFO-27::VE-822
A101D::Sorafenib
HPAF-II::Temozolomide
NB10::PRT062607
SNU-61::VE-822
NCI-H2141::I-BET-762
CL-11::I-BET-762
NY::Linsitinib
KS-1::I-BET-762
TCCSUP::PRT062607
AN3-CA::RVX-208
HT-115::AZD6482
K-562::RVX-208
A388::SL0101
A375::IOX2
NCI-H1975::Dactolisib
SK-MEL-31::AZD6482
HSC-2::Dactolisib
KM-H2::Sorafenib
LB2241-RCC::Ibrutinib
TE-6::PFI-1
CGTH-W-1::Lapatinib
NCI-H2087::Dactolisib
SK-MG-1::Dactolisib
BL-41::Ibrutinib
JEG-3::Palbociclib
KYSE-70::Dactolisib
LXF-289::PRT062607
COLO-824::AZD6482
NB14::VE-822
JIMT-1::Ibrutinib
NCI-H929::RVX-208
HCC70::Sorafenib
KP-4::RVX-208
Detroit562::PFI-1
NCI-H1355::Lapatinib
CHSA0108::VE-822
TGW::Osimertinib
SK-HEP-1::Dactolisib
JJN-3::Ibrutinib
KU-19-19::I-BET-762
NCI-H647::Ibrutinib
CAL-12T::VE-822
AsPC-1::RVX-208
NCI-H28::Temozolomide
CHSA0011::Palbociclib
MFE-296::Lapatinib
EW-7::Temozolomide
RH-41::Palbociclib
OACM5-1::Osimertinib
NMC-G1::RVX-208
EW-22::RVX-208
BB65-RCC::Palbociclib
CADO-ES1::PFI-1
OE21::Lapatinib
SNU-407::Dactolisib
EW-13::Ibrutinib
CHSA0108::Palbociclib
U-698-M::Sorafenib
NB1::Avagacestat
KYSE-180::Doramapimod
LB2518-MEL::PFI-1
NOMO-1::Dactolisib
EFO-21::Osimertinib
H-EMC-SS::Dactolisib
EW-11::Osimertinib
OCI-AML2::Osimertinib
EW-11::PRT062607
OV-7::Doramapimod
SK-LMS-1::I-BET-762
LCLC-103H::I-BET-762
NCI-H2444::IOX2
MDA-MB-157::PFI-1
OSC-19::I-BET-762
NCI-H28::Doramapimod
GI-ME-N::Osimertinib
KYSE-450::I-BET-762
Ca-Ski::Avagacestat
LB831-BLC::Dactolisib
NCI-H322M::Temozolomide
CHP-126::AZD6482
LXF-289::VE-822
huH-1::PRT062607
LXF-289::I-BET-762
EPLC-272H::Lapatinib
NCI-H2228::Ibrutinib
JSC-1::Sorafenib
NEC8::Temozolomide
GI-ME-N::Dactolisib
RH-41::Dactolisib
NCI-H1048::PRT062607
NY::Lapatinib
RERF-LC-KJ::VE-822
NCI-H1792::Lapatinib
U-698-M::Osimertinib
NCI-H292::Osimertinib
SK-MES-1::Linsitinib
LN-18::I-BET-762
PANC-08-13::Sorafenib
P30-OHK::RVX-208
SU-DHL-16::Lapatinib
HCT-116::Temozolomide
JHH-4::Sorafenib
ES7::Doramapimod
Calu-3::Osimertinib
NCI-H1355::RVX-208
NCI-H2023::I-BET-762
GR-ST::RVX-208
A4-Fuk::Linsitinib
C3A::Temozolomide
OAW-42::Doramapimod
PSN1::VE-822
OCUM-1::VE-822
KMRC-1::Sorafenib
D-263MG::I-BET-762
LU-139::RVX-208
647-V::RVX-208
HuP-T3::Sorafenib
RCC-ER::SL0101
RPMI-8226::I-BET-762
GB-1::Palbociclib
LS-513::Avagacestat
DOHH-2::PRT062607
HT-144::Dactolisib
NCI-H838::AZD6482
KYSE-510::Sorafenib
K2::Avagacestat
NU-DUL-1::Lapatinib
HL-60::Osimertinib
WM-115::Palbociclib
SW872::Ibrutinib
MLMA::RVX-208
SNU-387::PRT062607
G-MEL::Lapatinib
BV-173::Doramapimod
IPC-298::RVX-208
NCI-H2029::IOX2
EVSA-T::RVX-208
EMC-BAC-1::Doramapimod
DMS-53::Osimertinib
CAKI-1::VE-822
ML-1::RVX-208
SU-DHL-5::Linsitinib
KP-2::Doramapimod
NCI-H522::Doramapimod
COR-L279::Palbociclib
RD::Avagacestat
OV-56::Dactolisib
U-266::Linsitinib
MDA-MB-231::PRT062607
EW-18::Linsitinib
CAL-85-1::Temozolomide
LAN-6::Avagacestat
NUGC-4::Temozolomide
BB65-RCC::Osimertinib
RCC10RGB::Dactolisib
HGC-27::Sorafenib
HCC1500::Doramapimod
GP5d::Ibrutinib
H9::PFI-1
ABC-1::Lapatinib
MOLM-16::PRT062607
SW962::Sorafenib
PCI-4B::Palbociclib
BT-474::Sorafenib
CP50-MEL-B::Osimertinib
NCI-H3122::VE-822
NCCIT::Dactolisib
GI-ME-N::Linsitinib
NEC8::Avagacestat
NCI-H2030::Temozolomide
KMS-11::Linsitinib
CAL-85-1::PFI-1
HCC1395::AZD6482
NCI-H1573::Avagacestat
PA-1::Doramapimod
BICR10::I-BET-762
HOS::Temozolomide
LN-405::Linsitinib
SW620::IOX2
CTV-1::Osimertinib
COR-L105::PRT062607
MG-63::Linsitinib
K-562::PRT062607
NCI-H1648::Palbociclib
HT-115::PRT062607
GDM-1::VE-822
OVISE::Lapatinib
QIMR-WIL::Dactolisib
SU-DHL-1::Avagacestat
SBC-3::Doramapimod
NCI-H510A::Dactolisib
RERF-LC-KJ::Palbociclib
GCT::Lapatinib
SUP-B15::Avagacestat
JURL-MK1::Linsitinib
H9::Doramapimod
UMC-11::I-BET-762
LS-513::Temozolomide
OAW-42::VE-822
NB7::Avagacestat
LP-1::Sorafenib
NCI-H524::Osimertinib
NCI-H647::RVX-208
COLO-824::I-BET-762
NCI-H841::Doramapimod
TYK-nu::Avagacestat
JHU-011::Doramapimod
A2058::PRT062607
IA-LM::Sorafenib
KG-1::VE-822
TE-441-T::I-BET-762
FU-OV-1::PFI-1
SJRH30::I-BET-762
OVK-18::Palbociclib
IST-SL2::Palbociclib
NCI-H3122::Ibrutinib
Hs-578-T::AZD6482
GI-ME-N::VE-822
RH-1::PRT062607
CAL-62::Doramapimod
TE-6::Linsitinib
LC-2-ad::Palbociclib
SW1088::Linsitinib
DOK::Linsitinib
NCI-H520::I-BET-762
697::Ibrutinib
MM1S::Temozolomide
MDA-MB-361::RVX-208
OVCA420::I-BET-762
COR-L95::Avagacestat
JHOS-3::I-BET-762
ME-1::Avagacestat
CAL-54::PRT062607
NUGC-3::Lapatinib
PC-3::Dactolisib
SK-LMS-1::Osimertinib
NCI-H524::RVX-208
NCI-H520::VE-822
KOSC-2::Sorafenib
SBC-5::PFI-1
DSH1::Doramapimod
EPLC-272H::Avagacestat
COLO-684::Avagacestat
HARA::Avagacestat
NCI-H1563::PRT062607
UWB1.289::Temozolomide
OCI-AML5::Doramapimod
COR-L23::Lapatinib
SF295::Palbociclib
JVM-2::Osimertinib
MLMA::I-BET-762
NCC021::Temozolomide
L-1236::PRT062607
DMS-53::Dactolisib
TE-441-T::Osimertinib
SW626::I-BET-762
LS-513::Linsitinib
HCC-15::RVX-208
H4::VE-822
NCI-H82::Sorafenib
SNU-C1::Lapatinib
RL::Temozolomide
IGR-1::Palbociclib
SNU-C5::PRT062607
Calu-3::VE-822
WM278::Sorafenib
NCI-H446::Temozolomide
NCI-H292::Avagacestat
SJSA-1::Temozolomide
M059J::Linsitinib
SCC-4::Temozolomide
BT-474::Temozolomide
EW-13::Linsitinib
CHL-1::Doramapimod
AN3-CA::Temozolomide
CPC-N::Temozolomide
SW962::PRT062607
MPP-89::Palbociclib
RCC-MF::Temozolomide
CAPAN-1::Temozolomide
K2::Sorafenib
OVCA420::Osimertinib
MHH-CALL-4::Dactolisib
EW-16::PFI-1
639-V::I-BET-762
VAL::Avagacestat
MFH-ino::Temozolomide
BL-41::RVX-208
SNU-C2B::PRT062607
NCI-H2135::Ibrutinib
SK-CO-1::I-BET-762
KATOIII::Sorafenib
SCC90::Doramapimod
LC-1-sq::VE-822
C32::Avagacestat
SK-GT-2::Linsitinib
NB14::RVX-208
SW1088::Doramapimod
SW1710::Palbociclib
MRK-nu-1::Ibrutinib
BB65-RCC::Linsitinib
OE19::Palbociclib
HCE-4::Sorafenib
NCI-H1435::PRT062607
D-392MG::PFI-1
NCI-H69::Osimertinib
SAS::Doramapimod
SNU-423::Ibrutinib
DMS-273::Doramapimod
NCI-H64::Dactolisib
ONS-76::Ibrutinib
RCM-1::Dactolisib
CAS-1::Dactolisib
OPM-2::Osimertinib
SW620::RVX-208
KYSE-450::VE-822
SK-CO-1::Avagacestat
EPLC-272H::Sorafenib
EPLC-272H::Palbociclib
EW-11::Linsitinib
G-MEL::I-BET-762
CCRF-CEM::Temozolomide
NCI-H23::Linsitinib
NY::I-BET-762
EoL-1-cell::Palbociclib
OVCAR-3::Osimertinib
CADO-ES1::Osimertinib
SNU-C1::VE-822
SH-4::Palbociclib
RCC-FG2::Palbociclib
QGP-1::PRT062607
OVCA420::Avagacestat
H-EMC-SS::VE-822
PANC-08-13::Lapatinib
GR-ST::Doramapimod
IM-95::Palbociclib
AsPC-1::Palbociclib
NCI-H211::I-BET-762
ECC10::PRT062607
SLVL::Ibrutinib
RERF-LC-MS::IOX2
MHH-CALL-4::Sorafenib
Calu-3::PRT062607
KALS-1::Avagacestat
MDA-MB-361::Osimertinib
SNU-423::Lapatinib
ATN-1::PRT062607
T84::Ibrutinib
QIMR-WIL::Linsitinib
MFE-296::Dactolisib
CAL-78::VE-822
IGR-37::Sorafenib
SW1116::Palbociclib
GAK::Doramapimod
SK-MEL-3::Dactolisib
HC-1::Palbociclib
QGP-1::Palbociclib
T98G::RVX-208
NCI-H226::VE-822
JiyoyeP-2003::Dactolisib
KON::Osimertinib
KP-4::VE-822
SU-DHL-1::Lapatinib
SHP-77::PFI-1
QGP-1::AZD6482
JHOS-4::Osimertinib
SK-N-FI::PFI-1
EW-7::Sorafenib
SW626::Lapatinib
EB2::PRT062607
SK-MES-1::RVX-208
BONNA-12::PRT062607
G-361::RVX-208
AsPC-1::Dactolisib
WSU-DLCL2::Dactolisib
OVCAR-4::PFI-1
MCF7::Lapatinib
PCI-4B::RVX-208
ETK-1::Linsitinib
NCI-H1048::VE-822
RCC-MF::PFI-1
BB49-HNC::Osimertinib
RERF-GC-1B::PFI-1
LOUCY::VE-822
RKN::PFI-1
HDQ-P1::PRT062607
TE-10::Dactolisib
TE-8::Dactolisib
EW-12::PRT062607
C32::Temozolomide
M059J::Sorafenib
WM793B::Linsitinib
EPLC-272H::Temozolomide
JiyoyeP-2003::Doramapimod
SNU-C2B::VE-822
LU-134-A::Ibrutinib
Calu-6::Temozolomide
JEKO-1::Avagacestat
KOSC-2::AZD6482
TOV-21G::Ibrutinib
JHU-022::Dactolisib
Ca9-22::PFI-1
NCI-H596::PFI-1
no-10::Dactolisib
MOG-G-UVW::PFI-1
JSC-1::Doramapimod
D-392MG::Linsitinib
SCC90::Palbociclib
MOLT-13::Palbociclib
RH-1::Ibrutinib
MZ7-mel::I-BET-762
BFTC-909::Sorafenib
Daoy::Dactolisib
Hs-445::Dactolisib
NCI-H2087::Doramapimod
SAS::Temozolomide
EVSA-T::AZD6482
Jurkat::I-BET-762
OSC-20::VE-822
no-10::PRT062607
NCI-H526::PRT062607
LB2241-RCC::Temozolomide
RL::PFI-1
SCC-4::Sorafenib
YH-13::PRT062607
EW-24::Linsitinib
SHP-77::Doramapimod
PWR-1E::Linsitinib
TE-6::PRT062607
NCI-H2122::Osimertinib
HT-3::VE-822
HCC1954::AZD6482
SUP-M2::Dactolisib
BALL-1::Sorafenib
CGTH-W-1::Osimertinib
ROS-50::Palbociclib
SNB75::Doramapimod
BHY::AZD6482
NCI-H1915::Temozolomide
DND-41::I-BET-762
NUGC-3::Temozolomide
451Lu::Ibrutinib
NCI-H1651::RVX-208
HDQ-P1::I-BET-762
GAMG::PRT062607
TE-441-T::RVX-208
COLO-783::Palbociclib
NCI-H209::VE-822
MOLM-13::PRT062607
NCI-H2170::VE-822
SIG-M5::AZD6482
JHOS-3::RVX-208
HuCCT1::Dactolisib
LB2241-RCC::Avagacestat
HuO-3N1::I-BET-762
SK-MEL-30::I-BET-762
DSH1::VE-822
TT2609-C02::Doramapimod
LB373-MEL-D::Dactolisib
KARPAS-299::Doramapimod
VMRC-RCZ::Osimertinib
JSC-1::Palbociclib
LCLC-97TM1::Sorafenib
TC-71::Osimertinib
RH-41::Avagacestat
IGROV-1::RVX-208
GB-1::Temozolomide
CAS-1::Doramapimod
JHOS-4::Avagacestat
KM12::Palbociclib
VA-ES-BJ::Temozolomide
ML-1::Palbociclib
SK-MEL-1::Lapatinib
L-1236::PFI-1
Daudi::Osimertinib
T47D::Linsitinib
DBTRG-05MG::VE-822
NCI-H661::Palbociclib
ZR-75-30::VE-822
COLO-680N::RVX-208
GAK::RVX-208
NCI-H1975::VE-822
VMRC-LCD::Linsitinib
MS751::RVX-208
JHH-7::PFI-1
RKN::Sorafenib
COLO-684::PRT062607
P12-ICHIKAWA::Temozolomide
A427::AZD6482
GOTO::Palbociclib
NCI-H1734::Ibrutinib
CADO-ES1::RVX-208
MDA-MB-436::PFI-1
QIMR-WIL::PFI-1
OV-17R::PFI-1
Hs-578-T::Lapatinib
SCC-4::VE-822
LS-1034::Palbociclib
NCI-H3122::Sorafenib
MFE-280::Temozolomide
NCI-H2347::PFI-1
HCC1187::I-BET-762
TC-YIK::Dactolisib
ATN-1::Temozolomide
TK10::RVX-208
LXF-289::Dactolisib
COLO-668::Temozolomide
LC4-1::PFI-1
ONS-76::PRT062607
5637::Ibrutinib
SW1116::I-BET-762
NCI-H596::Sorafenib
KNS-81-FD::Doramapimod
DOHH-2::Palbociclib
KU-19-19::PRT062607
JVM-3::Avagacestat
FU-OV-1::Palbociclib
CAL-62::PFI-1
NCI-H1435::Ibrutinib
CAMA-1::Palbociclib
JHU-029::Temozolomide
LOXIMVI::PFI-1
COR-L95::Palbociclib
ME-1::Doramapimod
HH::Ibrutinib
UMC-11::RVX-208
NCI-H64::Temozolomide
SW954::Dactolisib
NB12::Linsitinib
CHP-126::I-BET-762
CESS::PRT062607
KYSE-180::Linsitinib
G-MEL::RVX-208
NCI-H1568::I-BET-762
RKO::Sorafenib
D-502MG::Dactolisib
VMRC-LCD::Doramapimod
SW620::Linsitinib
KCL-22::RVX-208
SNU-C2B::Avagacestat
RCM-1::Sorafenib
639-V::Avagacestat
A253::Dactolisib
EW-16::Sorafenib
CL-11::Temozolomide
8505C::Avagacestat
ONS-76::Temozolomide
SW626::Avagacestat
OCUB-M::PRT062607
DAN-G::Sorafenib
Ca-Ski::Temozolomide
KP-4::PRT062607
OACp4C::Ibrutinib
PA-1::Avagacestat
LOXIMVI::Temozolomide
LOU-NH91::Temozolomide
MKN7::PRT062607
WM1552C::Palbociclib
WM1552C::Linsitinib
L-1236::Lapatinib
PCI-6A::Doramapimod
EC-GI-10::Doramapimod
NCI-H929::Linsitinib
MOLT-4::Sorafenib
HO-1-u-1::Dactolisib
D-263MG::PFI-1
PA-TU-8902::VE-822
697::Temozolomide
Hs-445::Doramapimod
SW837::Linsitinib
HCC-15::I-BET-762
SAS::Osimertinib
NCI-H2029::PFI-1
L-540::Avagacestat
NCI-H2405::Lapatinib
MCF7::Avagacestat
EFM-19::Osimertinib
SK-LU-1::Linsitinib
SF268::I-BET-762
NCI-H292::Dactolisib
ESO26::Osimertinib
WIL2-NS::Temozolomide
PC-14::Ibrutinib
RCC-MF::I-BET-762
L-428::Sorafenib
RS4-11::RVX-208
NB(TU)1-10::Sorafenib
VA-ES-BJ::PFI-1
NCI-H2029::Lapatinib
MHH-CALL-2::RVX-208
EW-24::I-BET-762
RERF-GC-1B::RVX-208
COLO-800::Dactolisib
NCC010::RVX-208
KARPAS-45::Palbociclib
SBC-1::Temozolomide
STS-0421::Doramapimod
LCLC-103H::Linsitinib
OV-7::IOX2
ML-1::Dactolisib
NUGC-4::PRT062607
647-V::PFI-1
LB771-HNC::Doramapimod
TE-441-T::Dactolisib
HCC1419::I-BET-762
NCI-H2122::Dactolisib
NCI-H1836::VE-822
CHSA0011::Temozolomide
SK-PN-DW::Dactolisib
GOTO::Lapatinib
RCC-MF::IOX2
NCI-H226::Dactolisib
EN::Sorafenib
RC-K8::Palbociclib
MDA-MB-157::Palbociclib
DMS-79::Osimertinib
BALL-1::Doramapimod
WM278::Linsitinib
OVCAR-4::Osimertinib
KMRC-1::Temozolomide
H4::Dactolisib
JHU-011::PFI-1
SK-MEL-5::VE-822
KARPAS-620::Temozolomide
MLMA::Temozolomide
LN-405::Dactolisib
SW837::Lapatinib
LU-165::I-BET-762
NCI-H1838::Avagacestat
D-392MG::PRT062607
NCI-H835::Linsitinib
NCI-H28::Sorafenib
MOLP-8::Sorafenib
SNU-387::Avagacestat
PA-TU-8902::Dactolisib
KYSE-510::PFI-1
MSTO-211H::Osimertinib
SK-OV-3::Sorafenib
LS-123::Linsitinib
KARPAS-299::Palbociclib
DOK::Lapatinib
ASH-3::Avagacestat
NCI-H2228::Avagacestat
DU-145::Linsitinib
JHH-2::RVX-208
LS-1034::VE-822
ESO51::Avagacestat
GDM-1::PFI-1
NCI-H1435::Palbociclib
SW156::I-BET-762
SW872::Dactolisib
BEN::Doramapimod
SW982::Avagacestat
PA-TU-8988T::Sorafenib
NCI-H1734::AZD6482
Ca-Ski::VE-822
BE2-M17::Sorafenib
RH-1::Avagacestat
MDA-MB-468::Avagacestat
UACC-893::Lapatinib
SW620::Palbociclib
TOV-112D::Dactolisib
KATOIII::Palbociclib
DAN-G::I-BET-762
SNU-C5::Lapatinib
NCI-H1915::VE-822
LoVo::Ibrutinib
HDQ-P1::Doramapimod
JHOS-4::Palbociclib
HEL::Lapatinib
NCI-H1341::PFI-1
ROS-50::VE-822
U-698-M::Ibrutinib
SK-MG-1::VE-822
KNS-81-FD::AZD6482
SK-MEL-3::VE-822
UACC-62::Avagacestat
HO-1-u-1::PFI-1
KYSE-180::Dactolisib
TE-1::Linsitinib
CAKI-1::Lapatinib
PANC-10-05::Ibrutinib
EW-11::Temozolomide
RERF-LC-KJ::PRT062607
HCC1954::Temozolomide
TGBC1TKB::Palbociclib
JVM-3::Ibrutinib
EFM-192A::I-BET-762
HCC1500::Dactolisib
LB771-HNC::Palbociclib
Daoy::Sorafenib
LU-165::Ibrutinib
451Lu::I-BET-762
Detroit562::Dactolisib
LP-1::Osimertinib
MG-63::RVX-208
RVH-421::PRT062607
KM-H2::Doramapimod
A673::Sorafenib
HDQ-P1::Temozolomide
OCUB-M::Dactolisib
HAL-01::Ibrutinib
LS-180::I-BET-762
EVSA-T::Osimertinib
LB1047-RCC::Avagacestat
LB647-SCLC::Sorafenib
OAW-28::Palbociclib
OVCAR-5::Temozolomide
A388::Palbociclib
JHOS-3::Doramapimod
TE-441-T::PRT062607
PFSK-1::Palbociclib
OCI-LY7::RVX-208
BC-1::Palbociclib
NCC010::Lapatinib
U-698-M::I-BET-762
RCM-1::VE-822
TE-4::Osimertinib
HT-3::PFI-1
K5::PRT062607
MDA-MB-436::RVX-208
SF126::Lapatinib
AN3-CA::PFI-1
RMG-I::PFI-1
SNU-61::Sorafenib
LN-405::RVX-208
NCC010::Temozolomide
HPAC::Linsitinib
NCI-H2110::Sorafenib
PCI-6A::Dactolisib
SK-UT-1::Palbociclib
NCI-H647::IOX2
PA-1::Osimertinib
SNU-C2B::Osimertinib
Saos-2::Lapatinib
MOLM-13::Avagacestat
DMS-53::Doramapimod
KMS-11::Lapatinib
NCI-H2170::Lapatinib
PEO1::Avagacestat
KP-N-YN::Palbociclib
HCT-15::Ibrutinib
OVCAR-8::Osimertinib
HCC38::Ibrutinib
MZ1-PC::I-BET-762
SIG-M5::IOX2
NCI-H1963::Dactolisib
MDA-MB-453::Doramapimod
IST-MES1::PRT062607
LS-1034::Osimertinib
HPAC::Doramapimod
SN12C::Doramapimod
RCC10RGB::Linsitinib
NB69::VE-822
K-562::Doramapimod
KLE::Palbociclib
EW-3::Osimertinib
K2::Osimertinib
NCI-H2030::Palbociclib
BB65-RCC::SL0101
LU-99A::Temozolomide
U-698-M::Palbociclib
647-V::Avagacestat
NCI-H2196::I-BET-762
SK-MM-2::Ibrutinib
CA46::RVX-208
WM1552C::Osimertinib
EB2::Ibrutinib
NCI-H322M::VE-822
OV-17R::RVX-208
CAPAN-1::Avagacestat
U-87-MG::Sorafenib
Ramos-2G6-4C10::Dactolisib
NCI-H2228::Palbociclib
P31-FUJ::PFI-1
D-336MG::IOX2
NCI-H2030::SL0101
SK-OV-3::I-BET-762
NCI-H841::I-BET-762
OAW-42::PFI-1
COLO-678::Ibrutinib
RH-41::Doramapimod
A431::I-BET-762
TGW::Ibrutinib
HCC1428::Ibrutinib
NCC010::Ibrutinib
CPC-N::VE-822
NCI-H2066::Lapatinib
LN-18::Doramapimod
CAL-62::VE-822
KARPAS-422::Linsitinib
LB2241-RCC::Palbociclib
PFSK-1::Osimertinib
GAK::I-BET-762
CPC-N::Palbociclib
P32-ISH::RVX-208
Hs-578-T::PFI-1
NCI-H1648::Sorafenib
SK-MEL-2::Linsitinib
LCLC-103H::Avagacestat
KYSE-70::Sorafenib
YH-13::Ibrutinib
NMC-G1::PRT062607
ML-2::RVX-208
HCC-827::Linsitinib
ML-2::Lapatinib
Raji::Lapatinib
IM-9::PRT062607
DOHH-2::RVX-208
U251::Palbociclib
SU-DHL-10::Lapatinib
ES-2::I-BET-762
no-10::Linsitinib
KP-3::VE-822
NCI-H2172::Doramapimod
NCI-H2196::PFI-1
NCI-H1915::Palbociclib
RH-41::I-BET-762
ROS-50::Linsitinib
SW156::Sorafenib
SK-N-DZ::Lapatinib
CP50-MEL-B::AZD6482
HOP-92::Sorafenib
MSTO-211H::Avagacestat
CHSA0108::PFI-1
OSC-19::RVX-208
ML-1::Lapatinib
HSC-2::Ibrutinib
451Lu::IOX2
OCI-M1::PFI-1
EMC-BAC-1::Palbociclib
HMV-II::Osimertinib
MDA-MB-330::Sorafenib
LU-139::PRT062607
BT-20::Lapatinib
BHY::Ibrutinib
RCC-JF::Lapatinib
LK-2::I-BET-762
RL95-2::Linsitinib
KOPN-8::PRT062607
NCI-H2452::Sorafenib
ASH-3::Osimertinib
NCI-H1581::VE-822
C-4-I::Dactolisib
NCI-H2342::Doramapimod
BL-41::Doramapimod
SW48::Lapatinib
SK-N-AS::I-BET-762
SW1271::Doramapimod
ECC12::Osimertinib
SK-MEL-30::Osimertinib
NAMALWA::I-BET-762
SUP-B8::Temozolomide
ONS-76::VE-822
MDA-MB-415::Ibrutinib
MHH-NB-11::AZD6482
KMRC-1::Palbociclib
NCI-H2122::RVX-208
COR-L105::Temozolomide
BALL-1::VE-822
MES-SA::I-BET-762
CS1::Temozolomide
Raji::Dactolisib
RXF393::PFI-1
MN-60::Linsitinib
DOHH-2::Ibrutinib
KYSE-220::RVX-208
SNU-C1::Ibrutinib
NCI-H2291::Avagacestat
FU97::Palbociclib
IPC-298::AZD6482
SW1088::Lapatinib
SNU-C1::Avagacestat
JHU-029::PRT062607
CTV-1::I-BET-762
COLO-824::Sorafenib
NCI-H1092::RVX-208
JEG-3::SL0101
OSC-19::VE-822
MHH-NB-11::PRT062607
OVCAR-3::Ibrutinib
BT-549::AZD6482
JHU-022::Lapatinib
HCC2998::I-BET-762
DMS-53::PRT062607
MDA-MB-231::RVX-208
SK-MEL-2::Dactolisib
HCC1187::Palbociclib
AGS::Palbociclib
HuP-T4::PFI-1
NCI-H2029::VE-822
no-11::Doramapimod
IST-SL1::PFI-1
SNU-449::Sorafenib
Caov-4::Sorafenib
SNU-175::Ibrutinib
NCI-H1975::Avagacestat
OV-17R::Doramapimod
UACC-257::PRT062607
GOTO::Ibrutinib
BEN::Temozolomide
MOLT-13::I-BET-762
KU812::Palbociclib
TE-10::AZD6482
OCUM-1::Osimertinib
SK-LU-1::Sorafenib
BHY::Palbociclib
MFM-223::Temozolomide
C32::Palbociclib
ESO51::RVX-208
SUP-M2::Palbociclib
NCI-H1436::Linsitinib
NCI-H1915::Lapatinib
NCI-H1341::Palbociclib
RH-1::Dactolisib
KMS-12-BM::Avagacestat
MOLM-13::Palbociclib
SF126::AZD6482
CCK-81::Linsitinib
NU-DUL-1::PRT062607
LCLC-103H::Lapatinib
KARPAS-45::Temozolomide
NAMALWA::Sorafenib
EW-22::Temozolomide
TE-8::Sorafenib
AsPC-1::Linsitinib
EVSA-T::Ibrutinib
NCI-H650::PRT062607
MDA-MB-330::PRT062607
NCI-H196::Sorafenib
PL-21::Doramapimod
MDA-MB-453::I-BET-762
SW1463::I-BET-762
MSTO-211H::Sorafenib
SCC90::Sorafenib
KYSE-70::Lapatinib
MC116::Palbociclib
OCI-M1::Lapatinib
BT-474::Dactolisib
ROS-50::SL0101
NCI-N87::Linsitinib
KYSE-510::Palbociclib
TCCSUP::Linsitinib
NCI-H1915::Osimertinib
C3A::I-BET-762
COLO-678::Osimertinib
CP66-MEL::Temozolomide
SK-MEL-1::Osimertinib
CAL-85-1::Ibrutinib
MDA-MB-415::Sorafenib
DEL::VE-822
PL-21::Dactolisib
SNU-1040::Linsitinib
HCC-366::AZD6482
IPC-298::Doramapimod
OPM-2::Sorafenib
DEL::Sorafenib
LN-229::Sorafenib
UACC-893::Sorafenib
LS-123::Lapatinib
MDA-MB-361::Ibrutinib
OE21::Dactolisib
SK-MES-1::Osimertinib
KM12::Osimertinib
CHSA0011::Avagacestat
IGR-1::Ibrutinib
HCC1937::Sorafenib
ETK-1::PRT062607
QIMR-WIL::I-BET-762
LB771-HNC::Ibrutinib
SW954::Temozolomide
GCT::VE-822
RCC-AB::RVX-208
SW1463::Ibrutinib
NCI-H1623::VE-822
NCI-H1694::Ibrutinib
KELLY::Temozolomide
LU-139::Temozolomide
Daudi::Sorafenib
CA46::PRT062607
NCI-H2405::PRT062607
HSC-39::Linsitinib
NCI-H441::Sorafenib
COLO-320-HSR::I-BET-762
TCCSUP::PFI-1
NCI-H1650::Linsitinib
HuCCT1::Doramapimod
FTC-133::Lapatinib
NCI-H2172::Ibrutinib
CHP-212::PFI-1
TE-4::Avagacestat
ES4::Sorafenib
no-10::AZD6482
SF268::VE-822
MDA-MB-468::Linsitinib
LAN-6::Dactolisib
SW1573::PFI-1
PANC-02-03::I-BET-762
42-MG-BA::Dactolisib
OVCA420::Lapatinib
RERF-GC-1B::PRT062607
SUP-HD1::Linsitinib
SK-MEL-30::AZD6482
697::PFI-1
NALM-6::Lapatinib
HMV-II::Ibrutinib
MOG-G-UVW::Avagacestat
MLMA::Dactolisib
AU565::AZD6482
HSC-2::PFI-1
SK-GT-4::Linsitinib
KY821::Ibrutinib
NALM-6::Sorafenib
LAMA-84::Dactolisib
SNU-C5::Sorafenib
HCC1954::RVX-208
A172::RVX-208
BB49-HNC::Palbociclib
BB49-HNC::Linsitinib
HCC-44::Avagacestat
KM12::Temozolomide
KARPAS-231::RVX-208
NEC8::Ibrutinib
TE-4::Dactolisib
NCI-H1770::Doramapimod
EW-24::Temozolomide
L-540::Sorafenib
JEKO-1::RVX-208
A549::PRT062607
H3255::Doramapimod
NCI-H1105::IOX2
M059J::Ibrutinib
MEL-HO::Lapatinib
SNU-283::Osimertinib
RVH-421::Dactolisib
SW13::Osimertinib
GCIY::PFI-1
HCC1806::Ibrutinib
SK-N-SH::Sorafenib
COLO-783::Lapatinib
CAL-29::Linsitinib
TE-9::Lapatinib
BHY::Sorafenib
HCT-116::Avagacestat
KMRC-20::Dactolisib
KY821::Osimertinib
D-283MED::Avagacestat
KYSE-180::VE-822
LU-99A::Lapatinib
EFM-19::Dactolisib
NCI-H1568::Doramapimod
U031::Lapatinib
C3A::Osimertinib
IST-SL2::PFI-1
HO-1-N-1::Linsitinib
KP-N-YN::Dactolisib
HA7-RCC::Sorafenib
ESO51::Temozolomide
LB2518-MEL::Temozolomide
SW1783::Avagacestat
OVMIU::Linsitinib
OVMIU::Doramapimod
SW156::Ibrutinib
8505C::Lapatinib
JVM-3::Linsitinib
LOXIMVI::Lapatinib
KYSE-510::AZD6482
639-V::Doramapimod
A253::Lapatinib
SCC-25::Dactolisib
SK-MEL-31::Lapatinib
NKM-1::Sorafenib
ROS-50::I-BET-762
P32-ISH::PRT062607
SKN::RVX-208
TE-5::PFI-1
WIL2-NS::RVX-208
H4::PRT062607
SIG-M5::PRT062607
Detroit562::Lapatinib
KYSE-520::PFI-1
SNU-423::Dactolisib
MZ2-MEL::AZD6482
COLO-205::Doramapimod
EFM-192A::Osimertinib
EN::VE-822
SCC-4::Dactolisib
CP50-MEL-B::Ibrutinib
OE19::Ibrutinib
BL-41::Palbociclib
RKN::Lapatinib
KYSE-270::PRT062607
CAPAN-1::Osimertinib
SISO::RVX-208
K2::Doramapimod
RL::Palbociclib
BICR10::Osimertinib
LU-65::Palbociclib
NCI-H647::Palbociclib
PL-21::Ibrutinib
NCI-H1793::RVX-208
SUP-M2::Lapatinib
CFPAC-1::Dactolisib
TK10::Doramapimod
GCT::RVX-208
MDA-MB-330::VE-822
WM35::Sorafenib
647-V::Ibrutinib
KARPAS-299::Ibrutinib
CAPAN-1::Linsitinib
T98G::Osimertinib
TE-10::Avagacestat
U-118-MG::Palbociclib
LN-229::I-BET-762
SBC-1::Osimertinib
LN-229::Dactolisib
SK-HEP-1::Palbociclib
NCI-H250::Avagacestat
A673::Lapatinib
LB831-BLC::Temozolomide
Daoy::RVX-208
SCH::Avagacestat
SNU-C2B::Lapatinib
TE-9::Doramapimod
ML-1::Osimertinib
PANC-10-05::Sorafenib
SF295::AZD6482
MKN7::Ibrutinib
42-MG-BA::VE-822
SK-GT-4::Doramapimod
NB14::PFI-1
H4::Linsitinib
HCC1419::Avagacestat
NB(TU)1-10::PRT062607
KYSE-140::PRT062607
NCI-H2170::Doramapimod
ECC10::Lapatinib
NCI-H292::I-BET-762
MEL-HO::Linsitinib
22RV1::PRT062607
SW1271::Linsitinib
451Lu::Doramapimod
8305C::Ibrutinib
MOLM-13::Temozolomide
HCC-366::Dactolisib
RC-K8::RVX-208
EVSA-T::Temozolomide
KOSC-2::Palbociclib
JURL-MK1::Lapatinib
DU-4475::PFI-1
KYSE-70::Linsitinib
NB13::VE-822
ChaGo-K-1::Doramapimod
ASH-3::RVX-208
RCC-JW::Dactolisib
M14::I-BET-762
CRO-AP2::VE-822
JEKO-1::Doramapimod
KURAMOCHI::VE-822
HCC-15::Temozolomide
NB(TU)1-10::Osimertinib
UACC-893::Dactolisib
SW982::PRT062607
U-87-MG::I-BET-762
C-33-A::VE-822
NCI-H740::PFI-1
SK-CO-1::Lapatinib
T47D::Osimertinib
A2058::Temozolomide
BICR22::I-BET-762
SW684::PRT062607
SF268::PFI-1
NCI-H2009::Doramapimod
COR-L321::Lapatinib
TE-5::Ibrutinib
SK-MEL-5::SL0101
COLO-680N::PFI-1
SNU-1040::VE-822
NALM-6::Avagacestat
OVCAR-5::Palbociclib
EFM-192A::Sorafenib
HSC-4::I-BET-762
SK-MEL-31::Ibrutinib
JVM-2::PFI-1
CGTH-W-1::PFI-1
HCC1143::Doramapimod
RT-112::PFI-1
KYSE-520::I-BET-762
NUGC-4::Osimertinib
KYSE-450::Sorafenib
NCI-H1793::Lapatinib
CHP-134::Dactolisib
RCC-ER::Osimertinib
EVSA-T::PFI-1
D-542MG::Linsitinib
COLO-783::PRT062607
SKN-3::Doramapimod
SU-DHL-10::Avagacestat
RCC10RGB::VE-822
PC-3::PFI-1
JVM-3::Osimertinib
NB7::Temozolomide
Daoy::I-BET-762
A375::Avagacestat
C-33-A::Doramapimod
D-423MG::Doramapimod
DND-41::Palbociclib
TE-11::IOX2
SU-DHL-8::RVX-208
A2780::Doramapimod
WM793B::PFI-1
SAT::VE-822
STS-0421::Dactolisib
IA-LM::Doramapimod
NB7::VE-822
UM-UC-3::Doramapimod
NB12::Dactolisib
CHSA0108::IOX2
NCI-H2135::Sorafenib
NCI-H660::IOX2
YH-13::Avagacestat
GCT::Temozolomide
T47D::AZD6482
ESS-1::PFI-1
COR-L311::Osimertinib
TE-1::Lapatinib
NCI-H2227::PRT062607
AN3-CA::Ibrutinib
SW1088::PRT062607
SUP-B15::Palbociclib
HAL-01::Lapatinib
KOPN-8::PFI-1
NCI-H69::Sorafenib
SNU-81::PRT062607
A101D::Lapatinib
MOLM-13::Sorafenib
C-4-I::Avagacestat
NCI-H146::I-BET-762
8305C::Avagacestat
NCI-H520::Avagacestat
NCI-H661::Lapatinib
M059J::Temozolomide
IST-SL1::IOX2
COLO-678::Avagacestat
EM-2::Linsitinib
RPMI-8866::PFI-1
NCI-H1781::Doramapimod
SNU-81::Lapatinib
ML-2::Dactolisib
KYSE-410::Linsitinib
HT-1080::Dactolisib
DBTRG-05MG::Palbociclib
RH-1::I-BET-762
OAW-28::Avagacestat
SR::Dactolisib
NCI-H2009::Sorafenib
NCI-H2030::PFI-1
LB771-HNC::Osimertinib
GOTO::I-BET-762
KMS-11::Palbociclib
KY821::Avagacestat
MDST8::I-BET-762
VMRC-LCD::RVX-208
KOSC-2::Doramapimod
ACHN::PFI-1
SW156::Palbociclib
SK-MEL-2::Osimertinib
TYK-nu::Sorafenib
OE21::Sorafenib
PCI-15A::Sorafenib
NB6::I-BET-762
ESO51::PRT062607
RPMI-6666::Lapatinib
KATOIII::Linsitinib
TC-71::Lapatinib
HT-29::Osimertinib
EJM::Sorafenib
ME-180::PFI-1
no-10::IOX2
SKM-1::Dactolisib
FU-OV-1::Dactolisib
HO-1-N-1::Dactolisib
CCRF-CEM::Avagacestat
RT4::Doramapimod
ES1::Sorafenib
HCC1599::Palbociclib
HSC-3::Lapatinib
SW780::Doramapimod
TE-4::Ibrutinib
MDA-MB-436::Lapatinib
RD::Ibrutinib
SAT::Ibrutinib
PCI-15A::PFI-1
STS-0421::Palbociclib
SK-MG-1::PFI-1
OCUB-M::Doramapimod
NCI-H716::RVX-208
H3255::PFI-1
DU-145::I-BET-762
ABC-1::Palbociclib
CHSA8926::Osimertinib
KELLY::Sorafenib
LB771-HNC::RVX-208
PANC-02-03::Palbociclib
G-402::Sorafenib
Hey::PRT062607
COLO-205::Linsitinib
8305C::Osimertinib
OE21::Ibrutinib
CAL-51::Temozolomide
Mo-T::Dactolisib
NCI-H2141::Doramapimod
HT-1197::Lapatinib
RL95-2::PRT062607
CAL-85-1::Linsitinib
NCI-H1792::Doramapimod
U-87-MG::PRT062607
huH-1::I-BET-762
STS-0421::RVX-208
MHH-CALL-4::Avagacestat
SNU-C1::I-BET-762
KM-H2::Avagacestat
JHH-6::Doramapimod
DoTc2-4510::VE-822
JHOS-3::Sorafenib
LC-2-ad::IOX2
SCC-3::Temozolomide
NCI-H748::Dactolisib
D-502MG::PFI-1
EW-1::PFI-1
MV-4-11::PFI-1
KARPAS-299::Avagacestat
SUIT-2::Ibrutinib
no-11::Palbociclib
NCI-H2196::Doramapimod
COLO-684::Linsitinib
ES5::I-BET-762
BONNA-12::VE-822
PA-1::PFI-1
RCH-ACV::SL0101
CP66-MEL::Lapatinib
OAW-42::Sorafenib
CAL-120::Sorafenib
HuO-3N1::Palbociclib
WM35::PRT062607
COR-L311::Palbociclib
AGS::PFI-1
SW1116::Temozolomide
CP66-MEL::PRT062607
MOLM-16::I-BET-762
NCI-H2030::PRT062607
LB2241-RCC::IOX2
SCC-3::Palbociclib
K2::IOX2
ME-1::VE-822
RVH-421::Ibrutinib
A704::Lapatinib
PC-14::Doramapimod
Raji::RVX-208
KM-H2::VE-822
COR-L23::Palbociclib
J82::Osimertinib
EFM-192A::AZD6482
SISO::Doramapimod
SiHa::PRT062607
GCT::I-BET-762
SIMA::Lapatinib
K5::Osimertinib
ZR-75-30::PRT062607
SLVL::PFI-1
MKN1::Lapatinib
D-566MG::Palbociclib
OVMIU::Sorafenib
KNS-42::Avagacestat
RH-41::PFI-1
Ca9-22::Temozolomide
BT-474::I-BET-762
42-MG-BA::Lapatinib
JHOS-3::Temozolomide
A431::Dactolisib
KYM-1::Palbociclib
CESS::Temozolomide
LB996-RCC::RVX-208
NCI-H747::Temozolomide
LAN-6::I-BET-762
EW-3::Linsitinib
MS751::PFI-1
NCI-H1703::Osimertinib
SK-PN-DW::Sorafenib
42-MG-BA::RVX-208
SCC-9::Sorafenib
NCI-H2030::Ibrutinib
NEC8::VE-822
KYSE-270::Lapatinib
SH-4::PFI-1
SKG-IIIa::Linsitinib
LP-1::Palbociclib
SISO::Linsitinib
TE-11::Linsitinib
QGP-1::Doramapimod
OCI-LY-19::Avagacestat
LB1047-RCC::AZD6482
HCC1500::PRT062607
JHH-4::Osimertinib
CHSA0011::VE-822
SCC-15::Ibrutinib
ZR-75-30::I-BET-762
NCI-H322M::Ibrutinib
NCI-H1650::PFI-1
TE-11::Ibrutinib
RCC-JF::Ibrutinib
COLO-824::PFI-1
NB17::IOX2
PSN1::Doramapimod
LNCaP-Clone-FGC::Palbociclib
MEL-HO::SL0101
NCI-H838::Avagacestat
CHP-126::RVX-208
OVCAR-4::Sorafenib
GDM-1::RVX-208
A101D::PFI-1
D-566MG::Dactolisib
Calu-3::Dactolisib
NCC021::Palbociclib
HuCCT1::Avagacestat
H9::Avagacestat
MKN1::Ibrutinib
COR-L88::Linsitinib
JHH-2::Avagacestat
MFE-296::Osimertinib
SISO::VE-822
RXF393::IOX2
NCI-H1623::Palbociclib
IA-LM::Lapatinib
NCI-H1048::Ibrutinib
NCI-H211::Palbociclib
M14::Osimertinib
MKN45::PRT062607
MKN45::Sorafenib
SUP-B15::Temozolomide
TE-9::Dactolisib
HGC-27::Temozolomide
EW-16::Palbociclib
ES5::IOX2
RCM-1::Avagacestat
MS-1::PFI-1
THP-1::PFI-1
NB5::Palbociclib
MOLT-13::Osimertinib
SF539::Ibrutinib
HARA::Ibrutinib
Mewo::Lapatinib
ChaGo-K-1::PFI-1
WM1552C::RVX-208
T-T::Osimertinib
MFH-ino::Sorafenib
8305C::PRT062607
KYSE-520::PRT062607
A172::I-BET-762
HC-1::Lapatinib
AN3-CA::Dactolisib
P12-ICHIKAWA::RVX-208
EFM-192A::Lapatinib
SW756::Osimertinib
Hey::Palbociclib
IPC-298::IOX2
EW-1::Sorafenib
OACp4C::Avagacestat
NB13::I-BET-762
ES1::Avagacestat
NCI-H146::Osimertinib
WSU-NHL::Osimertinib
BB30-HNC::Sorafenib
JIMT-1::VE-822
BHY::Osimertinib
SW1573::PRT062607
MDST8::Lapatinib
CTV-1::RVX-208
THP-1::Doramapimod
SU-DHL-1::PFI-1
J82::Lapatinib
DOV13::Palbociclib
RERF-GC-1B::I-BET-762
NCI-H196::Avagacestat
BB49-HNC::I-BET-762
COLO-320-HSR::Palbociclib
RL::Linsitinib
DOV13::Dactolisib
DAN-G::PFI-1
LU-139::Palbociclib
BL-41::Lapatinib
EW-22::I-BET-762
H3255::VE-822
SHP-77::VE-822
OPM-2::Ibrutinib
RMG-I::Palbociclib
SCC90::I-BET-762
SIG-M5::Ibrutinib
KYSE-450::Palbociclib
RD::Palbociclib
BT-483::Lapatinib
CADO-ES1::Avagacestat
KP-2::Dactolisib
NCI-H1792::Temozolomide
EMC-BAC-2::Dactolisib
DEL::PRT062607
MDST8::Linsitinib
RT-112::Temozolomide
G-MEL::PRT062607
KNS-81-FD::Linsitinib
HuCCT1::PFI-1
DAN-G::Lapatinib
NCI-H2135::I-BET-762
NCI-H1435::Sorafenib
TE-4::Linsitinib
OCI-LY7::Lapatinib
BT-474::Linsitinib
T47D::Doramapimod
SBC-1::IOX2
U-698-M::Linsitinib
AU565::Temozolomide
MDA-MB-415::Temozolomide
NCI-H2009::Dactolisib
SW156::Doramapimod
ME-180::Ibrutinib
OAW-28::RVX-208
JHOS-2::I-BET-762
OVCA420::Dactolisib
23132-87::RVX-208
HCC70::AZD6482
NCI-H3122::Avagacestat
NCI-H510A::PRT062607
JHOS-4::RVX-208
COLO-679::Linsitinib
LS-123::RVX-208
EM-2::Palbociclib
CAL-51::VE-822
JM1::Avagacestat
CAL-72::Palbociclib
TE-9::Sorafenib
PF-382::I-BET-762
DB::Temozolomide
SUIT-2::PFI-1
HOS::Sorafenib
JHU-011::Palbociclib
AGS::I-BET-762
SK-MEL-5::Lapatinib
RPMI-8866::VE-822
RCC-MF::SL0101
T98G::Palbociclib
EVSA-T::VE-822
HCC-44::Osimertinib
TE-5::Temozolomide
NCI-H841::Temozolomide
COR-L23::Temozolomide
KINGS-1::Osimertinib
MOG-G-CCM::Linsitinib
NCI-H810::Avagacestat
JHU-029::IOX2
IGR-37::Palbociclib
CAL-85-1::Lapatinib
RCC10RGB::Palbociclib
C2BBe1::Avagacestat
ML-2::Ibrutinib
THP-1::Linsitinib
MDA-MB-231::PFI-1
8305C::Sorafenib
C3A::Dactolisib
MM1S::Avagacestat
SU-DHL-4::Ibrutinib
ACHN::VE-822
KARPAS-422::Doramapimod
NCI-H2405::Sorafenib
NMC-G1::IOX2
YAPC::Osimertinib
NCI-H2029::Doramapimod
NCI-H510A::Ibrutinib
COR-L303::Lapatinib
H3255::Palbociclib
KU-19-19::Linsitinib
HuP-T3::Lapatinib
HuO9::Ibrutinib
UACC-812::Temozolomide
RCC-JF::PFI-1
SNU-283::PFI-1
NCI-H929::PRT062607
SR::Sorafenib
T-T::Linsitinib
NCI-H1703::Dactolisib
BT-20::PFI-1
UM-UC-3::Osimertinib
ChaGo-K-1::Sorafenib
JHOS-3::Osimertinib
A498::Avagacestat
TOV-112D::Ibrutinib
CADO-ES1::PRT062607
639-V::PFI-1
NCI-H2141::Lapatinib
SK-HEP-1::Temozolomide
SNU-423::Temozolomide
NCI-H209::Doramapimod
UACC-257::VE-822
SW954::Avagacestat
BT-549::Avagacestat
D-392MG::Avagacestat
DAN-G::Dactolisib
GR-ST::Linsitinib
SUP-M2::I-BET-762
MKN1::Dactolisib
HuP-T4::Linsitinib
MV-4-11::Osimertinib
NCI-H2172::Osimertinib
NOMO-1::PFI-1
KARPAS-45::Osimertinib
SCH::PFI-1
TGBC1TKB::Osimertinib
KMRC-1::Linsitinib
LAMA-84::Osimertinib
NCI-H510A::Palbociclib
OV-17R::Lapatinib
RCC-AB::Osimertinib
Caov-4::Lapatinib
no-11::AZD6482
NCI-H526::Dactolisib
NCI-H441::Doramapimod
RO82-W-1::Lapatinib
COR-L303::Doramapimod
TYK-nu::Palbociclib
DJM-1::RVX-208
JHU-011::Lapatinib
OCI-AML3::PRT062607
SUIT-2::Sorafenib
KG-1::Palbociclib
KP-1N::Ibrutinib
KINGS-1::Dactolisib
CaR-1::Dactolisib
NB(TU)1-10::Lapatinib
KURAMOCHI::Osimertinib
PL-21::Palbociclib
HCC2998::PFI-1
NCI-H524::Palbociclib
SJRH30::Ibrutinib
A431::Temozolomide
PA-TU-8902::Avagacestat
SW1463::Lapatinib
SK-PN-DW::Osimertinib
HCC1395::Lapatinib
HMV-II::PFI-1
SNB75::VE-822
PCI-6A::Lapatinib
FADU::VE-822
GI-ME-N::PFI-1
SU-DHL-6::Osimertinib
BB30-HNC::AZD6482
CHSA0011::PFI-1
RERF-LC-KJ::Doramapimod
HA7-RCC::Temozolomide
NCI-H2141::PFI-1
RCC-AB::PFI-1
CAL-29::VE-822
JHH-6::I-BET-762
PWR-1E::I-BET-762
RPMI-8402::Linsitinib
BFTC-909::RVX-208
CHL-1::Dactolisib
SK-N-SH::Temozolomide
NCI-H1793::PRT062607
NCI-H1755::Avagacestat
MPP-89::Osimertinib
HEL::I-BET-762
D-336MG::SL0101
CAL-39::Sorafenib
JSC-1::Ibrutinib
HA7-RCC::Avagacestat
HCC1599::IOX2
MDA-MB-231::VE-822
NCI-H647::SL0101
MFH-ino::Palbociclib
DMS-79::Temozolomide
NOMO-1::I-BET-762
BHT-101::RVX-208
TK::Palbociclib
KARPAS-231::Osimertinib
NCI-H1963::Temozolomide
GP5d::I-BET-762
NCI-H1734::IOX2
LU-134-A::SL0101
LAMA-84::Doramapimod
huH-1::Palbociclib
HOP-62::Sorafenib
WM793B::Lapatinib
RCC-FG2::Temozolomide
BHY::IOX2
KNS-81-FD::I-BET-762
KYSE-510::VE-822
TC-YIK::PRT062607
YKG-1::Osimertinib
PEO1::Palbociclib
SiHa::Avagacestat
MEL-JUSO::Ibrutinib
SBC-3::VE-822
EN::RVX-208
SNU-449::VE-822
D-566MG::Linsitinib
SNU-61::Lapatinib
HT-29::Avagacestat
HCC1395::Avagacestat
A101D::PRT062607
PA-1::I-BET-762
NCI-H2291::RVX-208
NCI-H1755::I-BET-762
NCI-H446::RVX-208
SW872::Doramapimod
HuO9::Doramapimod
LU-99A::PFI-1
RO82-W-1::Sorafenib
NCI-H1581::Avagacestat
PCI-4B::IOX2
SNU-449::Temozolomide
ME-180::Temozolomide
NCI-H1688::Linsitinib
HCE-4::VE-822
NCI-H2170::Temozolomide
NCI-H847::Avagacestat
BHT-101::Doramapimod
HCC1937::Palbociclib
JM1::Osimertinib
G-MEL::IOX2
KMS-11::PFI-1
L-1236::I-BET-762
COLO-824::Osimertinib
KARPAS-1106P::Doramapimod
TGW::Avagacestat
CFPAC-1::Ibrutinib
COLO-783::PFI-1
SKM-1::PFI-1
LNZTA3WT4::Avagacestat
NCI-H1836::RVX-208
D-247MG::AZD6482
NCI-H1435::PFI-1
DG-75::PFI-1
HCC2218::RVX-208
JSC-1::Temozolomide
JHH-1::Sorafenib
NCI-H2085::VE-822
JVM-3::RVX-208
CADO-ES1::Sorafenib
KATOIII::RVX-208
HCC-78::Dactolisib
ZR-75-30::Dactolisib
HO-1-N-1::PFI-1
HTC-C3::Linsitinib
HEL::Dactolisib
PEO1::Doramapimod
SW780::Temozolomide
MDA-MB-330::Lapatinib
CAL-12T::SL0101
DMS-114::Sorafenib
L-363::Temozolomide
SNG-M::Lapatinib
SK-MEL-28::Doramapimod
639-V::RVX-208
KLE::PRT062607
NCI-H810::Lapatinib
MOG-G-CCM::Osimertinib
BT-20::VE-822
DMS-79::AZD6482
MRK-nu-1::Lapatinib
NCI-H209::Temozolomide
D-502MG::Linsitinib
A3-KAW::Lapatinib
KYSE-520::Avagacestat
RPMI-8226::VE-822
NCI-H1666::RVX-208
LOUCY::I-BET-762
Farage::Osimertinib
KYAE-1::Linsitinib
HT-1197::Avagacestat
YAPC::VE-822
NCI-H2444::VE-822
A253::Palbociclib
C-33-A::PFI-1
NCI-H1155::Ibrutinib
TE-9::Temozolomide
HC-1::Linsitinib
MLMA::Avagacestat
NB12::Lapatinib
MFE-280::RVX-208
KASUMI-1::IOX2
NB5::Avagacestat
COR-L303::PRT062607
Calu-6::Palbociclib
DMS-273::Osimertinib
TE-8::PFI-1
RF-48::RVX-208
NCI-H1781::Avagacestat
NKM-1::Avagacestat
MDA-MB-361::Temozolomide
PANC-08-13::PRT062607
MES-SA::Temozolomide
YH-13::Palbociclib
BFTC-909::Palbociclib
IPC-298::Dactolisib
HSC-39::Avagacestat
SW954::AZD6482
RCH-ACV::Linsitinib
ARH-77::Sorafenib
MHH-NB-11::I-BET-762
UMC-11::Osimertinib
KNS-62::RVX-208
ATN-1::Palbociclib
OV-56::PFI-1
RO82-W-1::Avagacestat
SUP-B8::I-BET-762
LU-65::VE-822
NCI-H2227::IOX2
HCC2218::VE-822
NCI-H1693::Dactolisib
U251::I-BET-762
BT-20::RVX-208
SK-MG-1::RVX-208
SBC-1::Avagacestat
NCI-H1876::Avagacestat
NCI-H2228::Doramapimod
CW-2::Osimertinib
NCI-H2228::RVX-208
ETK-1::Temozolomide
MOLM-16::IOX2
JHH-4::RVX-208
JHOS-3::Linsitinib
NOS-1::RVX-208
RPMI-7951::Dactolisib
NCI-H1693::Linsitinib
NCI-H929::Sorafenib
MZ2-MEL::Sorafenib
OVTOKO::Dactolisib
D-247MG::Avagacestat
HCC-44::PRT062607
U251::PFI-1
CAL-29::Lapatinib
TE-12::I-BET-762
KARPAS-231::Sorafenib
NB13::RVX-208
ESS-1::VE-822
SK-PN-DW::PFI-1
LU-99A::VE-822
Ca9-22::Linsitinib
NOMO-1::Doramapimod
FTC-133::Avagacestat
no-10::Lapatinib
ECC12::IOX2
DMS-79::PFI-1
CAL-51::Lapatinib
DJM-1::I-BET-762
U-2-OS::Doramapimod
CAL-72::VE-822
LB2518-MEL::I-BET-762
MEL-JUSO::Osimertinib
UACC-62::RVX-208
ALL-SIL::Palbociclib
ABC-1::Sorafenib
WSU-DLCL2::Temozolomide
RPMI-8226::Osimertinib
VCaP::PFI-1
NCI-H929::PFI-1
CHP-126::PRT062607
SUP-B15::RVX-208
CFPAC-1::Osimertinib
UACC-812::Palbociclib
NU-DUL-1::Sorafenib
BICR22::Sorafenib
A498::Doramapimod
GI-ME-N::Temozolomide
RCM-1::Palbociclib
NCI-H929::Ibrutinib
Calu-6::Linsitinib
SW156::Linsitinib
PCI-30::Doramapimod
BONNA-12::Dactolisib
OC-314::Palbociclib
HCC-366::Lapatinib
NH-12::Dactolisib
NCC010::PFI-1
M059J::Doramapimod
SUIT-2::Avagacestat
SF126::VE-822
NCI-H2196::VE-822
CTB-1::AZD6482
OCI-LY7::Dactolisib
SNG-M::Ibrutinib
U251::RVX-208
Hs-445::Sorafenib
TGBC11TKB::Lapatinib
KY821::PRT062607
MDA-MB-468::AZD6482
NCI-H716::Osimertinib
MOLT-16::Temozolomide
KP-N-YN::VE-822
SBC-1::VE-822
NCI-H1703::Palbociclib
COR-L105::VE-822
QGP-1::Lapatinib
BxPC-3::Lapatinib
JHH-7::Lapatinib
NCI-H522::Dactolisib
BT-474::RVX-208
HLE::Palbociclib
OVK-18::Linsitinib
DEL::Linsitinib
P30-OHK::VE-822
NCI-H1341::Dactolisib
NCI-H82::PFI-1
BICR31::RVX-208
CAL-78::Ibrutinib
SNU-398::Dactolisib
EC-GI-10::Lapatinib
NCI-H1155::Linsitinib
K2::SL0101
MZ1-PC::SL0101
NCI-H441::Lapatinib
MN-60::I-BET-762
CAL-12T::Dactolisib
SU-DHL-16::Avagacestat
HCC1599::AZD6482
SW982::Dactolisib
PL-21::PRT062607
SK-CO-1::PRT062607
MHH-NB-11::Temozolomide
NCI-H841::Sorafenib
TE-12::Temozolomide
WM278::Dactolisib
SK-MEL-3::PRT062607
CAL-120::AZD6482
G-402::Doramapimod
769-P::Temozolomide
OCI-AML2::PRT062607
BE2-M17::I-BET-762
Calu-6::Avagacestat
NCI-H1581::Temozolomide
A498::Lapatinib
451Lu::Dactolisib
NCI-N87::Osimertinib
NCI-H1666::PRT062607
IPC-298::PRT062607
COR-L88::Avagacestat
TYK-nu::VE-822
FLO-1::Osimertinib
HuO9::Linsitinib
RERF-LC-KJ::I-BET-762
RERF-LC-KJ::Temozolomide
MZ7-mel::RVX-208
ETK-1::Avagacestat
KARPAS-422::I-BET-762
LB1047-RCC::SL0101
PF-382::Sorafenib
D-263MG::Palbociclib
SNU-175::Lapatinib
NKM-1::Linsitinib
CHP-126::IOX2
EW-18::Doramapimod
KARPAS-299::Lapatinib
CAL-27::Temozolomide
BFTC-909::PFI-1
NB7::Sorafenib
SK-UT-1::Doramapimod
SUP-M2::Ibrutinib
SNU-1040::RVX-208
HPAF-II::Palbociclib
LN-405::Palbociclib
AM-38::Temozolomide
EBC-1::PRT062607
NCI-H2227::Temozolomide
MV-4-11::Sorafenib
RD::Temozolomide
LB2518-MEL::SL0101
HSC-4::PRT062607
MOLM-16::AZD6482
MN-60::Temozolomide
HCC1419::Osimertinib
KARPAS-422::Dactolisib
QGP-1::SL0101
Mo-T::VE-822
GB-1::PRT062607
LC-2-ad::AZD6482
KGN::Sorafenib
22RV1::Temozolomide
A375::RVX-208
KM12::Sorafenib
NCC021::Linsitinib
NCI-H847::PFI-1
GA-10::I-BET-762
TK::Avagacestat
NCI-H1693::I-BET-762
PCI-15A::Ibrutinib
RERF-GC-1B::VE-822
LB831-BLC::Avagacestat
NCI-H2030::Sorafenib
OCUB-M::Ibrutinib
SK-MEL-28::Sorafenib
LN-405::Doramapimod
SK-N-FI::Osimertinib
MDA-MB-415::I-BET-762
OACp4C::PRT062607
OACp4C::Dactolisib
BC-1::Temozolomide
KYSE-270::I-BET-762
NCI-H647::Dactolisib
IM-95::I-BET-762
KELLY::I-BET-762
CAL-27::Linsitinib
SCC-25::PFI-1
NCI-H211::Ibrutinib
HCC1143::Linsitinib
DMS-114::Avagacestat
MHH-CALL-4::Doramapimod
DSH1::Avagacestat
HLE::Temozolomide
CP50-MEL-B::Avagacestat
KYAE-1::Palbociclib
SW954::RVX-208
K2::Temozolomide
NCI-H1436::Dactolisib
VAL::Lapatinib
TGBC11TKB::Temozolomide
CESS::VE-822
LU-135::Linsitinib
DOHH-2::Sorafenib
EW-12::I-BET-762
HT-115::VE-822
CHSA0108::Ibrutinib
Daudi::I-BET-762
SK-OV-3::PFI-1
RCM-1::Temozolomide
KARPAS-45::Linsitinib
RKN::I-BET-762
JURL-MK1::Temozolomide
RS4-11::Palbociclib
BB30-HNC::Doramapimod
EJM::Osimertinib
SK-MEL-3::Doramapimod
OVMIU::Temozolomide
UACC-62::Linsitinib
ROS-50::AZD6482
NCI-H3122::Osimertinib
D-542MG::Palbociclib
SK-N-SH::Doramapimod
SNU-283::Avagacestat
NKM-1::Osimertinib
SNU-175::Palbociclib
NCI-H1355::Temozolomide
EW-12::Lapatinib
NCI-H1694::RVX-208
697::Doramapimod
SK-MES-1::I-BET-762
SK-GT-4::Palbociclib
GR-ST::PRT062607
SAT::PFI-1
SW954::I-BET-762
CL-11::PFI-1
MDA-MB-415::Avagacestat
UWB1.289::I-BET-762
SW156::Avagacestat
KP-4::Palbociclib
SK-UT-1::PRT062607
G-402::VE-822
BxPC-3::PRT062607
RPMI-8866::RVX-208
NCI-H522::Ibrutinib
SKN::Palbociclib
EB-3::Linsitinib
HCT-15::Sorafenib
OS-RC-2::PFI-1
NCI-H446::Linsitinib
SW1463::PFI-1
SH-4::I-BET-762
NCI-H2023::Avagacestat
KYSE-450::Osimertinib
EoL-1-cell::Dactolisib
P32-ISH::Palbociclib
OSC-19::Linsitinib
ML-1::PRT062607
AM-38::Linsitinib
BT-20::I-BET-762
HARA::Dactolisib
CAS-1::Ibrutinib
NOMO-1::Ibrutinib
VAL::Doramapimod
HA7-RCC::Doramapimod
GCT::Osimertinib
SU-DHL-5::Dactolisib
NCI-H2023::Lapatinib
BICR22::Avagacestat
H3255::RVX-208
QGP-1::IOX2
OSC-19::Palbociclib
RPMI-8402::Sorafenib
SNU-C5::Avagacestat
AsPC-1::Doramapimod
NCC021::RVX-208
BB30-HNC::Avagacestat
BEN::SL0101
SK-N-DZ::PRT062607
CAMA-1::Sorafenib
IST-SL1::Temozolomide
KG-1::PRT062607
HCC1187::Avagacestat
DoTc2-4510::PRT062607
SK-MEL-31::Doramapimod
NCI-H1838::Lapatinib
U-2-OS::Avagacestat
KOPN-8::Linsitinib
BL-41::Temozolomide
LS-1034::PRT062607
JHH-7::Dactolisib
TUR::Avagacestat
LB771-HNC::PFI-1
UACC-893::AZD6482
no-11::SL0101
SNU-449::Avagacestat
SIMA::Temozolomide
FU97::Lapatinib
SNU-283::SL0101
NCI-H345::Sorafenib
RD::Doramapimod
A253::Temozolomide
SW756::VE-822
NB13::Osimertinib
TE-5::Dactolisib
CAL-85-1::I-BET-762
T-T::Temozolomide
SNG-M::Palbociclib
Ramos-2G6-4C10::Ibrutinib
LoVo::I-BET-762
PA-TU-8902::Sorafenib
Saos-2::Avagacestat
HA7-RCC::IOX2
COR-L105::Linsitinib
BT-483::Palbociclib
JM1::Dactolisib
DOHH-2::Osimertinib
HTC-C3::Ibrutinib
NCI-H82::Temozolomide
ES6::Linsitinib
BE-13::Palbociclib
WIL2-NS::Lapatinib
KARPAS-1106P::PFI-1
A549::Palbociclib
UMC-11::Doramapimod
ARH-77::Doramapimod
NCI-H727::Temozolomide
Jurkat::Dactolisib
IHH-4::Temozolomide
NCI-H64::Palbociclib
HSC-3::Ibrutinib
T98G::I-BET-762
NCI-H2023::Ibrutinib
SK-MEL-30::VE-822
HCC38::AZD6482
SUP-M2::Doramapimod
SKN-3::RVX-208
CAL-148::Sorafenib
NCI-H716::PFI-1
ARH-77::VE-822
CAL-148::Osimertinib
IHH-4::Linsitinib
MZ7-mel::Lapatinib
PL-21::AZD6482
LU-65::Lapatinib
LNCaP-Clone-FGC::RVX-208
CHP-134::I-BET-762
CRO-AP2::Osimertinib
BE2-M17::Dactolisib
HCC1954::Sorafenib
MOLM-16::Palbociclib
SHP-77::Osimertinib
UACC-812::PFI-1
KG-1::Linsitinib
PEO1::PRT062607
C32::Ibrutinib
CHP-212::PRT062607
OVTOKO::VE-822
PCI-15A::Palbociclib
PA-TU-8988T::VE-822
KYSE-510::Ibrutinib
MFE-280::Doramapimod
ES5::VE-822
NCI-H2122::Lapatinib
EBC-1::VE-822
LB647-SCLC::Temozolomide
NB7::PRT062607
CAL-51::Sorafenib
NCI-H2023::RVX-208
22RV1::Avagacestat
IA-LM::Linsitinib
CHP-134::PRT062607
TGW::PRT062607
SK-MEL-28::Palbociclib
HuP-T4::Dactolisib
TE-6::VE-822
H3255::IOX2
NCI-H196::Doramapimod
RPMI-6666::VE-822
Mo-T::Doramapimod
COLO-783::SL0101
HCC1806::Osimertinib
KYSE-50::PFI-1
SW1710::PRT062607
LXF-289::Osimertinib
TC-YIK::Linsitinib
HCT-116::Ibrutinib
WM278::I-BET-762
KYSE-270::VE-822
SU-DHL-16::Linsitinib
RCC-MF::Palbociclib
HPAF-II::Lapatinib
C-4-I::Doramapimod
IGR-1::Avagacestat
JAR::IOX2
SK-UT-1::Sorafenib
SCC-15::RVX-208
NCI-H226::Palbociclib
WSU-DLCL2::Linsitinib
L-540::Dactolisib
SF268::RVX-208
NCI-H841::VE-822
NCI-H358::RVX-208
HOP-92::Linsitinib
OS-RC-2::Palbociclib
NCI-H1573::Dactolisib
GDM-1::I-BET-762
CML-T1::Osimertinib
HCC38::Palbociclib
MDA-MB-453::Palbociclib
HCC70::Avagacestat
C32::SL0101
DMS-79::IOX2
CAL-62::Avagacestat
OSC-19::Ibrutinib
NCI-H2227::Osimertinib
NUGC-3::Ibrutinib
KASUMI-1::Osimertinib
SU8686::RVX-208
Hey::Linsitinib
MHH-PREB-1::PFI-1
MFE-319::Linsitinib
TT::PFI-1
PCI-30::Palbociclib
SW982::Temozolomide
SK-GT-4::Sorafenib
ATN-1::VE-822
SU-DHL-8::PFI-1
ASH-3::Doramapimod
SW1990::Palbociclib
GAMG::Osimertinib
BxPC-3::Ibrutinib
COR-L95::Temozolomide
RPMI-8402::Temozolomide
ChaGo-K-1::Lapatinib
SK-MEL-31::I-BET-762
NCI-H847::Temozolomide
NCI-H345::PFI-1
LOXIMVI::Linsitinib
NCI-H358::Dactolisib
NCI-H3122::Temozolomide
SKN::VE-822
NCI-N87::Dactolisib
OACM5-1::Dactolisib
KM-H2::RVX-208
EW-3::VE-822
RERF-LC-MS::AZD6482
MEG-01::Avagacestat
CHP-212::Temozolomide
UACC-257::Palbociclib
SCC90::Linsitinib
G-361::PRT062607
SCC-3::I-BET-762
SK-MEL-30::Avagacestat
SK-MEL-24::VE-822
MPP-89::PRT062607
NCI-H1648::Temozolomide
C2BBe1::Osimertinib
Farage::Doramapimod
ML-2::VE-822
SK-MEL-1::Sorafenib
A549::Doramapimod
EW-13::Doramapimod
RCM-1::I-BET-762
HARA::Osimertinib
EW-18::Temozolomide
MOLM-16::SL0101
EB2::RVX-208
NCI-H1734::Avagacestat
MM1S::Ibrutinib
OCI-M1::Temozolomide
HTC-C3::Temozolomide
TOV-21G::VE-822
KATOIII::PFI-1
COLO-680N::Palbociclib
U-2-OS::Lapatinib
NCI-H2052::Palbociclib
LN-229::Ibrutinib
RCC-JW::Palbociclib
NCI-H847::Lapatinib
EFO-21::Lapatinib
NU-DUL-1::Dactolisib
SCC-4::Osimertinib
A4-Fuk::RVX-208
COLO-679::I-BET-762
TE-5::RVX-208
NY::Doramapimod
UWB1.289::SL0101
HEL::Linsitinib
TCCSUP::Dactolisib
OAW-28::PFI-1
SW948::Palbociclib
KLE::Temozolomide
SW1573::RVX-208
SNU-423::Doramapimod
OVK-18::Ibrutinib
OPM-2::Dactolisib
SNU-407::Sorafenib
OVTOKO::Avagacestat
SKG-IIIa::VE-822
MES-SA::Sorafenib
SNU-175::I-BET-762
LC4-1::Sorafenib
OS-RC-2::Temozolomide
NCI-H1688::Dactolisib
YT::Linsitinib
GAK::Sorafenib
LOUCY::Doramapimod
NB12::Avagacestat
ESS-1::Avagacestat
DG-75::I-BET-762
BT-549::I-BET-762
JEG-3::I-BET-762
HDLM-2::Dactolisib
MDA-MB-231::Doramapimod
SK-MEL-30::Palbociclib
VCaP::RVX-208
COR-L95::Lapatinib
EFO-27::Avagacestat
NALM-6::Temozolomide
NCI-H2135::AZD6482
AM-38::RVX-208
SN12C::I-BET-762
MOLM-16::Avagacestat
G-401::Palbociclib
CAL-12T::Temozolomide
NOS-1::Linsitinib
SNU-C2B::Linsitinib
ES1::Doramapimod
EW-3::Dactolisib
KASUMI-1::VE-822
647-V::Linsitinib
KM12::VE-822
SK-UT-1::RVX-208
UMC-11::Ibrutinib
EW-24::VE-822
HA7-RCC::Osimertinib
SK-N-DZ::Temozolomide
NCI-H2172::I-BET-762
NCI-H1666::Temozolomide
IGROV-1::PRT062607
PL-21::IOX2
PC-14::Palbociclib
EFM-19::Doramapimod
SNU-387::Doramapimod
ESO51::Palbociclib
SK-CO-1::Linsitinib
SK-PN-DW::Avagacestat
SBC-1::PFI-1
RCC-JW::Ibrutinib
SW962::Osimertinib
MDA-MB-468::I-BET-762
SKM-1::SL0101
SCC-3::Lapatinib
SW954::SL0101
LU-134-A::Doramapimod
TGW::Doramapimod
NCI-H1105::Ibrutinib
KNS-81-FD::PRT062607
GP5d::VE-822
WM35::Osimertinib
MFH-ino::Osimertinib
NCI-H838::Temozolomide
Hey::RVX-208
A427::IOX2
NB69::Linsitinib
MDA-MB-436::Linsitinib
NCI-H2405::Temozolomide
JURL-MK1::I-BET-762
SH-4::Ibrutinib
TOV-112D::Sorafenib
TT2609-C02::Palbociclib
DND-41::Temozolomide
HCC-44::Sorafenib
NCI-H2291::AZD6482
EM-2::Temozolomide
JHU-029::Ibrutinib
BICR31::Avagacestat
NCI-H2444::Doramapimod
Daudi::Palbociclib
EM-2::I-BET-762
NCI-H1341::Osimertinib
COR-L311::Dactolisib
A172::Temozolomide
639-V::Linsitinib
GB-1::Ibrutinib
TE-12::IOX2
NOS-1::Dactolisib
SW954::Sorafenib
SAT::PRT062607
NCI-H1105::VE-822
A172::Osimertinib
NCI-H520::Sorafenib
RF-48::Palbociclib
ES-2::PFI-1
COR-L321::Linsitinib
TYK-nu::Ibrutinib
NCI-H2291::Doramapimod
COR-L303::Osimertinib
HTC-C3::VE-822
SBC-5::Dactolisib
D-542MG::RVX-208
TGBC24TKB::Temozolomide
RCC-JW::Lapatinib
CAL-62::RVX-208
BICR31::Osimertinib
CHP-126::SL0101
PANC-08-13::Temozolomide
SW837::PRT062607
TE-9::PRT062607
TGBC1TKB::Linsitinib
NCI-H1838::PFI-1
C-33-A::I-BET-762
SNU-449::Doramapimod
BB65-RCC::Temozolomide
LOUCY::Osimertinib
OE21::Osimertinib
NCI-H1155::Dactolisib
SAT::Temozolomide
IST-SL2::IOX2
CPC-N::Sorafenib
Ca-Ski::RVX-208
SK-LMS-1::Dactolisib
EKVX::Linsitinib
A498::PFI-1
A498::Palbociclib
SKM-1::AZD6482
D-283MED::Lapatinib
NCI-H1563::VE-822
NCI-H28::Osimertinib
Farage::VE-822
Farage::I-BET-762
HCE-4::Dactolisib
GOTO::Temozolomide
BALL-1::I-BET-762
PCI-4B::Dactolisib
HCC-78::Doramapimod
Jurkat::Osimertinib
NCI-H835::Palbociclib
NCI-H1568::Temozolomide
ES-2::Dactolisib
IGROV-1::Sorafenib
SK-LMS-1::Palbociclib
KOSC-2::I-BET-762
U031::Dactolisib
JIMT-1::I-BET-762
DK-MG::PRT062607
SUP-M2::RVX-208
HCC1806::I-BET-762
H-EMC-SS::RVX-208
OVCAR-5::VE-822
NCI-H1793::Ibrutinib
ABC-1::Osimertinib
MOLT-4::Ibrutinib
NCI-H596::Osimertinib
NCI-H2122::Ibrutinib
CESS::Palbociclib
NB17::Sorafenib
8-MG-BA::PFI-1
MOLP-8::PFI-1
NB5::Sorafenib
SISO::Dactolisib
KARPAS-1106P::PRT062607
TGBC24TKB::Lapatinib
U-698-M::Dactolisib
DSH1::Osimertinib
IST-SL1::Linsitinib
COR-L23::RVX-208
GP5d::Osimertinib
MCF7::Linsitinib
MRK-nu-1::RVX-208
KON::Temozolomide
A2780::PRT062607
IM-95::VE-822
LOXIMVI::Avagacestat
T47D::Ibrutinib
SK-OV-3::VE-822
YH-13::VE-822
ROS-50::Ibrutinib
ES7::PRT062607
HOP-62::Dactolisib
HCC1419::AZD6482
NCI-H196::PRT062607
KU812::Sorafenib
LCLC-103H::Palbociclib
OVCAR-5::Ibrutinib
SCC-9::Lapatinib
CHSA0108::Dactolisib
SU-DHL-4::I-BET-762
MZ1-PC::Linsitinib
MEL-HO::Doramapimod
OE21::PFI-1
BICR10::PRT062607
ATN-1::Avagacestat
TGBC1TKB::Avagacestat
RCC-AB::Ibrutinib
NCI-H748::Avagacestat
MFM-223::Linsitinib
TGBC24TKB::RVX-208
SKG-IIIa::Doramapimod
LB2518-MEL::Sorafenib
23132-87::PFI-1
NCI-H1793::Avagacestat
TOV-21G::I-BET-762
LU-135::I-BET-762
NCI-H520::Ibrutinib
HL-60::PFI-1
OC-314::Dactolisib
VA-ES-BJ::VE-822
OVKATE::Linsitinib
SU-DHL-1::Dactolisib
SCC-3::PRT062607
22RV1::Doramapimod
NCI-H1915::Sorafenib
GDM-1::Avagacestat
JiyoyeP-2003::Sorafenib
SU-DHL-16::I-BET-762
MONO-MAC-6::Sorafenib
Raji::Temozolomide
STS-0421::Lapatinib
OVCA420::VE-822
SW1783::Sorafenib
BICR22::Ibrutinib
SKG-IIIa::Dactolisib
VCaP::Palbociclib
DJM-1::Temozolomide
MEG-01::I-BET-762
A204::Avagacestat
TOV-21G::Avagacestat
RT-112::Avagacestat
CAL-78::PFI-1
NCI-H2110::IOX2
A375::Lapatinib
MCF7::I-BET-762
NB13::Lapatinib
NCI-H596::Temozolomide
HARA::I-BET-762
KE-37::Lapatinib
EFO-21::PFI-1
PEO1::Ibrutinib
KY821::Doramapimod
D-392MG::Lapatinib
A2058::Doramapimod
HOP-92::Temozolomide
ES5::Temozolomide
DEL::I-BET-762
A388::Lapatinib
SBC-1::Ibrutinib
HOP-92::Doramapimod
D-502MG::Osimertinib
NCI-H2405::RVX-208
LU-165::Linsitinib
D-283MED::Sorafenib
NCI-H1792::Avagacestat
G-402::I-BET-762
IM-9::Doramapimod
IST-MEL1::Palbociclib
8-MG-BA::Avagacestat
WM-115::Ibrutinib
CFPAC-1::Lapatinib
SKN::I-BET-762
LoVo::Doramapimod
MKN7::I-BET-762
NCI-H1734::Temozolomide
RKN::RVX-208
HSC-4::Avagacestat
KYSE-70::Osimertinib
NCI-H345::Avagacestat
UACC-257::I-BET-762
NCI-H1688::Sorafenib
RERF-LC-MS::Linsitinib
JHH-7::Doramapimod
SK-LMS-1::Ibrutinib
PEO1::Lapatinib
NCI-H1781::PFI-1
NCI-H2452::Avagacestat
HDQ-P1::PFI-1
MZ2-MEL::IOX2
CHL-1::Temozolomide
RCC-AB::AZD6482
G-361::VE-822
RKO::Ibrutinib
PC-14::Dactolisib
SCC-9::PFI-1
SJSA-1::Osimertinib
T-T::Avagacestat
MHH-NB-11::Palbociclib
COLO-800::Linsitinib
EFO-27::SL0101
RD::Sorafenib
NB13::Doramapimod
8505C::Temozolomide
NCI-H2444::Avagacestat
A2780::Osimertinib
NCI-H1581::I-BET-762
HCC1187::Doramapimod
HCC-15::Sorafenib
SW1116::Linsitinib
SH-4::Temozolomide
TC-71::RVX-208
SK-GT-2::I-BET-762
NKM-1::Dactolisib
AMO-1::Lapatinib
SK-HEP-1::PFI-1
OAW-28::Linsitinib
MN-60::VE-822
SK-ES-1::Doramapimod
LC-2-ad::PFI-1
DoTc2-4510::Lapatinib
JEKO-1::Temozolomide
EKVX::Sorafenib
DMS-79::Linsitinib
OVTOKO::Lapatinib
GAK::VE-822
MHH-CALL-4::RVX-208
TGBC11TKB::Doramapimod
TGW::Sorafenib
KYM-1::Osimertinib
5637::Linsitinib
SW1573::Sorafenib
Ca-Ski::Ibrutinib
HT55::Palbociclib
NCI-H1944::Lapatinib
JHOS-2::Palbociclib
DoTc2-4510::I-BET-762
MHH-NB-11::Osimertinib
NCI-H2023::Dactolisib
NCI-H1650::Doramapimod
OVK-18::Osimertinib
OCI-AML5::RVX-208
KU812::Linsitinib
JHU-029::SL0101
IMR-5::Temozolomide
TE-8::Osimertinib
KASUMI-1::SL0101
NCI-H226::Lapatinib
HCC1569::Palbociclib
Detroit562::RVX-208
OACp4C::Lapatinib
SW948::PRT062607
SW948::Temozolomide
PCI-15A::Dactolisib
LoVo::PFI-1
CADO-ES1::Palbociclib
LK-2::Ibrutinib
T47D::RVX-208
NCI-H1734::PRT062607
KCL-22::Palbociclib
SU-DHL-16::Ibrutinib
Hs-578-T::Ibrutinib
BxPC-3::Avagacestat
HuCCT1::RVX-208
UMC-11::VE-822
NCI-H929::Temozolomide
BB30-HNC::PFI-1
NCI-H1975::Doramapimod
CFPAC-1::Temozolomide
EMC-BAC-1::VE-822
KG-1::Avagacestat
NCI-H1568::VE-822
LU-139::Ibrutinib
Farage::Avagacestat
IA-LM::VE-822
RCC-MF::Lapatinib
RC-K8::Ibrutinib
COR-L321::PRT062607
NCI-H1703::Doramapimod
HeLa::Osimertinib
22RV1::Osimertinib
BL-41::Osimertinib
RCC-JW::Doramapimod
HT-1197::VE-822
KARPAS-422::PRT062607
OCI-AML2::Doramapimod
SU-DHL-10::Palbociclib
CAL-120::Doramapimod
QGP-1::Osimertinib
COLO-679::Avagacestat
NCI-H1623::Avagacestat
ES5::Linsitinib
SN12C::VE-822
AN3-CA::Sorafenib
LNZTA3WT4::Lapatinib
OCI-M1::Palbociclib
LB373-MEL-D::PRT062607
JAR::Doramapimod
OVKATE::Doramapimod
8305C::Doramapimod
LS-180::Linsitinib
NCC021::PRT062607
CHP-134::VE-822
HT-1376::Palbociclib
HCC1143::Dactolisib
HCC38::VE-822
SBC-5::Avagacestat
NCI-H2066::Avagacestat
T84::RVX-208
LC-1-sq::RVX-208
NCI-H1975::Ibrutinib
EC-GI-10::Palbociclib
CAL-51::Palbociclib
HCC2998::Doramapimod
SU-DHL-4::Avagacestat
SK-N-FI::Avagacestat
SF126::PRT062607
NCI-H441::RVX-208
NCI-H1688::Osimertinib
OVK-18::AZD6482
SW1088::Palbociclib
SW756::RVX-208
KATOIII::Avagacestat
GB-1::Linsitinib
LAN-6::Sorafenib
SW1990::Avagacestat
SK-MEL-28::Linsitinib
no-10::Osimertinib
NCI-H1975::Lapatinib
RCC-MF::Osimertinib
CP66-MEL::I-BET-762
TK::Osimertinib
SKN::Lapatinib
GDM-1::Dactolisib
SW620::Ibrutinib
HCC2998::Avagacestat
RL95-2::Avagacestat
COLO-829::Doramapimod
K-562::I-BET-762
OCUM-1::Temozolomide
HuH-7::Lapatinib
NCI-H2085::RVX-208
EW-16::PRT062607
NB1::Doramapimod
PF-382::RVX-208
EoL-1-cell::PFI-1
GCIY::Doramapimod
CAL-27::Avagacestat
SUP-B8::RVX-208
ARH-77::Avagacestat
P30-OHK::Dactolisib
JHU-022::PRT062607
D-566MG::RVX-208
RCH-ACV::I-BET-762
MHH-PREB-1::Dactolisib
COLO-684::Palbociclib
HCC70::PRT062607
HCC1419::Dactolisib
P31-FUJ::Lapatinib
DEL::Dactolisib
NCI-H2172::Avagacestat
SW1463::Osimertinib
NOMO-1::Osimertinib
C2BBe1::PRT062607
LB831-BLC::PFI-1
huH-1::Dactolisib
no-10::Avagacestat
NCI-H146::Palbociclib
Ca-Ski::Linsitinib
RO82-W-1::RVX-208
NCI-H250::AZD6482
LU-165::Avagacestat
42-MG-BA::Linsitinib
SLVL::Lapatinib
BB30-HNC::I-BET-762
AsPC-1::Osimertinib
BFTC-909::Osimertinib
NCI-H1105::Avagacestat
TGW::Dactolisib
MDA-MB-453::Ibrutinib
COLO-678::Doramapimod
SU-DHL-4::Temozolomide
NCI-H146::IOX2
SBC-3::Linsitinib
IMR-5::Osimertinib
NCI-H524::Lapatinib
SK-MES-1::Dactolisib
DND-41::Sorafenib
KYSE-450::PFI-1
BHY::RVX-208
KP-N-YN::Osimertinib
COLO-668::Linsitinib
SW780::RVX-208
SW962::PFI-1
LB647-SCLC::PRT062607
QGP-1::Sorafenib
OV-17R::Linsitinib
ETK-1::Palbociclib
IST-SL2::Osimertinib
K2::PRT062607
NCI-H2172::PRT062607
CaR-1::Lapatinib
HeLa::VE-822
DK-MG::I-BET-762
SK-MEL-24::Linsitinib
RCC-AB::IOX2
IM-95::PRT062607
NCI-H740::Avagacestat
PEO1::Osimertinib
HT-3::Dactolisib
SU-DHL-6::Ibrutinib
KON::Doramapimod
NCI-H1693::VE-822
IGR-37::Lapatinib
SK-PN-DW::Palbociclib
NCI-H661::Temozolomide
MZ2-MEL::SL0101
GCIY::Lapatinib
LP-1::I-BET-762
DoTc2-4510::Ibrutinib
COR-L23::Osimertinib
CTB-1::Temozolomide
RCC-JF::I-BET-762
NCI-H1792::Ibrutinib
KP-N-YN::Doramapimod
CAL-54::Palbociclib
SK-N-SH::Lapatinib
OE33::Osimertinib
U-2-OS::PFI-1
NCI-H727::Sorafenib
TE-1::VE-822
NCI-H2141::VE-822
OACp4C::I-BET-762
BPH-1::PRT062607
KU-19-19::Osimertinib
CPC-N::Lapatinib
H4::Doramapimod
NB13::Avagacestat
CTV-1::Avagacestat
CW-2::PFI-1
BICR10::RVX-208
P31-FUJ::Avagacestat
SW1088::Avagacestat
MHH-PREB-1::Avagacestat
IST-MES1::Dactolisib
DU-4475::Avagacestat
PA-1::Lapatinib
HC-1::Dactolisib
IST-MES1::RVX-208
NCI-H1993::Osimertinib
MHH-NB-11::IOX2
MS-1::Dactolisib
SNU-407::Avagacestat
769-P::Osimertinib
T84::Osimertinib
KYSE-520::Dactolisib
NCI-H1092::Doramapimod
BB65-RCC::I-BET-762
CAKI-1::SL0101
LB2518-MEL::AZD6482
OVCAR-8::Doramapimod
D-423MG::PFI-1
EM-2::Sorafenib
HCC-15::Ibrutinib
KARPAS-231::I-BET-762
SW1573::Doramapimod
LK-2::Osimertinib
COLO-684::PFI-1
LB1047-RCC::Osimertinib
Daoy::Temozolomide
ECC12::Avagacestat
BICR31::Temozolomide
RVH-421::Osimertinib
LAN-6::Doramapimod
NCI-H196::VE-822
NCI-H1581::Osimertinib
SK-N-DZ::I-BET-762
JHH-1::RVX-208
MDA-MB-415::Lapatinib
A3-KAW::Avagacestat
ETK-1::PFI-1
OV-17R::IOX2
HSC-4::Dactolisib
DJM-1::Avagacestat
OV-90::RVX-208
ES4::PFI-1
ETK-1::Sorafenib
C32::Osimertinib
PANC-08-13::Linsitinib
GCIY::VE-822
OV-17R::Dactolisib
KYSE-220::Osimertinib
NB1::Palbociclib
ESO26::I-BET-762
SU-DHL-1::IOX2
NCI-H1581::Linsitinib
A431::Sorafenib
NCI-H1299::Avagacestat
OCI-M1::Sorafenib
SW837::PFI-1
AMO-1::I-BET-762
PCI-6A::Linsitinib
DK-MG::Temozolomide
PC-3::Sorafenib
KASUMI-1::Lapatinib
KP-N-YN::Linsitinib
MEG-01::Sorafenib
COR-L23::I-BET-762
TE-1::RVX-208
647-V::Temozolomide
SW962::Avagacestat
no-10::VE-822
KARPAS-422::Sorafenib
L-1236::Temozolomide
IGROV-1::Palbociclib
WIL2-NS::Sorafenib
FLO-1::PFI-1
C32::RVX-208
UACC-812::Sorafenib
ES5::Avagacestat
EW-3::Temozolomide
PANC-10-05::VE-822
COLO-829::Temozolomide
WM278::Palbociclib
IA-LM::PRT062607
PA-1::Linsitinib
BV-173::Avagacestat
KLE::Lapatinib
NCI-H1666::Osimertinib
KYM-1::Temozolomide
NCI-H747::VE-822
ES6::Lapatinib
HCC1954::VE-822
PANC-10-05::RVX-208
Ramos-2G6-4C10::Temozolomide
ETK-1::VE-822
NCI-H716::VE-822
NCI-H2342::Lapatinib
NALM-6::I-BET-762
EFO-21::PRT062607
KASUMI-1::Avagacestat
NCI-H1755::Lapatinib
RS4-11::PFI-1
RD::Lapatinib
SU-DHL-1::I-BET-762
NCI-H1581::PRT062607
NCI-H82::Ibrutinib
KU812::Dactolisib
SW780::Avagacestat
SW1417::PRT062607
NCI-H2029::I-BET-762
HCC1954::Lapatinib
769-P::I-BET-762
SK-GT-2::Palbociclib
GR-ST::Temozolomide
EN::Lapatinib
ALL-PO::Dactolisib
HCC-44::Ibrutinib
JHU-029::RVX-208
NB5::Lapatinib
MKN1::Sorafenib
SBC-5::Sorafenib
C32::Lapatinib
EFO-27::Sorafenib
LU-135::Temozolomide
NCI-H2172::Sorafenib
SU-DHL-8::Avagacestat
NCI-H1770::RVX-208
JHH-2::Ibrutinib
NCI-H1341::Temozolomide
CAMA-1::VE-822
KYSE-50::VE-822
OVCAR-4::PRT062607
BL-41::VE-822
SK-LMS-1::Sorafenib
LC4-1::RVX-208
MDA-MB-330::Avagacestat
LS-123::Osimertinib
IMR-5::Ibrutinib
OS-RC-2::VE-822
RVH-421::Sorafenib
NCI-H2196::Palbociclib
Detroit562::Linsitinib
GR-ST::I-BET-762
OVCAR-5::Dactolisib
NCI-H1836::Temozolomide
SK-UT-1::Avagacestat
ALL-SIL::Temozolomide
NALM-6::PRT062607
TC-YIK::Avagacestat
SW1990::Doramapimod
NCI-H929::I-BET-762
NCI-H841::RVX-208
HCC-366::PRT062607
HCC-44::VE-822
JHH-4::Ibrutinib
L-540::PRT062607
KYSE-70::Doramapimod
NCI-H1792::RVX-208
EN::Palbociclib
C-4-I::Osimertinib
D-263MG::PRT062607
U031::Sorafenib
PF-382::Avagacestat
OE19::VE-822
MEG-01::Dactolisib
SNU-407::Doramapimod
5637::PFI-1
NCI-H2135::PFI-1
HTC-C3::Dactolisib
LXF-289::Doramapimod
EW-16::Linsitinib
NCI-H1755::Ibrutinib
KCL-22::Doramapimod
RCM-1::Doramapimod
PSN1::Lapatinib
PCI-15A::SL0101
LB996-RCC::PRT062607
23132-87::PRT062607
HCC1395::Doramapimod
BV-173::Palbociclib
FADU::Sorafenib
CAL-12T::Ibrutinib
GOTO::PRT062607
23132-87::Linsitinib
EVSA-T::I-BET-762
NCI-N87::Temozolomide
SiHa::Ibrutinib
HEC-1::Dactolisib
RCM-1::PFI-1
ECC12::PFI-1
D-283MED::Linsitinib
SNU-81::Linsitinib
MOLT-13::RVX-208
SNU-C1::Temozolomide
SK-HEP-1::Sorafenib
HCC-827::Sorafenib
RERF-LC-Sq1::Palbociclib
MDA-MB-453::Linsitinib
A101D::Linsitinib
KARPAS-1106P::Temozolomide
451Lu::PFI-1
OV-56::Avagacestat
NB(TU)1-10::Palbociclib
CAMA-1::AZD6482
NCI-H1155::Lapatinib
NB1::Temozolomide
769-P::PFI-1
BC-1::Linsitinib
EW-22::PFI-1
KALS-1::Doramapimod
DSH1::Sorafenib
AU565::PFI-1
LS-411N::Linsitinib
RCH-ACV::Doramapimod
NUGC-3::VE-822
ME-180::Doramapimod
Raji::Linsitinib
TC-71::Sorafenib
SNU-C1::Osimertinib
CESS::I-BET-762
TE-12::Dactolisib
P31-FUJ::Dactolisib
MOG-G-CCM::Doramapimod
HCC-44::Linsitinib
JURL-MK1::Ibrutinib
JHH-2::Dactolisib
KOSC-2::Linsitinib
SKN::PRT062607
UWB1.289::Doramapimod
HT-1080::Temozolomide
697::Lapatinib
NCI-H720::PRT062607
AGS::Osimertinib
MIA-PaCa-2::Linsitinib
SW948::Sorafenib
GB-1::Doramapimod
PC-3::Ibrutinib
SW13::PFI-1
HCC2157::Osimertinib
MC116::Avagacestat
OCI-M1::PRT062607
LCLC-103H::PRT062607
BE2-M17::VE-822
SNU-387::Temozolomide
HCE-4::SL0101
CAL-54::VE-822
CA46::PFI-1
SK-ES-1::Avagacestat
QIMR-WIL::Palbociclib
NCI-H650::Palbociclib
ESS-1::Doramapimod
HLE::Doramapimod
PWR-1E::PRT062607
MZ1-PC::Avagacestat
NCI-H520::Dactolisib
SW1088::Dactolisib
SKN-3::Sorafenib
KYSE-140::Lapatinib
MDST8::Osimertinib
TT::Doramapimod
BPH-1::Temozolomide
HLE::Osimertinib
CAL-12T::AZD6482
LXF-289::Sorafenib
HCC2157::Linsitinib
SW780::Sorafenib
MFE-280::PRT062607
Becker::Avagacestat
EC-GI-10::I-BET-762
COLO-668::RVX-208
RERF-LC-MS::Sorafenib
UACC-257::Osimertinib
JVM-2::Linsitinib
Daudi::RVX-208
JHH-1::Doramapimod
NEC8::PFI-1
CRO-AP2::AZD6482
786-0::Lapatinib
ABC-1::RVX-208
IST-SL2::AZD6482
NB6::PRT062607
G-MEL::Linsitinib
SK-GT-4::Dactolisib
T98G::PFI-1
BE-13::Doramapimod
SBC-5::Osimertinib
SBC-1::Palbociclib
SK-MEL-31::IOX2
HCC1419::Palbociclib
SW780::Osimertinib
NCI-N87::PRT062607
CAL-72::PRT062607
CAL-85-1::Dactolisib
NCI-H345::AZD6482
HCC1599::Osimertinib
CaR-1::Avagacestat
OACp4C::Doramapimod
WSU-NHL::Doramapimod
NCI-H524::Linsitinib
PC-14::I-BET-762
PCI-15A::Linsitinib
OCI-LY-19::Linsitinib
A204::I-BET-762
HEC-1::Osimertinib
ECC12::Dactolisib
TE-10::VE-822
CHP-134::Linsitinib
C3A::Avagacestat
MHH-CALL-2::Lapatinib
FU97::PFI-1
SW626::PRT062607
HCC1569::Lapatinib
NCI-H2110::VE-822
KATOIII::Doramapimod
LC4-1::Lapatinib
C-33-A::Temozolomide
HOS::Ibrutinib
HCC-44::I-BET-762
SiHa::Linsitinib
LP-1::PRT062607
TUR::Sorafenib
COR-L32::VE-822
NB13::Ibrutinib
EW-12::Osimertinib
8305C::VE-822
Ca-Ski::PFI-1
SK-UT-1::Osimertinib
SU-DHL-5::PFI-1
Saos-2::Palbociclib
NB6::SL0101
ATN-1::RVX-208
COLO-792::Doramapimod
NCI-H1975::Palbociclib
RCC-MF::PRT062607
TT2609-C02::Avagacestat
Ca-Ski::Osimertinib
OCI-LY7::PRT062607
UACC-893::I-BET-762
REH::I-BET-762
CaR-1::Sorafenib
NCI-H446::Palbociclib
COR-L23::Linsitinib
COR-L32::SL0101
MKN45::Osimertinib
SK-GT-4::RVX-208
KASUMI-1::AZD6482
EPLC-272H::Doramapimod
D-392MG::RVX-208
CAPAN-1::Lapatinib
Ramos-2G6-4C10::I-BET-762
NCI-H2170::Avagacestat
NCI-H526::Osimertinib
MOLM-13::PFI-1
CL-11::Osimertinib
SU-DHL-16::AZD6482
LU-134-A::RVX-208
ALL-PO::Doramapimod
NB7::Doramapimod
NCI-H1048::Palbociclib
THP-1::VE-822
EW-16::Doramapimod
G-MEL::Doramapimod
NCI-H2135::Palbociclib
TOV-112D::Temozolomide
CESS::Osimertinib
NCI-H1793::Osimertinib
SW982::VE-822
TE-1::Sorafenib
EFO-27::Dactolisib
697::Osimertinib
MG-63::Doramapimod
NCI-H522::Linsitinib
OPM-2::Temozolomide
Ca9-22::Palbociclib
JEG-3::Avagacestat
RT4::Temozolomide
HOP-62::PRT062607
SK-MEL-5::Doramapimod
ECC10::Osimertinib
TCCSUP::Osimertinib
JiyoyeP-2003::RVX-208
SW1783::Temozolomide
CHL-1::Palbociclib
NCI-H211::Linsitinib
KYSE-150::Doramapimod
COR-L321::Temozolomide
HuO9::RVX-208
D-423MG::VE-822
CAL-85-1::Osimertinib
NCI-H1355::PFI-1
TE-12::Doramapimod
CP50-MEL-B::Sorafenib
NCI-H345::Temozolomide
HSC-3::Osimertinib
NMC-G1::Dactolisib
AU565::Lapatinib
ZR-75-30::Ibrutinib
KYSE-220::Temozolomide
SUP-B8::Dactolisib
NCI-H727::Linsitinib
BE-13::Avagacestat
LB2241-RCC::Sorafenib
PL-21::PFI-1
TE-8::Linsitinib
NCI-H292::Sorafenib
U-87-MG::Ibrutinib
NCI-H1092::I-BET-762
J82::PFI-1
Jurkat::Sorafenib
COR-L321::AZD6482
NCI-H1092::PFI-1
SK-MEL-2::Sorafenib
KELLY::Osimertinib
CAL-33::I-BET-762
NCI-H196::Lapatinib
Ca9-22::RVX-208
SJRH30::Lapatinib
8505C::Osimertinib
SU8686::Temozolomide
BICR10::Linsitinib
RH-1::Osimertinib
NU-DUL-1::Temozolomide
GA-10::Lapatinib
IHH-4::PRT062607
RCC-MF::Dactolisib
PANC-02-03::VE-822
NCI-H524::I-BET-762
TE-1::Doramapimod
SUP-HD1::Dactolisib
HT-115::Linsitinib
DU-145::Dactolisib
MDA-MB-436::I-BET-762
OS-RC-2::Linsitinib
PCI-15A::VE-822
LB2518-MEL::Palbociclib
DOHH-2::Dactolisib
NCC021::VE-822
OACM5-1::PRT062607
T98G::Ibrutinib
CCK-81::Dactolisib
DMS-273::VE-822
HH::Lapatinib
SK-MEL-24::Doramapimod
WM793B::Dactolisib
LCLC-103H::Temozolomide
NB1::PFI-1
HT-1197::Ibrutinib
H3255::Ibrutinib
ROS-50::Avagacestat
NB13::PRT062607
VMRC-LCD::Sorafenib
TE-1::PRT062607
H3255::Linsitinib
H4::Palbociclib
PCI-6A::PFI-1
EFM-192A::VE-822
SNU-283::I-BET-762
P30-OHK::Temozolomide
EFO-21::Temozolomide
T98G::Linsitinib
KYSE-450::Lapatinib
SAS::I-BET-762
SNU-449::Osimertinib
MPP-89::Avagacestat
DMS-273::Temozolomide
ABC-1::SL0101
NCI-H748::I-BET-762
HCC1428::Linsitinib
SW962::SL0101
SN12C::PFI-1
LB647-SCLC::I-BET-762
HOS::Osimertinib
OV-56::I-BET-762
OV-17R::SL0101
T-T::Dactolisib
JHOS-2::Sorafenib
HCC1419::RVX-208
A3-KAW::Dactolisib
SBC-5::Temozolomide
SUP-M2::PFI-1
MLMA::Linsitinib
RERF-GC-1B::Dactolisib
HCC1419::Linsitinib
JHH-7::I-BET-762
RXF393::SL0101
SISO::Palbociclib
SIG-M5::VE-822
G-401::Linsitinib
MKN7::Sorafenib
LCLC-103H::VE-822
OVKATE::Dactolisib
SU-DHL-5::Doramapimod
NCI-H526::Palbociclib
GP5d::Doramapimod
LB373-MEL-D::Palbociclib
HDLM-2::VE-822
SK-MG-1::Sorafenib
UACC-62::Doramapimod
BT-549::VE-822
TE-1::Temozolomide
TE-9::Palbociclib
CAL-72::Ibrutinib
NB69::Palbociclib
ZR-75-30::PFI-1
NCI-H1568::Sorafenib
IHH-4::Doramapimod
PANC-04-03::Temozolomide
NCI-H250::Sorafenib
BE2-M17::PFI-1
STS-0421::Sorafenib
A253::Sorafenib
LoVo::Sorafenib
NCI-H446::Sorafenib
LB2241-RCC::VE-822
HCC2998::Temozolomide
LN-229::Linsitinib
PC-14::PRT062607
NCI-H1993::PRT062607
PANC-03-27::Linsitinib
RCC-ER::IOX2
OSC-20::PRT062607
HCC38::Dactolisib
RPMI-8402::Palbociclib
DOK::Osimertinib
C3A::Palbociclib
SK-MEL-30::PRT062607
HCC1599::I-BET-762
ES-2::RVX-208
LB647-SCLC::IOX2
JHU-011::SL0101
PANC-10-05::PFI-1
EW-11::I-BET-762
SNU-175::PRT062607
CAL-51::Osimertinib
NCI-H520::Lapatinib
COR-L32::Dactolisib
NB6::AZD6482
KYSE-270::RVX-208
MKN7::IOX2
MHH-CALL-4::VE-822
Mo-T::Lapatinib
CTB-1::PRT062607
WSU-NHL::PFI-1
H3255::Avagacestat
NCI-H1734::Dactolisib
RH-1::Temozolomide
TE-12::Lapatinib
OCI-AML3::VE-822
WM278::PFI-1
ONS-76::I-BET-762
HCC1500::PFI-1
RS4-11::VE-822
SCC-9::RVX-208
MFE-296::Doramapimod
HEL::Osimertinib
RCH-ACV::Avagacestat
JM1::Lapatinib
Daoy::VE-822
EFO-27::Palbociclib
M14::Linsitinib
ML-1::Doramapimod
LB1047-RCC::Dactolisib
SW1088::I-BET-762
KYSE-220::Lapatinib
M14::PRT062607
KNS-42::Lapatinib
ES6::Ibrutinib
PANC-08-13::VE-822
RO82-W-1::I-BET-762
Raji::I-BET-762
NCI-H1694::Sorafenib
SW1417::Ibrutinib
MOLT-4::PRT062607
NCI-H2066::Palbociclib
JEG-3::IOX2
A2780::Linsitinib
SU-DHL-5::PRT062607
ES1::Linsitinib
EKVX::Doramapimod
NCI-H1623::Doramapimod
LOUCY::Linsitinib
LU-135::Lapatinib
TE-10::Osimertinib
NAMALWA::Lapatinib
HT-144::I-BET-762
OCI-AML5::PFI-1
BHT-101::Osimertinib
MKN45::I-BET-762
SU-DHL-5::Sorafenib
SHP-77::Avagacestat
T98G::PRT062607
SNU-283::VE-822
SF268::Palbociclib
KP-1N::RVX-208
KOSC-2::Temozolomide
SK-MM-2::Sorafenib
PANC-03-27::Doramapimod
OVKATE::Osimertinib
HCC-15::Doramapimod
NCI-H2030::VE-822
MEL-JUSO::Doramapimod
CFPAC-1::I-BET-762
OAW-42::Osimertinib
KLE::Avagacestat
NCI-H1792::PRT062607
OCI-M1::Osimertinib
ES8::Palbociclib
SN12C::Osimertinib
ES5::RVX-208
NCI-H2196::Osimertinib
HCC70::Lapatinib
LB831-BLC::I-BET-762
EW-7::Avagacestat
TE-15::Doramapimod
LCLC-97TM1::Lapatinib
HO-1-N-1::VE-822
ES5::Palbociclib
COR-L32::RVX-208
SCH::Sorafenib
MDA-MB-468::Palbociclib
ESS-1::PRT062607
MPP-89::Doramapimod
Saos-2::Osimertinib
SW1573::Lapatinib
MRK-nu-1::Palbociclib
NCI-H446::Osimertinib
NCI-H1792::Osimertinib
SJRH30::PFI-1
NH-12::Palbociclib
RCC-JF::PRT062607
VMRC-LCD::Palbociclib
LB1047-RCC::PFI-1
GDM-1::Doramapimod
HT-1376::Linsitinib
BT-483::Doramapimod
ETK-1::Lapatinib
EKVX::IOX2
KARPAS-231::PFI-1
HOS::Palbociclib
EJM::I-BET-762
HH::Avagacestat
VAL::Ibrutinib
CAL-33::Palbociclib
QIMR-WIL::VE-822
AU565::I-BET-762
NCI-H1770::PRT062607
NCI-H23::Palbociclib
EC-GI-10::Dactolisib
NCCIT::PFI-1
G-MEL::Palbociclib
NCI-H1048::I-BET-762
IGR-1::RVX-208
NCI-H524::Doramapimod
NCI-H2170::Ibrutinib
NMC-G1::Ibrutinib
LN-18::Linsitinib
LU-99A::Avagacestat
HO-1-u-1::Palbociclib
HCT-116::VE-822
T84::PRT062607
MFM-223::Ibrutinib
IHH-4::Avagacestat
TC-YIK::VE-822
MZ2-MEL::RVX-208
CaR-1::Linsitinib
SW1463::Temozolomide
SK-MG-1::Lapatinib
CCK-81::Sorafenib
Ca-Ski::Doramapimod
NCI-H1781::I-BET-762
PCI-4B::Temozolomide
CW-2::RVX-208
ES4::Osimertinib
NU-DUL-1::Ibrutinib
RCC-ER::Palbociclib
JHH-4::Temozolomide
HT-144::VE-822
NMC-G1::SL0101
NCI-H196::Ibrutinib
SW684::Avagacestat
THP-1::RVX-208
NUGC-4::VE-822
NCI-H647::PFI-1
EPLC-272H::Ibrutinib
ESO26::Doramapimod
TK10::Osimertinib
HuP-T4::Ibrutinib
IM-9::Avagacestat
BE-13::PRT062607
A253::Ibrutinib
JURL-MK1::Avagacestat
JM1::PFI-1
CCK-81::Lapatinib
KYSE-270::Dactolisib
LS-123::Temozolomide
DEL::Doramapimod
639-V::Dactolisib
SR::PFI-1
MFE-319::Avagacestat
BICR78::VE-822
RCC-JW::Temozolomide
NCI-H1781::Sorafenib
JM1::VE-822
786-0::Dactolisib
U-266::Osimertinib
TCCSUP::VE-822
OVK-18::IOX2
A172::Palbociclib
PCI-6A::AZD6482
MONO-MAC-6::Avagacestat
KNS-42::Osimertinib
KM12::PRT062607
TK::I-BET-762
BICR78::Linsitinib
BT-474::AZD6482
KYSE-180::Ibrutinib
HCC70::Doramapimod
SW1417::Osimertinib
ML-2::I-BET-762
M14::Palbociclib
HH::PFI-1
BEN::Lapatinib
JVM-3::Sorafenib
J82::Ibrutinib
CAL-39::Lapatinib
DOHH-2::IOX2
HCC2998::PRT062607
RCC-JF::Linsitinib
IGR-1::Dactolisib
NCC010::Doramapimod
RERF-LC-MS::I-BET-762
T47D::I-BET-762
CTB-1::Lapatinib
CAL-62::I-BET-762
COLO-678::Linsitinib
KP-2::Avagacestat
RCC10RGB::Temozolomide
GR-ST::Osimertinib
SW1271::PFI-1
LNZTA3WT4::Temozolomide
SHP-77::Linsitinib
OAW-28::VE-822
MDA-MB-231::Linsitinib
NCI-H23::Sorafenib
NCI-H520::Linsitinib
A4-Fuk::PRT062607
A101D::Osimertinib
JHOS-3::VE-822
HPAF-II::Sorafenib
U-118-MG::Sorafenib
STS-0421::PFI-1
TOV-112D::Doramapimod
MC116::I-BET-762
HT-1376::PFI-1
KYAE-1::VE-822
ESO51::VE-822
Caov-4::Dactolisib
HCC1937::Temozolomide
CA46::Lapatinib
NCI-H2029::Dactolisib
HCC2157::Dactolisib
COLO-824::Temozolomide
JHH-6::PFI-1
ARH-77::Palbociclib
JIMT-1::Temozolomide
SW756::Avagacestat
NCI-H1573::PFI-1
ES4::RVX-208
NCI-N87::RVX-208
LOXIMVI::Sorafenib
BFTC-909::VE-822
H4::I-BET-762
NCI-H2030::RVX-208
SK-MEL-5::PFI-1
KOPN-8::Osimertinib
JHH-6::Linsitinib
GB-1::VE-822
OVCAR-4::Dactolisib
C2BBe1::PFI-1
LU-134-A::PRT062607
D-283MED::PRT062607
KMRC-20::Osimertinib
G-361::PFI-1
NB12::Sorafenib
NCI-H1155::I-BET-762
JHU-029::Dactolisib
CADO-ES1::Doramapimod
SW837::RVX-208
G-402::Palbociclib
RO82-W-1::VE-822
KU812::RVX-208
AMO-1::Temozolomide
TE-4::PFI-1
KCL-22::Sorafenib
LS-180::Avagacestat
LB831-BLC::VE-822
EMC-BAC-2::Lapatinib
DSH1::Lapatinib
G-361::Sorafenib
A427::Ibrutinib
SJRH30::VE-822
HCC1937::I-BET-762
GI-1::Osimertinib
K5::Ibrutinib
TGW::Linsitinib
PANC-08-13::Ibrutinib
CL-11::RVX-208
NCI-H2227::Linsitinib
KMRC-1::Doramapimod
SUP-T1::RVX-208
CAL-27::Dactolisib
PEO1::VE-822
SW872::Avagacestat
D-542MG::PFI-1
LoVo::Osimertinib
NCI-H1568::Avagacestat
WM1552C::Avagacestat
A172::Linsitinib
COR-L311::Ibrutinib
NCI-H1623::Dactolisib
REH::Lapatinib
MCF7::Sorafenib
TE-8::Ibrutinib
HT55::Sorafenib
NCI-H2347::Sorafenib
CAL-27::Palbociclib
BT-474::Ibrutinib
SNU-C2B::Temozolomide
ES6::PFI-1
SIMA::PRT062607
A172::Dactolisib
COLO-829::Ibrutinib
SIG-M5::Sorafenib
LS-123::Palbociclib
JEKO-1::Linsitinib
WM278::Ibrutinib
G-361::Temozolomide
LN-18::PRT062607
JHH-2::Linsitinib
MZ1-PC::Doramapimod
KNS-81-FD::IOX2
AN3-CA::Avagacestat
BICR31::IOX2
L-1236::RVX-208
KGN::Lapatinib
SU8686::Sorafenib
CA46::Doramapimod
SU-DHL-6::Doramapimod
KE-37::Doramapimod
SF268::Dactolisib
MFM-223::Dactolisib
BV-173::Lapatinib
A2058::RVX-208
LU-165::PFI-1
HT-144::Linsitinib
KMOE-2::Lapatinib
TK::Dactolisib
JHH-7::Palbociclib
KE-37::Temozolomide
VAL::Palbociclib
WM278::Osimertinib
Detroit562::Avagacestat
PWR-1E::Palbociclib
Mewo::Sorafenib
EC-GI-10::Sorafenib
A673::Doramapimod
SK-GT-2::RVX-208
NCI-H2052::PRT062607
A431::Osimertinib
PANC-10-05::Dactolisib
MSTO-211H::Palbociclib
NUGC-3::Osimertinib
SHP-77::Temozolomide
JJN-3::Linsitinib
THP-1::Dactolisib
OPM-2::Linsitinib
SK-LU-1::I-BET-762
LS-411N::Temozolomide
HL-60::PRT062607
OAW-28::Doramapimod
NCI-H2135::Avagacestat
NCI-H1694::Osimertinib
451Lu::SL0101
NCI-H838::SL0101
IM-95::Lapatinib
CRO-AP2::SL0101
HOP-92::Palbociclib
CP50-MEL-B::PRT062607
CP50-MEL-B::SL0101
TK10::Ibrutinib
ZR-75-30::Lapatinib
RCH-ACV::Lapatinib
TK10::Sorafenib
MSTO-211H::Lapatinib
786-0::Temozolomide
KG-1::Temozolomide
EW-13::Palbociclib
CAL-51::AZD6482
EW-11::Ibrutinib
BICR22::Osimertinib
HEL::Ibrutinib
SW872::Osimertinib
IMR-5::Lapatinib
NCI-H1694::Palbociclib
SW48::PFI-1
JiyoyeP-2003::I-BET-762
ES5::Dactolisib
647-V::Lapatinib
KOPN-8::Avagacestat
LAN-6::PFI-1
NCI-H2122::Linsitinib
SNU-175::Sorafenib
697::Avagacestat
NCI-H1694::Lapatinib
OCI-LY7::Sorafenib
HSC-2::VE-822
SNU-81::Palbociclib
L-1236::VE-822
TOV-21G::Linsitinib
CAPAN-1::I-BET-762
HEL::SL0101
ECC10::Avagacestat
MEG-01::PFI-1
KARPAS-620::Osimertinib
MKN1::Linsitinib
NCCIT::Temozolomide
TE-11::VE-822
OVCA420::Temozolomide
BICR31::Ibrutinib
A427::Linsitinib
DG-75::Linsitinib
ACHN::PRT062607
EW-7::Doramapimod
NCI-H720::Palbociclib
ML-2::Temozolomide
OS-RC-2::Avagacestat
A2780::Palbociclib
NB14::Linsitinib
KNS-42::Linsitinib
CRO-AP2::Ibrutinib
SW1463::Linsitinib
HCC1187::Lapatinib
EMC-BAC-2::Ibrutinib
LS-123::Avagacestat
CAL-62::Dactolisib
YKG-1::Ibrutinib
SK-HEP-1::RVX-208
NCI-H2110::Palbociclib
PL-21::RVX-208
NCI-H2135::SL0101
RCC-JF::VE-822
D-283MED::RVX-208
MOLM-16::Lapatinib
HuCCT1::Palbociclib
BB65-RCC::PFI-1
RL::Sorafenib
OC-314::Sorafenib
OVISE::RVX-208
Hs-445::PRT062607
RPMI-8226::Avagacestat
SNU-175::Linsitinib
HO-1-u-1::Avagacestat
KASUMI-1::Dactolisib
PANC-10-05::Osimertinib
NCI-H1435::Dactolisib
MSTO-211H::PRT062607
NCC010::I-BET-762
NCI-H1435::Temozolomide
PCI-4B::Ibrutinib
NCI-H740::RVX-208
MZ7-mel::IOX2
KP-1N::Lapatinib
MFE-319::Dactolisib
H4::Temozolomide
HT-1080::Osimertinib
NCI-H441::I-BET-762
D-247MG::SL0101
NOMO-1::Lapatinib
LS-513::PFI-1
CAL-78::Lapatinib
HCC70::RVX-208
EW-22::Palbociclib
UM-UC-3::Linsitinib
LNCaP-Clone-FGC::I-BET-762
SJRH30::Avagacestat
CCK-81::PRT062607
TUR::VE-822
EMC-BAC-1::SL0101
SK-N-DZ::Ibrutinib
NCI-H1666::PFI-1
FU-OV-1::Linsitinib
HCC38::Osimertinib
LN-405::I-BET-762
NCI-H82::Palbociclib
23132-87::Avagacestat
MFE-296::RVX-208
VAL::Linsitinib
VMRC-RCZ::Lapatinib
CP66-MEL::PFI-1
CL-11::PRT062607
JHU-022::I-BET-762
CPC-N::Avagacestat
SU-DHL-8::Osimertinib
MOLT-13::Lapatinib
MHH-CALL-4::Palbociclib
HO-1-u-1::Osimertinib
NCI-H1755::RVX-208
EW-3::RVX-208
EFM-192A::PFI-1
HCC1428::Sorafenib
ESO26::Lapatinib
BPH-1::Ibrutinib
no-11::IOX2
C2BBe1::RVX-208
MLMA::PFI-1
TT2609-C02::I-BET-762
SNU-407::Lapatinib
HCC2218::Doramapimod
MEL-JUSO::Avagacestat
PANC-08-13::PFI-1
HCC1428::I-BET-762
HCC-15::Dactolisib
HT55::Osimertinib
JVM-3::VE-822
HA7-RCC::SL0101
JHU-022::PFI-1
BEN::PFI-1
GP5d::Temozolomide
CAL-120::PFI-1
NCI-H2227::I-BET-762
PF-382::Osimertinib
SK-ES-1::Dactolisib
TGW::Temozolomide
HSC-4::PFI-1
ML-1::Ibrutinib
MEG-01::RVX-208
LU-139::VE-822
AM-38::PRT062607
EB2::Sorafenib
LC-2-ad::Lapatinib
YKG-1::Doramapimod
NCI-H1623::Sorafenib
NB(TU)1-10::Ibrutinib
KARPAS-299::RVX-208
LS-411N::PRT062607
EW-7::Dactolisib
SBC-1::Linsitinib
HT-3::Ibrutinib
ES4::PRT062607
JEKO-1::Ibrutinib
NCI-H226::Osimertinib
MS-1::PRT062607
OCI-M1::Avagacestat
NCI-H345::Palbociclib
TE-9::Linsitinib
SU-DHL-8::PRT062607
NCI-H2085::Temozolomide
NCI-H1770::IOX2
CAL-27::RVX-208
P30-OHK::Sorafenib
NCI-H650::VE-822
SCC-9::Linsitinib
PANC-03-27::Osimertinib
U-266::PRT062607
ZR-75-30::AZD6482
SW1783::PFI-1
NCI-H2085::Avagacestat
OAW-28::Lapatinib
H4::Lapatinib
NCI-H2444::AZD6482
COLO-792::Sorafenib
MFM-223::Avagacestat
G-401::Doramapimod
PFSK-1::Linsitinib
NCI-H748::AZD6482
NB14::Sorafenib
SW1116::Lapatinib
PA-TU-8988T::PFI-1
OCI-LY7::Temozolomide
DMS-53::Sorafenib
NCI-H661::PFI-1
RC-K8::Dactolisib
SW948::VE-822
EBC-1::Avagacestat
P32-ISH::PFI-1
LB996-RCC::Linsitinib
RCC-FG2::PFI-1
SK-MEL-5::IOX2
JAR::Lapatinib
CAS-1::RVX-208
GR-ST::Avagacestat
U-118-MG::Avagacestat
MIA-PaCa-2::Palbociclib
A427::PRT062607
SK-GT-4::I-BET-762
RL::Ibrutinib
KM12::Lapatinib
COR-L321::Avagacestat
451Lu::PRT062607
CAL-148::Lapatinib
OCUB-M::Temozolomide
KYSE-220::I-BET-762
LS-1034::Doramapimod
RF-48::Dactolisib
NCI-H209::Palbociclib
JURL-MK1::PFI-1
LNCaP-Clone-FGC::Lapatinib
OVTOKO::Doramapimod
OCI-M1::Ibrutinib
IGR-1::Doramapimod
D-283MED::Palbociclib
HCC1954::I-BET-762
U031::Avagacestat
JHH-4::Dactolisib
IST-SL1::PRT062607
VMRC-LCD::Temozolomide
D-336MG::Lapatinib
LN-18::Avagacestat
SK-ES-1::PFI-1
HCC1954::Dactolisib
RMG-I::Dactolisib
NCI-H596::Palbociclib
MLMA::Ibrutinib
YKG-1::Palbociclib
COR-L321::Sorafenib
LN-229::Avagacestat
NCI-H2066::Sorafenib
Saos-2::RVX-208
NCI-H1651::Doramapimod
ECC12::Ibrutinib
EMC-BAC-1::Osimertinib
EW-18::VE-822
NCC021::Sorafenib
CaR-1::RVX-208
LB373-MEL-D::Doramapimod
KYAE-1::Sorafenib
EB2::Linsitinib
CML-T1::Lapatinib
KP-3::PRT062607
ECC10::VE-822
SW13::Sorafenib
KYSE-140::Osimertinib
KCL-22::PFI-1
NCI-H358::Temozolomide
LC-2-ad::Avagacestat
DOK::RVX-208
LU-99A::Palbociclib
D-247MG::Doramapimod
G-402::Osimertinib
LP-1::RVX-208
HEC-1::Ibrutinib
SHP-77::RVX-208
CHSA8926::Dactolisib
SK-MEL-3::Avagacestat
LB647-SCLC::Ibrutinib
ME-1::Temozolomide
EW-24::Doramapimod
NCI-H841::Osimertinib
RPMI-8226::Dactolisib
CAL-72::Osimertinib
SIMA::Linsitinib
TC-YIK::Osimertinib
NCI-H1666::Dactolisib
JHOS-4::Temozolomide
NCI-H358::Ibrutinib
ESO26::Linsitinib
SNU-C2B::PFI-1
HCC1937::PFI-1
SK-N-DZ::Sorafenib
HT-115::Dactolisib
HSC-3::Temozolomide
NCI-H2342::PFI-1
NU-DUL-1::I-BET-762
SU-DHL-10::PRT062607
NCI-H929::Dactolisib
NCI-H835::Sorafenib
H9::Dactolisib
CAL-120::Osimertinib
JHH-7::PRT062607
MCF7::Doramapimod
OACM5-1::VE-822
MDA-MB-231::Avagacestat
MFM-223::AZD6482
NCI-H1915::Linsitinib
5637::PRT062607
LoVo::Palbociclib
HuO9::Sorafenib
MS-1::Lapatinib
P30-OHK::Ibrutinib
HA7-RCC::AZD6482
NCI-H1836::Sorafenib
EN::Avagacestat
SW684::RVX-208
NCI-H929::Doramapimod
JVM-2::PRT062607
Becker::Sorafenib
G-402::Lapatinib
OE33::RVX-208
ES6::I-BET-762
OS-RC-2::PRT062607
HOP-62::Palbociclib
A375::Linsitinib
HDQ-P1::VE-822
TE-12::Avagacestat
NUGC-3::Doramapimod
EFM-192A::Linsitinib
DU-145::Lapatinib
HH::Linsitinib
YT::Avagacestat
KP-4::Osimertinib
CAL-85-1::Avagacestat
DEL::Temozolomide
MHH-CALL-2::Sorafenib
MG-63::VE-822
NCI-H2342::Linsitinib
COR-L311::Lapatinib
HCC2218::Ibrutinib
PA-1::Temozolomide
MOLP-8::Lapatinib
YT::Lapatinib
OVTOKO::Linsitinib
NB10::VE-822
MOG-G-CCM::Temozolomide
NCI-H2052::Ibrutinib
SNU-283::PRT062607
SR::Lapatinib
SUP-HD1::RVX-208
DOHH-2::I-BET-762
HT55::Doramapimod
SK-LU-1::RVX-208
NCI-H2141::Temozolomide
COLO-800::Sorafenib
PA-TU-8902::Lapatinib
SH-4::PRT062607
IGR-37::Avagacestat
KOSC-2::VE-822
SW1116::Osimertinib
NCI-H1688::Palbociclib
FADU::Dactolisib
NCI-H2135::Linsitinib
NCI-H1568::Ibrutinib
BICR31::Sorafenib
MZ1-PC::Temozolomide
NCI-H3122::Palbociclib
Ramos-2G6-4C10::Avagacestat
DMS-79::Ibrutinib
BE2-M17::Lapatinib
BICR22::Dactolisib
ATN-1::Lapatinib
NCI-H2030::Doramapimod
OV-17R::VE-822
THP-1::I-BET-762
MM1S::Lapatinib
H3255::Lapatinib
SW620::Lapatinib
SKM-1::VE-822
AN3-CA::VE-822
IA-LM::Dactolisib
MFH-ino::Dactolisib
NCI-H1876::Palbociclib
SW954::VE-822
PC-3::Lapatinib
CGTH-W-1::Doramapimod
CAS-1::VE-822
SK-MG-1::I-BET-762
NCI-H2347::Lapatinib
NCI-H1048::Avagacestat
J82::Linsitinib
SW13::VE-822
RL95-2::Dactolisib
LB2241-RCC::Dactolisib
NCI-H2170::Dactolisib
LAMA-84::Lapatinib
AMO-1::Doramapimod
JEG-3::Osimertinib
KYAE-1::Ibrutinib
KARPAS-620::Lapatinib
ESS-1::Sorafenib
Farage::AZD6482
UACC-62::Dactolisib
MHH-CALL-4::AZD6482
COR-L95::Doramapimod
JM1::Sorafenib
LK-2::PRT062607
MSTO-211H::Doramapimod
SW1463::PRT062607
T98G::Sorafenib
TC-71::Temozolomide
VMRC-RCZ::Doramapimod
HCC-15::PRT062607
CAL-85-1::RVX-208
SNB75::Lapatinib
LNCaP-Clone-FGC::Avagacestat
RPMI-8226::Ibrutinib
NCI-H1650::Lapatinib
NAMALWA::Dactolisib
CAL-33::VE-822
NCI-H1048::Doramapimod
SLVL::Sorafenib
NCI-H1703::Linsitinib
ST486::Linsitinib
LN-229::Osimertinib
PCI-6A::Avagacestat
NCI-H841::PRT062607
NCI-H748::SL0101
CP50-MEL-B::Lapatinib
BB49-HNC::PRT062607
TC-71::Palbociclib
SiHa::Lapatinib
C3A::Lapatinib
MCF7::Palbociclib
M059J::PRT062607
RT4::PRT062607
SCC-9::VE-822
KM-H2::Osimertinib
HGC-27::Osimertinib
HOP-92::VE-822
NCI-H1355::Avagacestat
SKN::Ibrutinib
SKM-1::RVX-208
NCI-H2405::Ibrutinib
BT-474::PFI-1
GAMG::Temozolomide
COLO-684::Dactolisib
CFPAC-1::RVX-208
SU-DHL-8::Temozolomide
PCI-6A::SL0101
SAT::Sorafenib
JHU-029::I-BET-762
KYSE-70::Temozolomide
MS-1::RVX-208
ROS-50::Osimertinib
LC-2-ad::Temozolomide
COR-L105::Lapatinib
NCI-H1573::Temozolomide
SW1710::Sorafenib
JHOS-4::AZD6482
CHSA0108::SL0101
FU-OV-1::Lapatinib
SISO::Sorafenib
JiyoyeP-2003::Osimertinib
NCC010::Sorafenib
SNU-81::PFI-1
DU-4475::I-BET-762
RPMI-6666::Linsitinib
KU-19-19::Doramapimod
NCI-H322M::Doramapimod
H9::VE-822
NCI-H1155::PFI-1
NCI-H520::PFI-1
RH-41::Linsitinib
HT-144::Palbociclib
NOMO-1::RVX-208
MZ1-PC::IOX2
L-428::Doramapimod
CAKI-1::Linsitinib
CHSA0011::SL0101
U-87-MG::PFI-1
KU812::Ibrutinib
T84::Avagacestat
SUP-B15::Doramapimod
JIMT-1::Sorafenib
CAMA-1::RVX-208
SW1116::VE-822
RCC-ER::PRT062607
NAMALWA::PRT062607
OV-90::Temozolomide
MKN28::RVX-208
KARPAS-422::Temozolomide
ESO51::Doramapimod
EFM-19::Sorafenib
NCI-H841::Palbociclib
RL::IOX2
BICR22::PRT062607
EB-3::Avagacestat
REH::Dactolisib
GRANTA-519::I-BET-762
UACC-893::Avagacestat
CAL-51::Avagacestat
EBC-1::Temozolomide
RERF-LC-KJ::Ibrutinib
U-266::I-BET-762
PC-14::VE-822
DB::Linsitinib
CTV-1::Doramapimod
LNCaP-Clone-FGC::Ibrutinib
DOHH-2::AZD6482
UWB1.289::Osimertinib
SK-MEL-2::PRT062607
COR-L279::Temozolomide
NCI-H196::PFI-1
HDQ-P1::Dactolisib
SNU-283::Ibrutinib
SCC-9::Dactolisib
MV-4-11::Temozolomide
EKVX::RVX-208
SUP-M2::Avagacestat
786-0::Sorafenib
FTC-133::PRT062607
OV-7::Palbociclib
NB17::PRT062607
ES8::VE-822
CHSA0108::RVX-208
A375::Ibrutinib
SUP-B15::Sorafenib
IGR-37::Temozolomide
MPP-89::Linsitinib
CHSA8926::Lapatinib
TE-10::PRT062607
HCE-4::IOX2
NB5::VE-822
LOXIMVI::VE-822
LOU-NH91::Doramapimod
HO-1-N-1::Temozolomide
5637::Avagacestat
HLE::RVX-208
NCI-H2444::Dactolisib
BONNA-12::Temozolomide
CAL-27::Osimertinib
NCI-H740::Sorafenib
MZ2-MEL::Ibrutinib
TE-11::Doramapimod
HOP-62::PFI-1
BT-483::AZD6482
PL4::Linsitinib
HCC1937::Doramapimod
HCC1395::Temozolomide
SBC-3::Sorafenib
MCF7::Temozolomide
NCI-H522::I-BET-762
BFTC-905::Temozolomide
HuO9::Temozolomide
GAK::Dactolisib
ESO26::VE-822
LU-135::Doramapimod
HCC2998::Palbociclib
NCI-H1793::PFI-1
KYSE-450::Dactolisib
UACC-62::VE-822
NCI-H1105::RVX-208
EMC-BAC-1::Avagacestat
HL-60::Dactolisib
NCI-H1688::PFI-1
RCC-ER::Linsitinib
NY::RVX-208
HCC2157::I-BET-762
LNCaP-Clone-FGC::Sorafenib
NB(TU)1-10::Linsitinib
SUP-M2::VE-822
NCI-H520::Osimertinib
RERF-LC-Sq1::I-BET-762
U-698-M::Temozolomide
MRK-nu-1::Temozolomide
T84::Palbociclib
KNS-62::VE-822
A2058::Avagacestat
BPH-1::Sorafenib
FTC-133::Sorafenib
D-502MG::VE-822
BxPC-3::Palbociclib
COLO-678::Temozolomide
ML-1::Temozolomide
A2780::VE-822
DOHH-2::Linsitinib
KMOE-2::I-BET-762
D-336MG::RVX-208
KNS-62::Osimertinib
NCI-H1650::Avagacestat
SU8686::PFI-1
LB2518-MEL::VE-822
KON::AZD6482
CTB-1::IOX2
LXF-289::Avagacestat
HPAC::Dactolisib
KNS-42::Sorafenib
LN-18::Palbociclib
TK10::Avagacestat
CAL-148::AZD6482
A101D::I-BET-762
UACC-893::IOX2
SNU-423::VE-822
MFE-280::Sorafenib
ML-2::Avagacestat
KU812::Doramapimod
IGR-37::PRT062607
NB6::Osimertinib
NCI-H322M::RVX-208
EPLC-272H::PFI-1
KYSE-50::Temozolomide
CAL-72::RVX-208
NCI-H660::Doramapimod
BHY::Avagacestat
RO82-W-1::Doramapimod
BICR78::Palbociclib
LC-1-sq::Avagacestat
NB7::I-BET-762
IST-SL1::Palbociclib
KS-1::Temozolomide
JHOS-2::Temozolomide
SCC-25::IOX2
PA-TU-8988T::Lapatinib
EB2::Palbociclib
JHOS-2::PRT062607
SF539::Dactolisib
TUR::Palbociclib
TE-12::PRT062607
EFO-27::PFI-1
OVCAR-5::I-BET-762
A704::PRT062607
NB17::Lapatinib
22RV1::Linsitinib
SCC-15::PRT062607
MFM-223::I-BET-762
SW1088::Osimertinib
KYSE-270::Palbociclib
42-MG-BA::PFI-1
Becker::I-BET-762
SNU-283::Palbociclib
H9::Ibrutinib
639-V::PRT062607
HT-1197::RVX-208
OV-7::SL0101
TE-6::Doramapimod
SR::Palbociclib
SNU-81::Ibrutinib
ES-2::Temozolomide
RT4::Linsitinib
KMS-12-BM::Palbociclib
SNU-1040::Ibrutinib
LB996-RCC::Dactolisib
HMV-II::Temozolomide
RCC10RGB::I-BET-762
KYSE-450::Temozolomide
U-266::VE-822
OE33::Temozolomide
HCC1428::Palbociclib
SW1116::Avagacestat
DJM-1::IOX2
EoL-1-cell::VE-822
NCI-H1648::Lapatinib
HCT-15::Dactolisib
LC4-1::Osimertinib
EMC-BAC-1::Ibrutinib
SBC-5::Palbociclib
NCI-H526::RVX-208
NCI-H2196::IOX2
MFE-319::I-BET-762
Daoy::Avagacestat
D-263MG::Linsitinib
HCC1428::Avagacestat
OV-17R::AZD6482
OE19::Sorafenib
BxPC-3::Dactolisib
UACC-812::Avagacestat
5637::Temozolomide
LB2518-MEL::Ibrutinib
ESO51::I-BET-762
NU-DUL-1::SL0101
NUGC-3::PRT062607
EM-2::Avagacestat
NCI-H1435::Osimertinib
NCC021::Ibrutinib
NCI-H2029::AZD6482
SW620::Avagacestat
BHT-101::Palbociclib
A253::Linsitinib
KNS-62::I-BET-762
NCI-H1688::Temozolomide
CS1::Palbociclib
TOV-112D::Avagacestat
U-698-M::VE-822
KG-1::Ibrutinib
K2::Lapatinib
NCI-H1915::PFI-1
IM-95::PFI-1
CTB-1::PFI-1
CPC-N::I-BET-762
Ca9-22::Dactolisib
PFSK-1::I-BET-762
COR-L32::Doramapimod
GRANTA-519::PFI-1
LN-229::Temozolomide
NALM-6::Osimertinib
JVM-3::Lapatinib
VAL::PRT062607
C32::IOX2
Jurkat::VE-822
HCC1954::Avagacestat
RERF-LC-KJ::Sorafenib
NCI-H3122::I-BET-762
NCI-H1793::VE-822
SUIT-2::Linsitinib
OV-90::Palbociclib
NCI-H345::IOX2
RPMI-7951::Ibrutinib
PC-14::SL0101
BEN::Sorafenib
TCCSUP::Ibrutinib
639-V::Palbociclib
VA-ES-BJ::Doramapimod
8-MG-BA::Dactolisib
KALS-1::Sorafenib
UACC-257::Doramapimod
COLO-829::Palbociclib
TE-12::Palbociclib
CHP-212::Linsitinib
SU-DHL-10::PFI-1
WM35::PFI-1
MHH-CALL-4::SL0101
SK-MEL-2::Palbociclib
KP-3::Osimertinib
NCI-H2030::I-BET-762
MRK-nu-1::I-BET-762
LU-139::Lapatinib
TGBC11TKB::Sorafenib
22RV1::VE-822
JHU-029::PFI-1
WM278::Temozolomide
IST-MES1::Sorafenib
U251::Doramapimod
RH-1::RVX-208
MIA-PaCa-2::VE-822
GAMG::RVX-208
HT-115::Avagacestat
KM-H2::PRT062607
CADO-ES1::Linsitinib
COLO-320-HSR::Lapatinib
NCI-H1105::Doramapimod
BxPC-3::Doramapimod
TE-4::Temozolomide
EB2::Lapatinib
GA-10::Doramapimod
A704::Palbociclib
Hs-445::Temozolomide
CADO-ES1::Temozolomide
P32-ISH::Avagacestat
MOLM-16::Osimertinib
NCI-H2009::Avagacestat
KYSE-450::RVX-208
HSC-4::Linsitinib
OV-7::Sorafenib
TUR::Doramapimod
KYSE-450::Doramapimod
DB::RVX-208
MZ2-MEL::VE-822
CAL-12T::Doramapimod
TYK-nu::Linsitinib
KMOE-2::Avagacestat
SIG-M5::Temozolomide
KNS-62::Sorafenib
8305C::RVX-208
CAL-120::Temozolomide
JHH-4::PFI-1
SNU-283::IOX2
LC-1-sq::Linsitinib
DU-145::Temozolomide
A204::PFI-1
MFE-296::Linsitinib
Ramos-2G6-4C10::PRT062607
Saos-2::Dactolisib
SLVL::Avagacestat
COR-L321::PFI-1
COR-L311::Avagacestat
MDA-MB-415::Doramapimod
HC-1::Ibrutinib
KU-19-19::Temozolomide
NCI-H358::Avagacestat
NY::PFI-1
CAL-54::Doramapimod
KP-4::Avagacestat
JHOS-4::Lapatinib
GAK::Osimertinib
OACM5-1::Linsitinib
NCI-H650::PFI-1
SCC90::Lapatinib
A498::RVX-208
CHSA8926::Linsitinib
NUGC-4::Linsitinib
KARPAS-422::Osimertinib
CTV-1::Temozolomide
VA-ES-BJ::Linsitinib
D-247MG::Lapatinib
NCI-N87::Doramapimod
NCI-H28::PRT062607
OV-90::Ibrutinib
JVM-3::PRT062607
SH-4::Osimertinib
NCI-H1944::Dactolisib
AM-38::Sorafenib
CAL-27::Lapatinib
DSH1::I-BET-762
NCI-H1876::VE-822
SCC-3::Avagacestat
HCC-44::Lapatinib
G-402::Avagacestat
KMOE-2::Temozolomide
OVCAR-5::PFI-1
PSN1::Linsitinib
TE-6::Palbociclib
NCI-H660::Linsitinib
KNS-42::RVX-208
786-0::VE-822
HCC1419::Sorafenib
Raji::Sorafenib
LN-229::RVX-208
D-502MG::SL0101
LoVo::RVX-208
HT-3::RVX-208
8305C::Temozolomide
LB996-RCC::Doramapimod
COLO-680N::Osimertinib
SK-CO-1::Sorafenib
OV-90::Dactolisib
SW837::I-BET-762
AN3-CA::I-BET-762
SK-MEL-24::Dactolisib
ST486::I-BET-762
UACC-893::PRT062607
OVMIU::Dactolisib
RF-48::Osimertinib
A431::SL0101
H9::PRT062607
EW-1::Dactolisib
WM1552C::VE-822
NCI-H716::Temozolomide
NCI-H727::Lapatinib
MN-60::PFI-1
NCI-H2228::Temozolomide
NCI-H2291::Temozolomide
RPMI-8226::Lapatinib
SK-LMS-1::PFI-1
NCI-H250::Ibrutinib
JHU-029::Lapatinib
NCI-H1651::VE-822
NCC021::Avagacestat
CHL-1::Ibrutinib
42-MG-BA::Avagacestat
CHL-1::Sorafenib
PANC-03-27::Temozolomide
NCI-H2405::VE-822
SNU-61::Dactolisib
RT4::Osimertinib
LB1047-RCC::Sorafenib
NCI-H2087::Lapatinib
OSC-20::PFI-1
CHSA0108::AZD6482
RH-1::Lapatinib
TYK-nu::RVX-208
EMC-BAC-2::Sorafenib
TCCSUP::Temozolomide
D-247MG::Temozolomide
SK-N-AS::Ibrutinib
Farage::Linsitinib
SK-OV-3::Linsitinib
BICR78::Sorafenib
SF268::Temozolomide
CAL-29::Ibrutinib
EW-11::Doramapimod
NCI-H1836::Lapatinib
MS-1::Avagacestat
A2058::Osimertinib
ES5::Osimertinib
SNU-387::Osimertinib
OSC-19::Temozolomide
HCC-827::Doramapimod
ACHN::Ibrutinib
NCI-H1869::Lapatinib
SUP-B8::Osimertinib
H-EMC-SS::Temozolomide
NCI-H226::Ibrutinib
SU-DHL-6::PRT062607
LCLC-97TM1::Ibrutinib
L-1236::Palbociclib
NCI-N87::Sorafenib
NCI-H2029::Temozolomide
Hs-445::Lapatinib
KMOE-2::Osimertinib
COR-L105::I-BET-762
MDA-MB-157::Avagacestat
NCI-H1693::Avagacestat
OCI-AML3::Avagacestat
BONNA-12::Ibrutinib
OCI-M1::Linsitinib
OCI-AML2::Lapatinib
SW982::Sorafenib
OPM-2::Doramapimod
BICR78::Temozolomide
NCI-H2087::Palbociclib
SK-OV-3::Avagacestat
OE33::I-BET-762
C3A::Sorafenib
IST-MES1::PFI-1
CAKI-1::Osimertinib
EFM-19::PFI-1
QIMR-WIL::Avagacestat
SN12C::Temozolomide
OACp4C::Sorafenib
JSC-1::I-BET-762
HT-1080::Linsitinib
KARPAS-45::Dactolisib
ME-1::Linsitinib
NCI-H28::I-BET-762
MDA-MB-453::PRT062607
SiHa::Osimertinib
NOMO-1::Avagacestat
451Lu::Avagacestat
JAR::Avagacestat
SK-HEP-1::Osimertinib
Becker::Ibrutinib
NCI-N87::Ibrutinib
KGN::Avagacestat
NCI-H1838::Temozolomide
MHH-CALL-4::Osimertinib
COLO-678::PFI-1
SIMA::RVX-208
ESS-1::Osimertinib
CCK-81::RVX-208
CHP-134::Lapatinib
G-361::Osimertinib
NCI-H1694::Linsitinib
ASH-3::Dactolisib
NCI-H1838::Linsitinib
NCI-H1355::Linsitinib
SK-MM-2::Doramapimod
SW1271::Dactolisib
TE-6::Temozolomide
JHOS-2::Avagacestat
A431::PRT062607
THP-1::SL0101
SK-OV-3::RVX-208
DMS-114::Dactolisib
COR-L32::AZD6482
KARPAS-231::VE-822
LAMA-84::I-BET-762
COLO-679::Ibrutinib
CaR-1::PRT062607
CAKI-1::I-BET-762
TCCSUP::Avagacestat
SK-MM-2::Osimertinib
M059J::Palbociclib
MONO-MAC-6::Palbociclib
BE2-M17::Linsitinib
COLO-679::PFI-1
KURAMOCHI::I-BET-762
NCI-H146::PFI-1
A388::PFI-1
EW-12::Palbociclib
KMOE-2::PRT062607
DSH1::Palbociclib
HCC1500::Avagacestat
TE-10::IOX2
EM-2::PFI-1
IM-95::Dactolisib
KMS-12-BM::I-BET-762
no-11::PFI-1
EW-11::RVX-208
ES4::Temozolomide
KYSE-140::VE-822
NY::Sorafenib
NCI-H1435::I-BET-762
A427::Avagacestat
MDA-MB-415::PRT062607
NCI-H650::Avagacestat
huH-1::PFI-1
NCI-H2291::Dactolisib
D-502MG::Temozolomide
A253::PRT062607
ES-2::Doramapimod
DMS-79::PRT062607
TCCSUP::Doramapimod
OVCAR-5::Avagacestat
OCI-AML3::Temozolomide
NCI-H292::Doramapimod
DSH1::RVX-208
OCI-AML3::Sorafenib
SW156::RVX-208
SW837::Ibrutinib
KP-N-YN::I-BET-762
NCI-H2141::Sorafenib
RF-48::Avagacestat
KMOE-2::PFI-1
LCLC-97TM1::Dactolisib
KARPAS-620::Sorafenib
SR::Doramapimod
LN-229::PRT062607
NCI-H748::RVX-208
LAMA-84::Palbociclib
NCI-H1650::Ibrutinib
G-361::Ibrutinib
GA-10::Osimertinib
VMRC-RCZ::Avagacestat
NCI-H2227::Doramapimod
A498::VE-822
JIMT-1::Lapatinib
KMRC-20::PRT062607
SK-MEL-31::Palbociclib
HT-3::Doramapimod
LCLC-103H::Doramapimod
D-263MG::Temozolomide
RL95-2::I-BET-762
SK-ES-1::Ibrutinib
NCI-H526::I-BET-762
HARA::Palbociclib
NCI-H526::Sorafenib
SU-DHL-6::Sorafenib
U031::Ibrutinib
CAL-12T::Avagacestat
KARPAS-620::PFI-1
U-2-OS::PRT062607
MKN1::Osimertinib
MDA-MB-330::I-BET-762
HCC1806::Dactolisib
NCI-H441::Avagacestat
BALL-1::PRT062607
D-542MG::Avagacestat
LC-2-ad::RVX-208
MOG-G-CCM::Dactolisib
DU-145::RVX-208
KNS-81-FD::Osimertinib
NOS-1::Ibrutinib
Daudi::Dactolisib
WM278::Lapatinib
DJM-1::Palbociclib
LU-165::Sorafenib
LU-135::Palbociclib
NCI-H2347::Dactolisib
COLO-824::PRT062607
SK-LU-1::Lapatinib
MDA-MB-453::Lapatinib
SIG-M5::Lapatinib
HOP-62::Temozolomide
KMS-12-BM::Sorafenib
UACC-62::Sorafenib
HuO-3N1::Lapatinib
SW1271::RVX-208
BT-549::PFI-1
CAMA-1::I-BET-762
RH-41::Temozolomide
U-2-OS::VE-822
RCH-ACV::Osimertinib
GCT::Ibrutinib
UMC-11::Palbociclib
SNU-C2B::Doramapimod
NAMALWA::RVX-208
NCI-H716::PRT062607
OV-7::Avagacestat
KYSE-140::Sorafenib
PL4::Lapatinib
DU-4475::Temozolomide
EC-GI-10::Ibrutinib
FADU::RVX-208
GCT::Sorafenib
RCC10RGB::PRT062607
HeLa::Palbociclib
SU-DHL-8::Ibrutinib
ECC12::Sorafenib
LAN-6::Ibrutinib
LCLC-97TM1::Temozolomide
SISO::Lapatinib
PWR-1E::Doramapimod
KYSE-50::PRT062607
CHP-134::Sorafenib
LN-405::PFI-1
D-423MG::Lapatinib
SK-MEL-31::Temozolomide
ALL-SIL::I-BET-762
SW626::Doramapimod
NCI-H2347::Palbociclib
HT-115::Ibrutinib
TE-11::Sorafenib
TGBC11TKB::Osimertinib
CHSA8926::I-BET-762
BICR22::Lapatinib
no-10::Temozolomide
NCI-H650::Linsitinib
PL4::RVX-208
HDLM-2::Doramapimod
SF295::Osimertinib
ECC10::Sorafenib
CTB-1::RVX-208
NCI-H1650::PRT062607
NCI-H720::VE-822
SCC-9::Avagacestat
SK-MEL-24::Sorafenib
OCI-AML5::Temozolomide
MOLT-13::VE-822
SK-LU-1::Dactolisib
SUP-B15::Linsitinib
A498::PRT062607
UACC-893::Osimertinib
MC116::IOX2
VA-ES-BJ::Avagacestat
FU-OV-1::Avagacestat
KOSC-2::PRT062607
LN-405::VE-822
KG-1::Osimertinib
A172::Sorafenib
FU97::Doramapimod
HT-3::Palbociclib
NCI-H522::PRT062607
TCCSUP::Palbociclib
OE33::PRT062607
JIMT-1::Dactolisib
MDA-MB-436::Palbociclib
Mo-T::Ibrutinib
NB12::Temozolomide
NCI-H520::RVX-208
KG-1::PFI-1
VCaP::Lapatinib
PWR-1E::Dactolisib
NY::Temozolomide
SK-MEL-24::Avagacestat
SK-CO-1::Dactolisib
COLO-800::Avagacestat
PA-TU-8902::PFI-1
huH-1::Doramapimod
PA-TU-8902::Linsitinib
HT-1376::Doramapimod
U251::Lapatinib
SU-DHL-4::IOX2
OACM5-1::I-BET-762
D-392MG::Osimertinib
EMC-BAC-2::RVX-208
NCI-H748::Osimertinib
WM1552C::Lapatinib
HCT-15::RVX-208
KLE::VE-822
MIA-PaCa-2::Dactolisib
SiHa::Temozolomide
LCLC-97TM1::VE-822
SKM-1::Lapatinib
OCUM-1::Dactolisib
HEC-1::Sorafenib
SK-MG-1::PRT062607
A4-Fuk::PFI-1
D-263MG::Avagacestat
MEG-01::PRT062607
HCC38::PRT062607
BPH-1::Osimertinib
BxPC-3::PFI-1
NCI-H841::Ibrutinib
SK-GT-2::Temozolomide
MHH-CALL-2::VE-822
SK-MEL-31::Osimertinib
NCI-H661::VE-822
BHY::Linsitinib
NCI-H209::Osimertinib
AMO-1::Dactolisib
AU565::Avagacestat
NOS-1::Lapatinib
CW-2::VE-822
NCI-H2023::VE-822
NCI-H2066::Dactolisib
HCC2218::AZD6482
MOLM-13::Linsitinib
A427::Osimertinib
SBC-3::Avagacestat
TOV-112D::I-BET-762
GDM-1::Linsitinib
BPH-1::VE-822
KINGS-1::Avagacestat
LB2518-MEL::PRT062607
LB996-RCC::Ibrutinib
A2780::Sorafenib
NB6::Doramapimod
OAW-42::Lapatinib
BL-41::Linsitinib
NCI-H1836::I-BET-762
GAMG::Ibrutinib
HuO-3N1::Doramapimod
SBC-3::RVX-208
GRANTA-519::VE-822
EW-11::Lapatinib
PANC-02-03::RVX-208
TE-10::SL0101
NB6::Temozolomide
RO82-W-1::Palbociclib
EN::Linsitinib
HGC-27::I-BET-762
NCI-H1944::Osimertinib
PANC-04-03::Sorafenib
DJM-1::SL0101
SNU-C5::Ibrutinib
LXF-289::PFI-1
JM1::SL0101
ETK-1::Ibrutinib
EW-22::Sorafenib
BFTC-905::Dactolisib
PWR-1E::Sorafenib
LP-1::PFI-1
HCC38::RVX-208
SW872::Sorafenib
SR::Avagacestat
JJN-3::Doramapimod
MHH-CALL-2::Osimertinib
SW948::Doramapimod
G-MEL::PFI-1
COR-L32::Osimertinib
D-566MG::Ibrutinib
SUP-B8::Avagacestat
SU-DHL-8::Lapatinib
NCI-H1734::I-BET-762
DOV13::Sorafenib
OVCAR-8::Ibrutinib
TE-441-T::AZD6482
C32::Sorafenib
A2780::Ibrutinib
SCC-15::Dactolisib
CAL-39::VE-822
no-11::Sorafenib
ALL-SIL::Sorafenib
VMRC-LCD::PRT062607
HL-60::Avagacestat
RKN::PRT062607
NCI-H2452::Osimertinib
KU812::I-BET-762
NCI-H28::Linsitinib
NCI-H2110::PRT062607
DOV13::PRT062607
MFE-319::Osimertinib
ESO26::Palbociclib
A253::Osimertinib
JHU-011::IOX2
CHL-1::VE-822
8505C::Sorafenib
TE-10::Palbociclib
GI-1::I-BET-762
UM-UC-3::Avagacestat
SCC-15::PFI-1
COR-L32::PRT062607
NCI-H727::I-BET-762
D-263MG::RVX-208
NCI-H2444::Sorafenib
RCC10RGB::PFI-1
22RV1::Dactolisib
OCUB-M::Avagacestat
KON::Linsitinib
KARPAS-620::Dactolisib
JHOS-4::Linsitinib
CAMA-1::Osimertinib
Calu-6::PRT062607
TC-YIK::Sorafenib
REH::Palbociclib
LB373-MEL-D::Temozolomide
BT-20::Linsitinib
GCT::Doramapimod
SCC-25::Palbociclib
TE-6::Osimertinib
RKN::Palbociclib
Mo-T::Osimertinib
MIA-PaCa-2::Lapatinib
NCI-H747::Ibrutinib
T47D::Lapatinib
NCI-H596::Dactolisib
KYM-1::Avagacestat
HCC1187::Linsitinib
SKG-IIIa::Lapatinib
D-247MG::RVX-208
QIMR-WIL::Osimertinib
NCI-H146::Lapatinib
CP50-MEL-B::Palbociclib
HOP-92::PRT062607
EVSA-T::Lapatinib
NCI-H661::Sorafenib
NCI-H1869::Palbociclib
HCC1806::Lapatinib
NCI-H2291::PRT062607
CAL-54::Avagacestat
TE-11::PRT062607
CHSA0011::Lapatinib
NCI-H522::Temozolomide
CAKI-1::Doramapimod
NCI-H841::Lapatinib
MFE-319::PRT062607
TC-YIK::I-BET-762
IST-SL2::SL0101
IST-MES1::Osimertinib
BB65-RCC::Avagacestat
RERF-GC-1B::Ibrutinib
RERF-LC-Sq1::PRT062607
NCI-H441::Palbociclib
SNB75::Ibrutinib
LAN-6::AZD6482
NCI-H1755::Linsitinib
MDST8::Dactolisib
SCC-4::Avagacestat
NB69::Ibrutinib
COLO-205::Temozolomide
CAKI-1::Temozolomide
AMO-1::VE-822
DOK::Dactolisib
MOLM-13::Dactolisib
SR::PRT062607
P32-ISH::Linsitinib
SK-N-DZ::Dactolisib
HC-1::PFI-1
HDLM-2::Ibrutinib
GDM-1::Lapatinib
NCI-H929::Lapatinib
LOU-NH91::PFI-1
MDA-MB-330::RVX-208
OVCAR-5::Lapatinib
BPH-1::Linsitinib
HAL-01::Dactolisib
IST-SL1::Doramapimod
THP-1::AZD6482
NALM-6::RVX-208
ME-1::PRT062607
HOP-92::Ibrutinib
NUGC-4::Sorafenib
IGROV-1::VE-822
NCI-H2023::Temozolomide
BB30-HNC::Linsitinib
MOLT-13::Temozolomide
NCI-H1435::RVX-208
IM-9::I-BET-762
JVM-2::RVX-208
PSN1::Osimertinib
LP-1::Dactolisib
SK-N-SH::Dactolisib
KYAE-1::PFI-1
SU-DHL-8::Palbociclib
EN::Doramapimod
MN-60::RVX-208
SNU-C1::PFI-1
GB-1::Sorafenib
L-428::Avagacestat
MEG-01::Doramapimod
TE-441-T::Sorafenib
ASH-3::VE-822
SW1116::RVX-208
EW-24::PFI-1
PA-TU-8988T::RVX-208
KS-1::Palbociclib
EB-3::Temozolomide
JHU-022::Palbociclib
NCI-H1694::Temozolomide
MEL-JUSO::PRT062607
EW-18::Palbociclib
H-EMC-SS::Sorafenib
SNB75::RVX-208
NCI-H2029::RVX-208
RERF-LC-KJ::PFI-1
NCI-H292::Lapatinib
L-1236::Avagacestat
HCC70::Ibrutinib
G-402::Linsitinib
TE-4::Lapatinib
KYSE-520::Ibrutinib
UACC-893::VE-822
A375::SL0101
JiyoyeP-2003::Temozolomide
NCI-H2135::IOX2
A673::Dactolisib
JAR::VE-822
SW954::Osimertinib
CAS-1::Palbociclib
HCC1187::Sorafenib
NCI-H2405::Avagacestat
KCL-22::PRT062607
KP-1N::Linsitinib
BL-41::Dactolisib
KLE::Ibrutinib
D-566MG::SL0101
COR-L105::RVX-208
OAW-28::PRT062607
AMO-1::PFI-1
L-428::Temozolomide
HuO9::Osimertinib
SHP-77::Dactolisib
P12-ICHIKAWA::Doramapimod
DEL::Ibrutinib
MDST8::Palbociclib
HMV-II::Sorafenib
CAL-148::Avagacestat
MEG-01::Temozolomide
KYAE-1::PRT062607
OE33::PFI-1
EFM-19::Temozolomide
SK-MEL-31::PFI-1
SU-DHL-8::I-BET-762
TE-15::Avagacestat
SAS::Lapatinib
SiHa::RVX-208
MN-60::Dactolisib
SNU-449::Palbociclib
HCC1806::Linsitinib
NB7::Palbociclib
SU-DHL-5::Palbociclib
NCI-H661::Linsitinib
KP-2::Osimertinib
LOXIMVI::Doramapimod
SBC-3::PFI-1
KNS-81-FD::SL0101
HCC2218::Avagacestat
MCF7::Ibrutinib
SKN-3::VE-822
NCI-H2030::AZD6482
HT-3::PRT062607
GCIY::Dactolisib
PCI-6A::IOX2
NCI-H838::Dactolisib
NCI-H1793::Dactolisib
Hey::Avagacestat
ROS-50::PRT062607
NCI-H1092::Linsitinib
EW-12::Avagacestat
HCC1599::Sorafenib
SK-MEL-30::Doramapimod
RF-48::Ibrutinib
SBC-1::Doramapimod
ES1::PFI-1
EBC-1::Osimertinib
NCI-H2172::PFI-1
BB65-RCC::Ibrutinib
CCK-81::Ibrutinib
NCI-H1155::Avagacestat
JIMT-1::PFI-1
SUIT-2::Lapatinib
OE33::Linsitinib
SK-MEL-30::IOX2
K-562::Palbociclib
MG-63::Palbociclib
WM793B::Osimertinib
C2BBe1::Ibrutinib
EoL-1-cell::I-BET-762
CW-2::Lapatinib
KYM-1::Doramapimod
JVM-2::Sorafenib
HA7-RCC::VE-822
LAMA-84::PRT062607
SU-DHL-4::PRT062607
SK-MEL-1::Temozolomide
HGC-27::RVX-208
KYSE-150::Avagacestat
NCI-H661::Ibrutinib
NCI-H647::Doramapimod
MHH-PREB-1::RVX-208
A2058::Palbociclib
RL95-2::Osimertinib
EJM::Dactolisib
KNS-81-FD::PFI-1
NCI-H929::Osimertinib
SH-4::Linsitinib
BPH-1::RVX-208
NB17::Avagacestat
KLE::Doramapimod
CS1::PRT062607
WM35::Ibrutinib
MDA-MB-453::PFI-1
NCI-H747::RVX-208
SNU-C1::PRT062607
NB1::Dactolisib
ChaGo-K-1::Avagacestat
OVCAR-5::Doramapimod
NCI-H446::PFI-1
GB-1::PFI-1
CAL-33::RVX-208
KOPN-8::VE-822
SNU-283::Linsitinib
NCI-H292::VE-822
MM1S::VE-822
NCC010::Palbociclib
NCI-H1648::Osimertinib
SNU-C5::Dactolisib
ALL-PO::PRT062607
GCIY::PRT062607
PC-14::Lapatinib
BICR31::I-BET-762
THP-1::Temozolomide
NCI-H28::Ibrutinib
WM-115::Doramapimod
YKG-1::SL0101
NCI-H1299::Linsitinib
KINGS-1::Sorafenib
JHU-029::Osimertinib
HCT-15::PFI-1
451Lu::Linsitinib
NCI-H647::I-BET-762
A253::Avagacestat
HCC1806::AZD6482
H3255::Osimertinib
YKG-1::Avagacestat
RCC-AB::Avagacestat
IGROV-1::I-BET-762
J82::VE-822
KE-37::PRT062607
LB771-HNC::Sorafenib
HOP-62::Avagacestat
SNU-283::Sorafenib
SUP-T1::Lapatinib
NCI-H2170::PFI-1
NCI-H810::PRT062607
COLO-684::RVX-208
SCC-25::VE-822
TE-5::Osimertinib
NCC010::Avagacestat
LN-18::Temozolomide
LXF-289::RVX-208
EMC-BAC-2::Doramapimod
Jurkat::Ibrutinib
HuCCT1::VE-822
Calu-6::Doramapimod
LC-2-ad::SL0101
NCI-H250::Doramapimod
KMS-12-BM::Doramapimod
NMC-G1::Doramapimod
HT-29::Linsitinib
NCI-H1048::RVX-208
RS4-11::Doramapimod
OVKATE::Palbociclib
PANC-10-05::Linsitinib
OC-314::Temozolomide
MOLP-8::RVX-208
RCC-AB::Sorafenib
SISO::Osimertinib
OVCAR-4::Doramapimod
451Lu::Palbociclib
Detroit562::Ibrutinib
SCC-25::AZD6482
SIMA::Osimertinib
NCI-H2110::PFI-1
GOTO::RVX-208
CTV-1::Sorafenib
TK::Linsitinib
OVK-18::SL0101
CS1::Osimertinib
QGP-1::Dactolisib
451Lu::Lapatinib
RC-K8::VE-822
TE-10::I-BET-762
BE2-M17::Ibrutinib
BB30-HNC::RVX-208
M14::Ibrutinib
WM278::Avagacestat
RPMI-7951::Lapatinib
BHY::Temozolomide
CW-2::I-BET-762
HCC-78::Ibrutinib
KS-1::Lapatinib
DSH1::Temozolomide
OCI-AML3::Dactolisib
LN-229::Palbociclib
HL-60::Palbociclib
Jurkat::Palbociclib
HT55::Ibrutinib
CHSA8926::RVX-208
BFTC-909::Dactolisib
SW872::VE-822
SK-HEP-1::I-BET-762
DOK::I-BET-762
NCI-H1734::Palbociclib
REH::PRT062607
WM793B::Palbociclib
SW684::Dactolisib
LS-411N::I-BET-762
VA-ES-BJ::Ibrutinib
EW-12::Dactolisib
NCI-H250::Osimertinib
5637::Dactolisib
SF268::Linsitinib
TUR::RVX-208
GP5d::Sorafenib
NCI-H1048::Lapatinib
COR-L32::I-BET-762
ACHN::Avagacestat
NCI-H747::Lapatinib
KP-1N::Dactolisib
HCC-15::Osimertinib
TOV-21G::Temozolomide
AGS::Dactolisib
NCI-H1770::Ibrutinib
LNZTA3WT4::Palbociclib
QGP-1::Ibrutinib
SNU-C1::Palbociclib
CAL-39::Temozolomide
A427::RVX-208
HH::Palbociclib
YAPC::I-BET-762
D-566MG::PRT062607
BALL-1::Avagacestat
GAK::PFI-1
PANC-08-13::Dactolisib
NCI-H522::Osimertinib
SW156::PFI-1
NCI-H2135::PRT062607
A431::PFI-1
SCH::Temozolomide
NCI-H146::AZD6482
SK-GT-4::PFI-1
NH-12::Doramapimod
BFTC-909::Linsitinib
GDM-1::PRT062607
TOV-112D::Osimertinib
CML-T1::Avagacestat
YH-13::Lapatinib
SF539::Linsitinib
NCI-H1915::Dactolisib
DU-4475::RVX-208
NCI-H841::Linsitinib
PA-TU-8902::Doramapimod
CP50-MEL-B::IOX2
KARPAS-231::Ibrutinib
CAMA-1::PRT062607
C2BBe1::Sorafenib
GI-ME-N::Ibrutinib
OCI-LY7::IOX2
LB831-BLC::Lapatinib
OV-90::Avagacestat
639-V::Ibrutinib
KINGS-1::RVX-208
NCI-H647::Osimertinib
P32-ISH::I-BET-762
T98G::Doramapimod
NU-DUL-1::PFI-1
NCI-H526::Temozolomide
JHOS-3::SL0101
SKN-3::PRT062607
WM-115::I-BET-762
NCI-H1155::PRT062607
GCIY::Osimertinib
OVK-18::Avagacestat
22RV1::I-BET-762
CHSA8926::Temozolomide
COLO-783::VE-822
SK-MEL-24::Temozolomide
NUGC-3::Linsitinib
MPP-89::Lapatinib
U-266::Sorafenib
EN::PRT062607
MEL-JUSO::VE-822
NB69::I-BET-762
ChaGo-K-1::Linsitinib
OPM-2::PRT062607
U-87-MG::Linsitinib
NB13::PFI-1
MEL-HO::Palbociclib
SK-ES-1::I-BET-762
KALS-1::Linsitinib
G-361::Linsitinib
HT-1197::Osimertinib
KMRC-20::Lapatinib
HT-115::Osimertinib
ML-1::PFI-1
UM-UC-3::Sorafenib
SCC-15::VE-822
AsPC-1::PFI-1
ES7::RVX-208
CAL-120::PRT062607
NCI-H716::Palbociclib
RCC-AB::Palbociclib
CCRF-CEM::PRT062607
SK-MEL-2::Lapatinib
A375::AZD6482
MOG-G-UVW::Palbociclib
HCC-827::Palbociclib
MDA-MB-436::Ibrutinib
TK10::I-BET-762
OE19::Lapatinib
KINGS-1::VE-822
A172::Ibrutinib
COLO-792::Dactolisib
MDA-MB-231::Dactolisib
RERF-LC-MS::Dactolisib
NCI-H510A::Osimertinib
DU-145::Palbociclib
HuH-7::Sorafenib
JHH-6::Sorafenib
VMRC-LCD::Avagacestat
RCC-JW::PFI-1
Hs-445::PFI-1
SNU-C2B::Dactolisib
NAMALWA::Ibrutinib
MKN45::RVX-208
C3A::VE-822
SNU-81::Sorafenib
MEL-JUSO::Dactolisib
NCI-H1299::I-BET-762
M14::VE-822
HT-3::Osimertinib
HT55::PFI-1
KOPN-8::Temozolomide
JHOS-3::AZD6482
IGR-1::Lapatinib
NCI-H1770::VE-822
U251::Osimertinib
DMS-79::Dactolisib
NCI-H2291::Osimertinib
UACC-62::Ibrutinib
HCC1954::Palbociclib
SNU-398::RVX-208
KYAE-1::Dactolisib
HSC-3::VE-822
PCI-15A::Lapatinib
SNU-175::Osimertinib
TC-YIK::Lapatinib
PCI-6A::PRT062607
D-263MG::Dactolisib
EPLC-272H::RVX-208
HAL-01::VE-822
NCI-H2291::Ibrutinib
HeLa::Dactolisib
NCI-H660::VE-822
DMS-79::Palbociclib
MKN28::Osimertinib
RCC-FG2::I-BET-762
8305C::Linsitinib
LU-165::Dactolisib
SF126::Sorafenib
WM1552C::I-BET-762
NAMALWA::Osimertinib
SK-ES-1::PRT062607
NCI-H196::Dactolisib
RPMI-7951::PRT062607
IPC-298::VE-822
SK-N-DZ::Linsitinib
HMV-II::VE-822
NCI-H661::Doramapimod
NCI-H226::I-BET-762
M059J::Avagacestat
TGBC24TKB::Ibrutinib
NH-12::RVX-208
UACC-893::Linsitinib
CAKI-1::RVX-208
HOP-62::VE-822
CAL-72::Lapatinib
LNCaP-Clone-FGC::Linsitinib
VAL::I-BET-762
RKO::VE-822
SU-DHL-10::Linsitinib
ES6::Palbociclib
Ca9-22::Avagacestat
CESS::RVX-208
ST486::VE-822
BHY::PFI-1
RCC-AB::SL0101
ES8::Osimertinib
NCI-H1838::Sorafenib
RT-112::I-BET-762
M14::Lapatinib
L-1236::Linsitinib
GB-1::Osimertinib
HuO-3N1::Dactolisib
RERF-LC-Sq1::Osimertinib
Mo-T::Linsitinib
GCIY::Linsitinib
H3255::Dactolisib
HO-1-u-1::Lapatinib
KYSE-50::Lapatinib
MZ7-mel::Palbociclib
ECC10::RVX-208
LU-134-A::VE-822
NCI-H1838::Palbociclib
MM1S::Doramapimod
NB10::Doramapimod
MPP-89::Dactolisib
SK-HEP-1::VE-822
SIMA::I-BET-762
NCI-H82::Doramapimod
JHH-7::Avagacestat
DOHH-2::SL0101
BT-20::PRT062607
A375::Dactolisib
CHP-212::VE-822
EFO-27::IOX2
HAL-01::RVX-208
SK-UT-1::Dactolisib
GRANTA-519::Osimertinib
ARH-77::Lapatinib
MDA-MB-330::AZD6482
NB13::Temozolomide
NCI-H1703::Temozolomide
HeLa::I-BET-762
PL4::I-BET-762
NCI-H1792::Palbociclib
ST486::Osimertinib
EW-7::VE-822
LB1047-RCC::RVX-208
D-263MG::Osimertinib
HCC1143::I-BET-762
OPM-2::I-BET-762
MOG-G-CCM::Palbociclib
ABC-1::Dactolisib
HPAF-II::Ibrutinib
22RV1::Sorafenib
NCI-H1963::Linsitinib
LN-18::Sorafenib
NCI-H2347::Doramapimod
MS751::Dactolisib
D-566MG::Avagacestat
DOV13::VE-822
EMC-BAC-1::Dactolisib
NCI-H250::Lapatinib
P30-OHK::Lapatinib
SISO::PFI-1
PFSK-1::Doramapimod
OVISE::Doramapimod
HuO9::PRT062607
L-428::Lapatinib
NCI-H2110::Linsitinib
LB647-SCLC::Palbociclib
SAS::PRT062607
KNS-62::PRT062607
HCT-116::Sorafenib
TGBC1TKB::Sorafenib
REH::Osimertinib
LS-1034::Ibrutinib
MEL-HO::VE-822
KMS-11::Dactolisib
JSC-1::Dactolisib
RCH-ACV::RVX-208
EKVX::I-BET-762
HTC-C3::I-BET-762
KOPN-8::Dactolisib
NB6::Ibrutinib
SK-OV-3::Temozolomide
MHH-NB-11::Dactolisib
RERF-LC-KJ::Linsitinib
BALL-1::Osimertinib
SKN-3::PFI-1
PANC-08-13::Palbociclib
DOV13::Avagacestat
NB5::AZD6482
ZR-75-30::RVX-208
MOLT-13::Doramapimod
CGTH-W-1::Sorafenib
T47D::Sorafenib
RCH-ACV::PFI-1
NCI-H661::PRT062607
H3255::PRT062607
ST486::Doramapimod
SUP-T1::Doramapimod
MHH-PREB-1::VE-822
NCI-H64::Osimertinib
COLO-684::Sorafenib
OV-56::RVX-208
D-502MG::Palbociclib
KE-37::VE-822
ZR-75-30::Avagacestat
NCI-H2347::Avagacestat
OACM5-1::Lapatinib
KS-1::Sorafenib
PC-14::Temozolomide
SUP-HD1::Palbociclib
NCI-H2141::Ibrutinib
Daoy::Palbociclib
SUP-T1::I-BET-762
A549::Osimertinib
A4-Fuk::Palbociclib
A101D::VE-822
JEG-3::Ibrutinib
DBTRG-05MG::I-BET-762
EW-24::Palbociclib
SK-MEL-2::Ibrutinib
COLO-668::Doramapimod
TE-6::RVX-208
NCI-H727::RVX-208
SK-N-AS::RVX-208
COR-L321::IOX2
LB373-MEL-D::Sorafenib
KMS-12-BM::VE-822
WIL2-NS::Palbociclib
LC-2-ad::Linsitinib
SCC-4::Lapatinib
KP-2::Temozolomide
C-4-I::Lapatinib
PCI-6A::Osimertinib
QIMR-WIL::RVX-208
UMC-11::Sorafenib
TE-5::Palbociclib
BHT-101::Temozolomide
REH::PFI-1
WSU-NHL::Lapatinib
JHH-6::Ibrutinib
NCI-H292::IOX2
BICR31::Dactolisib
CP66-MEL::RVX-208
HSC-3::I-BET-762
MC116::Doramapimod
KMS-12-BM::PRT062607
MFE-319::Lapatinib
CW-2::Dactolisib
KYSE-270::Doramapimod
NCI-H1581::Ibrutinib
OE33::Palbociclib
KARPAS-45::Lapatinib
NCI-H1568::Linsitinib
LOU-NH91::Ibrutinib
ES6::RVX-208
BICR10::Palbociclib
NCI-H526::Ibrutinib
IA-LM::RVX-208
U-266::RVX-208
CTB-1::Avagacestat
MDA-MB-330::Palbociclib
LoVo::Linsitinib
SW780::Dactolisib
T47D::Palbociclib
NCI-H1651::I-BET-762
SNG-M::Avagacestat
NOS-1::Temozolomide
RERF-LC-Sq1::Dactolisib
Mewo::Avagacestat
FADU::Palbociclib
CS1::Ibrutinib
TE-8::Lapatinib
U-266::Ibrutinib
HCE-4::Avagacestat
T-T::Palbociclib
MS751::Osimertinib
H4::Avagacestat
OVCAR-8::PRT062607
LB996-RCC::Osimertinib
EMC-BAC-1::RVX-208
EW-13::PRT062607
NCI-H1666::VE-822
OVCAR-5::Osimertinib
NB6::Linsitinib
SCC-3::VE-822
OCI-AML5::VE-822
OCI-AML2::I-BET-762
NCI-H446::Dactolisib
OV-90::VE-822
NCI-H2085::Sorafenib
PANC-08-13::Avagacestat
CAL-72::Linsitinib
NCI-H1734::SL0101
NCI-H1650::VE-822
NCI-H716::Linsitinib
CHSA0108::PRT062607
MV-4-11::Doramapimod
HuP-T4::Avagacestat
UACC-62::PRT062607
SW837::VE-822
MOLT-4::VE-822
D-423MG::Sorafenib
MDA-MB-415::Linsitinib
NCI-H727::PFI-1
KM12::Dactolisib
LB996-RCC::PFI-1
MDA-MB-361::Dactolisib
SK-MEL-2::Temozolomide
EB2::VE-822
A498::Ibrutinib
BE-13::Osimertinib
HO-1-N-1::Ibrutinib
NCI-H2135::Osimertinib
SJSA-1::Doramapimod
NCI-H2023::Linsitinib
HT-1080::Avagacestat
TOV-21G::Palbociclib
C-4-I::PFI-1
LB2518-MEL::Osimertinib
RKO::Palbociclib
NB10::Avagacestat
CML-T1::RVX-208
RPMI-7951::Palbociclib
OV-56::Sorafenib
HT55::RVX-208
CRO-AP2::RVX-208
KOPN-8::Lapatinib
D-542MG::Ibrutinib
AsPC-1::PRT062607
CAKI-1::Palbociclib
RCC-MF::Sorafenib
NCI-H1693::PRT062607
EM-2::Dactolisib
SU-DHL-5::Osimertinib
FLO-1::Lapatinib
no-11::RVX-208
NCI-H2122::Temozolomide
Detroit562::Osimertinib
NCI-H510A::Avagacestat
SW1990::Linsitinib
TE-6::Ibrutinib
KYSE-510::Avagacestat
KYSE-510::Temozolomide
NCI-H1836::Linsitinib
NCI-H1155::VE-822
HMV-II::Lapatinib
OCI-AML2::Avagacestat
HT-1080::Lapatinib
H3255::Temozolomide
A704::I-BET-762
SU-DHL-1::PRT062607
OE33::Ibrutinib
STS-0421::AZD6482
CAMA-1::Doramapimod
Saos-2::Doramapimod
CML-T1::Doramapimod
SK-MEL-24::Osimertinib
HSC-39::Osimertinib
SKN::Sorafenib
OVCAR-4::Temozolomide
SW684::Temozolomide
TE-9::PFI-1
BB65-RCC::IOX2
PSN1::PRT062607
EBC-1::Linsitinib
MS-1::Temozolomide
JHH-2::Sorafenib
PANC-08-13::Doramapimod
SU8686::I-BET-762
MDA-MB-415::Dactolisib
IM-95::Sorafenib
SCC90::PFI-1
SW684::Osimertinib
D-542MG::PRT062607
U-2-OS::RVX-208
MIA-PaCa-2::PRT062607
SK-MM-2::I-BET-762
PA-1::PRT062607
KYSE-270::Ibrutinib
P12-ICHIKAWA::I-BET-762
CA46::I-BET-762
SF295::Dactolisib
TCCSUP::RVX-208
IST-SL2::Dactolisib
SW1573::Temozolomide
DMS-114::PRT062607
NCI-H2347::Temozolomide
SF126::Ibrutinib
SKN-3::Osimertinib
HCC-366::IOX2
CA46::Avagacestat
JHOS-4::Ibrutinib
LU-99A::I-BET-762
MCF7::AZD6482
GR-ST::Lapatinib
PANC-04-03::Doramapimod
COLO-678::Sorafenib
KYAE-1::Lapatinib
RXF393::Linsitinib
SCC-3::Sorafenib
786-0::Ibrutinib
MRK-nu-1::Linsitinib
NB5::Temozolomide
SW1990::PFI-1
Raji::PRT062607
NMC-G1::Temozolomide
PL-21::Osimertinib
ChaGo-K-1::Palbociclib
RS4-11::Sorafenib
NCI-H1876::RVX-208
HLE::Ibrutinib
CAPAN-1::Palbociclib
RCC-ER::Avagacestat
EW-1::PRT062607
PA-1::Dactolisib
SBC-1::I-BET-762
HCC70::Temozolomide
MZ1-PC::Ibrutinib
TK10::Dactolisib
697::RVX-208
GAK::Ibrutinib
SN12C::Lapatinib
OVCAR-8::Dactolisib
KNS-42::Doramapimod
GA-10::Avagacestat
MEL-HO::PFI-1
RVH-421::Avagacestat
KATOIII::Dactolisib
Raji::VE-822
RERF-LC-Sq1::Doramapimod
RL::PRT062607
HAL-01::PRT062607
KON::PRT062607
HeLa::Ibrutinib
LN-405::Avagacestat
OVCAR-8::Sorafenib
Calu-6::VE-822
EW-18::Avagacestat
KNS-42::IOX2
HCC1954::PFI-1
PFSK-1::RVX-208
U251::Avagacestat
NCI-H1092::Lapatinib
UACC-62::I-BET-762
LCLC-97TM1::Linsitinib
LC4-1::Dactolisib
L-1236::Sorafenib
647-V::Dactolisib
SK-MEL-28::Avagacestat
Ramos-2G6-4C10::RVX-208
NCI-H835::Doramapimod
HCC2218::Linsitinib
SBC-3::Temozolomide
AGS::Lapatinib
KM12::Linsitinib
COLO-684::Lapatinib
A204::Sorafenib
LP-1::Temozolomide
EB-3::Osimertinib
SNG-M::Osimertinib
MLMA::Osimertinib
HT-144::Sorafenib
NCI-H660::Ibrutinib
NCI-H1563::RVX-208
PF-382::Palbociclib
SNU-387::Linsitinib
D-542MG::I-BET-762
SJRH30::Dactolisib
SW1271::I-BET-762
K5::I-BET-762
SNU-C5::VE-822
EB2::Doramapimod
NH-12::PRT062607
HCC2998::Lapatinib
NCI-H740::SL0101
NCI-H1563::PFI-1
Becker::Palbociclib
COR-L105::PFI-1
SNU-407::I-BET-762
SW156::SL0101
KP-4::Ibrutinib
H-EMC-SS::PRT062607
LS-1034::RVX-208
HCC1419::PRT062607
L-363::Palbociclib
NCI-H211::Osimertinib
Daoy::PRT062607
KU-19-19::Dactolisib
CAL-39::Linsitinib
BICR78::I-BET-762
C-33-A::PRT062607
JSC-1::PRT062607
HDLM-2::Avagacestat
MHH-NB-11::RVX-208
Daudi::Temozolomide
ES5::AZD6482
CAL-78::Doramapimod
WM35::VE-822
SCH::IOX2
HOP-62::Ibrutinib
NCI-H1781::Osimertinib
KON::Avagacestat
RO82-W-1::PFI-1
COR-L32::PFI-1
SW954::Lapatinib
OCI-AML2::Dactolisib
DU-4475::VE-822
MC116::AZD6482
EFO-27::Doramapimod
JHOS-2::SL0101
EW-16::Avagacestat
NB7::RVX-208
NCI-H1963::Doramapimod
KYSE-510::Dactolisib
WSU-DLCL2::Osimertinib
HTC-C3::Palbociclib
HCT-15::VE-822
A3-KAW::Sorafenib
PCI-30::PFI-1
GRANTA-519::PRT062607
L-540::Temozolomide
LS-1034::PFI-1
SK-MEL-3::I-BET-762
SCC-25::Doramapimod
YAPC::PRT062607
CCRF-CEM::Linsitinib
RC-K8::Linsitinib
KARPAS-299::Sorafenib
NCI-H1568::Palbociclib
JEG-3::PFI-1
CP66-MEL::SL0101
K-562::Sorafenib
TC-YIK::RVX-208
MIA-PaCa-2::Temozolomide
NCI-H596::Doramapimod
NCI-H1693::RVX-208
SK-N-DZ::Doramapimod
Ca-Ski::Dactolisib
769-P::RVX-208
MKN45::Linsitinib
HuP-T4::Lapatinib
U251::VE-822
MOLT-4::Palbociclib
DMS-114::Palbociclib
NCI-H748::PFI-1
U-118-MG::I-BET-762
EBC-1::RVX-208
LK-2::Sorafenib
OE19::RVX-208
KYM-1::VE-822
NCI-H2029::Osimertinib
OVK-18::Temozolomide
Mewo::PFI-1
COLO-800::Lapatinib
HSC-4::RVX-208
DBTRG-05MG::Osimertinib
ETK-1::Dactolisib
MEL-JUSO::Temozolomide
OCI-LY-19::Lapatinib
FU-OV-1::Sorafenib
COR-L321::Ibrutinib
A431::VE-822
NCI-H209::PRT062607
RERF-LC-Sq1::Temozolomide
Daoy::Linsitinib
OE21::Avagacestat
COLO-800::Temozolomide
Jurkat::Doramapimod
CCK-81::I-BET-762
8-MG-BA::Temozolomide
SJRH30::Palbociclib
BT-20::Sorafenib
CAL-51::PFI-1
DMS-273::PRT062607
MZ7-mel::AZD6482
DAN-G::Palbociclib
NCI-H209::I-BET-762
RCC-JF::Sorafenib
MDST8::VE-822
SCC-15::Avagacestat
SBC-5::RVX-208
LB996-RCC::Palbociclib
JHH-1::VE-822
FLO-1::PRT062607
HCC1428::RVX-208
SIG-M5::Dactolisib
Calu-3::Lapatinib
NCI-H2009::Linsitinib
HCC-827::Avagacestat
NB5::Ibrutinib
PCI-6A::Palbociclib
CHSA8926::Sorafenib
SK-N-DZ::Palbociclib
DJM-1::Osimertinib
CHP-126::Temozolomide
LCLC-103H::Dactolisib
CAL-62::Temozolomide
CHL-1::Avagacestat
SKN::Osimertinib
NCI-H292::Palbociclib
BT-474::Palbociclib
SUP-B8::Doramapimod
769-P::Sorafenib
EKVX::Dactolisib
PC-3::Palbociclib
RCC-JW::VE-822
OPM-2::Palbociclib
HGC-27::Linsitinib
OCI-LY-19::Palbociclib
PCI-4B::Doramapimod
MDST8::Doramapimod
MHH-CALL-4::Temozolomide
SNU-449::Ibrutinib
QGP-1::RVX-208
NUGC-4::RVX-208
SW780::I-BET-762
MDA-MB-157::Linsitinib
TOV-21G::RVX-208
NCI-H522::VE-822
HPAF-II::Dactolisib
A704::Sorafenib
SK-HEP-1::Doramapimod
SUP-B8::VE-822
CCK-81::VE-822
KURAMOCHI::Ibrutinib
KYSE-140::Avagacestat
GCIY::Avagacestat
LNZTA3WT4::Doramapimod
JHH-4::Doramapimod
KYSE-220::VE-822
SW626::Sorafenib
NB17::Dactolisib
BxPC-3::Temozolomide
MOLT-16::Sorafenib
LU-134-A::Temozolomide
NCI-H1944::I-BET-762
RPMI-7951::Temozolomide
L-363::VE-822
YH-13::Sorafenib
HCC2218::PFI-1
HTC-C3::Sorafenib
OSC-19::Dactolisib
SW684::PFI-1
SNU-61::RVX-208
DSH1::PFI-1
SK-MEL-5::Temozolomide
ST486::Lapatinib
U251::Dactolisib
OV-17R::Temozolomide
SK-GT-4::VE-822
SK-MM-2::RVX-208
EFM-192A::Dactolisib
EKVX::SL0101
PC-3::RVX-208
Saos-2::Ibrutinib
TE-441-T::Avagacestat
SU-DHL-10::Sorafenib
OVMIU::PFI-1
TE-4::Doramapimod
ALL-SIL::Dactolisib
DBTRG-05MG::RVX-208
RPMI-8866::PRT062607
NCI-H647::PRT062607
5637::Sorafenib
DOV13::Doramapimod
NCI-H2444::PRT062607
TGBC1TKB::Temozolomide
HCC1187::PFI-1
KALS-1::I-BET-762
EoL-1-cell::Temozolomide
PSN1::Ibrutinib
HO-1-N-1::Avagacestat
23132-87::Osimertinib
KARPAS-45::I-BET-762
RF-48::I-BET-762
NCI-H292::PFI-1
ALL-SIL::PFI-1
SW626::Palbociclib
LB647-SCLC::Dactolisib
A431::Avagacestat
EKVX::VE-822
HT-115::Sorafenib
PSN1::Temozolomide
NCI-H727::Ibrutinib
NCI-H446::I-BET-762
DU-4475::Dactolisib
THP-1::PRT062607
8-MG-BA::Ibrutinib
NCI-H2122::Palbociclib
SAT::Dactolisib
MOLT-4::PFI-1
OE19::I-BET-762
MDA-MB-361::Doramapimod
HO-1-N-1::Doramapimod
IPC-298::Palbociclib
PCI-30::Temozolomide
MZ7-mel::Dactolisib
NB14::Lapatinib
ES8::Sorafenib
SF539::Lapatinib
KNS-81-FD::Avagacestat
A3-KAW::I-BET-762
HT-1080::Sorafenib
KON::IOX2
H9::RVX-208
ST486::PRT062607
MES-SA::Doramapimod
KP-N-YN::Temozolomide
NCI-H1105::Osimertinib
OCI-AML3::Lapatinib
LoVo::Avagacestat
OVMIU::Ibrutinib
SW620::Osimertinib
NCI-H1694::PRT062607
COR-L32::Ibrutinib
IM-9::PFI-1
KMRC-20::Palbociclib
SW1088::Ibrutinib
U-87-MG::VE-822
KOSC-2::Osimertinib
MPP-89::VE-822
Detroit562::I-BET-762
G-MEL::Osimertinib
SNU-423::PRT062607
D-336MG::Palbociclib
A388::Doramapimod
HCC1599::Ibrutinib
EoL-1-cell::Ibrutinib
SAT::Avagacestat
CESS::Dactolisib
COLO-668::Osimertinib
COLO-792::VE-822
FTC-133::Linsitinib
SK-HEP-1::Linsitinib
ES4::Lapatinib
MDST8::Ibrutinib
IA-LM::Osimertinib
A4-Fuk::Osimertinib
DU-145::PFI-1
KP-2::VE-822
UACC-812::Osimertinib
MES-SA::VE-822
IST-SL2::Doramapimod
J82::Avagacestat
PL4::Osimertinib
HTC-C3::PRT062607
HOP-62::Doramapimod
NCI-H82::Osimertinib
SNU-407::Palbociclib
NCI-H28::Lapatinib
NCI-H1944::PFI-1
ChaGo-K-1::PRT062607
ETK-1::Doramapimod
COLO-829::Dactolisib
KP-2::Sorafenib
LOXIMVI::RVX-208
SW1417::Dactolisib
CHSA0011::RVX-208
SR::Ibrutinib
KOSC-2::Dactolisib
CESS::Avagacestat
EFO-27::Ibrutinib
ES-2::Palbociclib
NB5::Dactolisib
PANC-02-03::Osimertinib
BFTC-905::RVX-208
MDA-MB-436::Osimertinib
SW1710::I-BET-762
CRO-AP2::PFI-1
COLO-792::Osimertinib
YAPC::RVX-208
VCaP::Avagacestat
KYSE-70::RVX-208
D-423MG::PRT062607
SCC-25::RVX-208
VA-ES-BJ::Osimertinib
HT-29::IOX2
NCC021::PFI-1
EB-3::Ibrutinib
KM-H2::Temozolomide
MKN7::RVX-208
MEL-JUSO::I-BET-762
A2058::VE-822
MKN7::SL0101
SW684::Linsitinib
JHU-022::Temozolomide
D-392MG::Temozolomide
KYSE-510::SL0101
NCI-H2029::Sorafenib
NCI-H446::PRT062607
RL95-2::Lapatinib
HO-1-N-1::PRT062607
KYSE-220::Linsitinib
RS4-11::Lapatinib
LU-99A::Ibrutinib
NCI-H810::I-BET-762
MOLT-13::Sorafenib
COLO-680N::Lapatinib
LN-18::Dactolisib
NCI-H441::Temozolomide
KYSE-50::I-BET-762
NCI-H2444::RVX-208
OS-RC-2::Osimertinib
MDA-MB-468::VE-822
HCC2218::PRT062607
CAL-148::PFI-1
L-1236::Osimertinib
AU565::PRT062607
NEC8::Sorafenib
HCC-366::Ibrutinib
HH::RVX-208
BICR22::Temozolomide
NCI-H810::Osimertinib
JHOS-2::VE-822
JJN-3::Avagacestat
TE-441-T::Lapatinib
KNS-81-FD::Palbociclib
TE-441-T::SL0101
SK-MEL-3::Linsitinib
IST-MEL1::Doramapimod
COLO-680N::Avagacestat
GR-ST::Dactolisib
EW-16::Osimertinib
HT-29::VE-822
LU-99A::Osimertinib
A204::RVX-208
EB-3::Palbociclib
SNG-M::Doramapimod
MDA-MB-436::AZD6482
MV-4-11::Lapatinib
Becker::PFI-1
BL-41::PRT062607
NCI-H2087::Temozolomide
NB13::Linsitinib
JHH-6::Palbociclib
RL95-2::Temozolomide
HCC-366::Linsitinib
TE-10::Lapatinib
K2::Dactolisib
SW48::Palbociclib
SBC-3::PRT062607
SW1088::VE-822
SK-ES-1::Linsitinib
SCC-15::Sorafenib
EW-7::Palbociclib
23132-87::Sorafenib
NCI-H64::Linsitinib
HCC-827::I-BET-762
SN12C::PRT062607
451Lu::Osimertinib
CA46::Linsitinib
OCI-LY7::SL0101
COLO-829::Avagacestat
UACC-893::Ibrutinib
KNS-81-FD::Temozolomide
PANC-03-27::Sorafenib
OCUM-1::Linsitinib
PCI-4B::Lapatinib
CAL-33::PFI-1
TE-1::PFI-1
NCI-H226::Temozolomide
MKN28::Doramapimod
IMR-5::Sorafenib
NCI-H2030::Lapatinib
LN-405::Temozolomide
MEG-01::Lapatinib
DMS-114::Temozolomide
SW620::Sorafenib
BICR10::Dactolisib
D-336MG::PRT062607
DU-4475::Sorafenib
NCI-H2170::Palbociclib
ROS-50::PFI-1
U-2-OS::SL0101
D-247MG::PFI-1
AN3-CA::Doramapimod
SU-DHL-1::Palbociclib
TC-71::Doramapimod
OVCAR-8::Temozolomide
SCC-25::Lapatinib
RVH-421::Temozolomide
MOLT-16::Avagacestat
HT-29::Doramapimod
NCI-H720::RVX-208
COLO-320-HSR::PFI-1
ZR-75-30::Sorafenib
OCI-LY-19::Sorafenib
RERF-LC-Sq1::PFI-1
G-361::Avagacestat
KYSE-520::Doramapimod
L-428::PRT062607
BT-483::Sorafenib
UWB1.289::Palbociclib
RCM-1::RVX-208
MFE-296::VE-822
KYSE-140::Doramapimod
SW13::Avagacestat
IMR-5::Dactolisib
Hs-578-T::RVX-208
RKO::I-BET-762
OVISE::Palbociclib
NCI-H838::PFI-1
ES-2::Osimertinib
HCC1187::VE-822
SK-MEL-5::AZD6482
ES4::Ibrutinib
DG-75::PRT062607
KS-1::Ibrutinib
JHH-1::Ibrutinib
SNU-423::RVX-208
RCC10RGB::RVX-208
TE-11::RVX-208
NB6::IOX2
KYSE-410::Ibrutinib
TK10::Temozolomide
NCI-H1703::Avagacestat
KMS-11::I-BET-762
NB17::Temozolomide
AN3-CA::Linsitinib
ESO26::Avagacestat
KMRC-1::Osimertinib
NB6::RVX-208
JiyoyeP-2003::Ibrutinib
EFO-27::RVX-208
NB17::SL0101
RPMI-8866::Palbociclib
MDA-MB-415::RVX-208
DOK::Ibrutinib
CAL-51::Dactolisib
MS751::Lapatinib
A375::PRT062607
OV-17R::Palbociclib
RXF393::Osimertinib
JJN-3::PRT062607
A498::Osimertinib
NCI-H2052::Sorafenib
HL-60::I-BET-762
NCI-H23::I-BET-762
FU97::Sorafenib
HTC-C3::RVX-208
MN-60::Doramapimod
EB2::Temozolomide
KASUMI-1::Sorafenib
HuP-T3::Dactolisib
CHP-212::Osimertinib
CHSA0011::Dactolisib
WSU-DLCL2::Doramapimod
EFO-27::Osimertinib
DMS-79::Doramapimod
SK-OV-3::Dactolisib
OVCAR-3::Avagacestat
U-2-OS::Temozolomide
HC-1::Avagacestat
NCI-H441::Osimertinib
TGW::PFI-1
NCI-H250::Palbociclib
NB10::PFI-1
H4::Ibrutinib
EKVX::PFI-1
Hs-445::Osimertinib
MN-60::Palbociclib
MSTO-211H::RVX-208
NOMO-1::Sorafenib
COLO-783::IOX2
EW-22::PRT062607
HDLM-2::Lapatinib
TOV-21G::PRT062607
PANC-03-27::PFI-1
ES6::Osimertinib
DMS-53::VE-822
RERF-LC-MS::Doramapimod
RERF-LC-Sq1::Avagacestat
NCI-H64::Sorafenib
NCI-H1755::Sorafenib
HuP-T4::PRT062607
HPAF-II::PRT062607
PA-TU-8988T::I-BET-762
RC-K8::PFI-1
HT-29::PRT062607
TGBC1TKB::PFI-1
NCI-H322M::Osimertinib
RERF-LC-KJ::RVX-208
G-401::Lapatinib
NCI-H69::Linsitinib
EFO-27::Temozolomide
HCC1143::Sorafenib
HCC-44::Palbociclib
HL-60::Lapatinib
NCC021::I-BET-762
G-MEL::Dactolisib
SK-CO-1::Osimertinib
YT::Dactolisib
LB2241-RCC::Lapatinib
KURAMOCHI::Doramapimod
A431::Linsitinib
KU-19-19::Sorafenib
MG-63::Osimertinib
KG-1::Lapatinib
CAL-12T::PFI-1
ES-2::Sorafenib
WSU-NHL::Sorafenib
OSC-19::AZD6482
NB10::Sorafenib
SIMA::Sorafenib
TK10::PFI-1
COLO-680N::VE-822
KYSE-220::Avagacestat
NOS-1::Osimertinib
COLO-680N::PRT062607
SW1271::Temozolomide
NB14::Doramapimod
SCH::Palbociclib
HMV-II::Dactolisib
EW-18::Sorafenib
SW962::Doramapimod
HAL-01::Linsitinib
NCI-H1944::Linsitinib
NUGC-4::Dactolisib
HCT-15::Lapatinib
CADO-ES1::Dactolisib
HCC1569::Sorafenib
CL-11::Dactolisib
EB2::Dactolisib
CHP-212::Dactolisib
NCI-H2030::Osimertinib
BC-1::VE-822
no-11::Temozolomide
SK-MES-1::PFI-1
SCC90::Avagacestat
BPH-1::Dactolisib
SW756::Ibrutinib
SCC-3::PFI-1
C-33-A::Dactolisib
HT55::Dactolisib
Caov-4::Avagacestat
CW-2::Palbociclib
RERF-LC-Sq1::Sorafenib
NCI-H250::SL0101
SW756::Sorafenib
JHH-2::PFI-1
KYSE-270::Linsitinib
ML-2::PRT062607
KELLY::RVX-208
HTC-C3::Avagacestat
RCC-FG2::VE-822
BICR22::Doramapimod
SW13::Ibrutinib
647-V::I-BET-762
CRO-AP2::Avagacestat
SW962::Linsitinib
MS751::I-BET-762
LAN-6::VE-822
SCC-4::RVX-208
KATOIII::Temozolomide
HCC1937::PRT062607
NCI-H835::Temozolomide
HCC1954::Osimertinib
NMC-G1::Linsitinib
NCI-H1793::Temozolomide
TE-1::Osimertinib
FTC-133::VE-822
PANC-02-03::Linsitinib
RD::Linsitinib
LB2241-RCC::Doramapimod
IST-MES1::Temozolomide
EW-3::PFI-1
MKN1::Avagacestat
NCI-H1770::Osimertinib
IST-MEL1::Avagacestat
LN-229::Lapatinib
Hey::Dactolisib
MDA-MB-468::Osimertinib
LB373-MEL-D::Avagacestat
CAL-85-1::VE-822
KURAMOCHI::Palbociclib
RCC-JF::Temozolomide
U-118-MG::Osimertinib
COR-L23::Dactolisib
SNB75::I-BET-762
SNB75::Osimertinib
MHH-NB-11::Doramapimod
IA-LM::Palbociclib
ESO26::RVX-208
EN::PFI-1
LC4-1::Temozolomide
NCI-H2291::VE-822
SF126::Linsitinib
RCC-FG2::Lapatinib
HT-29::Sorafenib
HEC-1::Avagacestat
KYSE-220::Doramapimod
OCI-LY-19::Osimertinib
EM-2::RVX-208
TCCSUP::I-BET-762
RH-1::VE-822
NCI-H2085::Doramapimod
U-87-MG::RVX-208
OACp4C::Linsitinib
LC4-1::PRT062607
OSC-20::Palbociclib
MOLP-8::Palbociclib
OVK-18::Doramapimod
HCT-116::RVX-208
WM-115::Linsitinib
AsPC-1::Avagacestat
EN::Ibrutinib
OCUB-M::Palbociclib
HCC1187::Temozolomide
DOHH-2::VE-822
NCI-H250::PRT062607
A704::Linsitinib
NCI-H2085::I-BET-762
HGC-27::PRT062607
BFTC-905::Osimertinib
PA-TU-8988T::PRT062607
GI-1::PRT062607
IST-SL1::SL0101
HCT-15::Linsitinib
KYM-1::PRT062607
HCC2157::Doramapimod
Saos-2::Sorafenib
SK-UT-1::VE-822
KMS-11::Ibrutinib
NCI-H2342::Palbociclib
PANC-08-13::Osimertinib
KYSE-270::Temozolomide
LOU-NH91::VE-822
STS-0421::SL0101
TE-1::Ibrutinib
SKG-IIIa::I-BET-762
OSC-19::Osimertinib
HCC1143::PRT062607
NCI-H292::Linsitinib
Raji::PFI-1
647-V::Doramapimod
NCI-H1155::Doramapimod
ASH-3::Temozolomide
HT-3::Avagacestat
MDST8::Avagacestat
UACC-257::Lapatinib
KARPAS-299::VE-822
CAKI-1::Ibrutinib
CAMA-1::Temozolomide
SKN-3::Dactolisib
SNB75::Linsitinib
VA-ES-BJ::I-BET-762
PL-21::Avagacestat
BHT-101::I-BET-762
FLO-1::Palbociclib
NB6::Palbociclib
WM278::RVX-208
LB647-SCLC::Osimertinib
MDST8::PRT062607
OSC-20::Osimertinib
SKM-1::Temozolomide
SW1463::Sorafenib
D-502MG::Lapatinib
OE19::Avagacestat
NCI-H510A::AZD6482
GA-10::Palbociclib
LU-139::Doramapimod
